dbACP: A Comprehensive Database of Anti-Cancer Peptides

2862 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp00028 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 14.2% inhibition at 10-6 M
dbacp00029 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 19.7% inhibition at 10-5 M
dbacp00030 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 24.9% inhibition at 10-4 M
dbacp00031 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 30.4% inhibition at 10-3 M
dbacp00032 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 10% inhibition at 10-5 M
dbacp00033 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 8.2% inhibition at 10-4 M
dbacp00034 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 36.1% inhibition at 10-3 M
dbacp00035 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 6.5% inhibition at 10-6 M
dbacp00036 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 14% inhibition at 10-5 M
dbacp00037 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 7.5% inhibition at 10-4 M
dbacp00038 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 14% inhibition at 10-3 M
dbacp00039 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 9.8% inhibition at 10-6 M
dbacp00040 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 1.6% inhibition at 10-5 M
dbacp00041 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 5.4% inhibition at 10-4 M
dbacp00042 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 26.5% inhibition at 10-3 M
dbacp00043 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 12.9% inhibition at 10-6 M
dbacp00044 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 16.5% inhibition at 10-5 M
dbacp00045 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 28.1% inhibition at 10-4 M
dbacp00046 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 58.2% inhibition at 10-3 M
dbacp00047 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 3.5% inhibition at 10-6 M
dbacp00048 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 22.7% inhibition at 10-5 M
dbacp00049 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 18.9% inhibition at 10-4 M
dbacp00050 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 26.4% inhibition at 10-3 M
dbacp00051 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 2.4% inhibition at 10-5 M
dbacp00052 Enkephalins7 analogue-8 YA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 7.5% inhibition at 10-4 M
dbacp00053 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 6.2% inhibition at 10-6 M
dbacp00054 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 6.4% inhibition at 10-5 M
dbacp00055 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 8.2% inhibition at 10-4 M
dbacp00056 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 21.2% inhibition at 10-3 M
dbacp00057 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 7.5% inhibition at 10-6 M
dbacp00058 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 6.1% inhibition at 10-5 M
dbacp00059 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 3.1% inhibition at 10-4 M
dbacp00060 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 14.8% inhibition at 10-3 M
dbacp00061 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 3.9% inhibition at 10-5 M
dbacp00062 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 7.3% inhibition at 10-3 M
dbacp00063 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 4.9% inhibition at 10-6 M
dbacp00064 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 8.9% inhibition at 10-5 M
dbacp00065 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 3.4% inhibition at 10-4 M
dbacp00066 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 20.8% inhibition at 10-3 M
dbacp00067 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 10.5% inhibition at 10-6 M
dbacp00068 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 21.9% inhibition at 10-5 M
dbacp00069 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 11.8% inhibition at 10-4 M
dbacp00070 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 17.9% inhibition at 10-3 M
dbacp00071 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 3.7% inhibition at 10-6 M
dbacp00072 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 16.5% inhibition at 10-5 M
dbacp00073 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 8.4% inhibition at 10-4 M
dbacp00074 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 14.5% inhibition at 10-3 M
dbacp00075 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 1.1% inhibition at 10-5 M
dbacp00076 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 1.2% inhibition at 10-4 M
dbacp00077 Enkephalins7 analogue-9 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 17.8% inhibition at 10-3 M
dbacp00078 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 8.5% inhibition at 10-6 M
dbacp00079 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 4.9% inhibition at 10-5 M
dbacp00080 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 1.9% inhibition at 10-4 M
dbacp00081 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 16.2% inhibition at 10-3 M
dbacp00082 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 7.2% inhibition at 10-6 M
dbacp00083 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 17.1% inhibition at 10-5 M
dbacp00084 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 11.0% inhibition at 10-4 M
dbacp00085 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 20.5% inhibition at 10-3 M
dbacp00086 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 3.0% inhibition at 10-6 M
dbacp00087 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 4.7% inhibition at 10-5 M
dbacp00088 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 2.7% inhibition at 10-4 M
dbacp00089 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 7.3% inhibition at 10-3 M
dbacp00090 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 0.7% inhibition at 10-6 M
dbacp00091 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 8.3% inhibition at 10-5 M
dbacp00092 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 10.5% inhibition at 10-4 M
dbacp00093 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 21.8% inhibition at 10-3 M
dbacp00094 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 10.7% inhibition at 10-6 M
dbacp00095 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 10.0% inhibition at 10-5 M
dbacp00096 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 7.7% inhibition at 10-4 M
dbacp00097 Enkephalins7 analogue-10 YSA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 18.7% inhibition at 10-3 M
dbacp00125 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 2.7% inhibition at 10-6 M
dbacp00126 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 2.0% inhibition at 10-5 M
dbacp00127 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 18.8% inhibition at 10-4 M
dbacp00128 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 26.7% inhibition at 10-3 M
dbacp00129 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 9.8% inhibition at 10-6 M
dbacp00130 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 7.3% inhibition at 10-5 M
dbacp00131 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 9.9% inhibition at 10-4 M
dbacp00132 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 28.2% inhibition at 10-3 M
dbacp00133 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 1.6% inhibition at 10-6 M
dbacp00134 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 2.9% inhibition at 10-5 M
dbacp00135 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 5.9% inhibition at 10-4 M
dbacp00136 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 17.9% inhibition at 10-3 M
dbacp00137 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 5.4% inhibition at 10-6 M
dbacp00138 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 7.4% inhibition at 10-5 M
dbacp00139 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 9.5% inhibition at 10-4 M
dbacp00140 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 15.7% inhibition at 10-3 M
dbacp00141 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 13.6% inhibition at 10-6 M
dbacp00142 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 20.4% inhibition at 10-5 M
dbacp00143 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 14.4% inhibition at 10-4 M
dbacp00144 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 23.4% inhibition at 10-3 M
dbacp00145 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 2.2% inhibition at 10-6 M
dbacp00146 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 4.2% inhibition at 10-5 M
dbacp00147 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 6.4% inhibition at 10-4 M
dbacp00148 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 6.2% inhibition at 10-3 M
dbacp00149 Enkephalins7 analogue-15 YSA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 21.2% inhibition at 10-3 M
dbacp00159 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 4.6% inhibition at 10-6 M
dbacp00160 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 4.9% inhibition at 10-5 M
dbacp00161 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 12.6% inhibition at 10-4 M
dbacp00162 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 26.4% inhibition at 10-3 M
dbacp00163 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 11.0% inhibition at 10-6 M
dbacp00164 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 11.7% inhibition at 10-5 M
dbacp00165 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 11.6% inhibition at 10-4 M
dbacp00166 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 28.2% inhibition at 10-3 M
dbacp00167 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 1.2% inhibition at 10-5 M
dbacp00168 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 3.3% inhibition at 10-4 M
dbacp00169 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 19.4% inhibition at 10-3 M
dbacp00170 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 7.6% inhibition at 10-6 M
dbacp00171 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 3.8% inhibition at 10-5 M
dbacp00172 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 12.4% inhibition at 10-4 M
dbacp00173 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 22.4% inhibition at 10-3 M
dbacp00174 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 17.0% inhibition at 10-6 M
dbacp00175 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 13.5% inhibition at 10-5 M
dbacp00176 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 13.5% inhibition at 10-4 M
dbacp00177 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 25.3% inhibition at 10-3 M
dbacp00178 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 8.1% inhibition at 10-6 M
dbacp00179 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 6.9% inhibition at 10-5 M
dbacp00180 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 8.1% inhibition at 10-4 M
dbacp00181 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 8.6% inhibition at 10-3 M
dbacp00182 Enkephalins7 analogue-16 YRA*G Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 15.6% inhibition at 10-3 M
dbacp00192 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 1.0% inhibition at 10-6 M
dbacp00193 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 10.1% inhibition at 10-5 M
dbacp00194 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 16.8% inhibition at 10-4 M
dbacp00195 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 36.1% inhibition at 10-3 M
dbacp00196 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 4.9% inhibition at 10-6 M
dbacp00197 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 10.2% inhibition at 10-5 M
dbacp00198 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 13.3% inhibition at 10-4 M
dbacp00199 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 28.0% inhibition at 10-3 M
dbacp00200 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 0.8% inhibition at 10-6 M
dbacp00201 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 1.4% inhibition at 10-5 M
dbacp00202 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 2.4% inhibition at 10-4 M
dbacp00203 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 18.3% inhibition at 10-3 M
dbacp00204 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 3.3% inhibition at 10-6 M
dbacp00205 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 11.0% inhibition at 10-5M
dbacp00206 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 7.9% inhibition at 10-4 M
dbacp00207 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 23.7% inhibition at 10-3 M
dbacp00208 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 12.2% inhibition at 10-6 M
dbacp00209 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 15.5% inhibition at 10-5 M
dbacp00210 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 24.7% inhibition at 10-4 M
dbacp00211 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 29.0% inhibition at 10-3 M
dbacp00212 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 3.0% inhibition at 10-6 M
dbacp00213 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 8.4% inhibition at 10-5 M
dbacp00214 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 18.5% inhibition at 10-4 M
dbacp00215 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 10.6% inhibition at 10-3 M
dbacp00216 Enkephalins7 analogue-17 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 22.8% inhibition at 10-3 M
dbacp00226 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 13.7% inhibition at 10-6 M
dbacp00227 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 25.8% inhibition at 10-5 M
dbacp00228 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 34.7% inhibition at 10-4 M
dbacp00229 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 44.5% inhibition at 10-3 M
dbacp00230 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 8.5% inhibition at 10-6 M
dbacp00231 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 9.5% inhibition at 10-5 M
dbacp00232 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 15.4% inhibition at 10-4 M
dbacp00233 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 24.1% inhibition at 10-3 M
dbacp00234 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 2.4% inhibition at 10-6 M
dbacp00235 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 4.5% inhibition at 10-5 M
dbacp00236 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 11.4% inhibition at 10-4 M
dbacp00237 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 23.2% inhibition at 10-3 M
dbacp00238 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 16.2% inhibition at 10-6 M
dbacp00239 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 6.6% inhibition at 10-5 M
dbacp00240 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 5.1% inhibition at 10-4 M
dbacp00241 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 14.5% inhibition at 10-3 M
dbacp00242 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 26.4% inhibition at 10-6 M
dbacp00243 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 13.1% inhibition at 10-5 M
dbacp00244 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 14.6% inhibition at 10-4 M
dbacp00245 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay SW-620 Colon cancer 38.4% inhibition at 10-3 M
dbacp00246 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 17.7% inhibition at 10-6 M
dbacp00247 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 10.9% inhibition at 10-5 M
dbacp00248 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 12.1% inhibition at 10-4 M
dbacp00249 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 8.1% inhibition at 10-3 M
dbacp00250 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 9.6% inhibition at 10-4 M
dbacp00251 Enkephalins7 analogue-18 YA*GFM Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 29.9% inhibition at 10-3 M
dbacp00279 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 3.9% inhibition at 10-5 M
dbacp00280 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HEp-2 Larynx cancer 45% inhibition at 10-3 M
dbacp00281 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HeLa Cervical cancer 9.3% inhibition at 10-3 M
dbacp00282 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 4.1% inhibition at 10-6 M
dbacp00283 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 70.7% inhibition at 10-5 M
dbacp00284 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HBL Skin cancer 34.4% inhibition at 10-3 M
dbacp00285 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay HT-29 Colon cancer 9.2% inhibition at 10-3 M
dbacp00286 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 11.08% inhibition at 10-5 M
dbacp00287 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay CaCo-2 Colon cancer 47.0% inhibition at 10-3 M
dbacp00288 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 2.2% inhibition at 10-6 M
dbacp00289 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 7.1% inhibition at 10-5 M
dbacp00290 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 6.9% inhibition at 10-4 M
dbacp00291 Enkephalins7 analogue-23 YGGFMA* Synthetic Peptide Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer 25.9% inhibition at 10-3 M
dbacp00301 (cpm)-1285 KNLWAAQRYGRELRRMSDEFEGSFKGL BH3-only, Sensizers (BAD, HRK, Noxa) Apoptosis inducing Not specified HL-60 Various cancers Not found
dbacp00302 (cpm)-1285 KNLWAAQRYGRELRRMSDEFEGSFKGL BH3-only, Sensizers (BAD, HRK, Noxa) Apoptosis inducing Not specified PBL Various cancers Not found
dbacp00303 Temporin-SHf FFFLSRIF* Sahara frog Apoptosis inducing MTT assay A549 Not specified IC50 : 24.03 ± 0.945 µM
dbacp00304 Temporin-SHf FFFLSRIF* Sahara frog Apoptosis inducing MTT assay MCF-7 Not specified IC50 : 32.76 ± 1.528 µM
dbacp00305 Temporin-SHf FFFLSRIF* Sahara frog Apoptosis inducing MTT assay HepG2 Not specified IC50 : 32.64 ± 1.350 µM
dbacp00306 Temporin-SHf FFFLSRIF* Sahara frog Apoptosis inducing MTT assay PC3 Not specified IC50 : 36.67 ± 0.729 µM
dbacp00308 (ATAP) Amphipathic tail-anchoring peptide of Bfl-1 KFEPKSGWMTFLEVTGKICEMLSLLKQYC Anti apoptotic (MCL-1, BFL1) Apoptosis inducing Not specified HeLa Not found Not found
dbacp00309 (Bl- LAAO) L-amino acid oxidases (L-AAO) ADDRNPLEECFRETDYEEFLEIAKNGLSTT Venom base Apoptosis inducing MTT assay MKN-45 Stomach cancer Not found
dbacp00310 (Bl- LAAO) L-amino acid oxidases (L-AAO) ADDRNPLEECFRETDYEEFLEIAKNGLSTT Venom base Apoptosis inducing MTT assay HUTU Adenocarcinoma Not found
dbacp00311 (Bl- LAAO) L-amino acid oxidases (L-AAO) ADDRNPLEECFRETDYEEFLEIAKNGLSTT Venom base Apoptosis inducing MTT assay RKO Colorectal cancer Not found
dbacp00318 (RGD-4C)-GG-D(KLAKLAK)2 ACDCRGDCFCGGKLAKLAKKLAKLAK Synthetic Peptide Apoptosis inducing Internalization assay,Mitochondrial swelling assay,Cell-free apoptosis assay,Caspase activation assay KS1767 Not specified LC50 : 10 μM
dbacp00701 072RB DMRPEIYI(Aib)QELRRIGDAFN(Aib)YRQIKIWFQNRRMKWKK BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Jurkat Leukemia Not found
dbacp00702 072RB DMRPEIYI(Aib)QELRRIGDAFN(Aib)YRQIKIWFQNRRMKWKK BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Namalwa Leukemia Not found
dbacp00703 072RB DMRPEIYI(Aib)QELRRIGDAFN(Aib)YRQIKIWFQNRRMKWKK BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified U937 Leukemia Not found
dbacp00704 10a NA Synthetic b2,2-amino acid derivatives Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 28 µM
dbacp00705 10b NA Synthetic b2,2-amino acid derivatives Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 11.4 µM
dbacp00706 10c NA Synthetic b2,2-amino acid derivatives Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 6.6 µM
dbacp00707 11a NA Synthetic b2,2-amino acid derivatives Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 5.2 µM
dbacp00708 11b NA Synthetic b2,2-amino acid derivatives Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 19 µM
dbacp00709 11c NA Synthetic b2,2-amino acid derivatives Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 7.2 µM
dbacp00710 12a NA Synthetic b2,2-amino acid derivatives Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 6.1 µM
dbacp00711 12b NA Synthetic b2,2-amino acid derivatives Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 27 µM
dbacp00712 12c NA Synthetic b2,2-amino acid derivatives Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 14 µM
dbacp00718 2XAkt-in VTDHPDRLWAWEKGGGVTDHPDRLWAWEK Not found Inducing apoptosis Cell death assay T4 Leukemia Not found
dbacp00719 3A LTAEHYAAQATS Not found Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : >100 µM
dbacp00722 5a NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 10.6 µM
dbacp00723 5b NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 7.1 µM
dbacp00724 5c NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 4.1 µM
dbacp00725 6,7-dimethyl-8-ribityllumazine synthase 2 MNQSCPNKTSFKIAFIQARWHADIVDEARKSFVAELAAKTGGSVEVEIFDVPGAYEIPLHAKTLARTGRYAAIVGAAFVIDGGIYRHDFVATAVINGMMQVQLETEVPVLSVVLTPHHFHESKEHHDFFHAHFKVKGVEAAHAALQIVSERSRIAALV Not found Apoptosis inducing Apoptosis assay B16 Melanoma Not found
dbacp00727 6a NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 14.4 µM
dbacp00728 6b NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 11.0 µM
dbacp00729 6c NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 4.3 µM
dbacp00730 7a NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : >63 µM
dbacp00731 7b NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : >78 µM
dbacp00732 7c NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 79 µM
dbacp00733 8a NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 136 µM
dbacp00734 8b NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : >254 µM
dbacp00735 8c NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 107 µM
dbacp00736 9a NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 31 µM
dbacp00737 9b NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 2.3 µM
dbacp00738 9c NA Not found Induction of apoptosis; Disruption of cell membrane MTT/MTS assay Ramos Lymphoma cancer IC50 : 3.1 µM
dbacp00739 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay LNCaP Prostate cancer IC50 : 44 µM
dbacp00740 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay LNCaP Prostate cancer IC50 : 23 µM
dbacp00741 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay LNCaP Prostate cancer IC50 : 28 µM
dbacp00742 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay MDA-MB-231 Breast cancer IC50 : 39 µM
dbacp00743 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay MDA-MB-231 Breast cancer IC50 : 29 µM
dbacp00744 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay MDA-MB-231 Breast cancer IC50 : 16 µM
dbacp00745 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay HUT-102 Lymphoma cancer IC50 : 93 µM
dbacp00746 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay HUT-102 Lymphoma cancer IC50 : 39 µM
dbacp00747 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay HUT-102 Lymphoma cancer IC50 : 37 µM
dbacp00748 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay HUT-102 Lymphoma cancer IC50 : 36 µM
dbacp00749 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay HUT-102 Lymphoma cancer IC50 : 25 µM
dbacp00750 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay J774A.1 Tumor IC50 : 47 µM
dbacp00751 9R RRRRRNWMWC Not found Cell membrane disintegration; Apoptosis MTT/MTS assay J774A.1 Tumor IC50 : 12 µM
dbacp00752 9S1R RRRRRWCMNW Not found Cell membrane disintegration; Apoptosis MTT/MTS assay LNCaP Prostate cancer IC50 : 26 µM
dbacp00753 9S1R RRRRRWCMNW Not found Cell membrane disintegration; Apoptosis MTT/MTS assay LNCaP Prostate cancer IC50 : 9 µM
dbacp00754 9S1R RRRRRWCMNW Not found Cell membrane disintegration; Apoptosis MTT/MTS assay LNCaP Prostate cancer IC50 : 8 µM
dbacp00755 9S1R RRRRRWCMNW Not found Cell membrane disintegration; Apoptosis MTT/MTS assay MDA-MB-231 Breast cancer IC50 : 18 µM
dbacp00756 9S1R RRRRRWCMNW Not found Cell membrane disintegration; Apoptosis MTT/MTS assay MDA-MB-231 Breast cancer IC50 : 12 µM
dbacp00757 9S1R RRRRRWCMNW Not found Cell membrane disintegration; Apoptosis MTT/MTS assay MDA-MB-231 Breast cancer IC50 : 10 µM
dbacp00758 9S1R RRRRRWCMNW Not found Cell membrane disintegration; Apoptosis MTT/MTS assay HUT-102 Lymphoma cancer IC50 : 38 µM
dbacp00759 9S1R RRRRRWCMNW Not found Cell membrane disintegration; Apoptosis MTT/MTS assay HUT-102 Lymphoma cancer IC50 : 43 µM
dbacp00760 9S1R RRRRRWCMNW Nullomer derived anticancer peptides (NulloPs) Cell membrane disintegration; Apoptosis MTT/MTS assay HUT-102 Lymphoma cancer IC50 : 43 µM
dbacp00761 9S1R RRRRRWCMNW Nullomer derived anticancer peptides (NulloPs) Cell membrane disintegration; Apoptosis MTT/MTS assay HUT-102 Lymphoma cancer IC50 : 45 µM
dbacp00762 9S1R RRRRRWCMNW Nullomer derived anticancer peptides (NulloPs) Cell membrane disintegration; Apoptosis MTT/MTS assay HUT-102 Lymphoma cancer IC50 : 36 µM
dbacp00763 9S1R RRRRRWCMNW Nullomer derived anticancer peptides (NulloPs) Cell membrane disintegration; Apoptosis MTT/MTS assay J774A.1 Tumor IC50 : 26 µM
dbacp00764 9S1R RRRRRWCMNW Nullomer derived anticancer peptides (NulloPs) Cell membrane disintegration; Apoptosis MTT/MTS assay J774A.1 Tumor IC50 : 17 µM
dbacp00771 A12 RPEIWMGQGLRRLGDEINAYYAR BH3-only, Direct activators, BIM analogues Apoptosis inducing Not specified Mcl-1/Myc 2640 Not found Not found
dbacp00772 A12 RPEIWMGQGLRRLGDEINAYYAR BH3-only, Direct activators, BIM analogues Apoptosis inducing Not specified Bcl-2/Myc 2924 Not found Not found
dbacp00813 A5 KAQIRAMECNIL Cyclin B (285-296) Apoptosis inducing MTT/MTS assay HCT-116 Colon cancer Not found
dbacp00814 AAD (or Aa-Pri1) MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVYPSDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYWECPWGSKRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN Purified from chestnut mushroom Apoptosis inducing MTT/MTS assay HepG-2 Liver cancer At 2.5 µM concentration,decrease in cell vibility: 35%
dbacp00815 AAD (or Aa-Pri1) MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVYPSDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYWECPWGSKRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN Purified from chestnut mushroom Apoptosis inducing MTT/MTS assay HeLa Cervical cancer At 2.5 µM concentration,decrease in cell vibility: 70%
dbacp00816 AAD (or Aa-Pri1) MDSNKDERAYAQWVIIILHNVGSSPFKIANLGLSWGKLYADGNKDKEVYPSDYNGKTVGPDEKIQINSCGRENASSGTEGSFDIVDPNDGNKTIRHFYWECPWGSKRNTWTPSGSNTKWMVEWSGQNLDSGALGTITVDVLRKGN Purified from chestnut mushroom Apoptosis inducing MTT/MTS assay SH-SY5Y Brain tumor At 2.5 µM concentration,decrease in cell vibility: 70%
dbacp00833 AAP-H YVPGP Marine invertebrates Apoptosis inducing MTT assay DU-145 Prostate cancer IC50 : 9.605 mM
dbacp00834 AAP-H YVPGP Marine invertebrates Apoptosis inducing MTT assay DU-146 Prostate cancer IC50 : 7.910 mM
dbacp00835 AAP-H YVPGP Marine invertebrates Apoptosis inducing MTT assay DU-147 Prostate cancer IC50 : 2.298 mM
dbacp00951 ABP-dHC-Cecropin A RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKALGK Synthetic construct Apoptosis inducing MTT assay K562 cells Leukemia IC50 : 349.5 μM
dbacp00952 ABP-dHC-Cecropin A RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKALGK Synthetic construct Apoptosis inducing MTT assay U937 cells Leukemia IC50 : 303.2 μM
dbacp00953 ABP-dHC-Cecropin A RWKIFKKIERVGQNVRDGIIKAGPAIQVLGTAKALGK Synthetic construct Apoptosis inducing MTT assay THP-1 cells Leukemia IC50 : 228.5 μM
dbacp00954 ABP-dHC-Cecropin A-K RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK Synthetic construct Apoptosis inducing MTT assay K562 cells Leukemia IC50 : 349.5 μM
dbacp00955 ABP-dHC-Cecropin A-K RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK Synthetic construct Apoptosis inducing MTT assay U937 cells Leukemia IC50 : 303.2 μM
dbacp00956 ABP-dHC-Cecropin A-K RWKIFKKIERVGQNVRDGIIKAGKAIQVLGTAKALGK Synthetic construct Apoptosis inducing MTT assay THP-1 cells Leukemia IC50 : 228.5 μM
dbacp00962 ACL LAO L-amino acid oxidase(LAO) ADSRNPLEEEFRETNYEEF Venom base Apoptosis inducing HL-60 cell culture assay HL-60 Not specified Not found
dbacp00991 AKPF dimer, Smac-1 (AKPF-NH2)2 SMAC Inducing apoptosis Not specified MDA-MB-231 Not specified IC50 : 3.93 ± 1.1 nM
dbacp00992 Akt-in AVTDHPDRLWAWEKF Not found Inducing apoptosis Co-immunoprecipitation, GST Pull-down,GST Competition, In Vitro Akt Kinase, PKA Kinase, In Vitro PDK1 Kinase, PtdIns(3,4,5)P3 Lipid-Protein Pull-down, Proliferation assay, Cell Death assay and Mitochondrial Permeability Transition assay T4 T-cell Leukemia Not found
dbacp01144 Ansalvamide A NA Marine fungus, Wilt of banana Apoptosis inducing Not specified COLO 205 Colorectal cancer IC50 : 3.5 µg/mL
dbacp01145 Ansalvamide A NA Marine fungus, Wilt of banana Apoptosis inducing Not specified SKMEL-2 Melanoma cells IC50 : 5.9 µg/mL
dbacp01146 Ansalvamide A NA Marine fungus, Wilt of banana Apoptosis inducing Not specified HCT-116 Colon cancer IC50 : 9.8 µg/mL
dbacp01147 Ant-Bad RQIKIWFQNRRMKWKKNLWAAQRYGRELRRMSDEFVD BH3-only, Sensizers (BAD, HRK, Noxa) Apoptosis inducing Not specified 1483 Head and neck squamous cell carcinomas (HNSCC) IC50 : 24.8 µM
dbacp01148 Ant-Bad RQIKIWFQNRRMKWKKNLWAAQRYGRELRRMSDEFVD BH3-only, Sensizers (BAD, HRK, Noxa) Apoptosis inducing Not specified UM-22A Head and neck squamous cell carcinomas (HNSCC) IC50 : 18.3 µM
dbacp01149 Ant-Bad RQIKIWFQNRRMKWKKNLWAAQRYGRELRRMSDEFVD BH3-only, Sensizers (BAD, HRK, Noxa) Apoptosis inducing Not specified UM-22B Head and neck squamous cell carcinomas (HNSCC) IC50 : 40.2 µM
dbacp01150 Ant-Bak RQIKIWFQNRRMKWKKMGQVGRQLAIIGDDINRRY Effectors (BAK, BAX) Apoptosis inducing Not specified 1483 Head and neck squamous cell carcinomas (HNSCC) IC50 : 32.9 µM
dbacp01151 Ant-Bak RQIKIWFQNRRMKWKKMGQVGRQLAIIGDDINRRY Effectors (BAK, BAX) Apoptosis inducing Not specified UM-22A Head and neck squamous cell carcinomas (HNSCC) IC50 : 82 µM
dbacp01152 Ant-Bak RQIKIWFQNRRMKWKKMGQVGRQLAIIGDDINRRY Effectors (BAK, BAX) Apoptosis inducing Not specified UM-22B Head and neck squamous cell carcinomas (HNSCC) IC50 : > 100 µM
dbacp01153 Ant-Bax RQIKIWFQNRRMKWKKSTKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Apoptosis inducing Not specified 1483 Head and neck squamous cell carcinomas (HNSCC) IC50 : 18.2 µM
dbacp01154 Ant-Bax RQIKIWFQNRRMKWKKSTKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Apoptosis inducing Not specified UM-22A Head and neck squamous cell carcinomas (HNSCC) IC50 : 45.5 µM
dbacp01155 Ant-Bax RQIKIWFQNRRMKWKKSTKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Apoptosis inducing Not specified UM-22B Head and neck squamous cell carcinomas (HNSCC) IC50 : > 100 µM
dbacp01156 Ant-p53pep GSRAHSSHLKSKKGQSTSRHKKWKMRRNQFWVKVQRG Not found Apoptosis inducing Annexin V-FITC Binding assay MDA-MB-468 Breast cancer IC50 : 30 µM
dbacp01157 Anthopleura anjunae anti-tumor peptide YVPGP Sea anemone anti-tumor peptide Apoptosis inducing MTT Cell Proliferation and Cytotoxicity assay DU-145 Prostate cancer IC50 : 9.605 μM
dbacp01158 Anticancer bioactive peptide NA Goat spleen Apoptosis inducing Cell proliferation assay HCT116 Human Colorectal cancer IC50 : 35 μg/mL
dbacp01172 Antp-LP4 RQIKIWFQNRRMKWKKSWTWEKKLETAVNLAWTAGNSNKWTWK VDAC1(voltage-dependent anion channel1) Apoptosis inducing Not specified CLL Leukemia IC50 : 0.7 ± 0.1 µM
dbacp01173 Antp-LP4 RQIKIWFQNRRMKWKKSWTWEKKLETAVNLAWTAGNSNKWTWK VDAC1(voltage-dependent anion channel1) Apoptosis inducing Not specified MEC-1 Leukemia IC50 : 2.5 ± 0.1 µM
dbacp01193 ATAP-iRGD peptide-Parental KFEPKSGWMTFLEVTGKIAEMLSLLKQYCRGDKGPDC Anti apoptotic (MCL-1, BFL1) Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 : 1.6 μM
dbacp01194 ATAP-iRGD-M1 AFEPKSGWMTFLEVTGKIAEMLSLLKQYCRGDKGPDC Anti apoptotic (MCL-1, BFL1) Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 : 36 μM
dbacp01195 ATAP-iRGD-M2 LFEPKSGWMTFLEVTGKIAEMLSLLKQYCRGDKGPDC Anti apoptotic (MCL-1, BFL1) Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 : 68 μM
dbacp01196 ATAP-iRGD-M3 KFEPLSGWMTFLEVTGKIAEMLSLLKQYCRGDKGPDC Anti apoptotic (MCL-1, BFL1) Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 : 25 μM
dbacp01197 ATAP-iRGD-M5 KFEPKSGWETFLEVTGKIAEMLSLLKQYCRGDKGPDC Anti apoptotic (MCL-1, BFL1) Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 : 6 μM
dbacp01198 ATAP-iRGD-M6 KKFEPKSGWMTFLEVTGKIAEMLSLLKQYCRGDKGPDC Anti apoptotic (MCL-1, BFL1) Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 : 3.1 μM
dbacp01199 ATAP-iRGD-M7 KFEPKSGWMTFLEVTGKIAEMLSLLKQYCRGDKGPDC Anti apoptotic (MCL-1, BFL1) Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 : 2.1 μM
dbacp01200 ATAP-iRGD-M8 KKFEPKSGWMTFLEVTGKIAEMLSLLKQYCRGDKGPDC Anti apoptotic (MCL-1, BFL1) Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 : 2.1 μM
dbacp01438 B3 RPEIWLGQSLQRLGDEINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Mcl-1/Myc 2640 Not found Not found
dbacp01439 B3 RPEIWLGQSLQRLGDEINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Bcl-2/Myc 2924 Not found Not found
dbacp01441 BAA-2 NA Bovine lactoferrin (Lf-B) Apoptosis inducing MTT/MTS assay Ramos Lymphoma cancer IC50 : 3.8 µg/ml
dbacp01442 Baceridin cyclo(L-Trp-D-Ala-D-allo-Ile-L-Val-D-Leu-L-Leu-) Synthetic construct Apoptosis inducing MTT assay HCT116 Not specified Not found
dbacp01443 Baceridin cyclo(L-Trp-D-Ala-D-allo-Ile-L-Val-D-Leu-L-Leu-) Synthetic construct Apoptosis inducing MTT assay RKO Not specified Not found
dbacp01444 Baceridin cyclo(L-Trp-D-Ala-D-allo-Ile-L-Val-D-Leu-L-Leu-) Synthetic construct Apoptosis inducing MTT assay HeLa Not specified Not found
dbacp01445 Baceridin WAIVLL Plant-associated rod-shaped, Gram-positive bacteria Apoptosis inducing MTT assay HCT116 Not specified Not found
dbacp01446 Baceridin WAIVLL Plant-associated rod-shaped, Gram-positive bacteria Apoptosis inducing MTT assay RKO Not specified Not found
dbacp01447 Baceridin WAIVLL Plant-associated rod-shaped, Gram-positive bacteria Apoptosis inducing MTT assay HeLa Not specified Not found
dbacp01448 Bad LWAAQRYGRELRRMSDEFEGSFKGL BH3-only, Sensizers (BAD, HRK, Noxa) Apoptosis inducing Not specified Not found Not specified Not found
dbacp01449 Bad LWAAQRYGRELRRMSDEFVDSFKK BH3-only, Sensizers (BAD, HRK, Noxa) Apoptosis inducing Not specified Not found Not found Not found
dbacp01450 Bad a NLWAARYGRELRRMSDKFVD BH3-only, Sensizers (BAD, HRK, Noxa) Apoptosis inducing Not specified Not found Not found Not found
dbacp01451 Bassianolide nonribosomal cyclodepsipeptide synthetase MEPPNNANTGQLGPTLPNGTVDLPTDLSREITRHFGLEQDEIEEILPCTPFQRDVIECASDDKRRAVGHVVYEIPEDVDTERLAAAWKATVRYTPALRTCIFTSETGNAFQVVLRDYFIFARMYCPSAHLKSAIVKDEATAAVAGPRCNRYVLTGEPNSKRRVLVWTFSHSFVDSAFQGRILQQVLAAYKDGHGRVFSLQPTTDLTESENGDHLSTPASERTVVIERATQFWQEKLHGLDASVFPHLPSHKRVPAIDARADHYLPCPPFIQHEWSSTTVCRTALAILLARYTHSSEALFGVVTEQSHEEHPLLLDGPTSTVVPFRVLCALNQSVSKVMEAITTYDHDMRQFAHAGLCNISRIGDDASAACGFQTVLMVTDSRTAGDDEIHQVLEESEKFIPCTDRALLLSCQMTDEGVLLVARYDQSILEPLQMARFLRQLGFLINKLQSTDGSPCVGQLDVLAPEDRTEIEGWNSEPLQTQDCLIHSEVVRNAGDTPNKPAVCAWDGEWTYSELNNVSSRLASYISSLDLGQQLIVPIYLEKSKWVMAAILAVLKAGHAFTLIDPNDPPARTAQIIKQASASIALTSALHQSKMQAVVGRCITVDDDLVQTLTTFEGSQVASAAKPGDLAYVIFTSGSTGDPKGIMIEHRAFYSSVVKFGKALGIRSSTRALQFATHGFGAFLLEVLTTLIHGGCICVPSDHDRMHNIPGFIRQNQINWMMATPSYMTTMKPEDVPGLETLVLVGEQMSSSINDVWLSELQLLDGYGQSESSSICFVGKIDDSSRDPNNLGWAIGAHSWIINPDNPDQLVPIGAIGELLIESPGIARGYLFSQSTETPFLERAPAWYASKQPPYGVKFYRTGDLARYAPDGTVICLGRMDSQVKIRGQRVELDAIENLLRRQFPSDVTVVAEAVKRSDLPSSVVITGFLISSEYVVGAPSTEDTYILDQVVTQEINAKMRQILPAHSIPSFYICMKSLPRTATGKVDRRKLRSIGSSLLALQAQSTAPRSSQAPDASAGVTKLEEVWMDIFNLTPNSHNIGGNFFALGGDSITAIKMVnMARAAGIQLKVSDIFQNPTLASLQAAIGGSSMTVTSIPALALDGPVEQSYSQGRLWFLDQLEIGANWYTIPYAVRLRGPLDVDALNRALLALEKRHETLRTTFEDQDGVGVQIIHETLLDQLRIINADHADYVQLLKQEQTAPFNLASESGWRVSLIRLDDDDNILSIVMHHIISDGWSIDVLRRELGQLYAAALHGADLFGSALSPLPIQYRDFSVWQKQDAQVAEHERQLQYWQKQLADCSPAKLPTDFHRPALLSGKATTVPVTITSELYYRLQEFCSTFNTTSFVVLLATFRAAHYRLTGVDDAVIGTPIANRNRHELENLIGFFVNTQCMRITINEDEDTFESLVRQVRSTTTAAFEHEDVPFERVVSAMLPGSRDLSQNPLAQLVFAIHSHKDLGKFELEALESEPLQNEVYTRFDAEFHFFQAPDGLTGYINFATELFKVETIQNVVSVFLQILRHGLEHPQTLISVVPLTDGLAELRSMGLLEIKKVEYPRDSSVVDVFRTQVASYPDTLAVVDSSSRLTYAELDHQSDLLATWLRQQNLPTEALVVVLAPRSCETIITFLGILKANLAYLPLDIRSPITRMRDVLSTLPGRTIALLCSDEVAPDFQLPSIELVRIADALEEAAGMTSLNGHEHVPVPSPSPTSLAYVLYTSGSTGRPKGVMIEHRAIVRLARSDIIPDYRPACGDTMAHMFNTAFDGATYEIYTMLLNGGTLVCVDYMDTLSPKSLEAVFKKEQVNATIMAPALLKLYLADARDALKGLDVLISGGDRFDPQDAVDAQSLVRGSCYNGYGPTENGVFSTVYKVDKNDPFVNGVPLGRAVNNSGAYVVDRNQQLVGPGIIGELVVTGDGLARGYTERAFDQNRFTQLKVEGQSVRGYRTGDRVRYRVGEGLIEFFGRMDFQFKIRSNRIEAGEVEAAILSHPAVRNAAVILRVEEKLEPEIVGFVVAEHDDTAEQEEAGDQVEGWQAFFESTTYTELDTVSSSEIGKDFKGWTSMYDGNEIDKAEMQEWLDDTIHTLTDGQALGHVLEIGTGSGMVLFNLGSGLQSFVGLEPSKSAAAFVNNAIKSTPALAGKAQVFVGTATDTNKLDDLHPDLVIFNSVLQYFPTRDYLERVVDALVHLRSAKRIFFGDVRSYATNRHFLAARAIYTLGNHTTKDEVRKKMAEMEEREEEFLVEPAFFTTLVNRLPDVRHVEIIPKnMQATNELSAYRYAAVVHLRGSDELTRPVHPIKMDDWVDFQASHMHKDALREYLRLAENTKTVAISNIPYGKTIFERQVVESLDETSEDAPHASLDGAAWISAVRSDAKARSSLSVPDLVLLAKETGFRVEVSAARQWSQSGALDAVFHRYPAEPGVRTLFQFPTDNDVRMSAPLTNQPLQRLQKRRVAVQVREWLQDRIPSYMIPSHIVALDQMPLNTSGKVDRKELSRQAKAIKKVQKSAPPTAPAFPLSEVEVMLCEELTKTFEMDVNITDDFFQLGGHSLLATRLVARISHRLGARLTVKDVFDYPVFSELADIIRQQLASKNTLLPTASAGGGGQDKKESAGVAPTTDMEAMLCEEFANILGMDVGITDNFFDLGGHSLMATRLAARIGHRLNTTISVKDIFSHPVIFQLSAKLEVSQLESSSGGTDIKMPDYTAFQLIPAADAEKFMQDHIYPQINFSQDMVQDVYLATHLQQCFLRDVFGRPKPLVPFYVEFPPDSNPHTLATACTSLVDKYDIFRTIFVEAEGNLYQVVLKHLNLDIDVVETDANVHKTSSDLVDAIAKEPVRLGQPMIQVKVLKQTSSVRVLLWLSHALYDGLSWEHIVRDLHILSKERSLPPATQFSRYMQYVDHTRGPGCDFWRDVLQNAPITNLSDAGSGGRPTKAGDPRVWHAGKVISGPSQAIRSSITQATVFNAACAIVLSKETGTDNVVFGRIVSGRQGLPVRWQNIIGPCTNAVPVRAVVDAHGNHQQMLRDLQEQYLLSLPYETIGFDEIKRSCTDWPDSARNYGCCVTYQNFEYHPESEVDQQRVEMGILAKKAELIKEEPLYNVAIAGEVEPDGVHLQVTVVVDSQLFSQEGATHLMEQVCNTFQALNASL White muscardine disease fungus Cell apoptosis Not specified PC-3M Prostate cancer Not found
dbacp01452 Bassianolide nonribosomal cyclodepsipeptide synthetase MEPPNNANTGQLGPTLPNGTVDLPTDLSREITRHFGLEQDEIEEILPCTPFQRDVIECASDDKRRAVGHVVYEIPEDVDTERLAAAWKATVRYTPALRTCIFTSETGNAFQVVLRDYFIFARMYCPSAHLKSAIVKDEATAAVAGPRCNRYVLTGEPNSKRRVLVWTFSHSFVDSAFQGRILQQVLAAYKDGHGRVFSLQPTTDLTESENGDHLSTPASERTVVIERATQFWQEKLHGLDASVFPHLPSHKRVPAIDARADHYLPCPPFIQHEWSSTTVCRTALAILLARYTHSSEALFGVVTEQSHEEHPLLLDGPTSTVVPFRVLCALNQSVSKVMEAITTYDHDMRQFAHAGLCNISRIGDDASAACGFQTVLMVTDSRTAGDDEIHQVLEESEKFIPCTDRALLLSCQMTDEGVLLVARYDQSILEPLQMARFLRQLGFLINKLQSTDGSPCVGQLDVLAPEDRTEIEGWNSEPLQTQDCLIHSEVVRNAGDTPNKPAVCAWDGEWTYSELNNVSSRLASYISSLDLGQQLIVPIYLEKSKWVMAAILAVLKAGHAFTLIDPNDPPARTAQIIKQASASIALTSALHQSKMQAVVGRCITVDDDLVQTLTTFEGSQVASAAKPGDLAYVIFTSGSTGDPKGIMIEHRAFYSSVVKFGKALGIRSSTRALQFATHGFGAFLLEVLTTLIHGGCICVPSDHDRMHNIPGFIRQNQINWMMATPSYMTTMKPEDVPGLETLVLVGEQMSSSINDVWLSELQLLDGYGQSESSSICFVGKIDDSSRDPNNLGWAIGAHSWIINPDNPDQLVPIGAIGELLIESPGIARGYLFSQSTETPFLERAPAWYASKQPPYGVKFYRTGDLARYAPDGTVICLGRMDSQVKIRGQRVELDAIENLLRRQFPSDVTVVAEAVKRSDLPSSVVITGFLISSEYVVGAPSTEDTYILDQVVTQEINAKMRQILPAHSIPSFYICMKSLPRTATGKVDRRKLRSIGSSLLALQAQSTAPRSSQAPDASAGVTKLEEVWMDIFNLTPNSHNIGGNFFALGGDSITAIKMVnMARAAGIQLKVSDIFQNPTLASLQAAIGGSSMTVTSIPALALDGPVEQSYSQGRLWFLDQLEIGANWYTIPYAVRLRGPLDVDALNRALLALEKRHETLRTTFEDQDGVGVQIIHETLLDQLRIINADHADYVQLLKQEQTAPFNLASESGWRVSLIRLDDDDNILSIVMHHIISDGWSIDVLRRELGQLYAAALHGADLFGSALSPLPIQYRDFSVWQKQDAQVAEHERQLQYWQKQLADCSPAKLPTDFHRPALLSGKATTVPVTITSELYYRLQEFCSTFNTTSFVVLLATFRAAHYRLTGVDDAVIGTPIANRNRHELENLIGFFVNTQCMRITINEDEDTFESLVRQVRSTTTAAFEHEDVPFERVVSAMLPGSRDLSQNPLAQLVFAIHSHKDLGKFELEALESEPLQNEVYTRFDAEFHFFQAPDGLTGYINFATELFKVETIQNVVSVFLQILRHGLEHPQTLISVVPLTDGLAELRSMGLLEIKKVEYPRDSSVVDVFRTQVASYPDTLAVVDSSSRLTYAELDHQSDLLATWLRQQNLPTEALVVVLAPRSCETIITFLGILKANLAYLPLDIRSPITRMRDVLSTLPGRTIALLCSDEVAPDFQLPSIELVRIADALEEAAGMTSLNGHEHVPVPSPSPTSLAYVLYTSGSTGRPKGVMIEHRAIVRLARSDIIPDYRPACGDTMAHMFNTAFDGATYEIYTMLLNGGTLVCVDYMDTLSPKSLEAVFKKEQVNATIMAPALLKLYLADARDALKGLDVLISGGDRFDPQDAVDAQSLVRGSCYNGYGPTENGVFSTVYKVDKNDPFVNGVPLGRAVNNSGAYVVDRNQQLVGPGIIGELVVTGDGLARGYTERAFDQNRFTQLKVEGQSVRGYRTGDRVRYRVGEGLIEFFGRMDFQFKIRSNRIEAGEVEAAILSHPAVRNAAVILRVEEKLEPEIVGFVVAEHDDTAEQEEAGDQVEGWQAFFESTTYTELDTVSSSEIGKDFKGWTSMYDGNEIDKAEMQEWLDDTIHTLTDGQALGHVLEIGTGSGMVLFNLGSGLQSFVGLEPSKSAAAFVNNAIKSTPALAGKAQVFVGTATDTNKLDDLHPDLVIFNSVLQYFPTRDYLERVVDALVHLRSAKRIFFGDVRSYATNRHFLAARAIYTLGNHTTKDEVRKKMAEMEEREEEFLVEPAFFTTLVNRLPDVRHVEIIPKnMQATNELSAYRYAAVVHLRGSDELTRPVHPIKMDDWVDFQASHMHKDALREYLRLAENTKTVAISNIPYGKTIFERQVVESLDETSEDAPHASLDGAAWISAVRSDAKARSSLSVPDLVLLAKETGFRVEVSAARQWSQSGALDAVFHRYPAEPGVRTLFQFPTDNDVRMSAPLTNQPLQRLQKRRVAVQVREWLQDRIPSYMIPSHIVALDQMPLNTSGKVDRKELSRQAKAIKKVQKSAPPTAPAFPLSEVEVMLCEELTKTFEMDVNITDDFFQLGGHSLLATRLVARISHRLGARLTVKDVFDYPVFSELADIIRQQLASKNTLLPTASAGGGGQDKKESAGVAPTTDMEAMLCEEFANILGMDVGITDNFFDLGGHSLMATRLAARIGHRLNTTISVKDIFSHPVIFQLSAKLEVSQLESSSGGTDIKMPDYTAFQLIPAADAEKFMQDHIYPQINFSQDMVQDVYLATHLQQCFLRDVFGRPKPLVPFYVEFPPDSNPHTLATACTSLVDKYDIFRTIFVEAEGNLYQVVLKHLNLDIDVVETDANVHKTSSDLVDAIAKEPVRLGQPMIQVKVLKQTSSVRVLLWLSHALYDGLSWEHIVRDLHILSKERSLPPATQFSRYMQYVDHTRGPGCDFWRDVLQNAPITNLSDAGSGGRPTKAGDPRVWHAGKVISGPSQAIRSSITQATVFNAACAIVLSKETGTDNVVFGRIVSGRQGLPVRWQNIIGPCTNAVPVRAVVDAHGNHQQMLRDLQEQYLLSLPYETIGFDEIKRSCTDWPDSARNYGCCVTYQNFEYHPESEVDQQRVEMGILAKKAELIKEEPLYNVAIAGEVEPDGVHLQVTVVVDSQLFSQEGATHLMEQVCNTFQALNASL White muscardine disease fungus Cell apoptosis Not specified MDA-MB-231 Breast cancer Not found
dbacp01453 Bassianolide nonribosomal cyclodepsipeptide synthetase MEPPNNANTGQLGPTLPNGTVDLPTDLSREITRHFGLEQDEIEEILPCTPFQRDVIECASDDKRRAVGHVVYEIPEDVDTERLAAAWKATVRYTPALRTCIFTSETGNAFQVVLRDYFIFARMYCPSAHLKSAIVKDEATAAVAGPRCNRYVLTGEPNSKRRVLVWTFSHSFVDSAFQGRILQQVLAAYKDGHGRVFSLQPTTDLTESENGDHLSTPASERTVVIERATQFWQEKLHGLDASVFPHLPSHKRVPAIDARADHYLPCPPFIQHEWSSTTVCRTALAILLARYTHSSEALFGVVTEQSHEEHPLLLDGPTSTVVPFRVLCALNQSVSKVMEAITTYDHDMRQFAHAGLCNISRIGDDASAACGFQTVLMVTDSRTAGDDEIHQVLEESEKFIPCTDRALLLSCQMTDEGVLLVARYDQSILEPLQMARFLRQLGFLINKLQSTDGSPCVGQLDVLAPEDRTEIEGWNSEPLQTQDCLIHSEVVRNAGDTPNKPAVCAWDGEWTYSELNNVSSRLASYISSLDLGQQLIVPIYLEKSKWVMAAILAVLKAGHAFTLIDPNDPPARTAQIIKQASASIALTSALHQSKMQAVVGRCITVDDDLVQTLTTFEGSQVASAAKPGDLAYVIFTSGSTGDPKGIMIEHRAFYSSVVKFGKALGIRSSTRALQFATHGFGAFLLEVLTTLIHGGCICVPSDHDRMHNIPGFIRQNQINWMMATPSYMTTMKPEDVPGLETLVLVGEQMSSSINDVWLSELQLLDGYGQSESSSICFVGKIDDSSRDPNNLGWAIGAHSWIINPDNPDQLVPIGAIGELLIESPGIARGYLFSQSTETPFLERAPAWYASKQPPYGVKFYRTGDLARYAPDGTVICLGRMDSQVKIRGQRVELDAIENLLRRQFPSDVTVVAEAVKRSDLPSSVVITGFLISSEYVVGAPSTEDTYILDQVVTQEINAKMRQILPAHSIPSFYICMKSLPRTATGKVDRRKLRSIGSSLLALQAQSTAPRSSQAPDASAGVTKLEEVWMDIFNLTPNSHNIGGNFFALGGDSITAIKMVnMARAAGIQLKVSDIFQNPTLASLQAAIGGSSMTVTSIPALALDGPVEQSYSQGRLWFLDQLEIGANWYTIPYAVRLRGPLDVDALNRALLALEKRHETLRTTFEDQDGVGVQIIHETLLDQLRIINADHADYVQLLKQEQTAPFNLASESGWRVSLIRLDDDDNILSIVMHHIISDGWSIDVLRRELGQLYAAALHGADLFGSALSPLPIQYRDFSVWQKQDAQVAEHERQLQYWQKQLADCSPAKLPTDFHRPALLSGKATTVPVTITSELYYRLQEFCSTFNTTSFVVLLATFRAAHYRLTGVDDAVIGTPIANRNRHELENLIGFFVNTQCMRITINEDEDTFESLVRQVRSTTTAAFEHEDVPFERVVSAMLPGSRDLSQNPLAQLVFAIHSHKDLGKFELEALESEPLQNEVYTRFDAEFHFFQAPDGLTGYINFATELFKVETIQNVVSVFLQILRHGLEHPQTLISVVPLTDGLAELRSMGLLEIKKVEYPRDSSVVDVFRTQVASYPDTLAVVDSSSRLTYAELDHQSDLLATWLRQQNLPTEALVVVLAPRSCETIITFLGILKANLAYLPLDIRSPITRMRDVLSTLPGRTIALLCSDEVAPDFQLPSIELVRIADALEEAAGMTSLNGHEHVPVPSPSPTSLAYVLYTSGSTGRPKGVMIEHRAIVRLARSDIIPDYRPACGDTMAHMFNTAFDGATYEIYTMLLNGGTLVCVDYMDTLSPKSLEAVFKKEQVNATIMAPALLKLYLADARDALKGLDVLISGGDRFDPQDAVDAQSLVRGSCYNGYGPTENGVFSTVYKVDKNDPFVNGVPLGRAVNNSGAYVVDRNQQLVGPGIIGELVVTGDGLARGYTERAFDQNRFTQLKVEGQSVRGYRTGDRVRYRVGEGLIEFFGRMDFQFKIRSNRIEAGEVEAAILSHPAVRNAAVILRVEEKLEPEIVGFVVAEHDDTAEQEEAGDQVEGWQAFFESTTYTELDTVSSSEIGKDFKGWTSMYDGNEIDKAEMQEWLDDTIHTLTDGQALGHVLEIGTGSGMVLFNLGSGLQSFVGLEPSKSAAAFVNNAIKSTPALAGKAQVFVGTATDTNKLDDLHPDLVIFNSVLQYFPTRDYLERVVDALVHLRSAKRIFFGDVRSYATNRHFLAARAIYTLGNHTTKDEVRKKMAEMEEREEEFLVEPAFFTTLVNRLPDVRHVEIIPKnMQATNELSAYRYAAVVHLRGSDELTRPVHPIKMDDWVDFQASHMHKDALREYLRLAENTKTVAISNIPYGKTIFERQVVESLDETSEDAPHASLDGAAWISAVRSDAKARSSLSVPDLVLLAKETGFRVEVSAARQWSQSGALDAVFHRYPAEPGVRTLFQFPTDNDVRMSAPLTNQPLQRLQKRRVAVQVREWLQDRIPSYMIPSHIVALDQMPLNTSGKVDRKELSRQAKAIKKVQKSAPPTAPAFPLSEVEVMLCEELTKTFEMDVNITDDFFQLGGHSLLATRLVARISHRLGARLTVKDVFDYPVFSELADIIRQQLASKNTLLPTASAGGGGQDKKESAGVAPTTDMEAMLCEEFANILGMDVGITDNFFDLGGHSLMATRLAARIGHRLNTTISVKDIFSHPVIFQLSAKLEVSQLESSSGGTDIKMPDYTAFQLIPAADAEKFMQDHIYPQINFSQDMVQDVYLATHLQQCFLRDVFGRPKPLVPFYVEFPPDSNPHTLATACTSLVDKYDIFRTIFVEAEGNLYQVVLKHLNLDIDVVETDANVHKTSSDLVDAIAKEPVRLGQPMIQVKVLKQTSSVRVLLWLSHALYDGLSWEHIVRDLHILSKERSLPPATQFSRYMQYVDHTRGPGCDFWRDVLQNAPITNLSDAGSGGRPTKAGDPRVWHAGKVISGPSQAIRSSITQATVFNAACAIVLSKETGTDNVVFGRIVSGRQGLPVRWQNIIGPCTNAVPVRAVVDAHGNHQQMLRDLQEQYLLSLPYETIGFDEIKRSCTDWPDSARNYGCCVTYQNFEYHPESEVDQQRVEMGILAKKAELIKEEPLYNVAIAGEVEPDGVHLQVTVVVDSQLFSQEGATHLMEQVCNTFQALNASL White muscardine disease fungus Cell apoptosis Not specified HUVEC-2 Prostate cancer Not found
dbacp01454 Bassianolide nonribosomal cyclodepsipeptide synthetase (BSLS) MEPPNNANTGQLGPTLPNGTVDLPTDLSREITRHFGLEQDEIEEILPCTPFQRDVIECASDDKRRAVGHVVYEIPEDVDTERLAAAWKATVRYTPALRTCIFTSETGNAFQVVLRDCFIFARMYCPSAHLKSAIVKDEATAAVAGPRCNRYVLTGEPNSKRRVLVWTFSHSFVDSAFQGRILQQVLAAYKDEHGRVFSLQPTTDLVESENGDCLSTPASERTVGIERATQFWQEKLHGLDASVFPHLPSHKRVPAIDARADHYLPCPPFIQHEWSSTTVCRTALAILLARYTHSSEALFGVVTEQSHEEHPLLLDGPTSTVVPFRVLCAPNQSVSEVMEAITTYDHDMRQFAHAGLCNISRIGDDASAACGFQTVLMVTDSRTASADEIHHVLEEPEKFIPCTDRALLLSCQMTDEGVLLVARYDQSILEPLQMARFLRQLGFLINKLQSTDGSPCVGQLDVLAPEDRTEIEGWNSEPLQTQDCLIHSEVVKNADDTPNKPAVCAWDGEWTYSELNNVSSRLASYISSLDLGQQLIVPIYLEKSKWVMAAILAVLKAGHAFTLIDPNDPPARTAQIIKQASASIALTSALHQSKMQTVVGRCITVDDDLFQTLTTFEGSQVASAAKPGDLAYVIFTSGSTGDPKGIMIEHRAFYSSVVKFGKALGIRSSTRALQFATHGFGAFLLEVLTTLIHGGCICIPSDHDRMHNIPGFIRQSQINWMMATPSYMTTMKPEDVPGLETLVLVGEQMSSSINDVWLSELQLLDGYGQSESSSICFVGKISDSSRDPNNLGRAIGSHSWIVNPDNPDQLVPIGAIGELLIESPGIARGYLFSQSTETPFLERAPAWYASKQPPYGVKFYRTGDLARYAPDGTVICLGRMDSQVKIRGQRVELDAIENLLRRQFPSDVTVVAEAVKRSDLPSSVVITGFLISSEYVVGAPSTEDTYILDQAVTQEINAKMRQILPAHSIPSFYICMKSLPRTATGKVDRRKLRSIGSSLLALQAQSTAPRSSQAPDASAGVTKLEEVWMDIFNLTPNSHNIGGNFFALGGDSITAIKMVnMARAAGIQLKVSDIFQNPTLASLQAAIGGSSMTVTSIPALALDGPVEQSYSQGRLWFLDQLEIGANWYTIPYAVRLRGPLDVDALNRALLALEKRHETLRTTFEDQDGVGVQIIHETLLDQLRIINADHADYVQLLKQEQTAPFNLASESGWRVSLIRLDDDDNILSIVMHHIISDGWSIDVLRRELGQLYAAALHGADLFGSALSPLPIQYRDFSVWQKQDAQVAEHERQLQYWQKQLADCSPAKLPTDFHRPALLSGKATTVPVTITSELYYRLQEFCSTFNTTSFVVLLATFRAAHYRLTGVDDAVIGTPIANRNRHELENLIGFFVNTQCMRITINEDEETFESLVRQVRSTTTAAFEHEDVPFERVVSAMLPGSRDLSQNPLAQLVFAIHSHKDLGKFELEALESEPLQNEVYTRFDAEFHFFQAPDGLTGYINFATELFKVETIQNVVSVFLQILRHGLEHPQTLISVVPLTDGLAELRSMGLLEIKKVEYPRDSSVVDVFATQVASYPDTLAVVDSSSRLTYAELDHQSDLLATWLRQQNLPTEALVVVLAPRSCETIITFLGILKANLAYLPLDIRSPITRMRDVLSTLPGRTIALLCSDEVAPDFQLPSIELVRIADALEEAAGMTSLNGHEHVPVPSPSPTSLAYVLYTSGSTGRPKGVMIEHRAIVRLARSDIIPDYRPACGDTMAHMFNTAFDGATYEIYTMLLNGGTLVCVDYMDTLSPKSLEAVFKKEQVNATIMAPALLKLYLADARDALKGLDVLISGGDRFDPQDAVDAQSLVRGSCYNGYGPTENGVFSTVYKVDKNDPFVNGVPLGRAVNNSGAYVVDRNQQLVGPGIIGELVVTGDGLARGYTERAFDQNRFIQLKIEGQSVRGYRTGDRVRYRVGEGLIEFFGRMDFQFKIRSNRIEAGEVEAAILSHPAVRNAAVILHVQEKLEPEIVGFVVAEHDDTAEQEEAGDQVEGWQAFFESTTYTELDTVSSSEIGKDFKGWTSMYDGNEIDKAEMQEWLDDTIHTLTDGQALGHVLEIGTGSGMVLFNLGSGLQSFVGLEPSKSAAAFVNNAIKSTPALAGKAHVFVGTATDTNKLDDLHPDLVIFNSVLQYFPTRDYLEQVVDALVHLRSAKRIFFGDVRSYATNRHFLAARAIYTLGNHTTKDEVRKKMAEMEEREEEFLVEPAFFTTLVNRLPDVRHVEIIPKnMQATNELSAYRYAAVVHLRGPDELTRPVHLIKMDDWVDFQASHMHKDALREYLRLAENTKTVAISNIPYGKTIFERQVVESLDDTSEDAPHASLDGAAWISAVRSDAKARSSLSVPDLVLLAKETGFRVEVSAARQWSQSGALDAVFHRYHPAEPDVRTLFQFPTDNDVRMSALLTNQPLQRLQKRRVAVQVREWLQDRIPSYMIPSHIVALDQMPLNTSGKVDRKELSRQAKAIKKVQKSAPPTAPAFPLSEVEVMLCEELTKTFEMDVNITDDFFQLGGHSLLATRLVARISHRLGARLTVKDVFDYPVFSELADIIRQQLASKNTLLPTASAGGGGQDKKESAGVAPTTDMEAMLCEEFANILGMDVGITDNFFDLGGHSLMATRLAARIGHRLNTTISVKDIFSHPVIFQLSAKLEVSQLESSSGGTDIKMPDYTAFQLIPAADAEKFMQDHIYPQINFSQDMVQDVYLATHLQQCFLRDVFGRPKPLVPFYVEFPPDSNPHTLATACTSLVDKYDIFRTIFVEAEGNLYQVVLKHLNLDIDVVETDANVHKTSSDLVDAIAKEPVRLGQPMIQVKVLKQTSSVRVLLWLSHALYDGLSWEHIVRDLHILSKERSLPPATQFSRYMQYVDHTRGPGCDFWRDVLQNAPITNLSDAGSGGRPTKAGDPRVWHAGKVISGPSQAIRSSITQATVFNAACAIVLSKETGTDNVVFGRIVSGRQGLPVRWQNIIGPCTNAVPVRAVVDAHGNHQQMLRDLQEQYLLSLPYETIGFDEIKRSCTDWPDSARNYGCCVTYQNFEYHPESEVDQQRVEMGILAKKAELIKEEPLYNVAIAGEVEPDGVHLQVTVVVDSQLFSQEGATHLMEQVCNTFQALNASL White muscardine disease fungus Cell apoptosis Not specified PC-3M Prostate cancer Not found
dbacp01455 Bassianolide nonribosomal cyclodepsipeptide synthetase (BSLS) MEPPNNANTGQLGPTLPNGTVDLPTDLSREITRHFGLEQDEIEEILPCTPFQRDVIECASDDKRRAVGHVVYEIPEDVDTERLAAAWKATVRYTPALRTCIFTSETGNAFQVVLRDCFIFARMYCPSAHLKSAIVKDEATAAVAGPRCNRYVLTGEPNSKRRVLVWTFSHSFVDSAFQGRILQQVLAAYKDEHGRVFSLQPTTDLVESENGDCLSTPASERTVGIERATQFWQEKLHGLDASVFPHLPSHKRVPAIDARADHYLPCPPFIQHEWSSTTVCRTALAILLARYTHSSEALFGVVTEQSHEEHPLLLDGPTSTVVPFRVLCAPNQSVSEVMEAITTYDHDMRQFAHAGLCNISRIGDDASAACGFQTVLMVTDSRTASADEIHHVLEEPEKFIPCTDRALLLSCQMTDEGVLLVARYDQSILEPLQMARFLRQLGFLINKLQSTDGSPCVGQLDVLAPEDRTEIEGWNSEPLQTQDCLIHSEVVKNADDTPNKPAVCAWDGEWTYSELNNVSSRLASYISSLDLGQQLIVPIYLEKSKWVMAAILAVLKAGHAFTLIDPNDPPARTAQIIKQASASIALTSALHQSKMQTVVGRCITVDDDLFQTLTTFEGSQVASAAKPGDLAYVIFTSGSTGDPKGIMIEHRAFYSSVVKFGKALGIRSSTRALQFATHGFGAFLLEVLTTLIHGGCICIPSDHDRMHNIPGFIRQSQINWMMATPSYMTTMKPEDVPGLETLVLVGEQMSSSINDVWLSELQLLDGYGQSESSSICFVGKISDSSRDPNNLGRAIGSHSWIVNPDNPDQLVPIGAIGELLIESPGIARGYLFSQSTETPFLERAPAWYASKQPPYGVKFYRTGDLARYAPDGTVICLGRMDSQVKIRGQRVELDAIENLLRRQFPSDVTVVAEAVKRSDLPSSVVITGFLISSEYVVGAPSTEDTYILDQAVTQEINAKMRQILPAHSIPSFYICMKSLPRTATGKVDRRKLRSIGSSLLALQAQSTAPRSSQAPDASAGVTKLEEVWMDIFNLTPNSHNIGGNFFALGGDSITAIKMVnMARAAGIQLKVSDIFQNPTLASLQAAIGGSSMTVTSIPALALDGPVEQSYSQGRLWFLDQLEIGANWYTIPYAVRLRGPLDVDALNRALLALEKRHETLRTTFEDQDGVGVQIIHETLLDQLRIINADHADYVQLLKQEQTAPFNLASESGWRVSLIRLDDDDNILSIVMHHIISDGWSIDVLRRELGQLYAAALHGADLFGSALSPLPIQYRDFSVWQKQDAQVAEHERQLQYWQKQLADCSPAKLPTDFHRPALLSGKATTVPVTITSELYYRLQEFCSTFNTTSFVVLLATFRAAHYRLTGVDDAVIGTPIANRNRHELENLIGFFVNTQCMRITINEDEETFESLVRQVRSTTTAAFEHEDVPFERVVSAMLPGSRDLSQNPLAQLVFAIHSHKDLGKFELEALESEPLQNEVYTRFDAEFHFFQAPDGLTGYINFATELFKVETIQNVVSVFLQILRHGLEHPQTLISVVPLTDGLAELRSMGLLEIKKVEYPRDSSVVDVFATQVASYPDTLAVVDSSSRLTYAELDHQSDLLATWLRQQNLPTEALVVVLAPRSCETIITFLGILKANLAYLPLDIRSPITRMRDVLSTLPGRTIALLCSDEVAPDFQLPSIELVRIADALEEAAGMTSLNGHEHVPVPSPSPTSLAYVLYTSGSTGRPKGVMIEHRAIVRLARSDIIPDYRPACGDTMAHMFNTAFDGATYEIYTMLLNGGTLVCVDYMDTLSPKSLEAVFKKEQVNATIMAPALLKLYLADARDALKGLDVLISGGDRFDPQDAVDAQSLVRGSCYNGYGPTENGVFSTVYKVDKNDPFVNGVPLGRAVNNSGAYVVDRNQQLVGPGIIGELVVTGDGLARGYTERAFDQNRFIQLKIEGQSVRGYRTGDRVRYRVGEGLIEFFGRMDFQFKIRSNRIEAGEVEAAILSHPAVRNAAVILHVQEKLEPEIVGFVVAEHDDTAEQEEAGDQVEGWQAFFESTTYTELDTVSSSEIGKDFKGWTSMYDGNEIDKAEMQEWLDDTIHTLTDGQALGHVLEIGTGSGMVLFNLGSGLQSFVGLEPSKSAAAFVNNAIKSTPALAGKAHVFVGTATDTNKLDDLHPDLVIFNSVLQYFPTRDYLEQVVDALVHLRSAKRIFFGDVRSYATNRHFLAARAIYTLGNHTTKDEVRKKMAEMEEREEEFLVEPAFFTTLVNRLPDVRHVEIIPKnMQATNELSAYRYAAVVHLRGPDELTRPVHLIKMDDWVDFQASHMHKDALREYLRLAENTKTVAISNIPYGKTIFERQVVESLDDTSEDAPHASLDGAAWISAVRSDAKARSSLSVPDLVLLAKETGFRVEVSAARQWSQSGALDAVFHRYHPAEPDVRTLFQFPTDNDVRMSALLTNQPLQRLQKRRVAVQVREWLQDRIPSYMIPSHIVALDQMPLNTSGKVDRKELSRQAKAIKKVQKSAPPTAPAFPLSEVEVMLCEELTKTFEMDVNITDDFFQLGGHSLLATRLVARISHRLGARLTVKDVFDYPVFSELADIIRQQLASKNTLLPTASAGGGGQDKKESAGVAPTTDMEAMLCEEFANILGMDVGITDNFFDLGGHSLMATRLAARIGHRLNTTISVKDIFSHPVIFQLSAKLEVSQLESSSGGTDIKMPDYTAFQLIPAADAEKFMQDHIYPQINFSQDMVQDVYLATHLQQCFLRDVFGRPKPLVPFYVEFPPDSNPHTLATACTSLVDKYDIFRTIFVEAEGNLYQVVLKHLNLDIDVVETDANVHKTSSDLVDAIAKEPVRLGQPMIQVKVLKQTSSVRVLLWLSHALYDGLSWEHIVRDLHILSKERSLPPATQFSRYMQYVDHTRGPGCDFWRDVLQNAPITNLSDAGSGGRPTKAGDPRVWHAGKVISGPSQAIRSSITQATVFNAACAIVLSKETGTDNVVFGRIVSGRQGLPVRWQNIIGPCTNAVPVRAVVDAHGNHQQMLRDLQEQYLLSLPYETIGFDEIKRSCTDWPDSARNYGCCVTYQNFEYHPESEVDQQRVEMGILAKKAELIKEEPLYNVAIAGEVEPDGVHLQVTVVVDSQLFSQEGATHLMEQVCNTFQALNASL White muscardine disease fungus Cell apoptosis Not specified MDA-MB-231 Breast cancer Not found
dbacp01456 Bassianolide nonribosomal cyclodepsipeptide synthetase (BSLS) MEPPNNANTGQLGPTLPNGTVDLPTDLSREITRHFGLEQDEIEEILPCTPFQRDVIECASDDKRRAVGHVVYEIPEDVDTERLAAAWKATVRYTPALRTCIFTSETGNAFQVVLRDCFIFARMYCPSAHLKSAIVKDEATAAVAGPRCNRYVLTGEPNSKRRVLVWTFSHSFVDSAFQGRILQQVLAAYKDEHGRVFSLQPTTDLVESENGDCLSTPASERTVGIERATQFWQEKLHGLDASVFPHLPSHKRVPAIDARADHYLPCPPFIQHEWSSTTVCRTALAILLARYTHSSEALFGVVTEQSHEEHPLLLDGPTSTVVPFRVLCAPNQSVSEVMEAITTYDHDMRQFAHAGLCNISRIGDDASAACGFQTVLMVTDSRTASADEIHHVLEEPEKFIPCTDRALLLSCQMTDEGVLLVARYDQSILEPLQMARFLRQLGFLINKLQSTDGSPCVGQLDVLAPEDRTEIEGWNSEPLQTQDCLIHSEVVKNADDTPNKPAVCAWDGEWTYSELNNVSSRLASYISSLDLGQQLIVPIYLEKSKWVMAAILAVLKAGHAFTLIDPNDPPARTAQIIKQASASIALTSALHQSKMQTVVGRCITVDDDLFQTLTTFEGSQVASAAKPGDLAYVIFTSGSTGDPKGIMIEHRAFYSSVVKFGKALGIRSSTRALQFATHGFGAFLLEVLTTLIHGGCICIPSDHDRMHNIPGFIRQSQINWMMATPSYMTTMKPEDVPGLETLVLVGEQMSSSINDVWLSELQLLDGYGQSESSSICFVGKISDSSRDPNNLGRAIGSHSWIVNPDNPDQLVPIGAIGELLIESPGIARGYLFSQSTETPFLERAPAWYASKQPPYGVKFYRTGDLARYAPDGTVICLGRMDSQVKIRGQRVELDAIENLLRRQFPSDVTVVAEAVKRSDLPSSVVITGFLISSEYVVGAPSTEDTYILDQAVTQEINAKMRQILPAHSIPSFYICMKSLPRTATGKVDRRKLRSIGSSLLALQAQSTAPRSSQAPDASAGVTKLEEVWMDIFNLTPNSHNIGGNFFALGGDSITAIKMVnMARAAGIQLKVSDIFQNPTLASLQAAIGGSSMTVTSIPALALDGPVEQSYSQGRLWFLDQLEIGANWYTIPYAVRLRGPLDVDALNRALLALEKRHETLRTTFEDQDGVGVQIIHETLLDQLRIINADHADYVQLLKQEQTAPFNLASESGWRVSLIRLDDDDNILSIVMHHIISDGWSIDVLRRELGQLYAAALHGADLFGSALSPLPIQYRDFSVWQKQDAQVAEHERQLQYWQKQLADCSPAKLPTDFHRPALLSGKATTVPVTITSELYYRLQEFCSTFNTTSFVVLLATFRAAHYRLTGVDDAVIGTPIANRNRHELENLIGFFVNTQCMRITINEDEETFESLVRQVRSTTTAAFEHEDVPFERVVSAMLPGSRDLSQNPLAQLVFAIHSHKDLGKFELEALESEPLQNEVYTRFDAEFHFFQAPDGLTGYINFATELFKVETIQNVVSVFLQILRHGLEHPQTLISVVPLTDGLAELRSMGLLEIKKVEYPRDSSVVDVFATQVASYPDTLAVVDSSSRLTYAELDHQSDLLATWLRQQNLPTEALVVVLAPRSCETIITFLGILKANLAYLPLDIRSPITRMRDVLSTLPGRTIALLCSDEVAPDFQLPSIELVRIADALEEAAGMTSLNGHEHVPVPSPSPTSLAYVLYTSGSTGRPKGVMIEHRAIVRLARSDIIPDYRPACGDTMAHMFNTAFDGATYEIYTMLLNGGTLVCVDYMDTLSPKSLEAVFKKEQVNATIMAPALLKLYLADARDALKGLDVLISGGDRFDPQDAVDAQSLVRGSCYNGYGPTENGVFSTVYKVDKNDPFVNGVPLGRAVNNSGAYVVDRNQQLVGPGIIGELVVTGDGLARGYTERAFDQNRFIQLKIEGQSVRGYRTGDRVRYRVGEGLIEFFGRMDFQFKIRSNRIEAGEVEAAILSHPAVRNAAVILHVQEKLEPEIVGFVVAEHDDTAEQEEAGDQVEGWQAFFESTTYTELDTVSSSEIGKDFKGWTSMYDGNEIDKAEMQEWLDDTIHTLTDGQALGHVLEIGTGSGMVLFNLGSGLQSFVGLEPSKSAAAFVNNAIKSTPALAGKAHVFVGTATDTNKLDDLHPDLVIFNSVLQYFPTRDYLEQVVDALVHLRSAKRIFFGDVRSYATNRHFLAARAIYTLGNHTTKDEVRKKMAEMEEREEEFLVEPAFFTTLVNRLPDVRHVEIIPKnMQATNELSAYRYAAVVHLRGPDELTRPVHLIKMDDWVDFQASHMHKDALREYLRLAENTKTVAISNIPYGKTIFERQVVESLDDTSEDAPHASLDGAAWISAVRSDAKARSSLSVPDLVLLAKETGFRVEVSAARQWSQSGALDAVFHRYHPAEPDVRTLFQFPTDNDVRMSALLTNQPLQRLQKRRVAVQVREWLQDRIPSYMIPSHIVALDQMPLNTSGKVDRKELSRQAKAIKKVQKSAPPTAPAFPLSEVEVMLCEELTKTFEMDVNITDDFFQLGGHSLLATRLVARISHRLGARLTVKDVFDYPVFSELADIIRQQLASKNTLLPTASAGGGGQDKKESAGVAPTTDMEAMLCEEFANILGMDVGITDNFFDLGGHSLMATRLAARIGHRLNTTISVKDIFSHPVIFQLSAKLEVSQLESSSGGTDIKMPDYTAFQLIPAADAEKFMQDHIYPQINFSQDMVQDVYLATHLQQCFLRDVFGRPKPLVPFYVEFPPDSNPHTLATACTSLVDKYDIFRTIFVEAEGNLYQVVLKHLNLDIDVVETDANVHKTSSDLVDAIAKEPVRLGQPMIQVKVLKQTSSVRVLLWLSHALYDGLSWEHIVRDLHILSKERSLPPATQFSRYMQYVDHTRGPGCDFWRDVLQNAPITNLSDAGSGGRPTKAGDPRVWHAGKVISGPSQAIRSSITQATVFNAACAIVLSKETGTDNVVFGRIVSGRQGLPVRWQNIIGPCTNAVPVRAVVDAHGNHQQMLRDLQEQYLLSLPYETIGFDEIKRSCTDWPDSARNYGCCVTYQNFEYHPESEVDQQRVEMGILAKKAELIKEEPLYNVAIAGEVEPDGVHLQVTVVVDSQLFSQEGATHLMEQVCNTFQALNASL White muscardine disease fungus Cell apoptosis Not specified HUVEC-2 Prostate cancer Not found
dbacp01457 Bax 1 STKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : 2.0 μmol/L
dbacp01458 Bax 1 STKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : 2.0 μmol/L
dbacp01459 Bax 1 STKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : 2.0 μmol/L
dbacp01460 Bax 1 STKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : 2.0 μmol/L
dbacp01461 Bax 10 KLSECLKRIGDELDS Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : > 500 μmol/L
dbacp01462 Bax 10 KLSECLKRIGDELDS Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : > 500 μmol/L
dbacp01463 Bax 10 KLSECLKRIGDELDS Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : > 500 μmol/L
dbacp01464 Bax 10 KLSECLKRIGDELDS Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : > 500 μmol/L
dbacp01465 Bax 11 LSECLKRIGDELDSN Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : > 500 μmol/L
dbacp01466 Bax 11 LSECLKRIGDELDSN Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : > 500 μmol/L
dbacp01467 Bax 11 LSECLKRIGDELDSN Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : > 500 μmol/L
dbacp01468 Bax 11 LSECLKRIGDELDSN Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : > 500 μmol/L
dbacp01469 Bax 12 STKKLECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : > 500 μmol/L
dbacp01470 Bax 12 STKKLECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : > 500 μmol/L
dbacp01471 Bax 12 STKKLECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : > 500 μmol/L
dbacp01472 Bax 12 STKKLECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : > 500 μmol/L
dbacp01473 Bax 13 STKKLCLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : > 500 μmol/L
dbacp01474 Bax 13 STKKLCLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : > 500 μmol/L
dbacp01475 Bax 13 STKKLCLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : > 500 μmol/L
dbacp01476 Bax 13 STKKLCLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : > 500 μmol/L
dbacp01477 Bax 14 STKKLLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : > 500 μmol/L
dbacp01478 Bax 14 STKKLLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : > 500 μmol/L
dbacp01479 Bax 14 STKKLLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : > 500 μmol/L
dbacp01480 Bax 14 STKKLLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : > 500 μmol/L
dbacp01481 Bax 15 STKKLSECLGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : > 500 μmol/L
dbacp01482 Bax 15 STKKLSECLGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : > 500 μmol/L
dbacp01483 Bax 15 STKKLSECLGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : > 500 μmol/L
dbacp01484 Bax 15 STKKLSECLGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : > 500 μmol/L
dbacp01485 Bax 16 STKKLSECLKRIGDEL Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : 20 μmol/L
dbacp01486 Bax 16 STKKLSECLKRIGDEL Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : 20 μmol/L
dbacp01487 Bax 16 STKKLSECLKRIGDEL Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : 20 μmol/L
dbacp01488 Bax 16 STKKLSECLKRIGDEL Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : 20 μmol/L
dbacp01489 Bax 17 TKKLSECLKRIGDEL Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : 79 μmol/L
dbacp01490 Bax 17 TKKLSECLKRIGDEL Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : 79 μmol/L
dbacp01491 Bax 17 TKKLSECLKRIGDEL Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : 79 μmol/L
dbacp01492 Bax 17 TKKLSECLKRIGDEL Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : 79 μmol/L
dbacp01493 Bax 18 TKKLSECLKRIGDE Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : > 500 μmol/L
dbacp01494 Bax 18 TKKLSECLKRIGDE Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : > 500 μmol/L
dbacp01495 Bax 18 TKKLSECLKRIGDE Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : > 500 μmol/L
dbacp01496 Bax 18 TKKLSECLKRIGDE Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : > 500 μmol/L
dbacp01497 Bax 2 AAKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : 2.3 μmol/L
dbacp01498 Bax 2 AAKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : 2.3 μmol/L
dbacp01499 Bax 2 AAKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : 2.3 μmol/L
dbacp01500 Bax 2 AAKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : 2.3 μmol/L
dbacp01501 Bax 3 STKKLSECLKRIGDELDS Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : 18.3 μmol/L
dbacp01502 Bax 3 STKKLSECLKRIGDELDS Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : 18.3 μmol/L
dbacp01503 Bax 3 STKKLSECLKRIGDELDS Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : 18.3 μmol/L
dbacp01504 Bax 3 STKKLSECLKRIGDELDS Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : 18.3 μmol/L
dbacp01505 Bax 4 STKKLSECLKRIGDELDSM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : 7.6 μmol/L
dbacp01506 Bax 4 STKKLSECLKRIGDELDSM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : 7.6 μmol/L
dbacp01507 Bax 4 STKKLSECLKRIGDELDSM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : 7.6 μmol/L
dbacp01508 Bax 4 STKKLSECLKRIGDELDSM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : 7.6 μmol/L
dbacp01509 Bax 5 STKKLSECLKRIGDELDM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : 2.1 μmol/L
dbacp01510 Bax 5 STKKLSECLKRIGDELDM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : 2.1 μmol/L
dbacp01511 Bax 5 STKKLSECLKRIGDELDM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : 2.1 μmol/L
dbacp01512 Bax 5 STKKLSECLKRIGDELDM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : 2.1 μmol/L
dbacp01513 Bax 6 STKKLSECLKRIGDELM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : 8.0 μmol/L
dbacp01514 Bax 6 STKKLSECLKRIGDELM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : 8.0 μmol/L
dbacp01515 Bax 6 STKKLSECLKRIGDELM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : 8.0 μmol/L
dbacp01516 Bax 6 STKKLSECLKRIGDELM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : 8.0 μmol/L
dbacp01517 Bax 7 STKKLSECLKRIGDEM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : 7.4 μmol/L
dbacp01518 Bax 7 STKKLSECLKRIGDEM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : 7.4 μmol/L
dbacp01519 Bax 7 STKKLSECLKRIGDEM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : 7.4 μmol/L
dbacp01520 Bax 7 STKKLSECLKRIGDEM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : 7.4 μmol/L
dbacp01521 Bax 8 STKKLSECLKRIGDM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : > 500 μmol/L
dbacp01522 Bax 8 STKKLSECLKRIGDM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : > 500 μmol/L
dbacp01523 Bax 8 STKKLSECLKRIGDM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : > 500 μmol/L
dbacp01524 Bax 8 STKKLSECLKRIGDM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : > 500 μmol/L
dbacp01525 Bax 9 KKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified Jurkat Not specified IC50 : 148.0 μmol/L
dbacp01526 Bax 9 KKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified HL-60 Not specified IC50 : 148.0 μmol/L
dbacp01527 Bax 9 KKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified U937 Not specified IC50 : 148.0 μmol/L
dbacp01528 Bax 9 KKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified PC-3 Not specified IC50 : 148.0 μmol/L
dbacp01529 BC46 c[(bA)(bA)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01530 BC46 c[(bA)(bA)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01531 BC46 c[(bA)(bA)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01532 BC46 c[(bA)(bA)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01533 BC46 c[(bA)(bA)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01534 BC48 c[(bA)GRKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01535 BC48 c[(bA)GRKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01536 BC48 c[(bA)GRKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01537 BC48 c[(bA)GRKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01538 BC48 c[(bA)GRKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01539 BC49 c[(bA)(4aba)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01540 BC49 c[(bA)(4aba)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01541 BC49 c[(bA)(4aba)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01542 BC49 c[(bA)(4aba)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01543 BC49 c[(bA)(4aba)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01544 BC50 c[(4aba)(bA)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01545 BC50 c[(4aba)(bA)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01546 BC50 c[(4aba)(bA)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01547 BC50 c[(4aba)(bA)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01548 BC50 c[(4aba)(bA)RKD] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01549 BC70 c[(bA)(k)RKD(1-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01550 BC70 c[(bA)(k)RKD(1-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01551 BC70 c[(bA)(k)RKD(1-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01552 BC70 c[(bA)(k)RKD(1-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01553 BC70 c[(bA)(k)RKD(1-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01554 BC71 c[(bA)(k)RKD(2-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01555 BC71 c[(bA)(k)RKD(2-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01556 BC71 c[(bA)(k)RKD(2-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01557 BC71 c[(bA)(k)RKD(2-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01558 BC71 c[(bA)(k)RKD(2-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01559 BC72 c[(bA)(o)RKD(f)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01560 BC72 c[(bA)(o)RKD(f)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01561 BC72 c[(bA)(o)RKD(f)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01562 BC72 c[(bA)(o)RKD(f)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01563 BC72 c[(bA)(o)RKD(f)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01564 BC74 c[(bA)(k)(Fguan)KD(f)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01565 BC74 c[(bA)(k)(Fguan)KD(f)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01566 BC74 c[(bA)(k)(Fguan)KD(f)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01567 BC74 c[(bA)(k)(Fguan)KD(f)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01568 BC74 c[(bA)(k)(Fguan)KD(f)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01569 BC75 c[(bA)(k)RKD(D-Bip)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01570 BC75 c[(bA)(k)RKD(D-Bip)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01571 BC75 c[(bA)(k)RKD(D-Bip)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01572 BC75 c[(bA)(k)RKD(D-Bip)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01573 BC75 c[(bA)(k)RKD(D-Bip)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01574 BC81 c[(2233tmpa)(k)RKD(2-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01575 BC81 c[(2233tmpa)(k)RKD(2-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01576 BC81 c[(2233tmpa)(k)RKD(2-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01577 BC81 c[(2233tmpa)(k)RKD(2-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01578 BC81 c[(2233tmpa)(k)RKD(2-D-NAl)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01579 BC83 c[(bA)(k)RKD(D-2Anth)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01580 BC83 c[(bA)(k)RKD(D-2Anth)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01581 BC83 c[(bA)(k)RKD(D-2Anth)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01582 BC83 c[(bA)(k)RKD(D-2Anth)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01583 BC83 c[(bA)(k)RKD(D-2Anth)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01584 BC84 c[(bA)(k)RKD(w)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp01585 BC84 c[(bA)(k)RKD(w)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp01586 BC84 c[(bA)(k)RKD(w)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp01587 BC84 c[(bA)(k)RKD(w)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp01588 BC84 c[(bA)(k)RKD(w)] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp01589 BCP-A WPP Marine invertebrates Inducing apoptosis Not specified PC-3 Not specified IC50 : 1.99 mg/ml
dbacp01590 BCP-A WPP Marine invertebrates Inducing apoptosis Not specified DU-145 Not specified IC50 : 2.80 mg/ml
dbacp01591 BCP-A WPP Marine invertebrates Inducing apoptosis Not specified H1299 Not specified IC50 : 3.3 mg/ml
dbacp01592 BCP-A WPP Marine invertebrates Inducing apoptosis Not specified HeLa Not specified IC50 : 2.54 mg/ml
dbacp01601 BH3 peptide spanned amino acids (53-86) BAX DASTKKLSECLKRIGDELDSnMELQRMIAAVDTD Effectors (BAK, BAX) Inducing apoptosis Not specified GT1-7 Not specified Not found
dbacp01602 BH3 peptide spanned amino acids (53-86) BAX DASTKKLSECLKRIGDELDSnMELQRMIAAVDTD Effectors (BAK, BAX) Inducing apoptosis Not specified PC12S Not specified Not found
dbacp01604 BiLAO L-amino acid oxidase ADDKNPLEECFREDDYEGFLEIAKNGLSTTSNPKRVVIVGAGMSGLAAY Venom base Inducing apoptosis Not specified Not found Not specified Not found
dbacp01605 BIM RPEIWIAQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Leukemia Not found
dbacp01606 BIM RPEIWIAQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01607 Bim EIWIAQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified EL4 Mouse T cell lymphoma Not found
dbacp01608 Bim EIWIAQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Panc-02 Pancreatic cancer Not found
dbacp01609 Bim EIWIAQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified B16 Melanoma Not found
dbacp01610 BIM 2A DMRPEIWIAQEARRIGDEANAYYARR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not specified Not found
dbacp01611 Bim A2eD MRPEIWIDQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01612 Bim A2eE MRPEIWIEQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01613 Bim A2eF MRPEIWIFQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01614 Bim A2eG MRPEIWIGQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01615 Bim A2eH MRPEIWIHQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01616 Bim A2eI MRPEIWIIQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01617 Bim A2eK MRPEIWIKQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01618 Bim A2eL MRPEIWILQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01619 Bim A2eN MRPEIWINQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01620 Bim A2eP MRPEIWIPQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01621 Bim A2eQ MRPEIWIQQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01622 Bim A2eR MRPEIWIRQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01623 Bim A2eS MRPEIWISQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01624 Bim A2eT MRPEIWITQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01625 Bim A2eV MRPEIWIVQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01626 Bim A2eW MRPEIWIWQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01627 Bim A2eY MRPEIWIYQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01628 BIM BH3 (E158S) EIWIAQELRRIGDSFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis MTT assay Not found Prostate cancer Not found
dbacp01629 BIM BH3 (I155R, E158A) EIWIAQELRRRGDAFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis MTT assay Not found Prostate cancer Not found
dbacp01630 BIM BH3 (I155R, E158S) EIWIAQELRRRGDSFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis MTT assay Not found Prostate cancer Not found
dbacp01631 BIM BH3 (R154S, I155R, E158S) EIWIAQELRSRGDSFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis MTT assay Not found Prostate cancer Not found
dbacp01632 Bim D3fA MRPEIWIAQELRRIGAEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01633 Bim D3fE MRPEIWIAQELRRIGEEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01634 Bim D3fF MRPEIWIAQELRRIGFEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01635 Bim D3fG MRPEIWIAQELRRIGGEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01636 Bim D3fH MRPEIWIAQELRRIGHEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01637 Bim D3fI MRPEIWIAQELRRIGIEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01638 Bim D3fK MRPEIWIAQELRRIGKEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01639 Bim D3fL MRPEIWIAQELRRIGLEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01640 Bim D3fN MRPEIWIAQELRRIGNEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01641 Bim D3fP MRPEIWIAQELRRIGPEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01642 Bim D3fQ MRPEIWIAQELRRIGQEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01643 Bim D3fR MRPEIWIAQELRRIGREFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01644 Bim D3fS MRPEIWIAQELRRIGSEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01645 Bim D3fT MRPEIWIAQELRRIGTEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01646 Bim D3fV MRPEIWIAQELRRIGVEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01647 Bim D3fW MRPEIWIAQELRRIGWEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01648 Bim D3fY MRPEIWIAQELRRIGYEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01649 Bim E2gA MRPEIWIAQALRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01650 Bim E2gD MRPEIWIAQDLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01651 Bim E2gF MRPEIWIAQFLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01652 Bim E2gG MRPEIWIAQGLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01653 Bim E2gH MRPEIWIAQHLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01654 Bim E2gI MRPEIWIAQILRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01655 Bim E2gK MRPEIWIAQKLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01656 Bim E2gL MRPEIWIAQLLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01657 Bim E2gN MRPEIWIAQNLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01658 Bim E2gP MRPEIWIAQPLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01659 Bim E2gQ MRPEIWIAQQLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01660 Bim E2gR MRPEIWIAQRLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01661 Bim E2gS MRPEIWIAQSLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01662 Bim E2gT MRPEIWIAQTLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01663 Bim E2gW MRPEIWIAQWLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01664 Bim E2gY MRPEIWIAQYLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01665 Bim E3gA MRPEIWIAQELRRIGDAFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01666 Bim E3gD MRPEIWIAQELRRIGDDFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01667 Bim E3gF MRPEIWIAQELRRIGDFFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01668 Bim E3gG MRPEIWIAQELRRIGDGFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01669 Bim E3gH MRPEIWIAQELRRIGDHFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01670 Bim E3gI MRPEIWIAQELRRIGDIFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01671 Bim E3gK MRPEIWIAQELRRIGDKFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01672 BIM E3gK MRPEIWIAQELRRIGDKFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01673 Bim E3gL MRPEIWIAQELRRIGDLFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01674 Bim E3gN MRPEIWIAQELRRIGDNFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01675 Bim E3gP MRPEIWIAQELRRIGDPFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01676 Bim E3gQ MRPEIWIAQELRRIGDQFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01677 Bim E3gR MRPEIWIAQELRRIGDRFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01678 Bim E3gS MRPEIWIAQELRRIGDSFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01679 Bim E3gT MRPEIWIAQELRRIGDTFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01680 Bim E3gV MRPEIWIAQELRRIGDVFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01681 Bim E3gW MRPEIWIAQELRRIGDWFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01682 Bim E3gY MRPEIWIAQELRRIGDYFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01683 Bim EgV MRPEIWIAQVLRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01684 BIM EL - I146Y LRPEIRYAQELRRIGDEFNE BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01685 BIM EL -CST-2A PQMVILQLLAFIFALVWRRH BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01686 BIM EL -I153M LRPEIRIAQELRRMGDEFNE BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01687 BIM EL -Q148R LRPEIRIARELRRIGDEFNE BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01688 BIM EL -V192E PQMVILQLLRFIFRLEWRRH BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01689 BIM EL I146Y-I153M LRPEIRYAQELRRMGDEFNE BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01690 BIM EL- I181E PQMVELQLLRFIFRLVWRRH BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01691 BIM EL- I188E PQMVILQLLRFEFRLVWRRH BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01692 BIM EL-CTS PQMVILQLLRFIFRLVWRRH BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01693 BIM EL-L185E PQMVILQLERFIFRLVWRRH BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01694 Bim F4aA MRPEIWIAQELRRIGDEANAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01695 Bim F4aD MRPEIWIAQELRRIGDEDNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01696 Bim F4aE MRPEIWIAQELRRIGDEENAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01697 BIM F4aE MRPEIWIAQELRRIGDEENAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01698 Bim F4aG MRPEIWIAQELRRIGDEGNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01699 Bim F4aH MRPEIWIAQELRRIGDEHNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01700 Bim F4aI MRPEIWIAQELRRIGDEINAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01701 Bim F4aK MRPEIWIAQELRRIGDEKNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01702 Bim F4aL MRPEIWIAQELRRIGDELNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01703 Bim F4aN MRPEIWIAQELRRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01704 Bim F4aP MRPEIWIAQELRRIGDEPNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01705 Bim F4aQ MRPEIWIAQELRRIGDEQNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01706 Bim F4aR MRPEIWIAQELRRIGDERNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01707 Bim F4aS MRPEIWIAQELRRIGDESNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01708 Bim F4aT MRPEIWIAQELRRIGDETNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01709 Bim F4aV MRPEIWIAQELRRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01710 Bim F4aW MRPEIWIAQELRRIGDEWNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01711 Bim F4aY MRPEIWIAQELRRIGDEYNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01712 BIM FA1 RPEIWIAQELRRAGDVLNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Leukemia Not found
dbacp01713 BIM FA1 RPEIWIAQELRRAGDVLNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01714 BIM FD1 RPEIWLAQYLRRLGDQINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Leukemia Not found
dbacp01715 BIM FD1 RPEIWLAQYLRRLGDQINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01716 BIM FD2 RPEIWMAQVLRRFGDLLNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Leukemia Not found
dbacp01717 BIM FD2 RPEIWMAQVLRRFGDLLNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01718 BIM FW1 RPEIWIAQGLRRIGDTWNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Leukemia Not found
dbacp01719 BIM FW1 RPEIWIAQGLRRIGDTWNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp01720 Bim G3eA MRPEIWIAQELRRIADEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01721 Bim G3eD MRPEIWIAQELRRIDDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01722 Bim G3eE MRPEIWIAQELRRIEDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01723 Bim G3eF MRPEIWIAQELRRIFDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01724 Bim G3eH MRPEIWIAQELRRIHDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01725 Bim G3eI MRPEIWIAQELRRIIDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01726 Bim G3eK MRPEIWIAQELRRIKDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01727 Bim G3eL MRPEIWIAQELRRILDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01728 Bim G3eN MRPEIWIAQELRRINDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01729 Bim G3eP MRPEIWIAQELRRIPDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01730 Bim G3eQ MRPEIWIAQELRRIQDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01731 Bim G3eR MRPEIWIAQELRRIRDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01732 Bim G3eS MRPEIWIAQELRRISDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01733 Bim G3eT MRPEIWIAQELRRITDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01734 Bim G3eV MRPEIWIAQELRRIVDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01735 Bim G3eW MRPEIWIAQELRRIWDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01736 Bim G3eY MRPEIWIAQELRRIYDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01737 BIM I2dA MRPEIWAAQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01738 Bim I2dA MRPEIWAAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01739 Bim I2dD MRPEIWDAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01740 Bim I2dE MRPEIWEAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01741 Bim I2dF MRPEIWFAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01742 Bim I2dG MRPEIWGAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01743 Bim I2dH MRPEIWHAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01744 Bim I2dK MRPEIWKAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01745 Bim I2dL MRPEIWLAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01746 Bim I2dN MRPEIWNAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01747 Bim I2dP MRPEIWPAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01748 Bim I2dQ MRPEIWQAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01749 Bim I2dR MRPEIWRAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01750 Bim I2dS MRPEIWSAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01751 Bim I2dT MRPEIWTAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01752 Bim I2dV MRPEIWVAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01753 Bim I2dW MRPEIWWAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01754 BIM I2dY MRPEIWYAQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01755 Bim I2dY MRPEIWYAQELRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01756 Bim I3dA MRPEIWIAQELRRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01757 Bim I3dD MRPEIWIAQELRRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01758 Bim I3dE MRPEIWIAQELRREGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01759 Bim I3dF MRPEIWIAQELRRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01760 BIM I3dF MRPEIWIAQELRRFGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01761 Bim I3dG MRPEIWIAQELRRGGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01762 Bim I3dH MRPEIWIAQELRRHGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01763 Bim I3dK MRPEIWIAQELRRKGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01764 Bim I3dL MRPEIWIAQELRRLGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01765 Bim I3dN MRPEIWIAQELRRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01766 Bim I3dP MRPEIWIAQELRRPGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01767 Bim I3dQ MRPEIWIAQELRRQGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01768 Bim I3dR MRPEIWIAQELRRRGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01769 Bim I3dS MRPEIWIAQELRRSGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01770 Bim I3dT MRPEIWIAQELRRTGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01771 Bim I3dV MRPEIWIAQELRRVGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01772 Bim I3dW MRPEIWIAQELRRWGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01773 Bim I3dY MRPEIWIAQELRRYGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01774 Bim L3aA MRPEIWIAQEARRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01775 Bim L3aD MRPEIWIAQEDRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01776 Bim L3aE MRPEIWIAQEERRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01777 Bim L3aF MRPEIWIAQEFRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01778 Bim L3aG MRPEIWIAQEGRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01779 Bim L3aH MRPEIWIAQEHRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01780 Bim L3aI MRPEIWIAQEIRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01781 Bim L3aK MRPEIWIAQEKRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01782 Bim L3aN MRPEIWIAQENRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01783 Bim L3aP MRPEIWIAQEPRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01784 Bim L3aQ MRPEIWIAQEQRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01785 Bim L3aR MRPEIWIAQERRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01786 Bim L3aS MRPEIWIAQESRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01787 Bim L3aT MRPEIWIAQETRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01788 Bim L3aV MRPEIWIAQEVRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01789 Bim L3aW MRPEIWIAQEWRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01790 Bim L3aY MRPEIWIAQEYRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01791 Bim R3bA MRPEIWIAQELARIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01792 Bim R3bD MRPEIWIAQELDRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01793 Bim R3bE MRPEIWIAQELERIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01794 Bim R3bF MRPEIWIAQELFRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01795 Bim R3bG MRPEIWIAQELGRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01796 Bim R3bH MRPEIWIAQELHRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01797 Bim R3bI MRPEIWIAQELIRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01798 Bim R3bK MRPEIWIAQELKRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01799 Bim R3bL MRPEIWIAQELLRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01800 Bim R3bN MRPEIWIAQELNRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01801 Bim R3bP MRPEIWIAQELPRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01802 Bim R3bQ MRPEIWIAQELQRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01803 Bim R3bS MRPEIWIAQELSRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01804 Bim R3bT MRPEIWIAQELTRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01805 Bim R3bV MRPEIWIAQELVRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01806 Bim R3bW MRPEIWIAQELWRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01807 Bim R3bY MRPEIWIAQELYRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01808 BIM SM-1 IWIAQELRRIGDEFNA BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01809 BIM SM-2 IWIAQELRRIGDEF BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01810 BIM SM-3 IAQELRRIGDEFNA BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01811 BIM SM-4 WIAQELRRIGDEFN BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01812 BIM SM-5 IAQELRRIGDEF BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01813 BIM SM-6 IAQELRRIGDEF BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01814 BIM SM-7 IAQELRRIGDEF BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp01815 BIM XXA1 RPEIWYAQGLKRFGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis MTT assay Not found Prostate cancer Not found
dbacp01816 BIM XXA1 F3dI RPEIWYAQGLKRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not specified Not found
dbacp01817 BIM XXA1 G2gE RPEIWYAQELKRFGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not specified Not found
dbacp01818 BIM XXA1 K3bR RPEIWYAQGLRRFGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not specified Not found
dbacp01819 BIM XXA1 Y2dI RPEIWIAQGLKRFGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not specified Not found
dbacp01820 BIM XXA1 Y4eK RPEIWYAQGLKRFGDEFNAYKAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not specified Not found
dbacp01821 BIM XXA4 RPEIWYAQWLKRFGDQFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not specified Not found
dbacp01822 BIM Y4eK- 18 IWYAQGLKRFGDEFNAYK BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not specified Not found
dbacp01823 BIM Y4eK- 21 RPEIWYAQGLKRFGDEFNAYK BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not specified Not found
dbacp01824 BIM- A2eT RPEIWITQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Mcl-1/Myc 2640 Not found Not found
dbacp01825 BIM- A2eT RPEIWITQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Bcl-2/Myc 2924 Not found Not found
dbacp01826 BIM- A2eT-E2gG RPEIWITQGLRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Mcl-1/Myc 2640 Not found Not found
dbacp01827 BIM- A2eT-E2gG RPEIWITQGLRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Bcl-2/Myc 2924 Not found Not found
dbacp01828 BIM- A2eT-F4aI RPEIWITQELRRIGDEINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Mcl-1/Myc 2640 Not found Not found
dbacp01829 BIM- A2eT-F4aI RPEIWITQELRRIGDEINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Bcl-2/Myc 2924 Not found Not found
dbacp01830 BIM- A2eT-I2dM RPEIWMTQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Mcl-1/Myc 2640 Not found Not found
dbacp01831 BIM- A2eT-I2dM RPEIWMTQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Bcl-2/Myc 2924 Not found Not found
dbacp01832 BIM- A2eT-I3dL RPEIWITQELRRLGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Mcl-1/Myc 2640 Not found Not found
dbacp01833 BIM- A2eT-I3dL RPEIWITQELRRLGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Bcl-2/Myc 2924 Not found Not found
dbacp01834 Bim-BH3W89Y DMRPEIYIAQELRRIGDEFNAY BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Jurkat Leukemia Not found
dbacp01835 Bim-BH3W89Y DMRPEIYIAQELRRIGDEFNAY BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Namalwa Leukemia Not found
dbacp01836 Bim-BH3W89Y DMRPEIYIAQELRRIGDEFNAY BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified U937 Leukemia Not found
dbacp01837 Bim-BH3YA2Aib DMRPEIYI(Aib)QELRRIGDAFN(Aib)Y BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Jurkat Leukemia Not found
dbacp01838 Bim-BH3YA2Aib DMRPEIYI(Aib)QELRRIGDAFN(Aib)Y BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Namalwa Leukemia Not found
dbacp01839 Bim-BH3YA2Aib DMRPEIYI(Aib)QELRRIGDAFN(Aib)Y BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified U937 Leukemia Not found
dbacp01840 BIRD-2 (Bcl-2 IP3R disrupter 2) RKKRRQRRRGGNVYTEIKCNSLLPLAAIVRV Not found Inducing apoptosis MTT assay DLBCL Leukemia Not found
dbacp01841 BIRD-2 (Bcl-2 IP3R disrupter 2) RKKRRQRRRGGNVYTEIKCNSLLPLAAIVRV Not found Inducing apoptosis MTT assay CLL Leukemia Not found
dbacp01842 BjarLAAO,L-amino-acid oxidase (BjarLAAO-I; LAAO; LAO; Snakes, reptils, animals) ADDKNPLEECFRETDYEEFLEIARNGLKATSNPKRVV Venom base Inducing apoptosis Not specified EAT Gastric cancer Not found
dbacp01892 BPC194 KKLKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay MDA-MB-231 Cervical cancer IC50 : 32.5 ± 0.5 μM
dbacp01893 BPC194 KKLKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay HeLa Cervical cancer IC50 : 29.5 ± 2 μM
dbacp01894 BPC194 KKLKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay HepG2 Cervical cancer IC50 : 46.0 ± 3 μM
dbacp01895 BPC194 KKLKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay A431 Cervical cancer IC50 : 50.0 ± 10 μM
dbacp01896 BPC194 KKLKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay Panc-1 Cervical cancer IC50 : 40.0 ± 3 Μm
dbacp01897 BPC88 KKLLKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay MDA-MB-231 Cervical cancer IC50 : 31.2 ± 5 μM
dbacp01898 BPC88 KKLLKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay HeLa Cervical cancer IC50 : 22.5 ± 0 μM
dbacp01899 BPC88 KKLLKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay HepG2 Cervical cancer IC50 : 32.5 ± 4 μM
dbacp01900 BPC88 KKLLKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay A431 Cervical cancer IC50 : 28.0 ± 3 μM
dbacp01901 BPC88 KKLLKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay Panc-1 Cervical cancer IC50 : 32.5 ± 11 μM
dbacp01902 BPC96 LKLKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay MDA-MB-231 Cervical cancer IC50 : 40.0 ± 7 μM
dbacp01903 BPC96 LKLKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay HeLa Cervical cancer IC50 : 24.5 ± 0.7 μM
dbacp01904 BPC96 LKLKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay HepG2 Cervical cancer IC50 : 34.5 ± 2 μM
dbacp01905 BPC96 LKLKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay A431 Cervical cancer IC50 : 35.0 ± 7 μM
dbacp01906 BPC96 LKLKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay Panc-1 Cervical cancer IC50 : 51.0 ± 6 Μm
dbacp01907 BPC98 LLKKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay MDA-MB-231 Cervical cancer IC50 : 40.7 ± 3 μM
dbacp01908 BPC98 LLKKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay HeLa Cervical cancer IC50 : 38.5 ± 4 μM
dbacp01909 BPC98 LLKKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay HepG2 Cervical cancer IC50 : 44.0 ± 3 μM
dbacp01910 BPC98 LLKKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay A431 Cervical cancer IC50 : 47.5 ± 4 μM
dbacp01911 BPC98 LLKKKFKKLQ Synthetic Peptide Inducing apoptosis MTT assay Panc-1 Cervical cancer IC50 : 44.5 ± 0.7 Μm
dbacp01912 BpirLAAO-I ADDKNPLEEFRETNYEVFLEIAKNGLKATSNPKRVVIVGAGMAGLSAAY Venom base Inducing apoptosis MTT assay SKBR-3 Breast cancer Not found
dbacp01913 BpirLAAO-I ADDKNPLEEFRETNYEVFLEIAKNGLKATSNPKRVVIVGAGMAGLSAAY Venom base Inducing apoptosis MTT assay Jurkat Acute T cell Leukemia Not found
dbacp01914 BpirLAAO-I ADDKNPLEEFRETNYEVFLEIAKNGLKATSNPKRVVIVGAGMAGLSAAY Venom base Inducing apoptosis MTT assay EAT Erlich ascitic tumor Not found
dbacp01915 BpirLAAO-I ADDKNPLEEFRETNYEVFLEIAKNGLKATSNPKRVVIVGAGMAGLSAAY Venom base Inducing apoptosis MTT assay S180 Tumor Not found
dbacp01916 BPP-II MTLTG Immunomodulatory bursal-derived Pentapeptide-II Inducing apoptosis MTT/MTS assay CEF Tumor Not found
dbacp01917 BPP-II MTLTG Immunomodulatory bursal-derived Pentapeptide-II Inducing apoptosis MTT/MTS assay Vero Renal cancer Not found
dbacp01918 BPP-II MTLTG Immunomodulatory bursal-derived Pentapeptide-II Inducing apoptosis MTT/MTS assay MDBK Renal cancer Not found
dbacp01919 BR-C CKLKNFAKGVAQSLLNKASKLSGQC Not found Inducing apoptosis Not specified MCF-7 Not specified IC50 : 45.72 μg/ml
dbacp01920 BR-C CKLKNFAKGVAQSLLNKASKLSGQC Not found Inducing apoptosis Not specified A549 Not specified IC50 : 75.44 μg/ml
dbacp01921 BR-D KLKNFAKGVAQSLLNKASCKLSGQC Not found Inducing apoptosis Not specified MCF-7 Not specified IC50 : 67.52 μg/ml
dbacp01922 BR-D KLKNFAKGVAQSLLNKASCKLSGQC Not found Inducing apoptosis Not specified A549 Not specified IC50 : 94.74 μg/ml
dbacp01946 Brevinin-1RL1 FFPLIAGLAARFLPKIFCSITKRC Not found Inducing apoptosis Cell death assay HCT116 Not specified IC50 : 5.87 ± 0.15 μM
dbacp01947 Brevinin-1RL1 FFPLIAGLAARFLPKIFCSITKRC Not found Inducing apoptosis Cell death assay MDA-MB-231 Not specified IC50 : 5.44 ± 0.33 μM
dbacp01948 Brevinin-1RL1 FFPLIAGLAARFLPKIFCSITKRC Not found Inducing apoptosis Cell death assay SW480 Not specified IC50 : 10.37 ± 0.40 μM
dbacp01949 Brevinin-1RL1 FFPLIAGLAARFLPKIFCSITKRC Not found Inducing apoptosis Cell death assay A549 Not specified IC50 : 5.81 ± 0.23 μM
dbacp01950 Brevinin-1RL1 FFPLIAGLAARFLPKIFCSITKRC Not found Inducing apoptosis Cell death assay SMMC-7721 Not specified IC50 : 6.87 ± 0.51 μM
dbacp01951 Brevinin-1RL1 FFPLIAGLAARFLPKIFCSITKRC Not found Inducing apoptosis Cell death assay B16F10 Not specified IC50 : 6.65 ± 0.33 μM
dbacp01952 Brevinin-1RL1 FFPLIAGLAARFLPKIFCSITKRC Not found Inducing apoptosis Cell death assay NCM460 Not specified IC50 : 16.84 ± 0.56 μM
dbacp01953 Brevinin-1RL1 FFPLIAGLAARFLPKIFCSITKRC Not found Inducing apoptosis Cell death assay BEAS-2B Not specified IC50 : 16.57 ± 0.29 μM
dbacp01954 Brevinin-1RL1 FFPLIAGLAARFLPKIFCSITKRC Not found Inducing apoptosis Cell death assay HaCaT Not specified IC50 : 28.67 ± 0.36 μM
dbacp01984 Brevinin-2R (BR-2R) KLKNFAKGVAQSLLNKASCKLSGQC Not found Inducing apoptosis Not specified MCF-7 Not specified IC50 : 24.11 μg/ml
dbacp01985 Brevinin-2R (BR-2R) KLKNFAKGVAQSLLNKASCKLSGQC Not found Inducing apoptosis Not specified A549 Not specified IC50 : 47.39 μg/ml
dbacp01987 Buforin 2 TRSSRAGLQFPVGRVHRLLRK Asiatic toad Disruption of electric potential of the cell membrane; Necrosis, Membranolytic activity leading to apoptosis MTT/MTS assay U-937 Lymphoma cancer IC50 : 90-95 µg/ml
dbacp01989 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay CCRF-CEM Leukemia cancer IC50 : 14.7 µg/ml
dbacp01990 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay HL-60 Leukemia cancer IC50 : 11.3 µg/ml
dbacp01991 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay K-562 Leukemia cancer IC50 : 8.2 µg/ml
dbacp01992 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay MOLT-4 Leukemia cancer IC50 : 17 µg/ml
dbacp01993 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay RPMI-8226 Leukemia cancer IC50 : 10.5 µg/ml
dbacp01994 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SR Leukemia cancer IC50 : 20.2 µg/ml
dbacp01995 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay MCF-7 Breast cancer IC50 : 15.1 µg/ml
dbacp01996 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay NCI/ADR-RES Breast cancer IC50 : 11.5 µg/ml
dbacp01997 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay MDA-MB-231 Breast cancer IC50 : 11.3 µg/ml
dbacp01998 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay HS578T Breast cancer IC50 : 11.7 µg/ml
dbacp01999 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay MDA-MB-435 Breast cancer IC50 : 11.3 µg/ml
dbacp02000 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay MDA-N Breast cancer IC50 : 10.6 µg/ml
dbacp02001 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay BT-549 Breast cancer IC50 : 12.9 µg/ml
dbacp02002 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay T-47D Breast cancer IC50 : 23.9 µg/ml
dbacp02003 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay A-549 Lung cancer IC50 : 11.7 µg/ml
dbacp02004 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay EKVX Lung cancer IC50 : 12.1 µg/ml
dbacp02005 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay HOP-62 Lung cancer IC50 : 12.6 µg/ml
dbacp02006 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay HOP-92 Lung cancer IC50 : 7.2 µg/ml
dbacp02007 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay NCI-H226 Lung cancer IC50 : 13.3 µg/ml
dbacp02008 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay NCI-H23 Lung cancer IC50 : 10.8 µg/ml
dbacp02009 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay NCI-H322M Lung cancer IC50 : 10.7 µg/ml
dbacp02010 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay NCI-H460 Lung cancer IC50 : 12.1 µg/ml
dbacp02011 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay NCI-H522 Lung cancer IC50 : 11.2 µg/ml
dbacp02012 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SF-268 Brain tumor IC50 : 12.4 µg/ml
dbacp02013 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SF-295 Brain tumor IC50 : 12.9 µg/ml
dbacp02014 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SF-539 Brain tumor IC50 : 9.5 µg/ml
dbacp02015 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SNB-19 Brain tumor IC50 : 13.8 µg/ml
dbacp02016 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SNB-75 Brain tumor IC50 : 15.5 µg/ml
dbacp02017 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay U-251 Brain tumor IC50 : 10.6 µg/ml
dbacp02018 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay LOXIMVI Skin cancer IC50 : 9.5 µg/ml
dbacp02019 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay MALME-3M Skin cancer IC50 : 10.9 µg/ml
dbacp02020 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay M14 Skin cancer IC50 : 15.1 µg/ml
dbacp02021 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SK-MEL-2 Skin cancer IC50 : 11.1 µg/ml
dbacp02022 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SK-MEL-5 Skin cancer IC50 : 8.9 µg/ml
dbacp02023 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay UACC-257 Skin cancer IC50 : 12.5 µg/ml
dbacp02024 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay UACC-62 Skin cancer IC50 : 10.6 µg/ml
dbacp02025 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay 786-0 Renal cancer IC50 : 12.2 µg/ml
dbacp02026 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay A-498 Renal cancer IC50 : 10 µg/ml
dbacp02027 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay ACHN Renal cancer IC50 : 12 µg/ml
dbacp02028 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay CAKI-1 Renal cancer IC50 : 14.1 µg/ml
dbacp02029 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay RFX393 Renal cancer IC50 : 11 µg/ml
dbacp02030 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SN-12C Renal cancer IC50 : 11.4 µg/ml
dbacp02031 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay TK-10 Renal cancer IC50 : 13.1 µg/ml
dbacp02032 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay UO-31 Renal cancer IC50 : 10.6 µg/ml
dbacp02033 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay IGROV1 Ovarian cancer IC50 : 9 µg/ml
dbacp02034 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay OVRCAR-3 Ovarian cancer IC50 : 15.2 µg/ml
dbacp02035 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay OVRCAR-4 Ovarian cancer IC50 : 17.6 µg/ml
dbacp02036 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay OVRCAR-5 Ovarian cancer IC50 : 13.8 µg/ml
dbacp02037 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay OVRCAR-8 Ovarian cancer IC50 : 13 µg/ml
dbacp02038 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SK-OV-3 Ovarian cancer IC50 : 12.6 µg/ml
dbacp02039 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay COLO-205 Colon cancer IC50 : 11.2 µg/ml
dbacp02040 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay HCT-116 Colon cancer IC50 : 14.6 µg/ml
dbacp02041 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay HCT-15 Colon cancer IC50 : 13.2 µg/ml
dbacp02042 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay HT-29 Colon cancer IC50 : 17.6 µg/ml
dbacp02043 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay KM12 Colon cancer IC50 : 12 µg/ml
dbacp02044 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay SW-620 Colon cancer IC50 : 12.7 µg/ml
dbacp02045 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay PC-3 Prostate cancer IC50 : 12 µg/ml
dbacp02046 Buforin IIb RAGLQFPVGRLLRRLLRRLLR Histone H2A Inducing mitochondria-dependent apoptosis MTT/MTS assay DU-145 Prostate cancer IC50 : 15.3 µg/ml
dbacp02047 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay CCRF-CEM Not specified IC50 : 14.7 µg/ml
dbacp02048 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay HL-60 Not specified IC50 : 11.3 µg/ml
dbacp02049 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay K562 Not specified IC50 : 8.2 µg/ml
dbacp02050 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay MOLT4 Not specified IC50 : 17.0 µg/ml
dbacp02051 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay RPMI-8226 Not specified IC50 : 10.5 µg/ml
dbacp02052 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SR Not specified IC50 : 20.2 µg/ml
dbacp02053 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay MCF-7 Not specified IC50 : 15.1 µg/ml
dbacp02054 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay NCI/ADR-RES Not specified IC50 : 11.5 µg/ml
dbacp02055 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay MDA-MB-231 Not specified IC50 : 11.3 µg/ml
dbacp02056 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay HS 578T Not specified IC50 : 11.7 µg/ml
dbacp02057 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay MDA-MB-435 Not specified IC50 : 11.3 µg/ml
dbacp02058 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay MDA-N Not specified IC50 : 10.6 µg/ml
dbacp02059 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay BT-549 Not specified IC50 : 12.9 µg/ml
dbacp02060 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay T-47D Not specified IC50 : 23.9 µg/ml
dbacp02061 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay A549 Not specified IC50 : 11.7 µg/ml
dbacp02062 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay EKVX Not specified IC50 : 12.1 µg/ml
dbacp02063 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay HOP-62 Not specified IC50 : 12.6 µg/ml
dbacp02064 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay HOP-92 Not specified IC50 : 7.2 µg/ml
dbacp02065 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay NCI-H226 Not specified IC50 : 13.3µg/ml
dbacp02066 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay NCI-H23 Not specified IC50 : 10.8 µg/ml
dbacp02067 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay NCI-H322M Not specified IC50 : 10.7 µg/ml
dbacp02068 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay NCI-H460 Not specified IC50 : 12.1 µg/ml
dbacp02069 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay NCI-H522 Not specified IC50 : 11.2 µg/ml
dbacp02070 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SF-268 Not specified IC50 : 12.4 µg/ml
dbacp02071 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SF-295 Not specified IC50 : 12.9 µg/ml
dbacp02072 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SF-539 Not specified IC50 : 9.5 µg/ml
dbacp02073 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SNB-19 Not specified IC50 : 13.8 µg/ml
dbacp02074 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SNB-75 Not specified IC50 : 15.5 µg/ml
dbacp02075 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay U251 Not specified IC50 : 10.6 µg/ml
dbacp02076 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay LOX IMVI Not specified IC50 : 9.5 µg/ml
dbacp02077 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay MALME-3M Not specified IC50 : 10.9 µg/ml
dbacp02078 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay M14 Not specified IC50 : 15.1 µg/ml
dbacp02079 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SK-MEL-2 Not specified IC50 : 11.1 µg/ml
dbacp02080 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SK-MEL-5 Not specified IC50 : 8.9 µg/ml
dbacp02081 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay UACC-257 Not specified IC50 : 12.5µg/ml
dbacp02082 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay UACC-62 Not specified IC50 : 10.6 µg/ml
dbacp02083 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay 786-0 Not specified IC50 : 12.2 µg/ml
dbacp02084 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay A498 Not specified IC50 : 10 µg/ml
dbacp02085 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay ACHN Not specified IC50 : 12 µg/ml
dbacp02086 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay CAKI-1 Not specified IC50 : 14.1 µg/ml
dbacp02087 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay RFX 393 Not specified IC50 : 11 µg/ml
dbacp02088 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SN12C Not specified IC50 : 11.1 µg/ml
dbacp02089 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay TK-10 Not specified IC50 : 13.1 µg/ml
dbacp02090 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay UO-31 Not specified IC50 : 10.6 µg/ml
dbacp02091 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay IGROV 1 Not specified IC50 : 9 µg/ml
dbacp02092 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay OVRCAR-3 Not specified IC50 : 15.2 µg/ml
dbacp02093 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay OVRCAR-4 Not specified IC50 : 17.6 µg/ml
dbacp02094 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay OVRCAR-5 Not specified IC50 : 13.8 µg/ml
dbacp02095 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay OVRCAR-8 Not specified IC50 : 13 µg/ml
dbacp02096 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SKOV3 Not specified IC50 : 12.6 µg/ml
dbacp02097 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay COLO-205 Not specified IC50 : 11.2 µg/ml
dbacp02098 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay HCT116 Not specified IC50 : 14.6 µg/ml
dbacp02099 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay HT-29 Not specified IC50 : 13.2 µg/ml
dbacp02100 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay HCT-15 Not specified IC50 : 12 µg/ml
dbacp02101 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay KM12 Not specified IC50 : 12 µg/ml
dbacp02102 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay SW-620 Not specified IC50 : 12.7 µg/ml
dbacp02103 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay HCT-15 Not specified IC50 : 17.6 µg/ml
dbacp02104 Buforin Iib RAGLQFPVGRLLRRLLRRLLR Not found Inducing apoptosis MTT/MTS assay DU-145 Not specified IC50 : 15.3 µg/ml
dbacp02105 Buforin2 TRSSRAGLQFPVGRVHRLLRK Asiatic toad Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-937 Lymphoma cancer 5% Cytotoxicity at 0.5 µg/ml
dbacp02108 cMastoparan-C(cMP-C) CLNLKALLAVAKKILC Synthetic construct Apoptosis MTT assay H157 Non-small cell Lung cancer IC50 : 7.02 μM
dbacp02109 cMastoparan-C(cMP-C) CLNLKALLAVAKKILC Synthetic construct Apoptosis MTT assay MBD-MB-435S Melanocyte IC50 : 13.87 μM
dbacp02110 cMastoparan-C(cMP-C) CLNLKALLAVAKKILC Synthetic construct Apoptosis MTT assay PC-3 Human prostate carcinoma IC50 : 13.87 μM
dbacp02111 cMastoparan-C(cMP-C) CLNLKALLAVAKKILC Synthetic construct Apoptosis MTT assay U251-MG Human glioblastoma astrocytoma IC50 : 8.56 μM
dbacp02112 cMastoparan-C(cMP-C) CLNLKALLAVAKKILC Synthetic construct Apoptosis MTT assay MCF-7 Human breast cancer IC50 : 13.66 μM
dbacp02168 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HCT-116 Colorectal cancer Cell viability : >50% at 25μM approx.
dbacp02169 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC24 Colorectal cancer Cell viability : >60% at 25μM approx.
dbacp02170 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC40 Colorectal cancer Cell viability : >60% at 25μM approx.
dbacp02171 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC60 Colorectal cancer Cell viability : >50% at 25μM approx.
dbacp02172 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC32 Colorectal cancer Cell viability : >60% at 25μM approx.
dbacp02173 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HCT-116 Colorectal cancer Cell viability : >40% at 12.5μM approx.
dbacp02174 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC18 Colorectal cancer Cell viability : >55% at 12.5μM approx.
dbacp02175 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC24 Colorectal cancer Cell viability : >55% at 12.5μM approx.
dbacp02176 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC40 Colorectal cancer Cell viability : >45% at 12.5μM approx.
dbacp02177 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC60 Colorectal cancer Cell viability : >70% at 12.5μM approx.
dbacp02178 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC113 Colorectal cancer Cell viability : >80% at 12.5μM approx.
dbacp02179 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC32 Colorectal cancer Cell viability : >55% at 12.5μM approx.
dbacp02180 C7A KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC107 Colorectal cancer Cell viability : >50% at 12.5μM approx.
dbacp02189 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HCT-116 Colorectal cancer Cell viability : 50% at 12.5μM approx.
dbacp02190 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC24 Colorectal cancer Cell viability : >50% at 25μM approx.
dbacp02191 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC40 Colorectal cancer Cell viability : >50% at 25μM approx..
dbacp02192 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC60 Colorectal cancer Cell viability : >50% at 25μM approx.
dbacp02193 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC32 Colorectal cancer Cell viability : 50% at 12.5μM approx.
dbacp02194 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HCT-116 Colorectal cancer Cell viability : >40% at 12.5μM approx.
dbacp02195 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC18 Colorectal cancer Cell viability : >55% at 12.5μM approx.
dbacp02196 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC24 Colorectal cancer Cell viability : >55% at 12.5μM approx.
dbacp02197 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC40 Colorectal cancer Cell viability : >80% at 12.5μM approx.
dbacp02198 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC60 Colorectal cancer Cell viability : >60% at 12.5μM approx.
dbacp02199 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC113 Colorectal cancer Cell viability : >65% at 12.5μM approx.
dbacp02200 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC32 Colorectal cancer Cell viability : >80% at 12.5μM approx.
dbacp02201 C7A-D21K KILRGVAKKIMRTFLRRISKKILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC107 Colorectal cancer Cell viability : >65% at 12.5μM approx.
dbacp02209 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HCT-116 Colorectal cancer Cell viability : >50% at 12.5μM approx.
dbacp02210 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC24 Colorectal cancer Cell viability : >60% at 25μM approx.
dbacp02211 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC40 Colorectal cancer Cell viability : >50% at 25μM approx.
dbacp02212 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC60 Colorectal cancer Cell viability : >50% at 25μM approx.
dbacp02213 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC32 Colorectal cancer Cell viability : 50% at 12.5μM approx.
dbacp02214 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HCT-116 Colorectal cancer Cell viability : >50% at 12.5μM approx.
dbacp02215 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC18 Colorectal cancer Cell viability : >75% at 12.5μM approx.
dbacp02216 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC24 Colorectal cancer Cell viability : >70% at 12.5μM approx.
dbacp02217 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC40 Colorectal cancer Cell viability : >85% at 12.5μM approx.
dbacp02218 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC60 Colorectal cancer Cell viability : >70% at 12.5μM approx.
dbacp02219 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC113 Colorectal cancer Cell viability : >70% at 12.5μM approx.
dbacp02220 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC32 Colorectal cancer Cell viability : >85% at 12.5μM approx.
dbacp02221 C7A-Δ KILRGVAKKIMRTFLRRISKDILTGKK NK-2 peptide based derivatives Apoptosis; Necrosis Cell viability assay HROC107 Colorectal cancer Cell viability : >70% at 12.5μM approx.
dbacp02235 CA-MA KWKLFKKIGIGKFLHSAKKF Ceropin A-African clawed frog Apoptosis MTT/MTS assay NCI-H69 Lung cancer IC50 : 15.8 µM
dbacp02236 CA-MA KWKLFKKIGIGKFLHSAKKF Ceropin A-African clawed frog Apoptosis MTT/MTS assay NCI-H128 Lung cancer IC50 : 16.1 µM
dbacp02237 CA-MA KWKLFKKIGIGKFLHSAKKF Ceropin A-African clawed frog Apoptosis MTT/MTS assay NCI-H146 Lung cancer IC50 : 15.8 µM
dbacp02253 CA-ME KWKLFKKIGIGAVLKVLTTG Ceropin A-African clawed frog Apoptosis MTT/MTS assay NCI-H69 Lung cancer IC50 : 32.2 µM
dbacp02254 CA-ME KWKLFKKIGIGAVLKVLTTG Ceropin A-African clawed frog Apoptosis MTT/MTS assay NCI-H128 Lung cancer IC50 : 28.6 µM
dbacp02255 CA-ME KWKLFKKIGIGAVLKVLTTG Ceropin A-African clawed frog Apoptosis MTT/MTS assay NCI-H146 Lung cancer IC50 : 28.6 µM
dbacp02304 Cartilage protein hydrolysate peptide FIMGPY Skate Cell proliferation inhibition; Apoptosis inducing MTT assay HeLa Cervical cancer IC50 : 4.81 mg/mL
dbacp02305 Caseinphosphopeptides PPPEE Bovine milk Regulation of immune response; Apoptosis inducing MTT/MTS assay AZ-97 Colon cancer Inhibition at 24-28g/l
dbacp02314 Cathepsin B MWWSLILLSCLLALTSAHDKPSFHPLSDDLINYINKQNTTWQAGRNFYNVDISYLKKLCGTVLGGPKLPGRVAFGEDIDLPETFDAREQWSNCPTIGQIRDQGSCGSCWAFGAVEAISDRTCIHTNGRVNVEVSAEDLLTCCGIQCGDGCNGGYPSGAWSFWTKKGLVSGGVYNSHVGCLPYTIPPCEHHVNGSRPPCTGEGDTPRCNKSCEAGYSPSYKEDKHFGYTSYSVSNSVKEIMAEIYKNGPVEGAFTVFSDFLTYKSGVYKHEAGDMMGGHAIRILGWGVENGVPYWLAANSWNLDWGDNGFFKILRGENHCGIESEIVAGIPRTDQYWGRF Mouse Apoptosis; Cell proliferation Not specified Not found Not found Not found
dbacp02378 Cercopin D GNFFKDLEKMGQRVRDAVISAAPAVDTLAKAKALGQ Domestic silk moth Apoptosis inducing Not specified Not found Not found Not found
dbacp02379 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 91.8% cell viability at 12.5 µM
dbacp02380 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 84.1% cell viability at 25 µM
dbacp02381 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 76.3% cell viability at 50 µM
dbacp02382 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 71.5 % cell viability at 75 µM
dbacp02383 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 54.2 % cell viability at 100 µM
dbacp02384 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 87.3 % cell viability at 25 µM
dbacp02385 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 75.6 % cell viability at 50 µM
dbacp02386 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 62.8 % cell viability at 75 µM
dbacp02387 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 54.3 % cell viability at 100 µM
dbacp02388 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 48.6 % cell viability at 100 µM
dbacp02389 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 72.1 % cell viability at 12.5 µM
dbacp02390 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 63.3 % cell viability at 25 µM
dbacp02391 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 49.7 % cell viability at 50 µM
dbacp02392 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 41.1 % cell viability at 75 µM
dbacp02393 Ceropin MNFNKLFVFVALVLAVCIGQSEAGWLKKIGKKIERVGQHTRDATIQTIGVAQQAANVAATLKG House fly Apoptosis inducing Trypan blue assay BEL-7402 Liver cancer 35.2 % cell viability at 100 µM
dbacp02458 Chartergellus-CP1 peptide IIGTILGLLKSLNH2 Social wasp Apoptosis inducing MTT assay A375 Human melanoma IC50 : 40.5 µg/mL
dbacp02459 Chartergellus-CP1 peptide IIGTILGLLKSLNH2 Social wasp Apoptosis inducing; Intracellular ROS formation MTT assay MNT-1 Human melanoma IC50 : 51.6 µg/mL
dbacp02472 Chickpea peptide ADLPGLK Plant sources Inducing apoptosis SRB assay A-549 Human endometrial cancer IC50 : 126.4 ± 1.98 µM
dbacp02473 Chickpea peptide ADLPGLK Plant sources Inducing apoptosis SRB assay HepG-2 Human endometrial cancer IC50 : 113.7 ± 0.99 µM
dbacp02474 Chickpea peptide ADLPGLK Plant sources Inducing apoptosis SRB assay Ishikawa Human endometrial cancer IC50 : 101.5 ± 1.83 µM
dbacp02475 Chickpea peptide ADLPGLK Plant sources Inducing apoptosis SRB assay MCF-7 Human endometrial cancer IC50 : 110.3 ± 2.97µM
dbacp02476 Chickpea peptide ADLPGLK Plant sources Inducing apoptosis SRB assay MDA-MB-231 Human endometrial cancer IIC50 : 107.2 ± 1.62µM
dbacp02477 Chickpea peptide ADLPGLK Plant sources Inducing apoptosis SRB assay PA-1 Human endometrial cancer IC50 : 133.4 ± 0.70µM
dbacp02483 Chrysophsin-1 FFGWLIKGAIHAGKAIHGLI The pyloric caeca and gills; Red sea bream Disruption of cancer cell membranes; Apoptosis MTS assay, Lactate dehydrogenase (LDH) detection assay HT-1080 Human fibrosarcoma MIC : 7 µg/ml
dbacp02484 Chrysophsin-1 FFGWLIKGAIHAGKAIHGLI The pyloric caeca and gills; Red sea bream Disruption of cancer cell membranes; Apoptosis MTS assay, Lactate dehydrogenase (LDH) detection assay U937 Histiocytic lymphoma MIC : 7 µg/ml
dbacp02485 Chrysophsin-1 FFGWLIKGAIHAGKAIHGLI The pyloric caeca and gills; Red sea bream Disruption of cancer cell membranes; Apoptosis MTS assay, Lactate dehydrogenase (LDH) detection assay HeLa Epithelial carcinoma MIC : 7 µg/ml
dbacp02487 Citropin 1.1 GLFDVIKKVASVIGGL Australian blue mountains tree frog Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-938 Lymphoma cancer IC50 :40 µg/ml
dbacp02512 Citropin1.1 GLFDVIKKVASVIGGL Australian blue mountains tree frog Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-937 Lymphoma cancer 60% Cytotoxicity at 0.5 µg/ml
dbacp02513 Citropin1.1 GLFDVIKKVASVIGGL Australian blue mountains tree frog Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-937 Lymphoma cancer 60% Cytotoxicity at 0.5 µg/ml
dbacp02534 CNGRC-GG-D(KLAKLAK)2 CNGRCGGKLAKLAKKLAKLAK Not found Inducing apoptosis Internalization assay, Mitochondrial swelling assay, Cell-free apoptosis assay, Caspase activation assay KS1767 Not specified LC50 : 42 μM
dbacp02535 CNGRC-GG-D(KLAKLAK)3 CNGRCGGKLAKLAKKLAKLAK Not found Inducing apoptosis Internalization assay, Mitochondrial swelling assay, Cell-free apoptosis assay, Caspase activation assay MDA-MB-435 Not specified LC50 : 415 Μm
dbacp02541 Conotoxin Cl14.1a (Conotoxin Cal14.1a) MNVTAMFIVLLLTMPLTDGFNIRAINGGELFGLVQRDAGNALDHGFYRRGDCPPWCVGARCRAEKC California cone Apoptosis MTT assay H1299 Non-small cell Lung cancer Not found
dbacp02542 Conotoxin Cl14.1a (Conotoxin Cal14.1a) MNVTAMFIVLLLTMPLTDGFNIRAINGGELFGLVQRDAGNALDHGFYRRGDCPPWCVGARCRAEKC California cone Apoptosis MTT assay H1437 Non-small cell Lung cancer Not found
dbacp02543 Conotoxin Cl14.1a (Conotoxin Cal14.1a) MNVTAMFIVLLLTMPLTDGFNIRAINGGELFGLVQRDAGNALDHGFYRRGDCPPWCVGARCRAEKC California cone Apoptosis MTT assay H1975 Non-small cell Lung cancer Not found
dbacp02544 Conotoxin Cl14.1a (Conotoxin Cal14.1a) MNVTAMFIVLLLTMPLTDGFNIRAINGGELFGLVQRDAGNALDHGFYRRGDCPPWCVGARCRAEKC California cone Apoptosis MTT assay H661 Non-small cell Lung cancer Not found
dbacp02545 Conotoxin Cl14.1a (Conotoxin Cal14.1a) MNVTAMFIVLLLTMPLTDGFNIRAINGGELFGLVQRDAGNALDHGFYRRGDCPPWCVGARCRAEKC California cone Apoptosis Not specified SK-BR-3 Breast cancer Not found
dbacp02546 Conotoxin Cl14.1a (Conotoxin Cal14.1a) MNVTAMFIVLLLTMPLTDGFNIRAINGGELFGLVQRDAGNALDHGFYRRGDCPPWCVGARCRAEKC California cone Apoptosis Not specified MCF-7 Breast cancer Not found
dbacp02552 Cpm-1285 KNLWAAQRYGRELRRMSDEFEGSFKGL BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified HL-60 Not specified IC50 : 130 nM
dbacp02553 Cpm-1285 KNLWAAQRYGRELRRMSDEFEGSFKGL BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified PBL Not specified IC50 : 130 nM
dbacp02554 Cpm-1285m KNLWAAQRYGREARRMSDEFEGSFKGL BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified HL-60 Not specified Not found
dbacp02555 Cpm-1285m KNLWAAQRYGREARRMSDEFEGSFKGL BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified PBL Not specified Not found
dbacp02560 Cr-AcACP1 AW(Ac)KLFDDGV Not found Inducing apoptosis MTT assay Not found Colon carcinoma Not found
dbacp02561 Cr-ACP1 AWKLFDDGV Seeds, sago palm Apoptosis inducing Not specified Not found Not found Not found
dbacp02562 Cr-ACP1 AWKLFDDGV Not found Inducing apoptosis MTT assay Hep2 Human epidermoid cancer IC50 : 1.5 mM
dbacp02580 CS5931 MVVCPDGQSECPDGN Marine invertebrates Inducing apoptosis Not specified HCT-8 Colorectal cancer Not found
dbacp02599 Cyclosaplin RLGDGCTR Not found Apoptosis DNA fragmentation assay MDA-MB-231 Breast cancer IC50 : 2.06 µg/mL
dbacp02608 Cytotoxin drCT-1 LKCNKLVPLFYKTCPAGKNL Not found Inducing apoptosis MTT assay U937 Leukemia IC50 : 8.9 µg/ml
dbacp02609 Cytotoxin drCT-1 LKCNKLVPLFYKTCPAGKNL Not found Inducing apoptosis MTT assay K562 Leukemia IC50 : 6.7 µg/ml
dbacp02611 D (KLAKLAK) 2-TAT KLAKLAKKLAKLAKGGRKKRRQRRR Not found Inducing apoptosis Not specified A549 Not specified IC50 : 5.3 μM
dbacp02618 D-Antp-LP4 RQIKIWFQNRRMKWKKSWTWEKKLETAVNLAWTAGNSNKWTWK Not found Inducing apoptosis Not specified CLL Leukemia IC50 : 0.7 ± 0.4 µM
dbacp02619 D-Antp-LP4 RQIKIWFQNRRMKWKKSWTWEKKLETAVNLAWTAGNSNKWTWK Not found Inducing apoptosis Not specified MEC-1 Leukemia IC50 : 1.6 ± 0.3 µM
dbacp02623 D-MinAntp-LP4 KRRMKWKKSWTWEKKLETAVNLAWTAGNSNKWTWK Not found Inducing apoptosis Not specified CLL Leukemia IC50 : 0.6 ± 0.2 µM
dbacp02624 D-MinAntp-LP4 KRRMKWKKSWTWEKKLETAVNLAWTAGNSNKWTWK Not found Inducing apoptosis Not specified MEC-1 Leukemia IC50 : 1.4 ± 0.1 µM
dbacp02625 D-N-Ter-Antp MAVPPTYADLGKSARDVFTKGYGFGLRQIKIWFQNRRMKWKK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified CLL Leukemia IC50 : 1.5 ± 0.6 µM
dbacp02626 D-N-Ter-Antp MAVPPTYADLGKSARDVFTKGYGFGLRQIKIWFQNRRMKWKK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified MEC-1 Leukemia IC50 : 2.2 ± 1.6 µM
dbacp02631 DC1 GAFLKCGESCVYLPCLTTVVGCSCQNSVCYRD Snake-needle grass Apoptosis inducing Colorimetric Cell viability assay,Migration assay ,Wound healing assay and Human prostate cancer xenograft assay DC3 Prostate cancer Not found
dbacp02632 DC1 GAFLKCGESCVYLPCLTTVVGCSCQNSVCYRD Snake-needle grass Apoptosis inducing Colorimetric Cell viability assay,Migration assay ,Wound healing assay and Human prostate cancer xenograft assay LNCap Prostate cancer Not found
dbacp02633 DC2 GAVPCGETCVYLPCITPDIGCSCQNKVCYRD Snake-needle grass Apoptosis inducing Colorimetric Cell viability assay,Migration assay ,Wound healing assay and Human prostate cancer xenograft assay DC3 Prostate cancer Not found
dbacp02634 DC2 GAVPCGETCVYLPCITPDIGCSCQNKVCYRD Snake-needle grass Apoptosis inducing Colorimetric Cell viability assay,Migration assay ,Wound healing assay and Human prostate cancer xenograft assay LNCap Prostate cancer Not found
dbacp02635 DC3 GTSCGETCVLLPCLSSVLGCTCQNKRCYKD Snake-needle grass Apoptosis inducing Colorimetric Cell viability assay,Migration assay ,Wound healing assay and Human prostate cancer xenograft assay DC3 Prostate cancer Not found
dbacp02636 DC3 GTSCGETCVLLPCLSSVLGCTCQNKRCYKD Snake-needle grass Apoptosis inducing Colorimetric Cell viability assay,Migration assay ,Wound healing assay and Human prostate cancer xenograft assay LNCap Prostate cancer Not found
dbacp02640 Defensin coprisin MAKLIAFALVASLCLSMVLCNPLPEEVQEEGLVRQKRVTCDVLSFEAKGIAVNHSACALHCIALRKKGGSCQNGVCVCRN Dung beetle Induces apoptosis and necrosis Radial diffusion assay, MIC assay SNU-484 Gastric cancer MIC : ≤ 50 μM
dbacp02641 Defensin coprisin MAKLIAFALVASLCLSMVLCNPLPEEVQEEGLVRQKRVTCDVLSFEAKGIAVNHSACALHCIALRKKGGSCQNGVCVCRN Dung beetle Induces apoptosis and necrosis Radial diffusion assay, MIC assay SNU-601 Gastric cancer MIC : ≤ 50 μM
dbacp02642 Defensin coprisin MAKLIAFALVASLCLSMVLCNPLPEEVQEEGLVRQKRVTCDVLSFEAKGIAVNHSACALHCIALRKKGGSCQNGVCVCRN Dung beetle Induces apoptosis and necrosis Radial diffusion assay, MIC assay SNU-638 Gastric cancer MIC : ≤ 50 μM
dbacp02643 Defensin coprisin MAKLIAFALVASLCLSMVLCNPLPEEVQEEGLVRQKRVTCDVLSFEAKGIAVNHSACALHCIALRKKGGSCQNGVCVCRN Dung beetle Induces apoptosis and necrosis Radial diffusion assay, MIC assay SNU-668 Gastric cancer MIC : ≤ 50 μM
dbacp02646 Demegen P-113 AKRHHGYKRKFH Thrush Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-939 Lymphoma cancer IC50 : 85-90 µg/ml
dbacp02647 Demegen P-113 AKRHHGYKRKFH Amphibian skin peptide Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-937 Lymphoma cancer 15% Cytotoxicity at 0.5 µg/ml
dbacp02648 DepA MYSSSDVASRRISAADKFGPHHAFPHREALSIARQLLWRAEASPDRLAYASADPVKNIALSYAGLCERASGIAARLAQATETGDRVMLVYQEPLDFLPAFFGCCLAGVIPVPVAPRHGRDTMLAIAEDCGAVIALTAEARDALPGLRWMRTDETEGAAPFLRAAGEGSPVLLQYTSGSTRTPQGVVVTQTGLWATIEDLDRGAMHDADSVMISWLPYFHDMGLVYGILTPLQCGFPAYLMAPEKFVAQPMSWLRAIEARRGTHTAAPNFAYALCADRAADLAPGTDLSSLRYALNGAEPVRCDTVRRFEAAFAPFGLKPSVVAPGYGLAEATLKVTAGRCGEGTRGVRFGRDALARGRVSPEADGVELAACGSSLIDTRVRIVNPDTREPCEADVVGEIWVSGSTVADSYWRRPEESREIFGARLADDNGVWLRTGDLGFLYDGDLFVTSRLKDLIIVGGRNFYSHDLEDTVSACHPSIRMGRVFAAAVDGEEGEGVLIGAEVRGGCEEADAREILPVIRAALAREHGVAPARVALLRRGSILRTSSGKTRRSATRDALLRGELSIIADDAADMSDDAILAEISSFVPGAAATSDARLIDLGLDSLSAARLAAMARARHGVELSFATLFALSAEQLRREIVAARARHDGSAAPVSVRGYAAGEPFELSEMQQAYWIGQQGGVPLGSVSPHIRVDFEIDAARAPELGRRLASLVARHPSLRMTVGADGRGVFDALAYDPLLPPQDLRGLDAAEAAERLEATRASLAERDGPPVVAAVTRLTDSTAILHMRLGLLAGDLRSFLQLMAELARGAAGDVPAQLITPMTPATPTGEQREAWLRRVEAIAPAPELPMKMALADVAEPRFAGRRRELPAALSAALAARAQGLGVTLTSLCIAAFADTLRLWTAAHAFTLNVTCNTRAEQAGQAIGDYTSNALLSLSERHESFAAFAREVQRQVWADLDAPWCSGVSILRELSRRNGAPVLMPVVLTSLLSGDPADDLSILDGIGRVVDMANPTPQVSLHAVLGRRGDRLLVMWEFVAQLFPEGMIDAMFDAFLGALETMATEAAALERPTVARLAPEQAARREAVNATEAERAPRRLETPIIRQALTTPEAVAVRQGAATLSYGELLRQAEDIAGALRQSGVARGDVVAAIVAPGPRAVAALLGIVMAGAVYLSIEPSWPAARIEELLGEAGARHAVVSEGGWTLPVQALRLDLPLPPGDAGPAPDLEAGDAAYVIFTSGSTGRPKGVLIAHEAAANTIDDINERFAVGPADRTLCVSSLAFDLSVYDIFGLLAVGGEVVFPERARDPDAMAQALCDGRITIWNSVPAVLELLLDVAAPRSPDLRLALLSGDWIAPGLAGRLRDAFPALRPISLGGATEVSIWSVVHPIAPEDAALASIPYGRPLSNQQCFVRAPDGRERPDGVVGELLLGGRGLALAYLGNEAETQRRFFIDAEGRRLYRTGDLARWQPDGELELLGRMDGQVKVQGYRIELGEIEAAAMRAGCLARAVASVVRRNNATAIQLHVVARPDYDGDIVAAVRAKLVLHLPAYMQPHHVTVLDALPLTANGKVDRARLAALAAPAPASAKPAATARRDDSLEATMLAAFAEVVGVEIDPQQGFFDAGATSMHVVRLRALLASRGVVVPPLVDFFSLATIRALAERADSGDADLSPMIDVDGARAYRQRVRARKEAL Gram-negative bacillus Inducing apoptosis GFP assay NIH 3T3 Cutaneous T-cell lymphoma Not found
dbacp02649 DepD MTMARLMTDLADAGVTLRRRGDQLQVQAPQGALDAALVARLREAKEELLRVLDDEGARAAPLAPAQPGEAGDAAALSPGQARLVAATRLGDPAMYNEQAAIELADAVDAEAVARAFAALARRHDILRTVFSDGEPVRQTVLPEPIVTLQAWTVDGDDALRARAADLARLPFAAGAPMWRVDLFSTPERAAVLVLTIHHAIFDRWSMSVLIRDFSAYLALPDAAEAPASGLSYRDYSAWQRRWMASPDYAAQLDAWVDDLAEVDEVPAIRGDRPRPPAMSGRGGTERFEIPADCMDAAAAFSRSRNTTLFTTLFSAFALLQHRYTGEARALTLTPAANRPFQAAEEIAGYFVNLVALATEVGEGDSFGALVDRARDASARAFARQGVPLDAIVERLRARGGPRHEQFAQTVFAFQNVRLPAVRTASGAAVPFDLDSPFARFDLYLSIEGDERGTFAVWQYNTDLYEAATIRQLGEHYLALLRAALASPDADARALPILSAEEEARLRGWGRHELPYRADAAIDRLFRERAADHPGRVALEQGGVRWTYAELDQWSDRAAGALRAAGVEAGAVVGVAGERSPRLLAAFLAVLKAGAAYLPLDPTYPAARLRAMTADAAPALMIIADGLDAGWLGDYAGPVLSLADCEAGVARPLQSEARPAEAESLAYVMYTSGSTGQPKGVAVPHRAVARLATGGGYARLDASTVMLQQSPLGFDASTFEIWGCWLNGGRLVVAEPGMPFLDAASRDGVTTMWLTADLFRMAVEEEPAALGGLRELLTGGDALPVASCRAFLEACPGVALINGYGPTENTTFTCSHRVTAGDARRGSIPIGRPIGNTEVRVVDAGGRLVPVGVPGELWAGGDGLALGYLGRADLTAERFVAAPPPDGGRWYRTGDRVRWRRDGVLEFLGRIDEQIKLRGYRIELGEIEATLGHYPGLSGCAVALRRSAADEKQLVGYLVARPDSGEAADSAAVQAWLEARLPGYMVPRVWVWLDALPQSANGKVDRKRLPDPVVETGAAAAETEAEAALVEIWQGLLGLERVGVRDNFFALGGDSILSIQMASRAAERGLRLSPQQVFRYPTIAELAAEGCAAEEAGAQAEQGEVVGEVRPGPIQAWYLDWPGTDWEQFNQGAYLGLDGVVDAESLIGALQAVAQRHDALRIGWRRDGERWIQASGAGEPVEVKAVDLRGLADAEAALERDAAALQSSLRLGGASLWAARLYRLDEGWRLLWLAHHASVDGVSWRILLEDLWRAYAALSRGEAAAWPAKTVSYQAWSQRLWEWAETLPDSTLSYWREMDAPGMPLPGFNAAEDTVAAESRVSLQWEPETTERWLRQAGEAYRMRPEELLVTALARALRQWTGAEECVLDLEGHGRDGLAGVDVSRTVGWFTSLYPLRLPLSGELSGDLKRVKERMRSVPDGGLAYHALRYGGRGSALGGHARTVCFNYLGQWRLEEGGEPRSTWLGEPPGGTRGAGMTRRYGLDVVAQVHEGRLRVDWLYSAARQREDAIKALAEGFRAELDAVLAHCQSPESGGLTPSDLPLAHLDQSEIDAIEREHPRLEALYGLTPLQQGILFHSIADDGAPLYVEQLHWKMSGAFDAERFRQAWFDVAAAHAALRTTFRWRGLKSAVQIVHPRLDPDWETLDWGDVSADACASRFAALCELHRERGFDLERGPLLRGTLVREPGDAWRFLWSYHHAVVDGWSVPLILKQVLGRYAELGAGEAAPLPGSRFLPFVNWLAARDAREQAEYWKQVLEGIEEPTPIGFASPARGPQAQGQGRRAFVFDAALREQVDRAARRAGVTRASLLTGAWALTLGYAGGGRDVVFGTTLSGRPATLPGVERMVGLFINTVPVRVGMDDDASVSQWLRQLHEQQSERARLGAASLTDIQRWAGYEGGELLSSLFVVENYPVDRTLARGDAGFDVSEFAAAETRTNYPLVGQLIPGEETVLYVDFDASRYDEESIGRLGASFMHLLSQLAAQPDARLGDLTLVDDDEARRLIHDWNATPPVGEGYLLHASIERHAELTPLAPAIIGVDEAMNYRELADETLRTARAVAAAGAKREPVAVLLPRSARAVAAYSGVMRAGCAYVPADPAMPPGRLRDLLATVGYVLTTREHLPMLDGVAARAILIDETPPADVALPDAAPDDLAYVMFTSGSTGKPKGVMITHRAASLTIEVFLRRYEIGASDRLMCVSAAGFDLSVFDFFGAFAAGAAVLLAPESSTIAPAVWLELMTREGATVWESVPAVMELLLLECRQSGRALPPSLKLAMLSGDRVPVGLPAQIRAAATSDPEVLALGGATEGAIWSCWYDTRELASDAAFVPYGRHLPGQRLYVLSSSLQAVPVGVPGDLWIAGAGVALGYLGQPDLTAYRFVDNPFVPGERMYRTGDRARVLADGNLEFLGRVDDQVKIGGFRIEIGEIEAALAAAPGVERGVASVVERDGRRIIAGYVLLLPGASLDLAAVRDALARRLPPYMLPASIMALDSLPLSANGKVDRKRLPDPVVETGAAAAETEAEAALVEIWQGLLGLERVGVRDNFFALGGDSILSIQMASRAAERGLRLSPQQVFRYPTIAELAAEGCAAEEAGAQAEQGEVVGEVRPGPIQAWYLDWPGTDWEQFNQGAYLGLDGVVDAESLIGALQAVAQRHDALRIGWRRDGERWIQASGAGEPVEVKAVDLRGLADAEAALERDAAALQSSLRLGGASLWAARLYRLDEGWRLLWLAHHASVDGVSWRILLEDLWRAYAALSRGEAAAWPAKTVSYQAWSQRLWEWAETLPDSTLSYWREMDAPGMPLPGFNAAEDTVAAESRVSLQWEPETTERWLRQAGEAYRMRPEELLVTALARALRQWTGAKECVLDLEGHGRDGLAGVDVSRTVGWFTSLYPLRLPLSGELSGDLKRVKERMRSVPDGGLAYHALRYGGRGSELGGHARTVCFNYLGQWRLEEGGEPRSTWLGEPPGGTRGAGMTRRYGLDVVAQVHEGRLRVDWLYSAARQREDAIKALAEGFRAELDAVLAHCQSPESGGLTPSDLPLAHLDQNDIDEVLQLLNEQL Gram-negative bacillus Inducing apoptosis GFP assay NIH 3T3 Cutaneous T-cell lymphoma Not found
dbacp02650 DepE MNQTLSNTAQQARSKVETMLPLTPTQQGLLFHTLKAPESGVYYEQVACSFHAALNAADYRRALEAVVARHGVLRTGFLWDGPSKPVQVVFRDVALPWVEEDWRAFDQEEQQRRLAAYRDADRRPGFHLSRAPLMRCALFRTGEERYEFVWSYHHLLLDGWSVQIVLGEALAFYDAYRRSAVPAMPPPQPYSAFLRWLDEQDGAEAEAFWRARLGDVRSATPLPFADDARPDRAPGHGLIERELDARTSEGLQRLARECELTQSTVIQAAWALLLARASGRDDVVFGTTVSGRPAALRGVEQMVGLFVNALPTRASVDLELRLGDWLRRLHRQHVDAEAYAYTPLHAIPGWSGVAPGAPLFESLVVFENYPARADAKRYREQLGVSDVEVVEQTNYPLTVVAIPGERLSLRLHFDRQRISAASAERVVEMLTGVLGQFERGGPALSVARVSLLGDEAGGALAARWNAAARRADDAERQCLHRRFEAQARSRPDAVALKCDGETLTYAELDRRANRLAWRLDAAGVRGNAPVALAFGRGMDSVVAILAVLKAGAFYVPLDLDHPSERLAWMLDDIGAGALICGEEARDRFGDFGGVLIGMGDAAAPGEREDAPPPRDTSPADLCYVIYTSGSTGQPKGVCVEHRNADHLFAATRRSYGIGPSDVWTLFHSYAFDFSVWEIWGALLHGGRLEIVPYRCSRTPDEFLALLEREGVTMLSQTPSAFKQLLRALDDARRPLPAGLRYVFFGGEATIPSQFAACLNDAGGVALVNLYGITETTVHVTERVLGPGDAQSSRSPVGRPLPGYRVYLLDAAGHPVPPGVPGEIHVGGEGVARGYHNRPELDRERFIADPFLPGERLYRSGDLGRFDARGELDYLGRIDDQVKIRGFRIELGEVEATLARHPDVAAAAVMVDDATIDGHAQLAGFVVARGSARVSGSALRDWLAQRLPPHAVPARVVEMDAIPLTSNGKLDRRRLAGALAADADAARPRIAPRNTVEQALVGVFESVLKRSPIGVTDNFFELGGDSILSIQILSAAHKVNIDFSLDDLMRSLTIERLAPRVRQAGSAPPTASAPPLDAVHEDAYPLSAMQMAMLANEMRHGQDSAYHNVNGQRLALPFDAAALEAALRGAFERHPALRTAFDLAADEEPLQYVHRQVPLPLTVSDWRGLDPERQDERIRDWREAERRRRFDVERPPLIRFAVHRLSEKAMHIGVTKHHAILDGWSFNLLLSELISDYSARLAGRPLTLAAPASRFRDFVEREREAARSESLRDWWRARLQSLPVTRLAREPGGDAEPVDVPISAAQSAGLEALAASAGASVKSVLLTAHLLALSRIAGASSVTSGVVFNGRSEGVDGDRVLGLFLNSLPLGFDFPAGAFDAVALVRAVQSAELEVFSRRRYPLIELHRQAGTVFDALFNFTHFRALEEAVRDIEVSDGYASDMTNVPLVVQSSFDGRQRALRITLVPSRGYFSMATVNRFAALYADALRTLLGEPAAEGAGAVGAIRADGGERRSGASTAATPAAAGRAAAARPSGAALRRELRALWAAVLKREPPSDDSDFVALGGDSLLMLRICSRAGRAFGLNSAVVARLLTAQTVAEQARVIETDGAGEDGARVGSLVALSAQGDAPPLFFAPGAGGHVPYLRALAAELPNAFSVWGMTLPGDAGSVEAMATALIADIRRAQPYGPYRLGGHSFGGWVAFEVARQLAGQGEAVDWVAVVDSLPPGPAAQSRKQDWQGGRWVAEIGNSFARLADAELAFDEGEFDALDDARRVEHLRERLVEAGAVPEALGLPEFAARVRAFIAHSLTDYTPATPYAGALHVIVAADGDGEALISGWRQAASGAATAVRLAGDHIGIMRRPFVNGLAAALRAAEAAARRSVSVKQTEEEQ Gram-negative bacillus Inducing apoptosis GFP assay NIH 3T3 Cutaneous T-cell lymphoma Not found
dbacp02660 Dermaseptin-B3 ALWKnMLKGIGKLAGQAALGAVKTLVGA South American frog, Giant leaf frog Apoptosis inducing Thymidine Incorporation assay MCF-7 Breast cancer Not found
dbacp02661 Dermaseptin-B4 ALWKDILKNVGKAAGKAVLNTVTDMVNQ Giant leaf frog Apoptosis inducing Thymidine Incorporation assay MCF-7 Breast cancer Not found
dbacp02723 Dermaseptin-PS1 ALWKTMLKKLGTVALHAGKAALGAVADTISQ Rock Kribensis Cichlid Disrupting cell membranes; Apoptosis Lactate dehydrogenase (LDH) assay, MTT cell proliferation assay U251MG Human glioblastoma MIC : 10−5 M and above
dbacp02746 DI LTFEHYWAQLTS E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : 0.29 µM
dbacp02747 DI LTFEHYWAQLTS E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : 1.6 µM
dbacp02760 Dimeric Smac Mature Smac (1-4) AVPIAQKKQAIPVA SMAC Inducing apoptosis Not specified HeLa Not specified Not found
dbacp02801 Dolastatin 10 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutaNAmide Wedge sea hare Apoptosis inducing TUNEL assay DU-145 Prostate cancer IC50 : 0.5 nM
dbacp02802 Dolastatin 10 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutaNAmide Wedge sea hare Apoptosis inducing Cell viability assay DB Lymphoma cancer IC50 : 0.0013 - 0.013 nM
dbacp02803 Dolastatin 10 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutaNAmide Wedge sea hare Apoptosis inducing Cell viability assay HT Lymphoma cancer IC50 : 0.0013 - 0.013 nM
dbacp02804 Dolastatin 10 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutaNAmide Wedge sea hare Apoptosis inducing Cell viability assay RL Lymphoma cancer IC50 : 0.0013 - 0.013 nM
dbacp02805 Dolastatin 10 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutaNAmide Wedge sea hare Apoptosis inducing Cell viability assay SR Leukemia cancer IC50 : 0.0013 - 0.013 nM
dbacp02806 Dolastatin 15 VV-nMe-VPP-2hydroxyisovaleryl-2-oxo-4-methoxy-5-benzyl-3-pyrroline Wedge sea hare Apoptosis inducing Cell viability assay DB Lymphoma cancer IC50 : 0.0013 - 0.013 nM
dbacp02807 Dolastatin 15 VV-nMe-VPP-2hydroxyisovaleryl-2-oxo-4-methoxy-5-benzyl-3-pyrroline Wedge sea hare Apoptosis inducing Cell viability assay HT Lymphoma cancer IC50 : 0.0013 - 0.013 nM
dbacp02808 Dolastatin 15 VV-nMe-VPP-2hydroxyisovaleryl-2-oxo-4-methoxy-5-benzyl-3-pyrroline Wedge sea hare Apoptosis inducing Cell viability assay RL Lymphoma cancer IC50 : 0.0013 - 0.013 nM
dbacp02809 Dolastatin 15 VV-nMe-VPP-2hydroxyisovaleryl-2-oxo-4-methoxy-5-benzyl-3-pyrroline Wedge sea hare Apoptosis inducing Cell viability assay SR Leukemia cancer IC50 : 0.0013 - 0.013 nM
dbacp02810 DP1 KLAKLAKKLAKLAK Protein transduction domain Induction of apoptosis MTT/MTS assay MCA205 Renal cancer LC50 : < 50 µM
dbacp02811 DP1 KLAKLAKKLAKLAK KLA sequence repeats, motif-based design Induction of apoptosis MTT/MTS assay MCA205 Renal cancer LC50 : < 50 µM
dbacp02812 DR-5 binding peptide YCKVILTHRCY Not found Inducing apoptosis Not specified COLO-205 Not found Not found
dbacp02815 DRS B3 ALWKnMLKGIGKLAGQAALGAVKTLVGA Dermaseptins B Apoptosis inducing Thymidine incorporation assay MCF-7 Breast cancer Cytotoxicity :12 µM
dbacp02816 DRS B4 ALWKDILKNVGKAAGKAVLNTVTDMVNQ Dermaseptins B Apoptosis inducing Thymidine incorporation assay MCF-7 Breast cancer Cytotoxicity :15 µM
dbacp02817 DRS S1 ALWKTMLKKLGTMALHAGKAALGAAADTISQGTQ Dermaseptins B Apoptosis inducing Thymidine incorporation assay MCF-7 Breast cancer Not found
dbacp02818 DRS-DU-1 ALWKSLLKNVGKAAGKAALNAVTDMVNQ Purple and orange leaf frog Apoptosis inducing Not specified Not found Not found Not found
dbacp02819 Dual-functional peptide LPLTPLP LPLTPLP Not found Inducing apoptosis CCK-8 assay A549 Lung cancer IC50 : 0.00022 M
dbacp02820 Dual-functional peptide LPLTPLP LPLTPLP Not found Inducing apoptosis CCK-8 assay WI-38 Lung cancer IC50 : 0.035 M
dbacp02821 DV3-RI-TATp53C’ LGASWHRPDKGRRRQRRKKRGKKHRSTSQGKKSKLHSSHARSG Not found Inducing apoptosis Not specified 293T Not specified IC50 (Binding for the CXCR4 receptor) <0.01 µMol/L
dbacp02822 DV3-RI-TATp53C’ LGASWHRPDKGRRRQRRKKRGKKHRSTSQGKKSKLHSSHARSG Not found Inducing apoptosis Not specified H1299 Not specified IC50 (Binding for the CXCR4 receptor) <0.01 µMol/L
dbacp02828 EGFR-related peptide ERRP EGFR-related peptide Apoptosis MTT/MTS assay PC-3 Prostate cancer 30% Cell viability at 5 µg/ml
dbacp02829 Elastin derived peptide VGVAPG Elastin derived Apoptosis inducing Cell viability assay MCF-7 Breast cancer Not found
dbacp02830 Elastin derived peptide VGVAPG Elastin derived Apoptosis inducing Cell viability assay A549 Lung cancer Not found
dbacp02836 Emericellipsin A PQAAIVASG **Emericellopsis alkaline** VKPM F1428, Alkalophile, extremophile Disrupt cell membrane structures; Apoptosis MTT assay HeLa Cervical cancer EC50 : < 0.5 µM
dbacp02837 Emericellipsin A PQAAIVASG **Emericellopsis alkaline** VKPM F1428, Alkalophile, extremophile Disrupt cell membrane structures; Apoptosis MTT assay Hep G2 Liver cancer EC50 : 2.8 µM
dbacp02838 EP3 AMVGT Not found Inducing apoptosis Not specified HeLa Not specified Not found
dbacp02839 EP3 AMVGT Earthworm Apoptosis Not specified HeLa Not found Not found
dbacp02840 EP3 AMVGT Earthworm Apoptosis Not specified MGC803 Not found Not found
dbacp02841 EP5 ACSAG Not found Inducing apoptosis Not specified HeLa Not specified Not found
dbacp02871 Epinecidin-1 GFIFHIIKGLFHAGKMIHGLV Not found Inducing apoptosis MTT assay U937 Leukemia Not found
dbacp02949 Figainin 2 FLGAILKIGHALAKTVLPMVTNAFKPKQ Skin secretions, Chaco tree frog, South America Cell membrane interaction; Necrosis; Apoptosis MTT/MTS assay B16F10 Murien melanoma IC50 : 12.8 µM
dbacp02950 Figainin 2 FLGAILKIGHALAKTVLPMVTNAFKPKQ Skin secretions, Chaco tree frog, South America Cell membrane interaction; Necrosis; Apoptosis MTT/MTS assay MCF-7 Murien melanoma IC50 : 15.3 µM
dbacp02951 Figainin 2 MAFLKKSLFLVLFLGIVSLSVCEEEKREGEEKEEKREEEEGKEENEDGNEEHKEKRFLGAILKIGHALAKTVLPMVTNAFKPKQ Chaco tree frog Necrosis; Apoptosis MTT/MTS assay B16F10 Skin cancer IC50 : 12.8 µM
dbacp02952 Figainin 2 MAFLKKSLFLVLFLGIVSLSVCEEEKREGEEKEEKREEEEGKEENEDGNEEHKEKRFLGAILKIGHALAKTVLPMVTNAFKPKQ Chaco tree frog Necrosis; Apoptosis MTT/MTS assay B16F10 Breast cancer IC50 : 12.8 µM
dbacp02953 Figainin 2 MAFLKKSLFLVLFLGIVSLSVCEEEKREGEEKEEKREEEEGKEENEDGNEEHKEKRFLGAILKIGHALAKTVLPMVTNAFKPKQ Chaco tree frog Necrosis; Apoptosis MTT/MTS assay MCF-7 Skin cancer IC50 : 15.3 µM
dbacp02954 Figainin 2 MAFLKKSLFLVLFLGIVSLSVCEEEKREGEEKEEKREEEEGKEENEDGNEEHKEKRFLGAILKIGHALAKTVLPMVTNAFKPKQ Chaco tree frog Necrosis; Apoptosis MTT/MTS assay MCF-7 Breast cancer IC50 : 15.3 µM
dbacp02961 FIMGPY FIMGPY Not found Inducing apoptosis MTT assay HeLa Cervical cancer IC50 : 4.81 mg/mL
dbacp02962 FK-16 FKRIVQRIKDFLRNLV Not found Inducing apoptosis MTT assay LoVo, HCT116 Colon cancer Not found
dbacp02968 FRAP-4 WEWT Not found Inducing apoptosis Not specified NOS4 Ovarian cancer IC50 : 7 µM
dbacp03034 Galaxamide derivative (Compound 3) cyclo(WnMLLLnML) Marine invertebrates Inducing apoptosis MTT assay HepG2 Breast cancer IC50 : 3.98 ± 0.71 μg/mL
dbacp03035 Galaxamide derivative (Compound 3) cyclo(WnMLLLnML) Marine invertebrates Inducing apoptosis MTT assay MCF-7 Breast cancer IC50 : 1.72 ± 0.85 μg/mL
dbacp03036 Galaxamide derivative (Compound 3) cyclo(WnMLLLnML) Marine invertebrates Inducing apoptosis MTT assay HeLa Breast cancer IC50 : 5.32 ± 0.42 μg/mL
dbacp03037 Galaxamide derivative (Compound 3) cyclo(WnMLLLnML) Marine invertebrates Inducing apoptosis MTT assay MD-MBA-231 Breast cancer IC50 :3.51 ± 1.32 μg/Ml
dbacp03038 Galaxamide derivative Compound 1 cyclo(FnMLLLnML) Marine invertebrates Inducing apoptosis MTT assay HepG2 Breast cancer IC50 : 6.25 ± 1.03 μg/mL
dbacp03039 Galaxamide derivative Compound 1 cyclo(FnMLLLnML) Marine invertebrates Inducing apoptosis MTT assay MCF-7 Breast cancer IC50 : 4.76 ± 1.36 μg/mL
dbacp03040 Galaxamide derivative Compound 1 cyclo(FnMLLLnML) Marine invertebrates Inducing apoptosis MTT assay HeLa Breast cancer IC50 : 13.22 ± 1.12 μg/mL
dbacp03041 Galaxamide derivative Compound 1 cyclo(FnMLLLnML) Marine invertebrates Inducing apoptosis MTT assay MD-MBA-231 Breast cancer IC50 : 5.83 ± 0.45 μg/M
dbacp03042 Galaxamide derivative Compound 2 cyclo(NAl-nMLLLnML) Marine invertebrates Inducing apoptosis MTT assay HepG2 Breast cancer IC50 : 8.42 ± 1.82 μg/mL
dbacp03043 Galaxamide derivative Compound 2 cyclo(NAl-nMLLLnML) Marine invertebrates Inducing apoptosis MTT assay MCF-7 Breast cancer IC50 : 3.16 ± 0.92 μg/mL
dbacp03044 Galaxamide derivative Compound 2 cyclo(NAl-nMLLLnML) Marine invertebrates Inducing apoptosis MTT assay HeLa Breast cancer IC50 : 6.43 ± 1.20 μg/mL
dbacp03045 Galaxamide derivative Compound 2 cyclo(NAl-nMLLLnML) Marine invertebrates Inducing apoptosis MTT assay MD-MBA-231 Breast cancer IC50 : 4.48 ± 2.24 μg/mL
dbacp03057 GGN6 FLPLLAGLAANFLPTIICKISYKC Skin of a Korean frog, wrinkled frog Induce apoptosis MTT/MTS assay A-549 Lung cancer IC50 : 6.49 µg/ml
dbacp03058 GGN6 FLPLLAGLAANFLPTIICKISYKC Skin of a Korean frog, wrinkled frog Induce apoptosis MTT/MTS assay HEK293 Renal cancer IC50 : 5.62 µg/ml
dbacp03059 GGN6 FLPLLAGLAANFLPTIICKISYKC Skin of a Korean frog, wrinkled frog Induce apoptosis MTT/MTS assay HEK301 Renal cancer IC50 : 5.75 µg/ml
dbacp03060 GGN6 FLPLLAGLAANFLPTIICKISYKC Skin of a Korean frog, wrinkled frog Induce apoptosis MTT/MTS assay Hep3B Liver cancer IC50 : 4.91 µg/ml
dbacp03061 GGN6 FLPLLAGLAANFLPTIICKISYKC Skin of a Korean frog, wrinkled frog Induce apoptosis MTT/MTS assay MCF-7 Breast cancer IC50 : 4.88 µg/ml
dbacp03105 GM15 GGTCVIRGCVPKKLM Not found Inducing apoptosis MTT assay KB Oral cancer Not found
dbacp03121 GO-203 RRRRRRRRRCQCRRKN Not found Inducing apoptosis Not specified COLO-205 Colorectal cancer Not found
dbacp03155 GR01 c[CRKDC]Disulfidebridge AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp03156 GR01 c[CRKDC]Disulfidebridge AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp03157 GR01 c[CRKDC]Disulfidebridge AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp03158 GR01 c[CRKDC]Disulfidebridge AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp03159 GR01 c[CRKDC]Disulfidebridge AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp03160 GR16 c[KRKDF] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp03161 GR16 c[KRKDF] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp03162 GR16 c[KRKDF] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp03163 GR16 c[KRKDF] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp03164 GR16 c[KRKDF] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp03165 GR35 c[KRAAF] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Breast cancer Not found
dbacp03166 GR35 c[KRAAF] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Prostate cancer Not found
dbacp03167 GR35 c[KRAAF] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Lung cancer Not found
dbacp03168 GR35 c[KRAAF] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Ovarian cancer Not found
dbacp03169 GR35 c[KRAAF] AMOP domain of ISM trigger apoptosis Inducing apoptosis LDH assay HUVECs Skin cancer Not found
dbacp03174 H-0, Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV Congo dwarf clawed frog Inducing apoptosis MTT assay A549 Not found IC50 : 15.22 ± 0.21 μM
dbacp03175 H-0, Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV Congo dwarf clawed frog Inducing apoptosis MTT assay HCT116 Not found IC50 : 12.76 ± 0.43 μM
dbacp03176 H-0, Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV Congo dwarf clawed frog Inducing apoptosis MTT assay HepG2 Not found IC50 : 8.07 ± 0.21 μM
dbacp03177 H-11 IKLSPETKKNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay A549 Not found IC50 : 1.82 ± 0.23 μM
dbacp03178 H-11 IKLSPETKKNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay HCT116 Not found IC50 : 6.50 ± 0.32 μM
dbacp03179 H-11 IKLSPETKKNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay HepG2 Not found IC50 : 4.96 ± 0.43 μM
dbacp03180 H-12 IKLSKETKDNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay A549 Not found IC50 : 2.35 ± 0.31 μM
dbacp03181 H-12 IKLSKETKDNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay HCT116 Not found IC50 : 8.09 ± 0.40 μM
dbacp03182 H-12 IKLSKETKDNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay HepG2 Not found IC50 : 4.28 ± 0.38 μM
dbacp03183 H-13 IKLSKETKKNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay A549 Not found IC50 : 1.17 ± 0.23 μM
dbacp03184 H-13 IKLSKETKKNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay HCT116 Not found IC50 : 4.93 ± 0.51 μM
dbacp03185 H-13 IKLSKETKKNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay HepG2 Not found IC50 : 2.46 ± 0.32 μM
dbacp03186 H-14 IKLSKKTKKNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay A549 Not found IC50 : 0.98 ± 0.11 μM
dbacp03187 H-14 IKLSKKTKKNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay HCT116 Not found IC50 : 1.841 ± 0.34 μM
dbacp03188 H-14 IKLSKKTKKNLKKVLKGAIKGAIAVAKMV Synthetic construct Inducing apoptosis MTT assay HepG2 Not found IC50 : 4.54 ± 0.25 μM
dbacp03289 HCAP18(109-135) FRKSKEKIGKEFKRIVQRIKDFLRNLV HCAP18 synthetic peptide Apoptosis inducing Not specified SAS-H1 Oral cancer Not found
dbacp03305 HIV-TAT48-57 GRKKRRQRRR Not found Apoptosis inducing LDH leakage assay HeLa Cervical cancer 7% apoptosis at 10 µM
dbacp03306 HIV-TAT48-57 GRKKRRQRRR Not found Apoptosis inducing LDH leakage assay HeLa Cervical cancer 15% apoptosis at 20 µM
dbacp03307 HIV-TAT48-57 GRKKRRQRRR Not found Apoptosis inducing LDH leakage assay HeLa Cervical cancer 35% apoptosis at 30 µM
dbacp03308 HIV-TAT48-57 GRKKRRQRRR Not found Apoptosis inducing LDH leakage assay HeLa Cervical cancer 65% apoptosis at 50 µM
dbacp03327 Hrk WSSAAQLTAARLKALGDELHQ BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified Not found Not specified Not found
dbacp03329 Human A-defensin-1 (HNP1) ACYCRIPACIAGERRYGTCIYQGRLWAFCC Not found Inducing apoptosis MTT assay A549 Lung cancer Not found
dbacp03330 Human A-defensin-1 (HNP1) ACYCRIPACIAGERRYGTCIYQGRLWAFCC Not found Inducing apoptosis MTT assay COS-7 Lung cancer Not found
dbacp03331 Human BAD peptide NLWAAQRYGRELRRMSDEFVDSFKK BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified EGY191 Not specified Not found
dbacp03332 Human BAD peptide NLWAAQRYGRELRRMSDEFVDSFKK BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified GM701 Not specified Not found
dbacp03356 Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV-NH2 Zaire dwarf clawed frog Induce apoptosis and cell cycle arrest LDH release assay, MTT assay NCI-H1299 Lung cancer MIC : 0 - 50 μM
dbacp03357 Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV-NH3 Zaire dwarf clawed frog Induce apoptosis and cell cycle arrest LDH release assay, MTT assay A549 Lung cancer MIC : 0 - 50 μM
dbacp03358 Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV-NH4 Zaire dwarf clawed frog Induce apoptosis and cell cycle arrest LDH release assay, MTT assay H460 Lung cancer MIC : 0 - 50 μM
dbacp03359 Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV-NH5 Zaire dwarf clawed frog Induce apoptosis and cell cycle arrest LDH release assay, MTT assay HepG2 Human hepatocellular carcinoma MIC : 0 - 50 μM
dbacp03360 Hymenochirin-1B IKLSPETKDNLKKVLKGAIKGAIAVAKMV-NH6 Zaire dwarf clawed frog Induce apoptosis and cell cycle arrest LDH release assay, MTT assay PLC Human hepatocellular carcinoma MIC : 0 - 50 μM
dbacp03366 IbACP AASTPVGGGRRLDRGQ Sweet potato leaves Apoptosis MTT/MTS assay H1299 Lung cancer MIC : 5 mg/ml
dbacp03367 Ichthyophthirius multifiliis (strain G5) B4 LKKLFKKILKYL White spot disease (strain G5) B4 Apoptosis inducing; Penetration of the cell membrane MTT assay MCF-7 Breast cancer MIC : 5 μM
dbacp03368 Ichthyophthirius multifiliis (strain G5) B4 LKKLFKKILKYL White spot disease (strain G5) B4 Apoptosis inducing; Penetration of the cell membrane MTT assay K562 Breast cancer MIC : 5 μM
dbacp03369 Ichthyophthirius multifiliis (strain G5) B8 LKKLFKKILKY White spot disease (strain G5) B8 Apoptosis inducing; Penetration of the cell membrane MTT assay MCF-7 Breast cancer MIC : 7 μM
dbacp03370 Ichthyophthirius multifiliis (strain G5) B8 LKKLFKKILKY White spot disease (strain G5) B8 Apoptosis inducing; Penetration of the cell membrane MTT assay K562 Breast cancer MIC : 7 μM
dbacp03371 Ichthyophthirius multifiliis BP100 KKLFKKILKYL White spot disease BP100 Apoptosis inducing; Penetration of the cell membrane MTT assay MCF-7 Breast cancer MIC : 25 μM
dbacp03372 Ichthyophthirius multifiliis BP100 KKLFKKILKYL White spot disease BP100 Apoptosis inducing; Penetration of the cell membrane MTT assay K562 Breast cancer MIC : 25 μM
dbacp03373 IL-4Rα-lytic hybrid peptide KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay BXPC-3 Pancreatic cancer IC50 : 6.8 µMol/L
dbacp03374 IL-4Rα-lytic hybrid peptide KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay SU.86.86 Pancreatic cancer IC50 : 7.5 µMol/L
dbacp03375 IL-4Rα-lytic hybrid peptide KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK Bovine lactoferrin (Lf-B) Induction of apoptosis WST-1 assay KB Oral cancer IC50 : 13.2 µMol/L
dbacp03376 IL-4Rα-lytic hybrid peptide KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay T98G Brain tumor IC50 : 18.5 µMol/L
dbacp03377 IL-4Rα-lytic hybrid peptide KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay A-172 Brain tumor IC50 : 6.8 µMol/L
dbacp03378 IL-4Rα-lytic hybrid peptide KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay H-322 Lung cancer IC50 : 3.6 µMol/L
dbacp03379 IL-4Rα-lytic hybrid peptide KQLIRFLKRLDRNGGGKLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay MDA-MB-231 Breast cancer IC50 : 5.7 µMol/L
dbacp03395 Interferon gamma (IFN-gamma) MKYTSYILAFQLCIVLGSLGCYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLFKNFKDDQSIQKSVETIKEDMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIHELIQVMAELSPAVKTGKRKRSQMLFRGRRASQ Chimpanzee Apoptosis; Immunomodulatory activity Not specified Not found Colorectal cancer Not found
dbacp03396 Interferon gamma (IFN-gamma) MKYTSYILAFQLCIVLGSLGCYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLFKNFKDDQSIQKSVETIKEDMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIHELIQVMAELSPAVKTGKRKRSQMLFRGRRASQ Chimpanzee Apoptosis; Immunomodulatory activity Not specified Not found Oral cancer Not found
dbacp03397 Interferon gamma (IFN-gamma) MKYTSYILAFQLCIVLGSLGCYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLFKNFKDDQSIQKSVETIKEDMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIHELIQVMAELSPAVKTGKRKRSQMLFRGRRASQ Chimpanzee Apoptosis; Immunomodulatory activity Not specified Not found Prostate cancer Not found
dbacp03458 Interferon gamma (IFN-gamma) MMNYTSYILAFQLCVILGSSSCYCQATFLKEIENLKEYFNASNSNVADGGNLFLDILKNWREESDKKIIQSQIVSFYFKLFENLKDNPIIQSSVQIIKEDLRVKFFNSNNSKLEDFKKVIQIPVNNQTVQRKAISELFKVMTDLSPKSNQRKRKRSQSLFRGWKA Black flying fox Immune response regulation, apoptosis Not specified Not found Not found Not found
dbacp03471 IP3R-derived peptide (IDP) NVYTEIKCNSLLPLDDIVRV Not found Inducing apoptosis Not specified CLL Leukemia Not found
dbacp03473 K4R2-Nal2-S1 Ac-KKKKRR-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay PC9 Human lung cancer MIC : 25 μM
dbacp03474 K4R2-Nal2-S1 Ac-KKKKRR-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay PC9-G Oral cancer MIC : 25 μM
dbacp03475 K4R2-Nal2-S1 Ac-KKKKRR-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay A549 Human lung cancer MIC : 25 μM
dbacp03476 K4R2-Nal2-S1 Ac-KKKKRR-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay C9 Oral cancer MIC : 25 μM
dbacp03477 K4R2-Nal2-S1 Ac-KKKKRR-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay OECM-1 Human lung cancer MIC : 25 μM
dbacp03478 K4R2-Nal2-S1 Ac-KKKKRR-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay SAS Oral cancer MIC : 25 μM
dbacp03479 K6-Nal2-S1 Ac-KKKKKK-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay PC9 Human lung cancer MIC : 3.1 μM
dbacp03480 K6-Nal2-S1 Ac-KKKKKK-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay PC9-G Oral cancer MIC : 3.1 μM
dbacp03481 K6-Nal2-S1 Ac-KKKKKK-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay A549 Human lung cancer MIC : 3.1 μM
dbacp03482 K6-Nal2-S1 Ac-KKKKKK-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay C9 Oral cancer MIC : 3.1 μM
dbacp03483 K6-Nal2-S1 Ac-KKKKKK-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay OECM-1 Human lung cancer MIC : 3.1 μM
dbacp03484 K6-Nal2-S1 Ac-KKKKKK-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay SAS Oral cancer MIC : 3.1 μM
dbacp03523 KLAK peptide KLAKLAKKLAKLAK Not found Inducing apoptosis Internalization assay,Mitochondrial swelling assay,Cell-free apoptosis assay,Caspase activation assay KS1767 Not specified LC50 : 387 μM
dbacp03524 KLAK peptide KLAKLAKKLAKLAK Not found Inducing apoptosis Internalization assay,Mitochondrial swelling assay,Cell-free apoptosis assay,Caspase activation assay MDA-MB-435 Not specified LC50 : 333 Μm
dbacp03525 KT2 NGVQPKYKWWKWWKKWW-NH2 Siamese freshwater crocodile leukocyte Inducing apoptosis Sulforhodamine B colorimetric assay CaSki Cervical cancer IC50 : 17.3 – 30.8 μM
dbacp03526 KT2 NGVQPKYKWWKWWKKWW-NH2 Siamese freshwater crocodile leukocyte Apoptosis inducing Sulforhodamine B colorimetric assay CaSki Cervical cancer IC50 : 17.3 – 30.8 μM
dbacp03527 KT2 NGVQPKYKWWKWWKKWW-NH2 Siamese freshwater crocodile leukocyte Apoptosis inducing Sulforhodamine B colorimetric assay CaSki Cervical cancer IC50 : 17.3 – 30.8 μM
dbacp03535 L-amino oxidase (CP-LAAO) (LAO) (EC 1.4.3.2) MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIARXXXXTSNPKHVVRVGAGMSGLSAAYVLAGAGHQVTVLEASERPGGRXXXXXXXXEGWYANLGPMRXXXXXXXXXXXXXKFGLNLNEFSQENDNAWYFIKXXXXXXXXXXDPGLLKYPVKPSEAGKSAGQLYEESLGKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFDEIVDGMDKLPTSMYQAIXXXXXXXXXXXXXXXXXXKVTVTYQTPAKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIFLTCTKKFWEDDGIHGGKSTTDLPSRXXXXXXXXXXXXXXVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKEEIPSFCYPSMIQKXXXXXXXXXXITTFFTPYQFQHFSEAXXXXXXXIYFAGEYTAQAHGWIDSTIK Mangrove pit viper Cytotoxic; Anti-proliferative; Apoptosis Not specified SW480 Colon cancer EC50 : 29.43 ± 0.48
dbacp03536 L-amino oxidase (CP-LAAO) (LAO) (EC 1.4.3.2) MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIARXXXXTSNPKHVVRVGAGMSGLSAAYVLAGAGHQVTVLEASERPGGRXXXXXXXXEGWYANLGPMRXXXXXXXXXXXXXKFGLNLNEFSQENDNAWYFIKXXXXXXXXXXDPGLLKYPVKPSEAGKSAGQLYEESLGKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFDEIVDGMDKLPTSMYQAIXXXXXXXXXXXXXXXXXXKVTVTYQTPAKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIFLTCTKKFWEDDGIHGGKSTTDLPSRXXXXXXXXXXXXXXVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKEEIPSFCYPSMIQKXXXXXXXXXXITTFFTPYQFQHFSEAXXXXXXXIYFAGEYTAQAHGWIDSTIK Mangrove pit viper Cytotoxic; Anti-proliferative; Apoptosis Not specified SW620 Colon cancer EC50 : 23.19 ± 1.57
dbacp03537 L-amino oxidase (CP-LAAO) (LAO) (EC 1.4.3.2) MNVFFMFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIARXXXXTSNPKHVVRVGAGMSGLSAAYVLAGAGHQVTVLEASERPGGRXXXXXXXXEGWYANLGPMRXXXXXXXXXXXXXKFGLNLNEFSQENDNAWYFIKXXXXXXXXXXDPGLLKYPVKPSEAGKSAGQLYEESLGKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXFDEIVDGMDKLPTSMYQAIXXXXXXXXXXXXXXXXXXKVTVTYQTPAKXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXIFLTCTKKFWEDDGIHGGKSTTDLPSRXXXXXXXXXXXXXXVIIAYGIGDDANFFQALDFKDCADIVFNDLSLIHQLPKEEIPSFCYPSMIQKXXXXXXXXXXITTFFTPYQFQHFSEAXXXXXXXIYFAGEYTAQAHGWIDSTIK Mangrove pit viper Cytotoxic; Anti-proliferative; Apoptosis Not specified CCD-18co Colon cancer EC50 : 15.99 ± 1.20
dbacp03538 L-amino-acid oxidase (BatroxLAAO) (LAO) (EC 1.4.3.2) MNVFFTFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIAKNGLSTTSNPKRVVIVGAGMSGLSAAYVLANAGHQVTVLEASERAGGRVKTYRNEKEGWYANLGPMRLPEKHRIVREYIRKFDLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEVGKSAGQLYEESLQKAVEELRRTNCSYMLNKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDKLPTSMYQAIQEKVHLNARVIKIQQDVKEVTVTYQTSEKETLSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFPNGVGVIIAYGIGDDANYFQALDFEDCGDIVINDLSLIHQLPKEEIQAICRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLRAARDVNRASEIKK Common lancehead Inducing apoptosis MTT assay PC12 Not found Not found
dbacp03539 L-amino-acid oxidase (BatroxLAAO) (LAO) (EC 1.4.3.2) MNVFFTFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIAKNGLSTTSNPKRVVIVGAGMSGLSAAYVLANAGHQVTVLEASERAGGRVKTYRNEKEGWYANLGPMRLPEKHRIVREYIRKFDLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEVGKSAGQLYEESLQKAVEELRRTNCSYMLNKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDKLPTSMYQAIQEKVHLNARVIKIQQDVKEVTVTYQTSEKETLSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFPNGVGVIIAYGIGDDANYFQALDFEDCGDIVINDLSLIHQLPKEEIQAICRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLRAARDVNRASEIKK Common lancehead Inducing apoptosis MTT assay B16F10 Not found Not found
dbacp03540 L-amino-acid oxidase (BatroxLAAO) (LAO) (EC 1.4.3.2) MNVFFTFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIAKNGLSTTSNPKRVVIVGAGMSGLSAAYVLANAGHQVTVLEASERAGGRVKTYRNEKEGWYANLGPMRLPEKHRIVREYIRKFDLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEVGKSAGQLYEESLQKAVEELRRTNCSYMLNKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDKLPTSMYQAIQEKVHLNARVIKIQQDVKEVTVTYQTSEKETLSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFPNGVGVIIAYGIGDDANYFQALDFEDCGDIVINDLSLIHQLPKEEIQAICRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLRAARDVNRASEIKK Common lancehead Inducing apoptosis MTT assay HL-60 Not found Not found
dbacp03541 L-amino-acid oxidase (BatroxLAAO) (LAO) (EC 1.4.3.2) MNVFFTFSLLFLAALGSCADDRNPLEECFRETDYEEFLEIAKNGLSTTSNPKRVVIVGAGMSGLSAAYVLANAGHQVTVLEASERAGGRVKTYRNEKEGWYANLGPMRLPEKHRIVREYIRKFDLQLNEFSQENENAWYFIKNIRKRVGEVNKDPGVLEYPVKPSEVGKSAGQLYEESLQKAVEELRRTNCSYMLNKYDTYSTKEYLLKEGNLSPGAVDMIGDLLNEDSGYYVSFIESLKHDDIFAYEKRFDEIVGGMDKLPTSMYQAIQEKVHLNARVIKIQQDVKEVTVTYQTSEKETLSVTADYVIVCTTSRAARRIKFEPPLPPKKAHALRSVHYRSGTKIFLTCTKKFWEDDGIHGGKSTTDLPSRFIYYPNHNFPNGVGVIIAYGIGDDANYFQALDFEDCGDIVINDLSLIHQLPKEEIQAICRPSMIQRWSLDKYAMGGITTFTPYQFQHFSEALTAPVDRIYFAGEYTAQAHGWIDSTIKSGLRAARDVNRASEIKK Common lancehead Inducing apoptosis MTT assay Jurkat Acute T-cell Leukemia Not found
dbacp03544 L-amino-acid oxidase ACTX-8 ADDRNPLEEFRENNYEEFL Venom base Inducing apoptosis MTT assay HeLa Cervical cancer MIC : 20 μg/ml
dbacp03545 L-amino-acid oxidase ACTX-8 (LAAO) (LAO) (EC 1.4.3.2) ADDRNPLEEFRENNYEEFL Hundred-pace Snake Inducing apoptosis MTT assay HeLa Cervical cancer MIC : 20 μg/ml
dbacp03638 Lactoferricin B FKCRRWQWRMKKLGA Temporins family Inducing mitochondria-dependent apoptosis MTT/MTS assay Kelly Brain tumor IC50 : 15.5 µM
dbacp03639 Lactoferricin B FKCRRWQWRMKKLGA Temporins family Inducing mitochondria-dependent apoptosis MTT/MTS assay IMR-32 Brain tumor IC50 : 29 µM
dbacp03640 Lactoferricin B FKCRRWQWRMKKLGA Temporins family Inducing mitochondria-dependent apoptosis MTT/MTS assay SK-N-DZ Brain tumor IC50 : 37 µM
dbacp03641 Lactoferricin B FKCRRWQWRMKKLGA Temporins family Inducing mitochondria-dependent apoptosis MTT/MTS assay SHEP-12 Brain tumor IC50 : 45 µM
dbacp03642 Lactoferricin B FKCRRWQWRMKKLGA Temporins family Inducing mitochondria-dependent apoptosis MTT/MTS assay SH-SY-5Y2 Brain tumor IC50 : 60 µM
dbacp03719 LB-DR5-1 QEVCMTSCDKLMKCNWMAAM Not found Inducing apoptosis Not specified SK-MES-1 Not specified IC50 : 6 nM
dbacp03720 LCP-3 WLHV Plant sources Inducing apoptosis Not specified Caco-2 Not specified Not found
dbacp03721 LFB GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC The Fujian Large Headed Frog Cell Apoptosis MTT assay H460 Colon cancer IC50 : 3.47 μM
dbacp03722 LFB GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC The Fujian Large Headed Frog Cell Apoptosis MTT assay MB435 Melanocyte IC50 : 18.99 μM
dbacp03723 LFB GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC The Fujian Large Headed Frog Cell Apoptosis MTT assay U251MG Breast cancer IC50 : 2.32 μM
dbacp03724 LFB GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC The Fujian Large Headed Frog Cell Apoptosis MTT assay HCT116 Lung cancer IC50 : 2.02 μM
dbacp03725 LFB GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC The Fujian Large Headed Frog, China, Asia Cell Apoptosis MTT assay H460 Colon cancer IC50 : 3.47 μM
dbacp03726 LFB GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC The Fujian Large Headed Frog, China, Asia Cell Apoptosis MTT assay MB435 Melanocyte IC50 : 18.99 μM
dbacp03727 LFB GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC The Fujian Large Headed Frog, China, Asia Cell Apoptosis MTT assay U251MG Breast cancer IC50 : 2.32 μM
dbacp03728 LFB GLFSVVKGVLKGVGKNVSGSLLDQLKCKISGGC The Fujian Large Headed Frog, China, Asia Cell Apoptosis MTT assay HCT116 Lung cancer IC50 : 2.02 μM
dbacp03729 LfcinB FKCRRWQWRMKK Bovine milk Regulation of immune response; Apoptosis MTT/MTS assay AZ-97 Colon cancer Inhibition at 0.1g/l
dbacp03730 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay HT-29 Colon cancer IC50 : > 160 µM
dbacp03731 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay MT-1 Breast cancer IC50 : > 160 µM
dbacp03732 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay Kelly Brain tumor IC50 : 141 ± 3 µM
dbacp03733 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay FEMX Skin cancer IC50 : 40 ± 7 µM
dbacp03734 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay HT-29 Colon cancer IC50 : 148 ± 8 µM
dbacp03735 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay KMS-5 Skin cancer IC50 : 38 µM
dbacp03736 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay U-266 Lymphoma cancer IC50 : 55 µM
dbacp03737 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay KMM-1 Skin cancer IC50 : 57 µM
dbacp03738 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay Sudhl-4 Skin cancer IC50 : 16 µM
dbacp03739 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay Raji Lymphoma cancer IC50 : 13 µM
dbacp03740 LfcinB FKCRRWQWRMKK Bovine lactoferrin (Lf-B) Cell membrane disintegration; Regulation of immune response; Apoptosis MTT/MTS assay Ramos Lymphoma cancer IC50 : 10 µM
dbacp03741 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay Jurkat Leukemia Not found
dbacp03742 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay MCF-7 Leukemia Not found
dbacp03743 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay Colo-35 Leukemia Not found
dbacp03744 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay MDA-MB-435 Leukemia Not found
dbacp03745 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay SKov3 Leukemia Not found
dbacp03746 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay CAov3 Leukemia Not found
dbacp03747 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay HT-29 Leukemia Not found
dbacp03748 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay T-47D Leukemia Not found
dbacp03749 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay CCRF-CEM Leukemia Not found
dbacp03750 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay K562 Leukemia Not found
dbacp03751 LfcinB (Bovine lactoferricin) FKCRRWQWRM Not found Inducing apoptosis MTT assay Raji Leukemia Not found
dbacp03752 LHRH–BH3 peptide luteinizing hormone-releasing hormone (LHRH) QHWSYGLRPGMGQVGRQLAIIGDDINRRY Effectors (BAK, BAX) Inducing apoptosis Cytotoxicity assay, MTT assay A2780 Ovarian carcinoma Not found
dbacp03753 LHRH–BH3 peptide luteinizing hormone-releasing hormone (LHRH) QHWSYGLRPGMGQVGRQLAIIGDDINRRY Effectors (BAK, BAX) Inducing apoptosis Cytotoxicity assay, MTT assay MCF-7 Human breast cancer Not found
dbacp03754 LHRH–BH3 peptide luteinizing hormone-releasing hormone (LHRH) QHWSYGLRPGMGQVGRQLAIIGDDINRRY Effectors (BAK, BAX) Inducing apoptosis Cytotoxicity assay, MTT assay PC-3 Prostate cancer Not found
dbacp03755 LHRH–BH3 peptide luteinizing hormone-releasing hormone (LHRH) QHWSYGLRPGMGQVGRQLAIIGDDINRRY Effectors (BAK, BAX) Inducing apoptosis Cytotoxicity assay, MTT assay SKOV-3 LHRH negative ovarian cancer Not found
dbacp03756 LIB10 MRPEIWIAQELRRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03757 LIB100 MRPEIWIAQEARRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03758 LIB101 MRPEIWIAQEARRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03759 LIB102 MRPEIWIAQEARRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03760 LIB103 MRPEIWIAQEARRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03761 LIB104 MRPEIWIAQEARRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03762 LIB105 MRPEIWIAQEARRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03763 LIB106 MRPEIWIAQEADRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03764 LIB107 MRPEIWIAQEADRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03765 LIB108 MRPEIWIAQEADRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03766 LIB109 MRPEIWIAQEADRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03767 LIB11 MRPEIWIAQELRRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03768 LIB110 MRPEIWIAQEADRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03769 LIB111 MRPEIWIAQEADRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03770 LIB112 MRPEIWIAQEADRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03771 LIB113 MRPEIWIAQEADRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03772 LIB114 MRPEIWIAQEADRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03773 LIB115 MRPEIWIAQEADRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03774 LIB116 MRPEIWIAQEADRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03775 LIB117 MRPEIWIAQEADRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03776 LIB118 MRPEIWIAQEADRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03777 LIB119 MRPEIWIAQEADRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03778 LIB12 MRPEIWIAQELRRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03779 LIB120 MRPEIWIAQEADRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03780 LIB122 MRPEIWAAQELRRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03781 LIB123 MRPEIWAAQELRRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03782 LIB124 MRPEIWAAQELRRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03783 LIB125 MRPEIWAAQELRRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03784 LIB126 MRPEIWAAQELRRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03785 LIB127 MRPEIWAAQELRRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03786 LIB128 MRPEIWAAQELRRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03787 LIB129 MRPEIWAAQELRRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03788 LIB130 MRPEIWAAQELRRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03789 LIB131 MRPEIWAAQELRRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03790 LIB132 MRPEIWAAQELRRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03791 LIB133 MRPEIWAAQELRRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03792 LIB134 MRPEIWAAQELRRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03793 LIB135 MRPEIWAAQELRRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03794 LIB136 MRPEIWAAQELDRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03795 LIB137 MRPEIWAAQELDRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03796 LIB138 MRPEIWAAQELDRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03797 LIB139 MRPEIWAAQELDRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03798 LIB14 MRPEIWIAQELRRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03799 LIB140 MRPEIWAAQELDRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03800 LIB141 MRPEIWAAQELDRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03801 LIB142 MRPEIWAAQELDRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03802 LIB143 MRPEIWAAQELDRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03803 LIB144 MRPEIWAAQELDRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03804 LIB145 MRPEIWAAQELDRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03805 LIB146 MRPEIWAAQELDRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03806 LIB147 MRPEIWAAQELDRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03807 LIB148 MRPEIWAAQELDRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03808 LIB149 MRPEIWAAQELDRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03809 LIB15 MRPEIWIAQELRRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03810 LIB150 MRPEIWAAQELDRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03811 LIB151 MRPEIWAAQEIRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03812 LIB152 MRPEIWAAQEIRRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03813 LIB153 MRPEIWAAQEIRRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03814 LIB154 MRPEIWAAQEIRRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03815 LIB155 MRPEIWAAQEIRRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03816 LIB156 MRPEIWAAQEIRRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03817 LIB157 MRPEIWAAQEIRRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03818 LIB158 MRPEIWAAQEIRRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03819 LIB159 MRPEIWAAQEIRRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03820 LIB160 MRPEIWAAQEIRRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03821 LIB161 MRPEIWAAQEIRRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03822 LIB162 MRPEIWAAQEIRRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03823 LIB163 MRPEIWAAQEIRRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03824 LIB164 MRPEIWAAQEIRRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03825 LIB165 MRPEIWAAQEIRRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03826 LIB166 MRPEIWAAQEIDRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03827 LIB167 MRPEIWAAQEIDRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03828 LIB168 MRPEIWAAQEIDRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03829 LIB169 MRPEIWAAQEIDRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03830 LIB17 MRPEIWIAQELDRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03831 LIB170 MRPEIWAAQEIDRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03832 LIB171 MRPEIWAAQEIDRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03833 LIB172 MRPEIWAAQEIDRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03834 LIB173 MRPEIWAAQEIDRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03835 LIB174 MRPEIWAAQEIDRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03836 LIB175 MRPEIWAAQEIDRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03837 LIB176 MRPEIWAAQEIDRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03838 LIB177 MRPEIWAAQEIDRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03839 LIB178 MRPEIWAAQEIDRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03840 LIB179 MRPEIWAAQEIDRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03841 LIB18 MRPEIWIAQELDRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03842 LIB180 MRPEIWAAQEIDRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03843 LIB181 MRPEIWAAQEFRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03844 LIB182 MRPEIWAAQEFRRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03845 LIB183 MRPEIWAAQEFRRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03846 LIB184 MRPEIWAAQEFRRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03847 LIB185 MRPEIWAAQEFRRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03848 LIB186 MRPEIWAAQEFRRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03849 LIB187 MRPEIWAAQEFRRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03850 LIB188 MRPEIWAAQEFRRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03851 LIB189 MRPEIWAAQEFRRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03852 LIB19 MRPEIWIAQELDRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03853 LIB190 MRPEIWAAQEFRRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03854 LIB191 MRPEIWAAQEFRRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03855 LIB192 MRPEIWAAQEFRRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03856 LIB193 MRPEIWAAQEFRRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03857 LIB194 MRPEIWAAQEFRRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03858 LIB195 MRPEIWAAQEFRRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03859 LIB196 MRPEIWAAQEFDRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03860 LIB197 MRPEIWAAQEFDRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03861 LIB198 MRPEIWAAQEFDRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03862 LIB199 MRPEIWAAQEFDRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03863 LIB20 MRPEIWIAQELDRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03864 LIB200 MRPEIWAAQEFDRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03865 LIB201 MRPEIWAAQEFDRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03866 LIB202 MRPEIWAAQEFDRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03867 LIB203 MRPEIWAAQEFDRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03868 LIB204 MRPEIWAAQEFDRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03869 LIB205 MRPEIWAAQEFDRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03870 LIB206 MRPEIWAAQEFDRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03871 LIB207 MRPEIWAAQEFDRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03872 LIB208 MRPEIWAAQEFDRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03873 LIB209 MRPEIWAAQEFDRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03874 LIB21 MRPEIWIAQELDRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03875 LIB210 MRPEIWAAQEFDRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03876 LIB211 MRPEIWAAQEARRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03877 LIB212 MRPEIWAAQEARRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03878 LIB213 MRPEIWAAQEARRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03879 LIB214 MRPEIWAAQEARRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03880 LIB215 MRPEIWAAQEARRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03881 LIB216 MRPEIWAAQEARRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03882 LIB217 MRPEIWAAQEARRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03883 LIB218 MRPEIWAAQEARRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03884 LIB219 MRPEIWAAQEARRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03885 LIB22 MRPEIWIAQELDRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03886 LIB220 MRPEIWAAQEARRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03887 LIB221 MRPEIWAAQEARRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03888 LIB222 MRPEIWAAQEARRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03889 LIB223 MRPEIWAAQEARRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03890 LIB224 MRPEIWAAQEARRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03891 LIB225 MRPEIWAAQEARRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03892 LIB226 MRPEIWAAQEADRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03893 LIB227 MRPEIWAAQEADRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03894 LIB228 MRPEIWAAQEADRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03895 LIB229 MRPEIWAAQEADRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03896 LIB23 MRPEIWIAQELDRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03897 LIB230 MRPEIWAAQEADRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03898 LIB231 MRPEIWAAQEADRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03899 LIB232 MRPEIWAAQEADRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03900 LIB233 MRPEIWAAQEADRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03901 LIB234 MRPEIWAAQEADRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03902 LIB235 MRPEIWAAQEADRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03903 LIB236 MRPEIWAAQEADRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03904 LIB237 MRPEIWAAQEADRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03905 LIB238 MRPEIWAAQEADRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03906 LIB239 MRPEIWAAQEADRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03907 LIB24 MRPEIWIAQELDRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03908 LIB240 MRPEIWAAQEADRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03909 LIB242 MRPEIWFAQELRRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03910 LIB243 MRPEIWFAQELRRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03911 LIB244 MRPEIWFAQELRRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03912 LIB245 MRPEIWFAQELRRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03913 LIB246 MRPEIWFAQELRRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03914 LIB247 MRPEIWFAQELRRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03915 LIB248 MRPEIWFAQELRRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03916 LIB249 MRPEIWFAQELRRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03917 LIB25 MRPEIWIAQELDRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03918 LIB250 MRPEIWFAQELRRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03919 LIB251 MRPEIWFAQELRRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03920 LIB252 MRPEIWFAQELRRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03921 LIB253 MRPEIWFAQELRRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03922 LIB254 MRPEIWFAQELRRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03923 LIB255 MRPEIWFAQELRRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03924 LIB256 MRPEIWFAQELDRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03925 LIB257 MRPEIWFAQELDRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03926 LIB258 MRPEIWFAQELDRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03927 LIB259 MRPEIWFAQELDRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03928 LIB26 MRPEIWIAQELDRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03929 LIB260 MRPEIWFAQELDRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03930 LIB261 MRPEIWFAQELDRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03931 LIB262 MRPEIWFAQELDRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03932 LIB263 MRPEIWFAQELDRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03933 LIB264 MRPEIWFAQELDRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03934 LIB265 MRPEIWFAQELDRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03935 LIB266 MRPEIWFAQELDRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03936 LIB267 MRPEIWFAQELDRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03937 LIB268 MRPEIWFAQELDRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03938 LIB269 MRPEIWFAQELDRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03939 LIB27 MRPEIWIAQELDRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03940 LIB270 MRPEIWFAQELDRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03941 LIB271 MRPEIWFAQEIRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03942 LIB272 MRPEIWFAQEIRRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03943 LIB273 MRPEIWFAQEIRRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03944 LIB274 MRPEIWFAQEIRRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03945 LIB275 MRPEIWFAQEIRRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03946 LIB276 MRPEIWFAQEIRRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03947 LIB277 MRPEIWFAQEIRRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03948 LIB278 MRPEIWFAQEIRRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03949 LIB279 MRPEIWFAQEIRRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03950 LIB28 MRPEIWIAQELDRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03951 LIB280 MRPEIWFAQEIRRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03952 LIB281 MRPEIWFAQEIRRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03953 LIB282 MRPEIWFAQEIRRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03954 LIB283 MRPEIWFAQEIRRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03955 LIB284 MRPEIWFAQEIRRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03956 LIB285 MRPEIWFAQEIRRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03957 LIB286 MRPEIWFAQEIDRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03958 LIB287 MRPEIWFAQEIDRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03959 LIB288 MRPEIWFAQEIDRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03960 LIB289 MRPEIWFAQEIDRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03961 LIB29 MRPEIWIAQELDRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03962 LIB290 MRPEIWFAQEIDRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03963 LIB291 MRPEIWFAQEIDRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03964 LIB292 MRPEIWFAQEIDRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03965 LIB293 MRPEIWFAQEIDRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03966 LIB294 MRPEIWFAQEIDRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03967 LIB295 MRPEIWFAQEIDRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03968 LIB296 MRPEIWFAQEIDRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03969 LIB297 MRPEIWFAQEIDRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03970 LIB298 MRPEIWFAQEIDRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03971 LIB299 MRPEIWFAQEIDRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03972 LIB30 MRPEIWIAQELDRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03973 LIB300 MRPEIWFAQEIDRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03974 LIB301 MRPEIWFAQEFRRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03975 LIB302 MRPEIWFAQEFRRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03976 LIB303 MRPEIWFAQEFRRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03977 LIB304 MRPEIWFAQEFRRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03978 LIB305 MRPEIWFAQEFRRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03979 LIB306 MRPEIWFAQEFRRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03980 LIB307 MRPEIWFAQEFRRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03981 LIB308 MRPEIWFAQEFRRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03982 LIB309 MRPEIWFAQEFRRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03983 LIB310 MRPEIWFAQEFRRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03984 LIB311 MRPEIWFAQEFRRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03985 LIB312 MRPEIWFAQEFRRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03986 LIB313 MRPEIWFAQEFRRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03987 LIB314 MRPEIWFAQEFRRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03988 LIB315 MRPEIWFAQEFRRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03989 LIB316 MRPEIWFAQEFDRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03990 LIB317 MRPEIWFAQEFDRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03991 LIB318 MRPEIWFAQEFDRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03992 LIB319 MRPEIWFAQEFDRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03993 LIB32 MRPEIWIAQEIRRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03994 LIB320 MRPEIWFAQEFDRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03995 LIB321 MRPEIWFAQEFDRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03996 LIB322 MRPEIWFAQEFDRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03997 LIB323 MRPEIWFAQEFDRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03998 LIB324 MRPEIWFAQEFDRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp03999 LIB325 MRPEIWFAQEFDRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04000 LIB326 MRPEIWFAQEFDRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04001 LIB327 MRPEIWFAQEFDRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04002 LIB328 MRPEIWFAQEFDRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04003 LIB329 MRPEIWFAQEFDRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04004 LIB33 MRPEIWIAQEIRRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04005 LIB330 MRPEIWFAQEFDRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04006 LIB331 MRPEIWFAQEARRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04007 LIB332 MRPEIWFAQEARRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04008 LIB333 MRPEIWFAQEARRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04009 LIB334 MRPEIWFAQEARRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04010 LIB335 MRPEIWFAQEARRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04011 LIB336 MRPEIWFAQEARRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04012 LIB337 MRPEIWFAQEARRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04013 LIB338 MRPEIWFAQEARRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04014 LIB339 MRPEIWFAQEARRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04015 LIB34 MRPEIWIAQEIRRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04016 LIB340 MRPEIWFAQEARRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04017 LIB341 MRPEIWFAQEARRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04018 LIB342 MRPEIWFAQEARRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04019 LIB343 MRPEIWFAQEARRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04020 LIB344 MRPEIWFAQEARRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04021 LIB345 MRPEIWFAQEARRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04022 LIB346 MRPEIWFAQEADRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04023 LIB347 MRPEIWFAQEADRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04024 LIB348 MRPEIWFAQEADRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04025 LIB349 MRPEIWFAQEADRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04026 LIB35 MRPEIWIAQEIRRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04027 LIB350 MRPEIWFAQEADRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04028 LIB351 MRPEIWFAQEADRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04029 LIB352 MRPEIWFAQEADRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04030 LIB353 MRPEIWFAQEADRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04031 LIB354 MRPEIWFAQEADRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04032 LIB355 MRPEIWFAQEADRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04033 LIB356 MRPEIWFAQEADRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04034 LIB357 MRPEIWFAQEADRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04035 LIB358 MRPEIWFAQEADRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04036 LIB359 MRPEIWFAQEADRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04037 LIB36 MRPEIWIAQEIRRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04038 LIB37 MRPEIWIAQEIRRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04039 LIB38 MRPEIWIAQEIRRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04040 LIB39 MRPEIWIAQEIRRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04041 LIB40 MRPEIWIAQEIRRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04042 LIB41 MRPEIWIAQEIRRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04043 LIB42 MRPEIWIAQEIRRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04044 LIB43 MRPEIWIAQEIRRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04045 LIB44 MRPEIWIAQEIRRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04046 LIB45 MRPEIWIAQEIRRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04047 LIB46 MRPEIWIAQEIDRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04048 LIB47 MRPEIWIAQEIDRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04049 LIB48 MRPEIWIAQEIDRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04050 LIB49 MRPEIWIAQEIDRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04051 LIB5 MRPEIWIAQELRRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04052 LIB50 MRPEIWIAQEIDRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04053 LIB51 MRPEIWIAQEIDRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04054 LIB52 MRPEIWIAQEIDRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04055 LIB53 MRPEIWIAQEIDRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04056 LIB54 MRPEIWIAQEIDRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04057 LIB55 MRPEIWIAQEIDRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04058 LIB56 MRPEIWIAQEIDRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04059 LIB57 MRPEIWIAQEIDRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04060 LIB58 MRPEIWIAQEIDRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04061 LIB59 MRPEIWIAQEIDRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04062 LIB6 MRPEIWIAQELRRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04063 LIB60 MRPEIWIAQEIDRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04064 LIB62 MRPEIWIAQEFRRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04065 LIB63 MRPEIWIAQEFRRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04066 LIB64 MRPEIWIAQEFRRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04067 LIB65 MRPEIWIAQEFRRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04068 LIB66 MRPEIWIAQEFRRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04069 LIB67 MRPEIWIAQEFRRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04070 LIB68 MRPEIWIAQEFRRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04071 LIB69 MRPEIWIAQEFRRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04072 LIB70 MRPEIWIAQEFRRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04073 LIB71 MRPEIWIAQEFRRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04074 LIB72 MRPEIWIAQEFRRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04075 LIB73 MRPEIWIAQEFRRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04076 LIB74 MRPEIWIAQEFRRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04077 LIB75 MRPEIWIAQEFRRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04078 LIB76 MRPEIWIAQEFDRIGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04079 LIB77 MRPEIWIAQEFDRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04080 LIB78 MRPEIWIAQEFDRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04081 LIB79 MRPEIWIAQEFDRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04082 LIB8 MRPEIWIAQELRRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04083 LIB80 MRPEIWIAQEFDRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04084 LIB81 MRPEIWIAQEFDRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04085 LIB82 MRPEIWIAQEFDRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04086 LIB83 MRPEIWIAQEFDRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04087 LIB84 MRPEIWIAQEFDRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04088 LIB85 MRPEIWIAQEFDRNGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04089 LIB86 MRPEIWIAQEFDRNGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04090 LIB87 MRPEIWIAQEFDRNGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04091 LIB88 MRPEIWIAQEFDRAGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04092 LIB89 MRPEIWIAQEFDRAGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04093 LIB9 MRPEIWIAQELRRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04094 LIB90 MRPEIWIAQEFDRAGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04095 LIB92 MRPEIWIAQEARRIGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04096 LIB93 MRPEIWIAQEARRIGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04097 LIB94 MRPEIWIAQEARRFGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04098 LIB95 MRPEIWIAQEARRFGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04099 LIB96 MRPEIWIAQEARRFGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04100 LIB97 MRPEIWIAQEARRDGDEFNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04101 LIB98 MRPEIWIAQEARRDGDEVNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04102 LIB99 MRPEIWIAQEARRDGDENNAYYARRV BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04128 LK-L1C/K6W/L8C CKKLLWLCKKLLKLAG Not found Inducing apoptosis MTS assay HeLa Not specified Not found
dbacp04129 LK-L1C/K6W/L8C CKKLLWLCKKLLKLAG Not found Inducing apoptosis MTS assay MCF-7 Not specified Not found
dbacp04152 LL-37 LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES Not found Inducing apoptosis Not specified SAS-H1 Not specified Not found
dbacp04153 LL-37 LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES Not found Inducing apoptosis Not specified HCT116 Not specified Not found
dbacp04255 LNV-LAO L-amino acid oxidase (LAO) ADDKNPLEEAFREADYEVFLEIAKNGL Venom base Inducing apoptosis MM6 cell culture assay MM6 Not specified IC50 : < 35 ng/ml
dbacp04256 Loading module of NRPS-PKS MCLPEDSSPLSGHRPVPAPRVSADRTFSCFLIGGNSLVATCAELLLSHGHRVLGLVSPDAGIRDWARQRRLPALDFGPGLTERLAATPFDYLFSIANLRMLPAALLDLPRELPVNFHDGPLPRHAGLNATTWAVLEREVSHGVTWHVMTEGADEGDVLVQRPVTVTDQDTSHTLNVKCFEAGYASFAELVGLLESGAVRRTAQDLSARSYHGRFDRPAGGGFLSWDRPAALLHAAVRAADHGPYPNEFGTAKFAAGDGAVLVSGLSPLPGPSQGPPGTVLRAGEDGLVVAVADGAVRLTGLTTPMGEPLTGTGLAGYGIRPGHRLPVPGPALLAAATDAQARHLRQERHWRRRLTDLVPADLTGADSTARGGHLAVPVPVPPGAAEAAARAGLRRDQWLLAAHLAFLTRTGVEEGTDVHWRLAHPPTGHRSVDALYASFVPLRIPPVDGADMAAFGSRVVTGTDEANRRGSHPHDLWLRDPRLRDRRPSAAGLPIAVEICDDTTAPATPADGTKLLIRIPAGEDPGPCRWLVREGTYDPGTLAALAGYAAAFLTAAATAEGGRDLSGIPLGTEAQRRGAHGEAIPADDPSPDACVHQLVTRRARLRPDAPAVSGAGQTLSYAELDRRSSALAGYLRARGIGAGHLVGVFLGRSVQLPVVLLGVMKSGAAYVPLDPVYPADRIGYMLRDTALRLVVTESGLATRLPAGHGETLVLDRSWPEVESAVPEPGARVTDEQDAYVLYTSGSTGRPKGVRIGHRALTNLIRSMCRTPGVTEDDTLLAVTTVCFDIAGLELYAPLVAGGRVEVAPEQATADGPALRDLLERVRPTVMQATPATWRMLLDAGWPRGADSPVPRVLCGGEALSDDLAGRLLAHGARLWNLYGPTETTIWSAVKRVRPEEPVTLGRPIANTVFHVVDRRLRPVPPGIPGELLIGGAGVARGYLNRPELTAERFVPDVYGGGDGTVYRTGDLVRLRPDGELEYLGRLDDQVKLHGYRIEPGEVEQALGRHPGVAEAVVVVREDRPGDRRLVAYLVPRTPGLRPAELRAHLLATLPAYMVPTAFVELDAIPLTGNGKTDRRALPRPAGVLGTRTAPTDLLERAVAGIWREVLVLDAVGAEDNFFEAGGTSLLLMRLMARINAEMDASLSRVEMFMYPTVRSMTRHLRSRRSGRTGPGPAVPQSRGTRPSRTGLADLRRRRQQVRTADETGR Streptomyces conglobatus Induce apoptosis Not specified Not found Not found Not found
dbacp04287 LP-4 peptide SWTWEKKLETAVNLAWTAGNSNKWTWK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified CLL Leukemia Not found
dbacp04288 LP-4 peptide SWTWEKKLETAVNLAWTAGNSNKWTWK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified MEC-1 Leukemia Not found
dbacp04309 Lunasin SKWQHQQDSCRKQLQGVNLTPCEKHIMEKIQGRDDDDDDDDDD Plant sources Inducing apoptosis MTT assay HCT116-derived spheres Colorectal cancer IC50 : 161.0 ± 2.4 μM
dbacp04310 Lunasin SKWQHQQDSCRKQLQGVNLTPCEKHIMEKIQGRDDDDDDDDDD Plant sources Inducing apoptosis MTT assay HCT-116 parentl Colorectal cancer IC50 : 107.5 ± 1.9 μM
dbacp04312 Lunasin SKWQHQQDSCRKQLQGVNLTPCEKHIMEKIQGRGDDDDDDDDD Soyabean Apoptosis inducing; Anti-proliferative MTT/MTS HT-29 Not specified IC50 : 61.7 µM
dbacp04313 Lunasin SKWQHQQDSCRKQLQGVNLTPCEKHIMEKIQGRGDDDDDDDDD Soyabean Apoptosis inducing; Anti-proliferative MTT/MTS HCT-116 Not specified IC50 : 31.6 µM
dbacp04314 Lunasin SKWQHQQDSCRKQLQGVNLTPCEKHIMEKIQGRGDDDDDDDDD Soyabean Apoptosis inducing; Anti-proliferative MTT/MTS MCF-7 Not specified IC50 : 431.9 µM
dbacp04317 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay HeLa Cervical cancer Not found
dbacp04318 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay HeLa Esophageal cancer Not found
dbacp04319 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay HeLa Liver cancer Not found
dbacp04320 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay HeLa Bladder cancer Not found
dbacp04321 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay EC109 Cervical cancer Not found
dbacp04322 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay EC109 Esophageal cancer Not found
dbacp04323 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay EC109 Liver cancer Not found
dbacp04324 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay EC109 Bladder cancer Not found
dbacp04325 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay HepG2 Cervical cancer Not found
dbacp04326 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay HepG2 Esophageal cancer Not found
dbacp04327 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay HepG2 Liver cancer Not found
dbacp04328 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay HepG2 Bladder cancer Not found
dbacp04329 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay EJ Cervical cancer Not found
dbacp04330 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay EJ Esophageal cancer Not found
dbacp04331 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay EJ Liver cancer Not found
dbacp04332 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay EJ Bladder cancer Not found
dbacp04333 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay THLE-3 Cervical cancer Not found
dbacp04334 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay THLE-3 Esophageal cancer Not found
dbacp04335 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay THLE-3 Liver cancer Not found
dbacp04336 LvHemB1 DVNFLLHKIYGNIRY Marine invertebrates Inducing apoptosis MTT assay THLE-3 Bladder cancer Not found
dbacp04337 LVTX-8 IWLTALKFLGKNLGKHLAKQQLSKL-NH2 True tarantula Promote apoptosis; Inhibits the proliferation and migration of lung cancer cells both in vitro and in vivo CCK-8 assay, Flow cytometry, Colony formation assay, Transwell invasion and migration assay A549 Lung cancer IC50 : approx. 8 µM
dbacp04338 LVTX-8 IWLTALKFLGKNLGKHLAKQQLSKL-NH2 True tarantula Promote apoptosis; Inhibits the proliferation and migration of lung cancer cells both in vitro and in vivo CCK-8 assay, Flow cytometry, Colony formation assay, Transwell invasion and migration assay H461 Lung cancer IC50 : approx. 8 µM
dbacp04339 LVTX-9 ASIGALIQKAIALIKAKAA-NH2 True tarantula Promote apoptosis; Inhibits the proliferation and migration of lung cancer cells both in vitro and in vivo CCK-8 assay, Flow cytometry, Colony formation assay, Transwell invasion and migration assay A549 Lung cancer IC50 : approx. 8 µM
dbacp04340 LVTX-9 ASIGALIQKAIALIKAKAA-NH2 True tarantula Promote apoptosis; Inhibits the proliferation and migration of lung cancer cells both in vitro and in vivo CCK-8 assay, Flow cytometry, Colony formation assay, Transwell invasion and migration assay H460 Lung cancer IC50 : approx. 8 µM
dbacp04341 Lycosin-1 Ac-KGWFKAMKSIAKFIAKEKLKEHL-amide Tarantula wolf spider Inhibit the migration of prostate cancer cell; Induce apoptosis MTT assay DU-145 Prostate cancer MIC : 10 μM
dbacp04342 Lycosin-1 Ac-KGWFKAMKSIAKFIAKEKLKEHL-amide Tarantula wolf spider Inhibit the migration of prostate cancer cell; Induce apoptosis MTT assay PC-3 Prostate cancer MIC : 20 μM
dbacp04343 Lycosin-I RKGWFKAMKSIAKFIAKEKLKEHL-OH Venom, wolf spider Apoptosis Not specified Not found Not found Not found
dbacp04344 Lycosin-I RKGWFKAMKSIAKFIAKEKLKEHL-OH Wolf spider Apoptosis Not specified Not found Not found Not found
dbacp04347 Lytic KLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay BXPC-3 Pancreatic cancer IC50 : 37.1 µMol/L
dbacp04348 Lytic KLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay SU.86.86 Pancreatic cancer IC50 : 28.0 µMol/L
dbacp04349 Lytic KLlLKlLkkLLKlLKKK Bovine lactoferrin (Lf-B) Induction of apoptosis WST-1 assay KB Oral cancer IC50 : 37.4 µMol/L
dbacp04350 Lytic KLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay T98G Brain tumor IC50 : 77.3 µMol/L
dbacp04351 Lytic KLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay A-172 Brain tumor IC50 : 30.5 µMol/L
dbacp04352 Lytic KLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay H-322 Lung cancer IC50 : 27.1 µMol/L
dbacp04353 Lytic KLlLKlLkkLLKlLKKK Interleukin-4 receptor a (IL-4Ra) chain Induction of apoptosis WST-1 assay MDA-MB-231 Breast cancer IC50 : 18.5 µMol/L
dbacp04541 Malanin chain A DYPKLTFTTS Plant sources Inducing apoptosis MTT assay HeLa Cervical cancer IC50 : 0.15 ± 0.08 nM
dbacp04542 Malanin chain A DYPKLTFTTS Plant sources Inducing apoptosis MTT assay PC-12 Breast cancer IC50 : 7.71 ± 0.24 nM
dbacp04543 Malanin chain A DYPKLTFTTS Plant sources Inducing apoptosis MTT assay MCF-7 Leukemia IC50 : 11.20 ± 0.02 nM
dbacp04544 Malanin chain A DYPKLTFTTS Plant sources Inducing apoptosis MTT assay K562 Not found IC50 : 15.80 ± 0.09 nM
dbacp04545 Malanin chain A DYPKLTFTTS Plant sources Inducing apoptosis MTT assay Vero Not found IC50 : 2.79 ± 0.05 nM
dbacp04546 Malanin chain A DYPKLTFTTS Plant sources Inducing apoptosis MTT assay MDCK Not found IC50 : 3.92 ± 0.01 nM
dbacp04547 Malanin chain B DETCTDEEFN Plant sources Inducing apoptosis MTT assay HeLa Cervical cancer IC50 : 0.15 ± 0.08 nM
dbacp04548 Malanin chain B DETCTDEEFN Plant sources Inducing apoptosis MTT assay PC-12 Breast cancer IC50 : 7.71 ± 0.24 nM
dbacp04549 Malanin chain B DETCTDEEFN Plant sources Inducing apoptosis MTT assay MCF-7 Leukemia IC50 : 11.20 ± 0.02 nM
dbacp04550 Malanin chain B DETCTDEEFN Plant sources Inducing apoptosis MTT assay K562 Not found IC50 : 15.80 ± 0.09 nM
dbacp04551 Malanin chain B DETCTDEEFN Plant sources Inducing apoptosis MTT assay Vero Not found IC50 : 2.79 ± 0.05 nM
dbacp04552 Malanin chain B DETCTDEEFN Plant sources Inducing apoptosis MTT assay MDCK Not found IC50 : 3.92 ± 0.01 nM
dbacp04562 Mastoparan INLKALAALAKKIL Venom base Inducing apoptosis Not specified A2058 Not specified IC50 : 140 ± 9.2 µM
dbacp04563 Mastoparan INLKALAALAKKIL Venom base Inducing apoptosis Not specified MCF-7 Not specified IC50 : 432.5 ± 10.9 µM
dbacp04564 Mastoparan INLKALAALAKKIL Venom base Inducing apoptosis Not specified MDA-MB-231 Not specified IC50 : 251.25 ± 11.5 µM
dbacp04565 Mastoparan INLKALAALAKKIL Venom base Inducing apoptosis Not specified SiHa Not specified IC50 : 172.1 ± 8.8 µM
dbacp04566 Mastoparan INLKALAALAKKIL Venom base Inducing apoptosis Not specified SK-BR3 Not specified IC50 : 320.3 ± 12.5 µM
dbacp04567 Mastoparan INLKALAALAKKIL Venom base Inducing apoptosis Not specified U87 Not specified IC50 : 311.7 ± 8.9 µM
dbacp04568 Mastoparan INLKALAALAKKIL Venom base Inducing apoptosis Not specified Jurkat Not specified IC50 : 77.9 ± 6.7 µM
dbacp04569 Mastoparan INLKALAALAKKIL-NH2 Eusocial wasp Induction of apoptosis; Alteration of mitochondrial permeability MTS assay A549 Lung cancer IC50 : 34.3 ± 1.6 µg/mL
dbacp04573 Mastoparan-C LNLKALLAVAKKIL European hornet Apoptosis MTT assay H157 Non-small cell Lung cancer IC50 : 13.57 μM
dbacp04574 Mastoparan-C LNLKALLAVAKKIL European hornet Apoptosis MTT assay MBD-MB-435S Melanocyte IC50 : 1.4 μM
dbacp04575 Mastoparan-C LNLKALLAVAKKIL European hornet Apoptosis MTT assay PC-3 Human prostate carcinoma IC50 : 1.4 μM
dbacp04576 Mastoparan-C LNLKALLAVAKKIL European hornet Apoptosis MTT assay U251-MG Human glioblastoma astrocytoma IC50 : 1.4 μM
dbacp04577 Mastoparan-C LNLKALLAVAKKIL European hornet Apoptosis MTT assay MCF-7 Human Breast cancer IC50 : 1.4 μM
dbacp04578 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay H157 Lung cancer MIC : 6.26 - 36.65 μM
dbacp04579 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay MDA-MB-435S Breast cancer MIC : 6.26 - 36.65 μM
dbacp04580 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay PC-3 Human prostate carcinoma MIC : 6.26 - 36.65 μM
dbacp04581 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay U251-MG Glioma MIC : 6.26 - 36.65 μM
dbacp04582 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay MCF-7 Breast cancer MIC : 6.26 - 36.65 μM
dbacp04583 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay HMEC-1 Glioma MIC : 6.26 - 36.65 μM
dbacp04584 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay H157 Lung cancer IC50 : < 4 μM
dbacp04585 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay MDA-MB-435S Breast cancer IC50 : < 4 μM
dbacp04586 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay PC-3 Human prostate carcinoma IC50 : < 4 μM
dbacp04587 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay U251-MG Glioma IC50 : < 4 μM
dbacp04588 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay MCF-7 Breast cancer IC50 : < 4 μM
dbacp04589 Mastoparan-Cimals. XXA; UCLL1c) LNLKALLAVAKKIL Venom, the European Hornet Inducing apoptosis MTT cell viability assay and Lactate dehydrogenase (LDH) leakage assay HMEC-1 Glioma IC50 : < 4 μM
dbacp04591 Mature Smac (1-4) AVPI SMAC Inducing apoptosis Not specified Not found Not specified Not found
dbacp04592 Mauriporin MNKKTLLVIFFITMLIVDEVNSFKIGGFIKKLWRSKLAKKLRAKGRELLKDYANRVINGGPEEEAAVPAERRR Fat-tailed scorpion Induce cell apoptosis; Targets on the cell membranes and caused membrane lysis MTT assay, Lactate dehydrogenase (LDH) Release assay Hela Human cervical cancer IC50 : 27.9 μM - 283.3 μM
dbacp04593 Mauriporin MNKKTLLVIFFITMLIVDEVNSFKIGGFIKKLWRSKLAKKLRAKGRELLKDYANRVINGGPEEEAAVPAERRR Fat-tailed scorpion Induce cell apoptosis; Targets on the cell membranes and caused membrane lysis MTT assay, Lactate dehydrogenase (LDH) Release assay SACC-83 Human salivary adenoid cystic carcinoma IC50 : 27.9 μM - 283.3 μM
dbacp04594 Mauriporin MNKKTLLVIFFITMLIVDEVNSFKIGGFIKKLWRSKLAKKLRAKGRELLKDYANRVINGGPEEEAAVPAERRR Fat-tailed scorpion Induce cell apoptosis; Targets on the cell membranes and caused membrane lysis MTT assay, Lactate dehydrogenase (LDH) Release assay HepG2 Human liver cancer IC50 : 27.9 μM - 283.3 μM
dbacp04595 Mauriporin MNKKTLLVIFFITMLIVDEVNSFKIGGFIKKLWRSKLAKKLRAKGRELLKDYANRVINGGPEEEAAVPAERRR Fat-tailed scorpion Induce cell apoptosis; Targets on the cell membranes and caused membrane lysis MTT assay, Lactate dehydrogenase (LDH) Release assay PC-3 Human Prostate cancer IC50 : 27.9 μM - 283.3 μM
dbacp04623 MB1 RPEIWIAQEIDRIGDEVNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04624 MB2 RPEIWFAQEIDRIGDEVNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04625 MB7 RPEIWAAQEIRRIGDENNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04629 MCL-1, BH3 (208-228) KALETLRRVGDGVQRNHETAF Anti apoptotic (MCL-1, BFL1) Inducing apoptosis Not specified Not found Blood cancer Not found
dbacp04630 MCL-1, BH3 (208-228) KALETLRRVGDGVQRNHETAF Anti apoptotic (MCL-1, BFL1) Inducing apoptosis Not specified Not found Leukemia Not found
dbacp04631 MCL-1, BH3 (208-228) KALETLRRVGDGVQRNHETAF Anti apoptotic (MCL-1, BFL1) Inducing apoptosis Not specified Not found Skin cancer Not found
dbacp04632 MCL-1, BH3 (208-228) KALETLRRVGDGVQRNHETAF Anti apoptotic (MCL-1, BFL1) Inducing apoptosis Not specified Not found Breast cancer Not found
dbacp04642 MEL-dKLA GIGAVLKVLTTGLPALISWIKRKRQQGGGGSKLAKLAKKLAKLAK Venom base Inducing apoptosis MTS assay RAW264.7 Lung cancer IC50 : 0.85 μM
dbacp04653 Melittin GIGAVLKVLTTGLPALISWIKRKRQQ Venom base Inducing apoptosis MTT assay SGC-7901 Gastric cancer Not found
dbacp04665 MF11 RPEIWVAQELERIGEEVNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04676 MG1 RPEIWFAQEFSRIGDEVNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp04683 Min-Antp-LP4 KRRMKWKKSWTWEKKLETAVNLAWTAGNSNKWTWK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified CLL Leukemia IC50 : 0.3 ± 0.1 µM
dbacp04684 Min-Antp-LP4 KRRMKWKKSWTWEKKLETAVNLAWTAGNSNKWTWK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified MEC-1 Leukemia IC50 : 1.7 ± 0.4 µM
dbacp04685 MIP PRFWEYWLRLME E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : 0.01 µM
dbacp04686 MIP PRFWEYWLRLME E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : 0.12 µM
dbacp04687 MIP(F3A) PRAWEYWLRLME E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : 0.57 µM
dbacp04688 MIP(L10A) PRFWEYWLRAME E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : 1.14 µM
dbacp04689 MIP(M11A) PRFWEYWLRLAE E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : 0.4 µM
dbacp04690 MIP(R9A) PRFWEYWLALME E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : 0.02 µM
dbacp04691 MIP(W7A) PRFWEYALRLME E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : >100 µM
dbacp04692 MIP(Y6A) PRFWEAWLRLME E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : >100 µM
dbacp04693 MIPP SLSLSVAR Plant sources Inducing apoptosis SRB assay HeLa Human endometrial cancer Not found
dbacp04694 MK58911 (a peptide Analog from the mastoparan class of wasps) INWLKIAKKVKGML Greater wax moth Apoptosis; Necrosis Cytotoxicity test MRC5 Not found IC50 : > 500 µg/mL
dbacp04695 MK58911 (a peptide Analog from the mastoparan class of wasps) INWLKIAKKVKGML Greater wax moth Apoptosis; Necrosis Cytotoxicity test U87 Not found IC50 : > 500 µg/mL
dbacp04698 MP06 LAVISWKCQEWNSLWKKRKRKT Green algae Apoptosis inducing CCK-8 assay MRC5 Lung cancer IC50 : 10 μM
dbacp04699 MP12 MDNHVCIPLCPP Not found Inducing apoptosis MTT assay Hep-2 Laryngeal cancer IC50 : 24.7 ± 0.34 Μm
dbacp04705 MS1 RPEIWMTQGLRRLGDEINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Mcl-1/Myc 2640 Not found Not found
dbacp04706 MS1 RPEIWMTQGLRRLGDEINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Bcl-2/Myc 2924 Not found Not found
dbacp04707 MS2 RPEIWLTQSLQRLGDEINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Mcl-1/Myc 2640 Not found Not found
dbacp04708 MS2 RPEIWLTQSLQRLGDEINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Bcl-2/Myc 2924 Not found Not found
dbacp04709 MS3 RPEIWLTQHLQRLGDEINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Mcl-1/Myc 2640 Not found Not found
dbacp04710 MS3 RPEIWLTQHLQRLGDEINAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Bcl-2/Myc 2924 Not found Not found
dbacp04713 mt_E17L/L22 W/P27A LTFSDWWKLLAE MDM3 Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : 15.1 µM
dbacp04714 mt_L22 W/P27A ETFSDWWKLLAE MDM2 Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : 16.3 µM
dbacp04715 mt_S20A/L22 W/P27A ETFADWWKLLAE MDM5 Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : 8.7 µM
dbacp04716 mt_T18S/L22 W/P27A ESFSDWWKLLAE MDM4 Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : 27 µM
dbacp04717 Multivalent DR5 binding peptides, TRAILmim/DR5 (1m) WDCLDNRIGRRQCVKL Not found Inducing apoptosis Not specified HCT 116 Colon cancer Kd (Binding constants of TRAIL mimics): 129 ± 3.68 nMol/L
dbacp04718 Multivalent DR5 binding peptides, TRAILmim/DR5 (2m) WDCLDNRIGKRQCVRL Not found Inducing apoptosis Not specified HCT 116 Colon cancer Kd (Binding constants of TRAIL mimics): 664 ± 18 nMol/L
dbacp04719 Multivalent DR5 binding peptides, TRAILmim/DR5 (3m) WDCLDNKIGRRQCVRL Not found Inducing apoptosis Not specified HCT 116 Colon cancer Kd (Binding constants of TRAIL mimics): 226 ± 5.64 nMol/L
dbacp04790 N-Ter RDVFTKGYGFGL VDAC1(voltage-dependent anion channel1) Inducing apoptosis SRB assay A375 Human endometrial cancer IC50 : > 50.0 μM
dbacp04791 N-Ter-Antp N-Ter-RQIKIWFQNRRMKWKK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified CLL Leukemia IC50 : 3.2 ± 0.5 µM
dbacp04792 N-Ter-Antp N-Ter-RQIKIWFQNRRMKWKK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified MEC-1 Leukemia IC50 : 4.2 ± 0.2 µM
dbacp04793 N-Ter-TAT RDVFTKGYGFGLGRKKRRQRRRPQ VDAC1(voltage-dependent anion channel1) Inducing apoptosis SRB assay A375 Human endometrial cancer IC50 : > 50.0 μM
dbacp04820 Nal2-S1 Ac-KKWRKWLAKK-NH2 Not found Necrosis; Apoptosis MTT assay PC9 Human Lung cancer MIC : 25 μM
dbacp04821 Nal2-S1 Ac-KKWRKWLAKK-NH2 Not found Necrosis; Apoptosis MTT assay PC9-G Oral cancer MIC : 25 μM
dbacp04822 Nal2-S1 Ac-KKWRKWLAKK-NH2 Not found Necrosis; Apoptosis MTT assay A549 Human Lung cancer MIC : 25 μM
dbacp04823 Nal2-S1 Ac-KKWRKWLAKK-NH2 Not found Necrosis; Apoptosis MTT assay C9 Oral cancer MIC : 25 μM
dbacp04824 Nal2-S1 Ac-KKWRKWLAKK-NH2 Not found Necrosis; Apoptosis MTT assay OECM-1 Human Lung cancer MIC : 25 μM
dbacp04825 Nal2-S1 Ac-KKWRKWLAKK-NH2 Not found Necrosis; Apoptosis MTT assay SAS Oral cancer MIC : 25 μM
dbacp04826 neo-N-methylSansalvamide A NA Marine fungus Apoptosis induction Not specified MES-SA Uterus cancer 1.00 ± 0.20 nM/L
dbacp04827 neo-N-methylSansalvamide A NA Marine fungus Apoptosis induction Not specified HCT15 Colon cancer 0.85 ± 0.63 nM/L
dbacp04849 Nisin ZP ITSISLCTPGCKTGALMGCnMKTATCNCSIHVSK Not found Inducing apoptosis Not specified HUVEC Not specified Not found
dbacp04850 Nisin ZP ITSISLCTPGCKTGALMGCnMKTATCNCSIHVSK Not found Inducing apoptosis Not specified HNSCC Not specified Not found
dbacp04884 Non-digestible fraction peptide GLTSK Common bean Cell proliferation inhibition; Apoptosis inducing MTS assay HCT116 Colorectal cancer IC50 : 0.51 mg/ml
dbacp04885 Non-digestible fraction peptide LSGNK Common bean Cell proliferation inhibition; Apoptosis inducing MTS assay HCT116 Colorectal cancer IC50 : 0.51 mg/ml
dbacp04886 Non-digestible fraction peptide GEGSGA Common bean Cell proliferation inhibition; Apoptosis inducing MTS assay HCT116 Colorectal cancer IC50 : 0.51 mg/ml
dbacp04887 Non-digestible fraction peptide MPACGSS Common bean Cell proliferation inhibition; Apoptosis inducing MTS assay HCT116 Colorectal cancer IC50 : 0.51 mg/ml
dbacp04888 Non-digestible fraction peptide MTEEY Common bean Cell proliferation inhibition; Apoptosis inducing MTS assay HCT116 Colorectal cancer IC50 : 0.51 mg/ml
dbacp04905 Noxa AELEVECATQLRRFGDKLNFRQKL BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified Not found Not found Not found
dbacp04906 Noxa C2dY AELEVEYATQLRRFGDKLNFRQKL BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified Not found Not found Not found
dbacp04907 NoxaA AELPPEFAAQLRKIGDKVYC BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified Mcl-1/Myc 2640 Not found Not found
dbacp04908 NoxaA AELPPEFAAQLRKIGDKVYC BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified Bcl-2/Myc 2924 Not found Not found
dbacp04998 NuBCP-9 FSRSLHSLL Not found Inducing apoptosis Not specified MCF-7 Not specified Not found
dbacp04999 NuBCP-9 FSRSLHSLL Not found Inducing apoptosis Not specified HepG2 Not specified Not found
dbacp05000 NuBCP-9 (DR8) FSRSLHSLLRRRRRRRR Not found Inducing apoptosis XTT assat MCF-7 Breast cancer IC50 : 7.11 μM
dbacp05001 NuBCP-9 (DR8) FSRSLHSLLRRRRRRRR Not found Inducing apoptosis XTT assat HepG2 Liver cancer IC50 : 9.10 μM
dbacp05009 Okinawa Habu apoxin protein-1(OHAP-1) ADDRNPLEECFRETDYEEFLEIARNGLKKT Venom base Inducing apoptosis DNA gel electrophoresis assay,TUNEL assay, MTT assay RBR17T Glioma IC50 : 2.1 ± 0.58 µg/ml
dbacp05010 Okinawa Habu apoxin protein-1(OHAP-1) ADDRNPLEECFRETDYEEFLEIARNGLKKT Venom base Inducing apoptosis DNA gel electrophoresis assay,TUNEL assay, MTT assay OHAP-1 Glioma IC50 : 1.9 ± 0.31 µg/ml
dbacp05011 Okinawa Habu apoxin protein-1(OHAP-1) ADDRNPLEECFRETDYEEFLEIARNGLKKT Venom base Inducing apoptosis DNA gel electrophoresis assay,TUNEL assay, MTT assay C6 Glioma IC50 : 2.48 ± 0.26 µg/ml
dbacp05012 Omiganan MBI-226 ILRWPWWPWRRK Cattle neutrophils Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-937 Lymphoma cancer IC50 : 80 - 85 µg/ml
dbacp05013 Omiganan MBI-226 ILRWPWWPWRRK Helical peptide with a predominance of one or more amino acids tryptophane-rich Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-937 Lymphoma cancer 27% Cytotoxicity at 0.5 µg/ml
dbacp05029 p-BIM BH3 (I155R, E158S) EIWIAQELRRRGDpSFNAYYAR‘pS’standsforthephosphorylatedserine BH3-only, Direct activators, BIM analogues Inducing apoptosis MTT assay Not found Prostate cancer Not found
dbacp05030 p-BIM BH3 (R154S, I155R, E158S) EIWIAQELRSRGDpSFNAYYAR‘pS’standsforthephosphorylatedserine BH3-only, Direct activators, BIM analogues Inducing apoptosis MTT assay Not found Prostate cancer Not found
dbacp05031 P04 IGEHTPSALAIMENANVLAR Aldolase A derived Apoptosis inducing MTT assay PDAC Pancreatic ductal adenocarcinoma MIC : 25 µg/mL
dbacp05032 P1 KWKLFKKIGIGAVLKVLKKG Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H69 Lung cancer IC50 :3.4 µM
dbacp05033 P1 KWKLFKKIGIGAVLKVLKKG Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H128 Lung cancer IC50 :3.5 µM
dbacp05034 P1 KWKLFKKIGIGAVLKVLKKG Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H146 Lung cancer IC50 :4.5 µM
dbacp05035 p120RasGAP (317-326) WMWVTNLRTD Not found Inducing apoptosis Luciferase assay HeLa Breast cancer Not found
dbacp05036 p120RasGAP (317-326) WMWVTNLRTD Not found Inducing apoptosis Luciferase assay MCF-7 Human malignant mesothelomia Not found
dbacp05037 P160 VPWMEPAYQRFL Not found Apoptosis inducing MTT cytotoxicity assay MCF-7 Breast cancer IC50 : 14.2 ± 1.5 μM
dbacp05052 P2 KWKLFKKIGIGKFLHSATTF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H69 Lung cancer IC50 : 36.2 µM
dbacp05053 P2 KWKLFKKIGIGKFLHSATTF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H128 Lung cancer IC50 : 37.9 µM
dbacp05054 P2 KWKLFKKIGIGKFLHSATTF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H146 Lung cancer IC50 : 47.7 µM
dbacp05055 P2 RALGWSCL Plant sources Inducing apoptosis MTS assay NB4 Not specified IC50 : 600 μg/mL
dbacp05056 P2 RALGWSCL Plant sources Inducing apoptosis MTS assay MOLT4 Not specified IC50 : 700 μg/mL
dbacp05057 P2 RALGWSCL Plant sources Inducing apoptosis MTS assay Raji Not specified IC50 : 700 μg/Ml
dbacp05058 P3 KWKLFKKIGIGAFLHSAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H69 Lung cancer IC50 : 9.3 µM
dbacp05059 P3 KWKLFKKIGIGAFLHSAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H128 Lung cancer IC50 : 9.3 µM
dbacp05060 P3 KWKLFKKIGIGAFLHSAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H146 Lung cancer IC50 : 10.9 µM
dbacp05071 P3Bax MDGSGEQLGSGGPTSSEQIMKTGAFLLQGFIQ Effectors (BAK, BAX) Inducing apoptosis Cell survival assay NRP-154 Prostate cancer Not found
dbacp05072 P4 KWKLFKKIGIGKFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H69 Lung cancer IC50 : 1.9 µM
dbacp05073 P4 KWKLFKKIGIGKFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H128 Lung cancer IC50 : 1.3 µM
dbacp05074 P4 KWKLFKKIGIGKFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H146 Lung cancer IC50 : 2.8 µM
dbacp05075 P5 KWKLFKKIGIGAFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H69 Lung cancer IC50 : 2.9 µM
dbacp05076 P5 KWKLFKKIGIGAFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H128 Lung cancer IC50 : 2.9 µM
dbacp05077 P5 KWKLFKKIGIGAFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H146 Lung cancer IC50 : 3.2 µM
dbacp05078 p53-C terminal peptide GSRAHSSHLKSKKGQSTSRHKK Not found Inducing apoptosis Annexin V-FITC Binding assay MDA-MB-468 Breast cancer Not found
dbacp05079 p53-C terminal peptide GSRAHSSHLKSKKGQSTSRHKK Not found Inducing apoptosis Annexin V-FITC Binding assay MDA-MB-231 Breast cancer Not found
dbacp05080 p53-C terminal peptide GSRAHSSHLKSKKGQSTSRHKK Not found Inducing apoptosis Annexin V-FITC Binding assay MCF-7 Breast cancer Not found
dbacp05081 p53-C terminal peptide GSRAHSSHLKSKKGQSTSRHKK Not found Inducing apoptosis Annexin V-FITC Binding assay MCF10-2A Breast cancer Not found
dbacp05082 P5317-28 QETFSDLWKLLP E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : 4.7 µM
dbacp05083 P5317-28 QETFSDLWKLLP E3 ubiquitin-protein ligase Cell cycle arrest or apoptosis of cells Immunoprecipitation assay HCT-116-p53+/+ Colon cancer IC50 : 30 µM
dbacp05084 p53C KKHRSTSQGKKSKLHSSHARSG Not found Inducing apoptosis Not specified 293T Not specified Not found
dbacp05085 p53C KKHRSTSQGKKSKLHSSHARSG Not found Inducing apoptosis Not specified H1299 Not specified Not found
dbacp05086 P6 KWKLFKKIGIGKFKLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H69 Lung cancer IC50 : 1.7 µM
dbacp05087 P6 KWKLFKKIGIGKFKLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H128 Lung cancer IC50 : 2 µM
dbacp05088 P6 KWKLFKKIGIGKFKLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H146 Lung cancer IC50 : 3.1 µM
dbacp05089 P6 WYIRKIRRFFKWLKKKLKKK Marine invertebrates Inducing apoptosis MTT assay HT-29 Colorectal cancer Not found
dbacp05090 P6 WYIRKIRRFFKWLKKKLKKK Marine invertebrates Inducing apoptosis MTT assay DLD-1 Colorectal cancer Not found
dbacp05091 P6 WYIRKIRRFFKWLKKKLKKK Marine invertebrates Inducing apoptosis MTT assay HCT116 Colorectal cancer Not found
dbacp05092 P6 WYIRKIRRFFKWLKKKLKKK Marine invertebrates Inducing apoptosis MTT assay SW-620 Colorectal cancer Not found
dbacp05093 P6 WYIRKIRRFFKWLKKKLKKK Marine invertebrates Inducing apoptosis MTT assay L02 Colorectal cancer Not found
dbacp05094 P7 PLLQATLGGGS Not found Apoptosis inducing WST-1 assay B16-F10 Skin cancer IC50 : 1 µM
dbacp05095 P7 KWKLFAKIGIGKFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H69 Lung cancer IC50 : 3.1 µM
dbacp05096 P7 KWKLFAKIGIGKFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H128 Lung cancer IC50 : 2.4 µM
dbacp05097 P7 KWKLFAKIGIGKFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H146 Lung cancer IC50 : 2.4 µM
dbacp05098 p776 GVGSPYVSRLLGICL Synthetic Peptide Inducing apoptosis ELISPOT assay Not found Tumor Not found
dbacp05099 P8 KWKKFLKIGIGKFLHLAKKF Ceropin A-African clawed frog Apoptosis MTT/MTS assay NCI-H69 Lung cancer IC50 : 2.6 µM
dbacp05100 P8 KWKKFLKIGIGKFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H128 Lung cancer IC50 : 2.3 µM
dbacp05101 P8 KWKKFLKIGIGKFLHLAKKF Ceropin A-African clawed frog Apoptosis inducing MTT/MTS assay NCI-H146 Lung cancer IC50 : 1.8 µM
dbacp05102 p85 LIAHNQVRQV Synthetic Peptide Inducing apoptosis ELISPOT assay Not found Tumor Not found
dbacp05103 PA10 RQIKIWFQNRRMKWKKGGGGNNETTSIQIAGSLHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MDA-MB231 Breast cancer MIC : 10 μM
dbacp05104 PA10 RQIKIWFQNRRMKWKKGGGGNNETTSIQIAGSLHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay HCC1806 Breast cancer MIC : 10 μM
dbacp05105 PA10 RQIKIWFQNRRMKWKKGGGGNNETTSIQIAGSLHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay 184B5 Breast cancer MIC : 10 μM
dbacp05106 PA10 RQIKIWFQNRRMKWKKGGGGNNETTSIQIAGSLHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MCF10A Breast cancer MIC : 10 μM
dbacp05107 PA15 RQIKIWFQNRRMKWKKGGSLSAACHEQWSLGAQHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MDA-MB231 Breast cancer MIC : 10 μM
dbacp05108 PA15 RQIKIWFQNRRMKWKKGGSLSAACHEQWSLGAQHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay HCC1806 Breast cancer MIC : 10 μM
dbacp05109 PA15 RQIKIWFQNRRMKWKKGGSLSAACHEQWSLGAQHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay 184B5 Breast cancer MIC : 10 μM
dbacp05110 PA15 RQIKIWFQNRRMKWKKGGSLSAACHEQWSLGAQHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MCF10A Breast cancer MIC : 10 μM
dbacp05111 PA2 RQIKIWFQNRRMKWKKGGATRPRVDTQPELCGMHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MDA-MB231 Breast cancer MIC : 10 μM
dbacp05112 PA2 RQIKIWFQNRRMKWKKGGATRPRVDTQPELCGMHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay HCC1806 Breast cancer MIC : 10 μM
dbacp05113 PA2 RQIKIWFQNRRMKWKKGGATRPRVDTQPELCGMHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay 184B5 Breast cancer MIC : 10 μM
dbacp05114 PA2 RQIKIWFQNRRMKWKKGGATRPRVDTQPELCGMHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MCF10A Breast cancer MIC : 10 μM
dbacp05115 PA3 RQIKIWFQNRRMKWKKGGDCLCISRRARLLRATHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MDA-MB231 Breast cancer MIC : 10 μM
dbacp05116 PA3 RQIKIWFQNRRMKWKKGGDCLCISRRARLLRATHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay HCC1806 Breast cancer MIC : 10 μM
dbacp05117 PA3 RQIKIWFQNRRMKWKKGGDCLCISRRARLLRATHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay 184B5 Breast cancer MIC : 10 μM
dbacp05118 PA3 RQIKIWFQNRRMKWKKGGDCLCISRRARLLRATHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MCF10A Breast cancer MIC : 10 μM
dbacp05119 PA38 RQIKIWFQNRRMKWKKGGKYNGRFTTHHLLHLLNHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MDA-MB231 Breast cancer MIC : 10 μM
dbacp05120 PA38 RQIKIWFQNRRMKWKKGGKYNGRFTTHHLLHLLNHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay HCC1806 Breast cancer MIC : 10 μM
dbacp05121 PA38 RQIKIWFQNRRMKWKKGGKYNGRFTTHHLLHLLNHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay 184B5 Breast cancer MIC : 10 μM
dbacp05122 PA38 RQIKIWFQNRRMKWKKGGKYNGRFTTHHLLHLLNHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MCF10A Breast cancer MIC : 10 μM
dbacp05123 PA49 RQIKIWFQNRRMKWKKGGAGVYTFLVGADNRGWEHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MDA-MB231 Breast cancer MIC : 10 μM
dbacp05124 PA49 RQIKIWFQNRRMKWKKGGAGVYTFLVGADNRGWEHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay HCC1806 Breast cancer MIC : 10 μM
dbacp05125 PA49 RQIKIWFQNRRMKWKKGGAGVYTFLVGADNRGWEHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay 184B5 Breast cancer MIC : 10 μM
dbacp05126 PA49 RQIKIWFQNRRMKWKKGGAGVYTFLVGADNRGWEHHHHHH Synthetic construct Cell proliferation inhibition; Cell penetration; Apoptosis Cell viability assay MCF10A Breast cancer MIC : 10 μM
dbacp05127 PaDef ATCETPSKHFNGLCIRSSNCASVCHGEHFTDGRCQGVRRRCMCLKPC Plant sources Inducing apoptosis MTT assay Jurkat Leukemia Not found
dbacp05129 Pal-N-Ter-TAT RDVFTKGYGFGLGRKKRRQRRRPQ VDAC1(voltage-dependent anion channel1) Inducing apoptosis SRB assay A375 Human endometrial cancer IC50 : 15.2 ± 0.7 μM
dbacp05130 Pal-pFL-N-Ter-TAT FPWWWPFLRDVFTKGYGFGLGRKKRRQRRRPQ VDAC1(voltage-dependent anion channel1) Inducing apoptosis MTT assay A375 Leukemia IC50 : 5.5 ± 1.1 μM
dbacp05134 Pardaxin GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Red sea moses sole Inducing apoptosis MTT/MTS assay HT-1080 Fibrosarcoma IC50 : 15.74 µg/ml
dbacp05135 Pardaxin GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Red sea moses sole Inducing apoptosis MTT/MTS assay HT-1080 Fibrosarcoma IC50 : 15.40 µg/ml
dbacp05136 Pardaxin GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Red sea moses sole Inducing apoptosis MTT/MTS assay HT-1080 Fibrosarcoma IC50 : 14.51 µg/ml
dbacp05137 Pardaxin GFFALIPKIISSPLFKTLLSAVGSALSSSGGQE Red sea moses sole Inducing apoptosis MTT/MTS assay HT-1080 Fibrosarcoma IC50 : 14.52 µg/ml
dbacp05216 PD-L1ip3 GTRLKPLIICVQWPGL Not found Inducing apoptosis MTT assay CT26 Colon cacer Not found
dbacp05222 Penaeidin-2 YRGGYTGPIPRPPPIGRPPLPRVVCACYRLSVSDARNCCIKFGSCCHLVK Pacific white shrimp Induction of apoptosis MTT assay HK-2 Kidney cancer MIC : 100 μg/mL
dbacp05223 Penaeidin-2 YRGGYTGPIPRPPPIGRPPLPRVVCACYRLSVSDARNCCIKFGSCCHLVK Pacific white shrimp Induction of apoptosis MTT assay ACHN Kidney cancer MIC : 100 μg/mL
dbacp05224 Penaeidin-2 YRGGYTGPIPRPPPIGRPPLPRVVCACYRLSVSDARNCCIKFGSCCHLVK Pacific white shrimp Induction of apoptosis MTT assay A498 Kidney cancer MIC : 100 μg/mL
dbacp05241 pentadactylin GLLDTLKGAAKNVVGSLASKVMEKL Not found Inducing apoptosis MTT assay B16F10 Melanoma IC50 : 25.7 µM
dbacp05242 pentadactylin GLLDTLKGAAKNVVGSLASKVMEKL Not found Inducing apoptosis MTT assay FHN Melanoma IC50 : 35.9 µM
dbacp05244 Pentapeptide (ILYMP) ILYMP Marine invertebrates Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 :11.25 mM
dbacp05245 pep1 FKCRRWQWRMKKLGAPSITCVR Bovine lactoferrin (Lf-B) Activating an apoptosis-inducing pathway MTT/MTS assay HL-60 Prostate cancer IC50 :77 µM
dbacp05246 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay AML-2 Leukemia cancer Not found
dbacp05247 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay HL-60 Leukemia cancer IC50 : > 70 µM
dbacp05248 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay Jurkat Blood cancer IC50 : > 70 µM
dbacp05249 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay SNU-601 Gastric cancer IC50 : > 70 µM
dbacp05250 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : > 70 µM
dbacp05251 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Not found Inducing apoptosis MTT assay AML-2 Acute myelogenous leukemia IC50 : > 70 µM
dbacp05252 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Not found Inducing apoptosis MTT assay HL-60 Acute promyelocytic leukemia IC50 : > 70 µM
dbacp05253 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Not found Inducing apoptosis MTT assay Jurkat T-cell leukemia IC50 : > 70 µM
dbacp05254 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Not found Inducing apoptosis MTT assay SNU-601 Gastric cancer IC50 : > 70 µM
dbacp05255 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Not found Inducing apoptosis MTT assay MCF-7 Breast cancer IC50 : > 70 µM
dbacp05256 Pep27 MRKEFHNVLSSGQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : > 70 µM
dbacp05257 Pep27 anal1 MWKWFHNVLSSWQLLADKRPARDYNRK Not found Inducing apoptosis MTT assay AML-2 Acute myelogenous leukemia IC50 : 50 µM
dbacp05258 Pep27 anal1 MWKWFHNVLSSWQLLADKRPARDYNRK Not found Inducing apoptosis MTT assay HL-60 Acute promyelocytic leukemia IC50 : 53 µM
dbacp05259 Pep27 anal1 MWKWFHNVLSSWQLLADKRPARDYNRK Not found Inducing apoptosis MTT assay Jurkat T-cell leukemia IC50 : 47 µM
dbacp05260 Pep27 anal1 MWKWFHNVLSSWQLLADKRPARDYNRK Not found Inducing apoptosis MTT assay SNU-601 Gastric cancer IC50 : 37 µM
dbacp05261 Pep27 anal1 MWKWFHNVLSSWQLLADKRPARDYNRK Not found Inducing apoptosis MTT assay MCF-7 Breast cancer IC50 : 55 µM
dbacp05262 Pep27 anal2 MWKWFHNVLSWWWLLADKRPARDYNRK Not found Inducing apoptosis MTT assay AML-2 Acute myelogenous leukemia IC50 : 29 µM
dbacp05263 Pep27 anal2 MWKWFHNVLSWWWLLADKRPARDYNRK Not found Inducing apoptosis MTT assay HL-60 Acute promyelocytic leukemia IC50 : 20 µM
dbacp05264 Pep27 anal2 MWKWFHNVLSWWWLLADKRPARDYNRK Not found Inducing apoptosis MTT assay Jurkat T cell leukemia IC50 : 23 µM
dbacp05265 Pep27 anal2 MWKWFHNVLSWWWLLADKRPARDYNRK Not found Inducing apoptosis MTT assay SNU-601 Gastric cancer IC50 : 25 µM
dbacp05266 Pep27 anal2 MWKWFHNVLSWWWLLADKRPARDYNRK Not found Inducing apoptosis MTT assay MCF-7 Breast cancer IC50 : < 10 µM
dbacp05267 Pep27 anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK Not found Inducing apoptosis MTT assay AML-2 Acute myelogenous leukemia IC50 : 67 µM
dbacp05268 Pep27 anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK Not found Inducing apoptosis MTT assay HL-60 Acute promyelocytic leukemia IC50 : 52 µM
dbacp05269 Pep27 anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK Not found Inducing apoptosis MTT assay Jurkat T cell leukemia IC50 : 50 µM
dbacp05270 Pep27 anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK Not found Inducing apoptosis MTT assay SNU-601 Gastric cancer IC50 : 50 µM
dbacp05271 Pep27 anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK Not found Inducing apoptosis MTT assay MCF-7 Breast cancer IC50 : 38 µM
dbacp05272 Pep27 anal4 MWKEFHNVLSSGQLLADKRWARWYNRW Not found Inducing apoptosis MTT assay AML-2 Acute myelogenous leukemia IC50 : 50 µM
dbacp05273 Pep27 anal4 MWKEFHNVLSSGQLLADKRWARWYNRW Not found Inducing apoptosis MTT assay HL-60 Acute promyelocytic leukemia IC50 : 51 µM
dbacp05274 Pep27 anal4 MWKEFHNVLSSGQLLADKRWARWYNRW Not found Inducing apoptosis MTT assay Jurkat T-cell Leukemia IC50 : 46 µM
dbacp05275 Pep27 anal4 MWKEFHNVLSSGQLLADKRWARWYNRW Not found Inducing apoptosis MTT assay SNU-601 Gastric cancer IC50 : 46 µM
dbacp05276 Pep27 anal4 MWKEFHNVLSSGQLLADKRWARWYNRW Not found Inducing apoptosis MTT assay MCF-7 Breast cancer IC50 : 29 µM
dbacp05277 Pep27 anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW Not found Inducing apoptosis MTT assay AML-2 Acute myelogenous leukemia IC50 : > 70 µM
dbacp05278 Pep27 anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW Not found Inducing apoptosis MTT assay HL-60 Acute promyelocytic leukemia IC50 : > 70 µM
dbacp05279 Pep27 anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW Not found Inducing apoptosis MTT assay Jurkat T cell leukemia IC50 : > 70 µM
dbacp05280 Pep27 anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW Not found Inducing apoptosis MTT assay SNU-601 Gastric cancer IC50 : > 70 µM
dbacp05281 Pep27 anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW Not found Inducing apoptosis MTT assay MCF-7 Breast cancer IC50 : > 70 µM
dbacp05282 Pep27anal1 MWKWFHNVLSSWQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay AML-2 Leukemia cancer IC50 : 50 µM
dbacp05283 Pep27anal1 MWKWFHNVLSSWQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay HL-60 Leukemia cancer IC50 : 53 µM
dbacp05284 Pep27anal1 MWKWFHNVLSSWQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay Jurkat Blood cancer IC50 : 47 µM
dbacp05285 Pep27anal1 MWKWFHNVLSSWQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay SNU-601 Gastric cancer IC50 : 37 µM
dbacp05286 Pep27anal1 MWKWFHNVLSSWQLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : 55 µM
dbacp05287 Pep27anal2 MWKWFHNVLSWWWLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay AML-2 Leukemia cancer IC50 : 29 µM
dbacp05288 Pep27anal2 MWKWFHNVLSWWWLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay HL-60 Leukemia cancer IC50 : 20 µM
dbacp05289 Pep27anal2 MWKWFHNVLSWWWLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay Jurkat Blood cancer IC50 : 23 µM
dbacp05290 Pep27anal2 MWKWFHNVLSWWWLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay SNU-601 Gastric cancer IC50 : 25 µM
dbacp05291 Pep27anal2 MWKWFHNVLSWWWLLADKRPARDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : < 10 µM
dbacp05292 Pep27anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay AML-2 Leukemia cancer IC50 : 67 µM
dbacp05293 Pep27anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay HL-60 Leukemia cancer IC50 : 52 µM
dbacp05294 Pep27anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay Jurkat Blood cancer IC50 : 50 µM
dbacp05295 Pep27anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay SNU-601 Gastric cancer IC50 : 50 µM
dbacp05296 Pep27anal3 MRKWFHNVLSSGQLLADKWPAWDYNRK Pneumococcus Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : 38 µM
dbacp05297 Pep27anal4 MWKEFHNVLSSGQLLADKRWARWYNRW Pneumococcus Apoptosis inducing MTT/MTS assay AML-2 Leukemia cancer IC50 : 50 µM
dbacp05298 Pep27anal4 MWKEFHNVLSSGQLLADKRWARWYNRW Pneumococcus Apoptosis inducing MTT/MTS assay HL-60 Leukemia cancer IC50 : 51 µM
dbacp05299 Pep27anal4 MWKEFHNVLSSGQLLADKRWARWYNRW Pneumococcus Apoptosis inducing MTT/MTS assay Jurkat Blood cancer IC50 : 46 µM
dbacp05300 Pep27anal4 MWKEFHNVLSSGQLLADKRWARWYNRW Pneumococcus Apoptosis inducing MTT/MTS assay SNU-601 Gastric cancer IC50 : 37 µM
dbacp05301 Pep27anal4 MWKEFHNVLSSGQLLADKRWARWYNRW Pneumococcus Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : 29 µM
dbacp05302 Pep27anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW Pneumococcus Apoptosis inducing MTT/MTS assay AML-2 Leukemia cancer IC50 : >70 µM
dbacp05303 Pep27anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW Pneumococcus Apoptosis inducing MTT/MTS assay HL-60 Leukemia cancer IC50 : >70 µM
dbacp05304 Pep27anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW Pneumococcus Apoptosis inducing MTT/MTS assay Jurkat Blood cancer IC50 : >70 µM
dbacp05305 Pep27anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW Pneumococcus Apoptosis inducing MTT/MTS assay SNU-601 Gastric cancer IC50 : >70 µM
dbacp05306 Pep27anal5 MWKWFHNVLSSGQLLADKWWAWWYNWW Pneumococcus Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer IC50 : >70 µM
dbacp05371 peptide containing the BH3 regions from Bad NLWAAQRYGRELRRMSDEFEGSFKGL BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Cell viability assay FL5.12 Not specified Not found
dbacp05372 peptide containing the BH3 regions from Bad(145-160) QRYGRELRRMSDEFEG BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Cell viability assay FL5.12 Not specified Not found
dbacp05373 peptide containing the BH3 regions from Bak(72-87) GQVGRQLAIIGDDINR Effectors (BAK, BAX) Inducing apoptosis Cell viability assay FL5.12 Not specified Not found
dbacp05374 peptide containing the BH3 regions from Bak(72-94) GQVGRQLAIIGDDINRRYDSEFQ Effectors (BAK, BAX) Inducing apoptosis Cell viability assay FL5.12 Not specified Not found
dbacp05375 peptide containing the BH3 regions from Bax(57-72) KKLSECLKRIGDELDS Effectors (BAK, BAX) Inducing apoptosis Cell viability assay FL5.12 Not specified Not found
dbacp05376 peptide containing the BH3 regions from Bid RNIARHLAQVGDSMDR BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis Agarose gel electrophoresis assay Not found Not specified Not found
dbacp05400 Peptide from Lentinus Squarrosulus RYGFTEVAGNFQQHNFGRG Plant sources Inducing apoptosis MTT assay H460 Breast cancer Not found
dbacp05401 Peptide from Lentinus Squarrosulus RYGFTEVAGNFQQHNFGRG Plant sources Inducing apoptosis MTT assay DPCs Breast cancer Not found
dbacp05402 Peptide from Lentinus Squarrosulus RYGFTEVAGNFQQHNFGRG Plant sources Inducing apoptosis MTT assay HK-2 Breast cancer Not found
dbacp05403 Peptide Glycyrrhetinic Acid Based Derivatives (compound 5) GGGG Not found Inducing apoptosis Not specified MCF-7 Cervical cancer IC50 : 5.0 ± 0.3 µg/mL
dbacp05404 Peptide Glycyrrhetinic Acid Based Derivatives (compound 5) GGGG Not found Inducing apoptosis Not specified HCT116 Cervical cancer IC50 : 5.2 ± 0.8 µg/mL
dbacp05438 Peptide-20 CSSRTMHHC Synthetic Peptide Inducing apoptosis MTT/MTS assay HL-60 Leukemia cancer At 100 µM 90% viablity
dbacp05439 Peptide-20 CSSRTMHHC Synthetic Peptide Inducing apoptosis MTT/MTS assay MDA-MB-231 Breast cancer At 100 µM 55% viablity
dbacp05440 Peptide-20 CSSRTMHHC Synthetic Peptide Inducing apoptosis MTT/MTS assay HeLa Cervical cancer At 100 µM 50% viablity
dbacp05441 Peptide-20 CSSRTMHHC Synthetic Peptide Inducing apoptosis MTT/MTS assay B16F10-Nex 2 Skin cancer At 100 µM 50% viablity
dbacp05442 Peptide-20 CSSRTMHHC Synthetic Peptide Inducing apoptosis MTT/MTS assay A-2058 Skin cancer At100 µM 30% viablity
dbacp05443 Peptide-20 CSSRTMHHC Synthetic Peptide Inducing apoptosis MTT/MTS assay Skmel-25 Skin cancer At 100 µM 55 - 60% viablity
dbacp05444 Peptide-20 CSSRTMHHC Synthetic Peptide Inducing apoptosis MTT/MTS assay Skmel-28 Skin cancer At 100 µM 35 - 40% viablity
dbacp05462 Peptidoglycan recognition protein 1 MLFAWAPFPALLGLADSCCFVVPRSEWKALPSECSKGLKKPVRYVVISHTAGSFCSSPDSCEQQARNVQLYQMKQLGWCDVAYNFLIGEDGHVYEGRGWTIKGDHTGPIWNPMSIGITFMGDYSHRVPAKRALRAALNLLKCGVSEGFLRSNYEVKGHRDVQSTLSPGDQLYEIIQSWDHYRE Rat Apoptosis inducing Not specified L929 Not found Not found
dbacp05463 Peptidoglycan recognition protein 1 MSRRSMLLAWALPSLLRLGAAQETEDPACCSPIVPRNEWKALASECAQHLSLPLRYVVVSHTAGSSCNTPASCQQQARNVQHYHMKTLGWCDVGYNFLIGEDGLVYEGRGWNFTGAHSGHLWNPMSIGISFMGNYMDRVPTPQAIRAAQGLLACGVAQGALRSNYVLKGHRDVQRTLSPGNQLYHLIQNWPHYRSP Human Apoptosis inducing; Necrotic cell death Enzyme inhibition assay K562 Not specified Not found
dbacp05464 Peptidoglycan recognition protein 1 MSRRSMLLAWALPSLLRLGAAQETEDPACCSPIVPRNEWKALASECAQHLSLPLRYVVVSHTAGSSCNTPASCQQQARNVQHYHMKTLGWCDVGYNFLIGEDGLVYEGRGWNFTGAHSGHLWNPMSIGISFMGNYMDRVPTPQAIRAAQGLLACGVAQGALRSNYVLKGHRDVQRTLSPGNQLYHLIQNWPHYRSP Human Apoptosis inducing; Necrotic cell death Enzyme inhibition assay Molt4 Not specified Not found
dbacp05465 Peptidoglycan recognition protein 1 MSRRSMLLAWALPSLLRLGAAQETEDPACCSPIVPRNEWKALASECAQHLSLPLRYVVVSHTAGSSCNTPASCQQQARNVQHYHMKTLGWCDVGYNFLIGEDGLVYEGRGWNFTGAHSGHLWNPMSIGISFMGNYMDRVPTPQAIRAAQGLLACGVAQGALRSNYVLKGHRDVQRTLSPGNQLYHLIQNWPHYRSP Human Apoptosis inducing; Necrotic cell death Enzyme inhibition assay HeLa Not specified Not found
dbacp05466 Peptidoglycan recognition protein 1 MSRRSMLLAWALPSLLRLGAAQETEDPACCSPIVPRNEWKALASECAQHLSLPLRYVVVSHTAGSSCNTPASCQQQARNVQHYHMKTLGWCDVGYNFLIGEDGLVYEGRGWNFTGAHSGHLWNPMSIGISFMGNYMDRVPTPQAIRAAQGLLACGVAQGALRSNYVLKGHRDVQRTLSPGNQLYHLIQNWPHYRSP Human Apoptosis inducing; Necrotic cell death Enzyme inhibition assay L929 Not specified Not found
dbacp05467 Peptidoglycan recognition protein 1 MLFACALLALLGLATSCSFIVPRSEWRALPSECSSRLGHPVRYVVISHTAGSFCNSPDSCEQQARNVQHYHKNELGWCDVAYNFLIGEDGHVYEGRGWNIKGDHTGPIWNPMSIGITFMGNFMDRVPAKRALRAALNLLECGVSRGFLRSNYEVKGHRDVQSTLSPGDQLYQVIQSWEHYRE Mouse Necrosis; Apoptosis Cytotoxicity assay VMR-0 Mammary adenocarcinoma Not found
dbacp05468 Peptidoglycan recognition protein 1 MLFACALLALLGLATSCSFIVPRSEWRALPSECSSRLGHPVRYVVISHTAGSFCNSPDSCEQQARNVQHYHKNELGWCDVAYNFLIGEDGHVYEGRGWNIKGDHTGPIWNPMSIGITFMGNFMDRVPAKRALRAALNLLECGVSRGFLRSNYEVKGHRDVQSTLSPGDQLYQVIQSWEHYRE Mouse Necrosis; Apoptosis Cytotoxicity assay VMR-L Mammary adenocarcinoma Not found
dbacp05469 Peptidoglycan recognition protein 1 MLFACALLALLGLATSCSFIVPRSEWRALPSECSSRLGHPVRYVVISHTAGSFCNSPDSCEQQARNVQHYHKNELGWCDVAYNFLIGEDGHVYEGRGWNIKGDHTGPIWNPMSIGITFMGNFMDRVPAKRALRAALNLLECGVSRGFLRSNYEVKGHRDVQSTLSPGDQLYQVIQSWEHYRE Mouse Necrosis; Apoptosis Cytotoxicity assay CSML-0 Mammary adenocarcinoma Not found
dbacp05470 Peptidoglycan recognition protein 1 MLFACALLALLGLATSCSFIVPRSEWRALPSECSSRLGHPVRYVVISHTAGSFCNSPDSCEQQARNVQHYHKNELGWCDVAYNFLIGEDGHVYEGRGWNIKGDHTGPIWNPMSIGITFMGNFMDRVPAKRALRAALNLLECGVSRGFLRSNYEVKGHRDVQSTLSPGDQLYQVIQSWEHYRE Mouse Necrosis; Apoptosis Cytotoxicity assay CSML-100 Mammary adenocarcinoma Not found
dbacp05488 Pexiganan MSI-78 GIGKFLKKAKKFGKAFVKILKK Analog of African clawed frog Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-941 Lymphoma cancer IC50 : 20-30 µg/ml
dbacp05490 PFL-N-Ter-TAT FPWWWPFLRDVFTKGYGFGLGRKKRRQRRRPQ VDAC1 Inducing apoptosis SRB assay A375 Human endometrial cancer IC50 : 5.5 ± 1.1 μM
dbacp05502 PHP ITCPQVTQSLAPCVPYLISG Plant sources Inducing apoptosis MTT assay Eca-109 Not found IC50 : 0.7 µM
dbacp05503 PHP ITCPQVTQSLAPCVPYLISG Plant sources Inducing apoptosis MTT assay HeLa Not found IC50 : 2.74 µM
dbacp05504 PHP ITCPQVTQSLAPCVPYLISG Plant sources Inducing apoptosis MTT assay MGC-7 Not found IC50 : 3.13 µM
dbacp05505 PHP ITCPQVTQSLAPCVPYLISG Plant sources Inducing apoptosis MTT assay B16 Not found IC50 : 1.47 µM
dbacp05506 Phthiocerol/phthiodiolone dimycocerosyl transferase (EC 2.3.1.282) (Acyltransferase PapA5) (Phthiocerol/phthiodiolone O-acyltransferase) (Polyketide synthase-associated protein A5) MALQRRHPLLRAKIVAGTPPRFTSQGVPPIALEVVERKAEESWQQHVEAELDRPFNSDPGPLVRFILVRGEHRSELLCSYDHLIGDAHSGIFALRDLLQVMASQDQHLPELAPRPAYEELIGPMVPGTRLLGAAVRRGSSALLRLSPTLNTLTERLVAPRGMARSSAEGQALYSHRILEPEQLARLLARCREQGSSVHAALGAALLIARAESQGAKKRVTLTLTSALDARERFGVGEDFGLFTTGKTDFFRARGSTPFWELAHRLRSPLQAARKKRSHLRLFRLILEISALTVDISSQPWMERATRLGLHSMLALSNVGRVEIAARYGNLTLEGLGFTGTTAAQFDVVLTAITFAQRLEASFLFNTAHMQREQVEQLASRTWELLAEATR Aeromonads Apoptosis; Cell nucleus fragmentation Toxicity assay, Cell nucleus fragmentation assay(cnf) L929 Not specified MIC : 50 ng/ml
dbacp05565 piscidin-1 FFHHIFRGIVHVGKTIHRLVTG Striped bass fish Apoptosis inducing; Elevation of ROS MTT/MTS assay SCC4 Oral squamous cell carcinoma IC50 : 10.82 – 13.77 μM
dbacp05566 piscidin-1 FFHHIFRGIVHVGKTIHRLVTG Striped bass fish Inhibits angiogenesis; Apoptosis inducing; Elevation of ROS MTT/MTS assay OC2 Oral cancer IC50 : 16.94 – 19.20 μM
dbacp05567 Piscidin-1 FFHHIFRGIVHVGKTIHRLVTG Striped bass x White bass Induce apoptosis; Necrotic activity MTS assay and soft-agar colony-formation assay HT1080 Not specified MIC : 20 μg/ml
dbacp05568 Piscidin-1 FFHHIFRGIVHVGKTIHRLVTG Striped bass x White bass Induce apoptosis; Necrotic activity MTS assay and soft-agar colony-formation assay HeLa Not specified MIC : 25 μg/ml
dbacp05576 Pleurocidin GWGSFFKKAAHVGKHVGKAALTHYL Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay J5 Hepatocellular carcinoma IC50 : 54.9 µM
dbacp05577 Pleurocidin GWGSFFKKAAHVGKHVGKAALTHYL Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay Hep3B Hepatocellular carcinoma IC50 : 340.9 µM
dbacp05578 Pleurocidin GWGSFFKKAAHVGKHVGKAALTHYL Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay A549 Non-small cell lung adenocarcinoma IC50 : 300.8 µM
dbacp05579 Pleurocidin GWGSFFKKAAHVGKHVGKAALTHYL Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay AGS Stomach adenocarcinoma IC50 : 186.5 µM
dbacp05580 Pleurocidin-a GWGSFFKKAAHVGKHVGKAALTHYL-NH2 Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay J5 Hepatocellular carcinoma IC50 :1 1 µM
dbacp05581 Pleurocidin-a GWGSFFKKAAHVGKHVGKAALTHYL-NH3 Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay Huh7 Hepatocellular carcinoma IC50 : 60 µM
dbacp05582 Pleurocidin-a GWGSFFKKAAHVGKHVGKAALTHYL-NH4 Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay Hep3B Hepatocellular carcinoma IC50 : 77.5 µM
dbacp05583 Pleurocidin-a GWGSFFKKAAHVGKHVGKAALTHYL-NH5 Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay A549 Non-small cell lung adenocarcinoma IC50 : 42.1 µM
dbacp05584 Pleurocidin-a GWGSFFKKAAHVGKHVGKAALTHYL-NH6 Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay AGS Stomach adenocarcinoma IC50 : 29.8 µM
dbacp05585 Pleurocidin-a GWGSFFKKAAHVGKHVGKAALTHYL-NH7 Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay WiDr Colon adenocarcinoma IC50 : 197.3 µM
dbacp05586 Pleurocidin-a GWGSFFKKAAHVGKHVGKAALTHYL-NH8 Winter flounder Apoptosis inducing; Anti-proliferative activity MTT assay NIH-3T3 Mouse fibroblast IC50 : 313 µM
dbacp05626 Precursor C-1 CRRRRFΦECΔDPPLHSpTA Not found Inducing apoptosis Not specified HeLa Not specified Not found
dbacp05649 Protegrin 1 RGGRLCYCRRRFCVCVGR Alpha helical peptide without cysteines Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-942 Lymphoma cancer IC50 : 30-40 µg/ml
dbacp05674 Protein S100-A8 MLTELEKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETECPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMGVAAHKKSHEESHKE Human Apoptosis inducing MTT/MTS assay MM46 Breast cancer IC50 : 10 µM
dbacp05684 Pseudosubstrate Peptides Inhibit Akt FEPRARERTYAFGH Human FOXO3, AKTide-2T Inducing apoptosis Not specified HeLa Not specified Not found
dbacp05685 Pseudosubstrate Peptides Inhibit Akt DPEFEPRARERTYAFGH Human FOXO3, AKTide-2T Inducing apoptosis Not specified HeLa Not specified Not found
dbacp05686 Pseudosubstrate Peptides Inhibit Akt VELDPEFEPRARERTYAFGH Human FOXO3, AKTide-2T Inducing apoptosis Not specified HeLa Not specified Not found
dbacp05687 Pseudosubstrate Peptides Inhibit Akt VELDPEFEPRARERTYSFGH Human FOXO3, AKTide-2T Inducing apoptosis Not specified HeLa Not specified Not found
dbacp05688 Pseudosubstrate Peptides Inhibit Akt VELDPEFEPRARERDYAFGH Human FOXO3, AKTide-2T Inducing apoptosis Akt kinase HeLa Not specified Not found
dbacp05689 Pseudosubstrate Peptides Inhibit Akt VELDPEFEPRARERAYAFGH Human FOXO3, AKTide-2T Inducing apoptosis Akt kinase HeLa Not specified Not found
dbacp05690 Pseudosubstrate Peptides Inhibit Akt ERTYAFGH Human FOXO3, AKTide-2T Inducing apoptosis Not specified HeLa Not specified Not found
dbacp05691 Pseudosubstrate Peptides Inhibit Akt RARERTYAFGH Human FOXO3, AKTide-2T Inducing apoptosis Not specified HeLa Not specified Not found
dbacp05692 Pseudosubstrate Peptides Inhibit Akt VELDPEFEPRARERTYAFGH Human FOXO3, AKTide-2T Inducing apoptosis Not specified HeLa Not specified Not found
dbacp05693 Pseudosubstrate Peptides Inhibit Akt ) VELDPEFEPRARERTYDFGH Human FOXO3, AKTide-2T Inducing apoptosis Akt kinase HeLa Not specified Not found
dbacp05708 PTP1 LLAGLAANFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay A-549 Lung cancer IC50 : >100 µg/ml
dbacp05709 PTP1 LLAGLAANFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay HEK294 Renal cancer IC50 : >100 µg/ml
dbacp05710 PTP1 LLAGLAANFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay HEK302 Renal cancer IC50 : >100 µg/ml
dbacp05711 PTP1 LLAGLAANFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay Hep3B Liver cancer IC50 : >100 µg/ml
dbacp05712 PTP1 LLAGLAANFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay MCF-7 Breast cancer IC50 : >100 µg/ml
dbacp05713 PTP2 FAGLAANFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay A-549 Lung cancer IC50 : >100 µg/ml
dbacp05714 PTP2 FAGLAANFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay HEK295 Renal cancer IC50 : >100 µg/ml
dbacp05715 PTP2 FAGLAANFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay HEK303 Renal cancer IC50 : >100 µg/ml
dbacp05716 PTP2 FAGLAANFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay Hep3B Liver cancer IC50 : >100 µg/ml
dbacp05717 PTP2 FAGLAANFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay MCF-7 Breast cancer IC50 : >100 µg/ml
dbacp05718 PTP4 FLKLLKKLAAKFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay A-549 Lung cancer IC50 : 13.71 µg/ml
dbacp05719 PTP4 FLKLLKKLAAKFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay HEK296 Renal cancer IC50 : 26.15 µg/ml
dbacp05720 PTP4 FLKLLKKLAAKFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay PC-3 Prostate cancer IC50 : 18.63 µg/ml
dbacp05721 PTP4 FLKLLKKLAAKFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay Hep3B Liver cancer IC50 : 18.18 µg/ml
dbacp05722 PTP4 FLKLLKKLAAKFLPTIICKISYKC Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay MCF-7 Breast cancer IC50 : 18.1 µg/ml
dbacp05723 PTP5 FLKLLKKLAAKLF Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay A-549 Lung cancer IC50 : 9.09 µg/ml
dbacp05724 PTP5 FLKLLKKLAAKLF Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay HEK297 Renal cancer IC50 : 15.11 µg/ml
dbacp05725 PTP5 FLKLLKKLAAKLF Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay PC-3 Prostate cancer Not found
dbacp05726 PTP5 FLKLLKKLAAKLF Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay Hep3B Liver cancer Not found
dbacp05727 PTP5 FLKLLKKLAAKLF Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay MCF-7 Breast cancer IC50 : 5.43 µg/ml
dbacp05728 PTP6 FLKLLKKLAAKLF Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay A-549 Lung cancer IC50 : 13.94 µg/ml
dbacp05729 PTP6 FLKLLKKLAAKLF Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay HEK298 Renal cancer IC50 : 14 µg/ml
dbacp05730 PTP6 FLKLLKKLAAKLF Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay PC-3 Prostate cancer IC50 : 13.27 µg/ml
dbacp05731 PTP6 FLKLLKKLAAKLF Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay Hep3B Liver cancer IC50 : 15.07 µg/ml
dbacp05732 PTP6 FLKLLKKLAAKLF Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay MCF-7 Breast cancer IC50 : 17.56 µg/ml
dbacp05733 PTP7 FLGALFKALSKLL Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay A-549 Lung cancer IC50 : 8.01 µg/ml
dbacp05734 PTP7 FLGALFKALSKLL Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay HEK299 Renal cancer IC50 : 6.71 µg/ml
dbacp05735 PTP7 FLGALFKALSKLL Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay PC-3 Prostate cancer IC50 : 5.01 µg/ml
dbacp05736 PTP7 FLGALFKALSKLL Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay Hep3B Liver cancer IC50 : 5.4 µg/ml
dbacp05737 PTP7 FLGALFKALSKLL Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay MCF-7 Breast cancer IC50 : 5.25 µg/ml
dbacp05738 PTP8 FLKLLAGLLKNFA Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay A-549 Lung cancer IC50 : 24.58 µg/ml
dbacp05739 PTP8 FLKLLAGLLKNFA Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay HEK300 Renal cancer IC50 : 26.8 µg/ml
dbacp05740 PTP8 FLKLLAGLLKNFA Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay PC-3 Prostate cancer IC50 : 28.9 µg/ml
dbacp05741 PTP8 FLKLLAGLLKNFA Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay Hep3B Liver cancer IC50 : 30.79 µg/ml
dbacp05742 PTP8 FLKLLAGLLKNFA Skin of a Korean frog, Wrinkled frog Induce apoptosis MTT/MTS assay MCF-7 Breast cancer IC50 : 32.23 µg/ml
dbacp05743 PTPRJ-pep19 CHHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 4.5 ± 0.1.4% cell growth inhibition at 160 µM
dbacp05744 PTPRJ-pep19 CHHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 19 ± 2.82% cell growth inhibition at 160 µM
dbacp05745 PTPRJ-pep19.0 CHHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 4 ± 1.4% cell growth inhibition at 160 µM
dbacp05746 PTPRJ-pep19.2 CAHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 16.5 ± 2.12% cell growth inhibition at 160 µM
dbacp05747 PTPRJ-pep19.2 CAHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 30 ± 2.82% cell growth inhibition at 160 µM
dbacp05748 PTPRJ-pep19.2 CAHNLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 32.0 ± 4.2% cell growth inhibition at 160 µM
dbacp05749 PTPRJ-pep19.3 CHANLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 28 ± 5.5% cell growth inhibition at 160 µM
dbacp05750 PTPRJ-pep19.3 CHANLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 46 ± 4.2% cell growth inhibition at 160 µM
dbacp05751 PTPRJ-pep19.3 CHANLTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 51 ± 1.4% cell growth inhibition at 160 µM
dbacp05752 PTPRJ-pep19.4 CHHALTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 48.0 ± 2.82% cell growth inhibition at 160 µM
dbacp05753 PTPRJ-pep19.4 CHHALTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 62.5 ± 4.9% cell growth inhibition at 160 µM
dbacp05754 PTPRJ-pep19.4 CHHALTHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 66.5 ± 2.12% cell growth inhibition at 160 µM
dbacp05755 PTPRJ-pep19.5 CHHNATHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 2 ± 1.5% cell growth inhibition at 160 µM
dbacp05756 PTPRJ-pep19.5 CHHNATHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 19 ± 4.2% cell growth inhibition at 160 µM
dbacp05757 PTPRJ-pep19.6 CHHNLAHAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 19 ± 4.2% cell growth inhibition at 160 µM
dbacp05758 PTPRJ-pep19.7 CHHNLTAAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 4.5 ± 2.13% cell growth inhibition at 160 µM
dbacp05759 PTPRJ-pep19.7 CHHNLTAAC PTPRJ agonist peptides Cell growth inhibition and apoptosis Trypan blue assay HeLa Cervical cancer 20 ± 1.4% cell growth inhibition at 160 µM
dbacp05760 PUMA BH3 EQWAREIGAQLRRMADDLNA BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis Not specified Not found Not specified Not found
dbacp05761 PUMA BH3 LRRMADDLN BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis Not specified MDA-MB-231 Colon cancer Not found
dbacp05762 PUMA BH4 LRRMADDLN BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis Not specified HCT116p53–/– Colon cancer Not found
dbacp05763 PUMA BH5 LRRMADDLN BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis Not specified HCT116p53+/+ Colon cancer Not found
dbacp05764 PUMA BH6 LRRMADDLN BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis Not specified GLC-82 Colon cancer Not found
dbacp05765 PUMA BH7 LRRMADDLN BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis Not specified SGC-7901 Colon cancer Not found
dbacp05766 PUMA BH8 LRRMADDLN BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis Not specified HEK293 Colon cancer Not found
dbacp05767 PUMA BH9 LRRMADDLN BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis Not specified 2BS Colon cancer Not found
dbacp05781 Putative nonribosomal peptide synthetase P4-B4-NRPS DAWRFLWSYHHAVVDGWSVPLILKQVLGRYAELGAGEAAPLPGSRFLPFVNWLAARDAREQAEYWKQVLEGIEEPTPIGFASPARGPQAQGQGRRAFVFDAALREQVDRAARRAGVTRASLLTGAWALTLGYAGGGRDVVFGTTLSGRPATLPGVERMVGLFINTVPVRVGMDDDASVSQWLRQLHEQQSERARLGAASLTDIQRWAGYEGGELLSSLFVVENYPVDRTLARGDAGFDVSEFAAAETRTNYPLVGQLIPGEETVLYVDFDASRYDEESIGRLGASFMHLLSQLAAQPDARLGDLTLVDDDEARRLIHDWNATPPVGEGYLLHASIERHAELTPLAPAIIGVDEAMNYRELADETLRTARAVAAAGAKREPVAVLLPRSARAVAAYSGVMRAGCAYVPADPAMPPGRLRDLLATVGYVLTTREHLPMLDGVAARAILIDETPPADVALPDAAPDDLAYVMFTSGSTGKPKGVMITHRAASLTIEVFLRRYEIGASDRLMCVSAAGFDLSVFDFFGAFAAGAAVLLAPESSTIAPAVWLELMTREGATVWESVPAVMELLLLECRQSGRALPPSLKLAMLSGDRVPVGLPAQIRAAATSDPEVLALGGATEGAIWSCWYDTRELASDAAFVPYGRHLPGQRLYVLSSSLQAVPVGVPGDLWIAGAGVALGYLGQPDLTAYRFVDNPFVPGERMYRTGDRARVLADGNLEFLGRVDDQVKIGGFRIEIGEIEAALAAAPGVERGVASVVERDGRRIIAGYVLLLPGASLDLAAVRDALARRLPPYMLPASIMALDSLPLSANGKVDRKRLPDPVVETGAAAAETEAEAALVEIWQGLLGLERVGVRDNFFALGGDSILSIQMASRAAERGLRLSPQQVFRYPTIAELAAEGCAAEEAGAQAEQGEVVGEVRPGPIQAWYLDWPGTDWEQFNQGAYLGLDGVVDAESLIGALQAVAQRHDALRIGWRRDGERWIQASGAGEPVEVKAVDLRGLADAEAALERDAAALQSSLRLGGASLWAARLYRLDEGWRLLWLAHHASVDGVSWRILLEDLWRAYAALSRGEAAAWPAKTVSYQAWSQRLWEWAETLPDSTLSYWREMDAPGMPLPGFNAAEDTVAAESRVSLQWEPETTERWLRQAGEAYRMRPEELLVTALARALRQWTGAKECVLDLEGHGRDGLAGVDVSRTVGWFTSLYPL Gram-negative bacillus Inducing apoptosis GFP assay NIH 3T3 Cutaneous T-cell lymphoma Not found
dbacp05782 Putative nonribosomal peptide synthetase P4-G7-NRPS MTMARLMTDLADAGVTLRRRGDQLQVQAPQGALDAALVARLREAKEELLRVLDDEGARAAPLAPAQPGEAGDAAALSPGQARLVAATRLGDPAMYNEQAAIELADAVDAEAVARAFAALARRHDILRTVFSDGEPVRQTVLPEPIVTLQAWTVDGDDALRARAADLARLPFAAGAPMWRVDLFSTPERAAVLVLTIHHAIFDRWSMSVLIRDFSAYLALPDAAEAPASGLSYRDYSAWQRRWMASPDYAAQLDAWVDDLAEVDEVPAIRGDRPRPPAMSGRGGTERFEIPADCMDAAAAFSRSRNTTLFTTLFSAFALLQHRYTGEARALTLTPAANRPFQAAEEIAGYFVNLVALATEVGEGDSFGALVDRARDASARAFARQGVPLDAIVERLRARGGPRHEQFAQTVFAFQNVRLPAVRTASGAAVPFDLDSPFARFDLYLSIEGDERGTFAVWQYNTDLYEAATIRQLGEHYLALLRAALASPDADARALPILSAEEEARLRGWGRHELPYRADAAIDRLFRERAADHPGRVALEQGGVRWTYAELDQWSDRAAGALRAAGVEAGAVVGVAGERSPRLLAAFLAVLKAGAAYLPLDPTYPAARLRAMTADAAPALMIIADGLDAGWLGDYAGPVLSLADCEAGVARPLQSEARPAEAESL Gram-negative bacillus Inducing apoptosis GFP assay NIH 3T3 Cutaneous T-cell lymphoma Not found
dbacp05793 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay H157 Lung cancer IC50 : 843.40 µM
dbacp05794 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay H157 Prostate cancer IC50 : 843.40 µM
dbacp05795 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay H157 Breast cancer IC50 : 843.40 µM
dbacp05796 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay H157 Lung cancer IC50 : 843.40 µM
dbacp05797 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay H157 Prostate cancer IC50 : 843.40 µM
dbacp05798 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay H157 Breast cancer IC50 : 843.40 µM
dbacp05799 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay H157 Glioma IC50 : 843.40 µM
dbacp05800 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Lung cancer IC50 : 872.70 µM
dbacp05801 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Prostate cancer IC50 : 872.70 µM
dbacp05802 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Breast cancer IC50 : 872.70 µM
dbacp05803 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Glioma IC50 : 872.70 µM
dbacp05804 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay PC-3 Lung cancer IC50 : 283.90 µM
dbacp05805 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay PC-3 Prostate cancer IC50 : 283.90 µM
dbacp05806 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay PC-3 Breast cancer IC50 : 283.90 µM
dbacp05807 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay PC-3 Glioma IC50 : 283.90 µM
dbacp05808 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay U251-MG Lung cancer IC50 : 104.10 µM
dbacp05809 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay U251-MG Prostate cancer IC50 : 104.10 µM
dbacp05810 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay U251-MG Breast cancer IC50 : 104.10 µM
dbacp05811 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay U251-MG Glioma IC50 : 104.10 µM
dbacp05812 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay MCF-7 Lung cancer IC50 : 109.30 µM
dbacp05813 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay MCF-7 Prostate cancer IC50 : 109.30 µM
dbacp05814 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay MCF-7 Breast cancer IC50 : 109.30 µM
dbacp05815 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay MCF-7 Glioma IC50 : 109.30 µM
dbacp05816 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay HMEC-1 Lung cancer IC50 : 588.20 µM
dbacp05817 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay HMEC-1 Prostate cancer IC50 : 588.20 µM
dbacp05818 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay HMEC-1 Breast cancer IC50 : 588.20 µM
dbacp05819 R2PLx-22 GIMDTVKNAAKNLAGQLLDKLK Not found Inducing apoptosis MTT and LDH assay HMEC-1 Glioma IC50 : 588.20 µM
dbacp05822 R8-BAD RRRRRRRRGCNLWAAQRYGRELRRMSDEFVD BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified HNSCC 1483 Head and neck squamous cell carcinomas (HNSCC) Not found
dbacp05823 R8-BAD RRRRRRRRGCNLWAAQRYGRELRRMSDEFVD BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified UM-22A Head and neck squamous cell carcinomas (HNSCC) Not found
dbacp05824 R8-BAD RRRRRRRRGCNLWAAQRYGRELRRMSDEFVD BH3-only, Sensizers (BAD, HRK, Noxa) Inducing apoptosis Not specified UM-22B Head and neck squamous cell carcinomas (HNSCC) Not found
dbacp05825 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay SK-N-AS Brain tumor 0% apoptosis at 10 µM
dbacp05826 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay SK-N-AS Brain tumor 10% apoptosis at 20 µM
dbacp05827 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay SK-N-AS Brain tumor 30% apoptosis at 50 µM
dbacp05828 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NB69 Brain tumor 30% apoptosis at 10 µM
dbacp05829 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NB69 Brain tumor 80% apoptosis at 20 µM
dbacp05830 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NB69 Brain tumor 80% apoptosis at 50 µM
dbacp05831 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NGP Tumor 20% apoptosis at 10 µM
dbacp05832 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NGP Tumor > 50% apoptosis at 20 µM
dbacp05833 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NGP Tumor 30% apoptosis at 50 µM
dbacp05834 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay IMR5 Tumor 15% apoptosis at 10 µM
dbacp05835 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay IMR5 Tumor 20% apoptosis at 20 µM
dbacp05836 R8-BadBH3 rrrrrrrrGNLWAAQRYGRELRRMSDEFVDSFKK Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay IMR5 Tumor 50% apoptosis at 50 µM
dbacp05837 R8-Bak RRRRRRRRGCMGQVGRQLAIIGDDINRRY Effectors (BAK, BAX) Inducing apoptosis Not specified HNSCCs Head and neck squamous cell carcinomas (HNSCC) Not found
dbacp05838 R8-Bax RRRRRRRRGCSTKKLSECLKRIGDELDSnM Effectors (BAK, BAX) Inducing apoptosis Not specified HNSCCs Head and neck squamous cell carcinomas (HNSCC) Not found
dbacp05839 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay SK-N-AS Brain tumor 8% apoptosis at 10 µM
dbacp05840 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay SK-N-AS Brain tumor 45% apoptosis at 20 µM
dbacp05841 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay SK-N-AS Brain tumor 65% apoptosis at 50 µM
dbacp05842 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NB69 Brain tumor 25% apoptosis at 10 µM
dbacp05843 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NB69 Brain tumor 66% apoptosis at 20 µM
dbacp05844 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NB69 Brain tumor 68% apoptosis at 50 µM
dbacp05845 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NGP Tumor 43% apoptosis at 10 µM
dbacp05846 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NGP Tumor 46% apoptosis at 20 µM
dbacp05847 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NGP Tumor 79% apoptosis at 50 µM
dbacp05848 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay IMR5 Tumor 23% apoptosis at 10 µM
dbacp05849 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay IMR5 Tumor 35% apoptosis at 20 µM
dbacp05850 R8-BidBH3 rrrrrrrrGEDIIRNIARHLAQVGDSMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay IMR5 Tumor 55% apoptosis at 50 µM
dbacp05851 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay SK-N-AS Brain tumor 1% apoptosis at 10 µM
dbacp05852 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay SK-N-AS Brain tumor 2% apoptosis at 20 µM
dbacp05853 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay SK-N-AS Brain tumor 3% apoptosis at 50 µM
dbacp05854 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NB69 Brain tumor 2% apoptosis at 10 µM
dbacp05855 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NB69 Brain tumor 1% apoptosis at 20 µM
dbacp05856 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NB69 Brain tumor 5% apoptosis at 50 µM
dbacp05857 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NGP Tumor 1% apoptosis at 10 µM
dbacp05858 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NGP Tumor 2% apoptosis at 20 µM
dbacp05859 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay NGP Tumor 3% apoptosis at 50 µM
dbacp05860 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay IMR5 Tumor 0% apoptosis at 10 µM
dbacp05861 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay IMR5 Tumor 1% apoptosis at 20 µM
dbacp05862 R8-BidBH3Alt rrrrrrrrGEDIIRNIARHAAQVGASMDR Synthetic Peptide Inducing mitochondrial apoptosis MTT/MTS assay IMR5 Tumor 2% apoptosis at 50 µM
dbacp05863 RA-V cyclopeptideRA-V-,cyclo(YAAYAY) Plant sources Inducing apoptosis MTT assay MCF-7 Breast cancer Not found
dbacp05864 RA-V cyclopeptideRA-V-,cyclo(YAAYAY) Plant sources Inducing apoptosis MTT assay MDA-MB-231 Breast cancer Not found
dbacp05865 RA-V cyclopeptideRA-V-,cyclo(YAAYAY) Plant sources Inducing apoptosis MTT assay 4T1 Breast cancer Not found
dbacp05873 Radical SAM domain protein MEAVLYVTRKCNLSCGHCIVDKEDNSDLPTDKVETLASDYPIDRTILSGGEPFLHDNFEELVALVPEPTVLSNGLVLSDEEYVGENSDMLEELNGIQLSVEGKEETTDARRGEGVWDRVMEAHQNLSEIGVESYLRSTYSREMMEEVGELMEFCDAEGISLVLFPEIGKPPLSPTENASFFDYAVEKGVVVATPDFHSYIGEGGECPAARTRISVDVNGEIYPCQFNWDYCLGEVGDEWGLIESRIERFDRTEPVPRTCSRCDFANKCRGCGVADTWSGCPIARGLSHSESPSRRPLKRVQETMNTLEDVGAPRGCHGC Uncultured archaeon Apoptosis inducing MTT assay MCF-7 Breast cancer MIC : 42% ± 8.1 μM
dbacp05874 Radical SAM domain protein MEAVLYVTRKCNLSCGHCIVDKEDNSDLPTDKVETLASDYPIDRTILSGGEPFLHDNFEELVALVPEPTVLSNGLVLSDEEYVGENSDMLEELNGIQLSVEGKEETTDARRGEGVWDRVMEAHQNLSEIGVESYLRSTYSREMMEEVGELMEFCDAEGISLVLFPEIGKPPLSPTENASFFDYAVEKGVVVATPDFHSYIGEGGECPAARTRISVDVNGEIYPCQFNWDYCLGEVGDEWGLIESRIERFDRTEPVPRTCSRCDFANKCRGCGVADTWSGCPIARGLSHSESPSRRPLKRVQETMNTLEDVGAPRGCHGC Uncultured archaeon Apoptosis inducing MTT assay U2OS Osteosarcoma No significant effect
dbacp05877 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay H157 Lung cancer IC50 : 5.90 µM
dbacp05878 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay H157 Prostate cancer IC50 : 5.90 µM
dbacp05879 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay H157 Breast cancer IC50 : 5.90 µM
dbacp05880 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay H157 Glioma IC50 : 5.90 µM
dbacp05881 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Lung cancer IC50 : 15.44 µM
dbacp05882 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Prostate cancer IC50 : 15.44 µM
dbacp05883 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Breast cancer IC50 : 15.44 µM
dbacp05884 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Glioma IC50 : 15.44 µM
dbacp05885 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay PC-3 Lung cancer IC50 : 5.79 µM
dbacp05886 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay PC-3 Prostate cancer IC50 : 5.79 µM
dbacp05887 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay PC-3 Breast cancer IC50 : 5.79 µM
dbacp05888 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay PC-3 Glioma IC50 : 5.79 µM
dbacp05889 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay U251-MG Lung cancer IC50 : 16.14 µM
dbacp05890 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay U251-MG Prostate cancer IC50 : 16.14 µM
dbacp05891 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay U251-MG Breast cancer IC50 : 16.14 µM
dbacp05892 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay U251-MG Glioma IC50 : 16.14 µM
dbacp05893 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay MCF-7) Lung cancer IC50 : 20.19 µM
dbacp05894 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay MCF-7) Prostate cancer IC50 : 20.19 µM
dbacp05895 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay MCF-7) Breast cancer IC50 : 20.19 µM
dbacp05896 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay MCF-7) Glioma IC50 : 20.19 µM
dbacp05897 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay HMEC-1 Lung cancer IC50 : 79.50 µM
dbacp05898 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay HMEC-1 Prostate cancer IC50 : 79.50 µM
dbacp05899 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay HMEC-1 Breast cancer IC50 : 79.50 µM
dbacp05900 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Not found Inducing apoptosis MTT and LDH assay HMEC-1 Glioma IC50 : 79.50 µM
dbacp05901 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Gram-negative purple non-sulfur bacteria Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay H157 Lung IC50 : 5.90 µM
dbacp05902 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Gram-negative purple non-sulfur bacteria Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay MBD-MB-435s Melanocyte IC50 : 15.44 µM
dbacp05903 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Gram-negative purple non-sulfur bacteria Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay PC-3 Human prostate carcinoma IC50 : 5.79 µM
dbacp05904 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Gram-negative purple non-sulfur bacteria Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay U251-MG Human glioblastoma astrocytoma IC50 : 16.14 µm
dbacp05905 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCKITAC Gram-negative purple non-sulfur bacteria Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay MCF-7 Human breast cancer IC50 : 20.19 µM
dbacp05906 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Skin secretions, the pickerel frog, North America Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay H157 Lung cancer IC50 : 5.90 µM
dbacp05907 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Skin secretions, the pickerel frog, North America Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay MDA-MB-435S Breast cancer IC50 : 15.44 µM
dbacp05908 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Skin secretions, the pickerel frog, North America Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay PC-3 Human prostate carcinoma IC50 : 5.79 µM
dbacp05909 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Skin secretions, the pickerel frog, North America Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay U251-MG Glioma IC50 : 16.14 µM
dbacp05910 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Skin secretions, the pickerel frog, North America Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay MCF-7 Breast cancer IC50 : 20.19 µM
dbacp05911 Ranatuerin-2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Skin secretions, the pickerel frog, North America Inducing apoptosis MTT Cell viability assay and Lactate dehydrogenase (LDH) leakage assay HMEC-1 Glioma IC50 : 79.50 µM
dbacp05928 Red Sea microbiome peptide AAEKEFIKYPYPTPLQYQQLATRLKVEKKLVRRW Red Sea microbiome derived peptide Apoptosis inducing MTT/MTS assay U2OS Osteosarcoma Not found
dbacp05961 RGD-mda-7 MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAFKQLDVEAALTKALGEVDILLTWMQKFYKL Derived from wtmda-7/IL-24 by insertion or a glycine residue between Arg(164) and Asp(165). Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer Cell viability(% of control):0.5 at concentration 4 µg/ml
dbacp05962 RGD-mda-7 MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAFKQLDVEAALTKALGEVDILLTWMQKFYKL Derived from wtmda-7/IL-24 by insertion or a glycine residue between Arg(164) and Asp(165). Apoptosis inducing MTT/MTS assay Ket-3 Tumor Cell viability(% of control): 0.5 at concentration 8 µg/ml
dbacp05963 RGD-mda-7 MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAFKQLDVEAALTKALGEVDILLTWMQKFYKL Derived from wtmda-7/IL-24 by insertion or a glycine residue between Arg(164) and Asp(165). Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer Apoptotic rate(%): >70% at concentration of 8 µg/ml
dbacp05964 RGD-mda-7 MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL Derived from wtmda-7/IL-24 by insertion or a glycine residue between Arg(164) and Asp(165). Apoptosis inducing MTT/MTS assay Ket-3 Tumor Apoptotic rate(%): >50% at concentration of 8 µg/ml
dbacp05965 RGD-tachyplesin CRGDCGGKWCFRVCYRGICYRRCR Not found Inducing apoptosis Not specified TSU Prostate cancer Not found
dbacp05966 RGD-tachyplesin CRGDCGGKWCFRVCYRGICYRRCR Not found Inducing apoptosis Not specified B16 Prostate cancer Not found
dbacp05967 RGD-tachyplesin CRGDCGGKWCFRVCYRGICYRRCR Not found Inducing apoptosis Not specified Cos-7 Prostate cancer Not found
dbacp05968 RGD-tachyplesin CRGDCGGKWCFRVCYRGICYRRCR Not found Inducing apoptosis Not specified NIH-3T3 Prostate cancer Not found
dbacp05969 RGSALTHLP RGSALTHLP Siamese crocodile Leukocyte Apoptosis inducing Sulforhodamine B colorimetric assay HeLa Cervical cancer IC50 : 126.24 ± 3.5 μM
dbacp05970 RGSALTHLP RGSALTHLP Siamese crocodile Leukocyte Apoptosis inducing Sulforhodamine B colorimetric assay CaSki Cervical cancer IC50 : 168.33 ± 1.6 μM
dbacp05974 RP9 RGSALTHLP Siamese crocodile leukocyte extract Apoptosis Sulforhodamine B colorimetric assay, apoptosis array assay HeLa Cervical cancer IC50 : 126.2 μM
dbacp05975 RP9 RGSALTHLP Siamese crocodile leukocyte extract Apoptosis Sulforhodamine B colorimetric assay, apoptosis array assay CaSki Cervical cancer IC50 :168.3 μM
dbacp05981 RT2 NGVQPKYRWWRWWRRWW-NH2 Siamese crocodile leukocyte Inducing apoptosis Sulforhodamine B colorimetric assay HeLa Cervical cancer IC50 : 28.7–53.4 μM
dbacp05982 RT2 NGVQPKYRWWRWWRRWW-NH2 Siamese crocodile leukocyte Apoptosis inducing Sulforhodamine B colorimetric assay HeLa Cervical cancer IC50 : 28.7–53.4 μM
dbacp05983 RT2 NGVQPKYRWWRWWRRWW-NH2 Siamese crocodile leukocyte Apoptosis inducing Sulforhodamine B colorimetric assay HeLa Cervical cancer IC50 : 28.7–53.4 μM
dbacp05984 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay H157 Lung cancer IC50 : 58.18 µM
dbacp05985 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay H157 Prostate cancer IC50 : 58.18 µM
dbacp05986 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay H157 Breast cancer IC50 : 58.18 µM
dbacp05987 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay H157 Glioma IC50 : 58.18 µM
dbacp05988 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Lung cancer IC50 : 179.00 µM
dbacp05989 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Prostate cancer IC50 : 179.00 µM
dbacp05990 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Breast cancer IC50 : 179.00 µM
dbacp05991 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay MBD-MB-435s Glioma IC50 : 179.00 µM
dbacp05992 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay PC-3 Lung cancer IC50 : 792.60 µM
dbacp05993 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay PC-3 Prostate cancer IC50 : 792.60 µM
dbacp05994 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay PC-3 Breast cancer IC50 : 792.60 µM
dbacp05995 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay PC-3 Glioma IC50 : 792.60 µM
dbacp05996 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay U251-MG Lung cancer IC50 : 278.30 µM
dbacp05997 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay U251-MG Prostate cancer IC50 : 278.30 µM
dbacp05998 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay U251-MG Breast cancer IC50 : 278.30 µM
dbacp05999 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay U251-MG Glioma IC50 : 278.30 µM
dbacp06000 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay MCF-7 Lung cancer IC50 : 316.90 µM
dbacp06001 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay MCF-7 Prostate cancer IC50 : 316.90 µM
dbacp06002 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay MCF-7 Breast cancer IC50 : 316.90 µM
dbacp06003 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay MCF-7 Glioma IC50 : 316.90 µM
dbacp06004 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay HMEC-1 Lung cancer IC50 : 1185.00 µM
dbacp06005 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay HMEC-1 Prostate cancer IC50 : 1185.00 µM
dbacp06006 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay HMEC-1 Breast cancer IC50 : 1185.00 µM
dbacp06007 S−24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Not found Inducing apoptosis MTT and LDH assay HMEC-1 Glioma IC50 : 1185.00 µM
dbacp06008 S1 (Ac-KKWRKWLAKK-NH2) Ac-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay PC9 Human Lung cancer Not found
dbacp06009 S1 (Ac-KKWRKWLAKK-NH2) Ac-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay PC9-G Oral cancer Not found
dbacp06010 S1 (Ac-KKWRKWLAKK-NH2) Ac-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay A549 Human lung cancer Not found
dbacp06011 S1 (Ac-KKWRKWLAKK-NH2) Ac-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay C9 Oral cancer Not found
dbacp06012 S1 (Ac-KKWRKWLAKK-NH2) Ac-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay OECM-1 Human lung cancer Not found
dbacp06013 S1 (Ac-KKWRKWLAKK-NH2) Ac-NAl-NAl-KKWRKWLAKK-NH2 Not found Necrosis or apoptosis MTT assay SAS Oral cancer Not found
dbacp06021 SALF Ac-ECKFTVKPYLKRFQVYYKGRMWCPNH2 Giant tiger prawn Regulate apoptosis related death receptor/NF-κB signaling pathway MTT assay HeLa Human lung cancer MIC : 100 µg/ml
dbacp06022 San A-amide NA Marine fungus, Wilt of banana Apoptosis induction Not specified HCT-116 Colon cancer MIC : 0.98 µg/mL
dbacp06023 Sansalv amide A NA Synthetic Peptide Apoptosis Cell viability assay S2-13 Pancreatic cancer EC50 : 7.5 µM
dbacp06024 SCAP1 LANAK Marine invertebrates Inducing apoptosis Not specified HT-29 Not specified IC50 : 90.31 ± 0.45 μM
dbacp06025 SCAP1 LANAK Marine invertebrates Inducing apoptosis Not specified HT-29 Not specified IC50 : 70.87 ± 0.82 μM
dbacp06026 SCAP1 LANAK Marine invertebrates Inducing apoptosis Not specified HT-29 Not specified IC50 : 60.21 ± 0.45 μM
dbacp06027 SCH-P10 DYVP Marine invertebrates Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 : 1.21 mg/mL
dbacp06028 SCH-P10 DYVP Marine invertebrates Inducing apoptosis MTT assay PC-3 Prostate cancer IC50 : 1.09 mg/mL
dbacp06029 SCH-P9 LPGP Marine invertebrates Inducing apoptosis MTT assay DU-145 Prostate cancer IC50 : 1.21 mg/mL
dbacp06030 SCH-P9 LPGP Marine invertebrates Inducing apoptosis MTT assay PC-3 Prostate cancer IC50 : 1.09 mg/mL
dbacp06035 Scolopin-2 ILKKFMLHRGTKVYKMRTLSKRSH Chinese red-headed centipede Regulate caspase-related apoptosis pathways MTT assay Hela Cervical cancer IC50 : 35 μM
dbacp06058 Sepia ink oligopeptide (SIO) QPK Not found Inducing apoptosis CCK-8 assay DU-145 Prostate cancer IC50 : < 5 mg/mL
dbacp06059 Sepia ink oligopeptide (SIO) QPK Not found Inducing apoptosis CCK-8 assay PC-3 Prostate cancer IC50 : < 5 mg/mL
dbacp06060 Sepia ink oligopeptide (SIO) QPK Not found Inducing apoptosis CCK-8 assay LNCaP Prostate cancer IC50 : < 10 mg/mL
dbacp06063 Shepherdin KHSSGCAFL Not found Inducing apoptosis MTT assay HeLa Cervical carcinoma IC50 : 25–75 µM
dbacp06064 Shepherdin KHSSGCAFL Not found Inducing apoptosis MTT assay PC3 Prostate adenocarcinoma IC50 : 25–75 µM
dbacp06065 Shepherdin KHSSGCAFL Not found Inducing apoptosis MTT assay p53+/+ HCT116 Colorectal carcinoma IC50 : 25–75 µM
dbacp06066 Shepherdin KHSSGCAFL Not found Inducing apoptosis MTT assay p53+/+ HCT116 Colorectal carcinoma IC50 : 25–75 µM
dbacp06067 Shepherdin (ATP) RQIKIWFQNRRMKWKKKHSSGCAFL Not found Inducing apoptosis MTT assay HeLa Cervical carcinoma IC50 : 50–75 μM
dbacp06068 Shepherdin (ATP) RQIKIWFQNRRMKWKKKHSSGCAFL Not found Inducing apoptosis MTT assay PC3 Prostate adenocarcinoma IC50 : 50–75 μM
dbacp06069 Shepherdin (ATP) RQIKIWFQNRRMKWKKKHSSGCAFL Not found Inducing apoptosis MTT assay p53+/+ HCT116 Colorectal carcinoma IC50 : 50–75 μM
dbacp06070 Shepherdin (ATP) RQIKIWFQNRRMKWKKKHSSGCAFL Not found Inducing apoptosis MTT assay p53+/+ HCT116 Colorectal carcinoma IC50 : 50–75 μM
dbacp06071 Shepherdin (TAT) YGRKKRRQRRRKHSSGCAFL Not found Inducing apoptosis MTT assay HeLa Cervical carcinoma IC50 : 50–75 μM
dbacp06072 Shepherdin (TAT) YGRKKRRQRRRKHSSGCAFL Not found Inducing apoptosis MTT assay PC3 Prostate adenocarcinoma IC50 : 50–75 μM
dbacp06073 Shepherdin (TAT) YGRKKRRQRRRKHSSGCAFL Not found Inducing apoptosis MTT assay p53+/+ HCT116 Colorectal carcinoma IC50 : 50–75 μM
dbacp06074 Shepherdin (TAT) YGRKKRRQRRRKHSSGCAFL Not found Inducing apoptosis MTT assay p53+/+ HCT116 Colorectal carcinoma IC50 : 50–75 μM
dbacp06079 Short α-helical peptide GIIKKIIKKI Alpha-helical proteins Cell membrane disruption; Cell apoptosis MTT/MTS assay HeLa Cervical cancer 99% Cytotoxicity at 4µM approx.
dbacp06080 Short α-helical peptide GIIKKIIKKIIKKI Alpha-helical proteins Cell membrane disruption; Cell apoptosis MTT/MTS assay HeLa Cervical cancer 95 % Cytotoxicity at 4µM approx.
dbacp06081 Short α-helical peptide GIIKKIIKKIIKKIIKKI Alpha-helical proteins Cell membrane disruption; Cell apoptosis MTT/MTS assay HeLa Cervical cancer 80% Cytotoxicity at 4µM
dbacp06082 Short α-helical peptide GIIKKIIKKI Alpha-helical proteins Cell membrane disruption; Cell apoptosis MTT/MTS assay HL-60 Leukemia cancer 100% Cytotoxicity at 4µM approx.
dbacp06083 Short α-helical peptide GIIKKIIKKIIKKI Alpha-helical proteins Cell membrane disruption; Cell apoptosis MTT/MTS assay HL-60 Leukemia cancer 90% Cytotoxicity at 4µM approx.
dbacp06084 Short α-helical peptide GIIKKIIKKIIKKIIKKI Alpha-helical proteins Cell membrane disruption; Cell apoptosis MTT/MTS assay HL-60 Leukemia cancer 70% Cytotoxicity at 5µM approx.
dbacp06128 Smac-CPP AVPIAQKSVSRRRRRRGGRRRR SMAC Inducing apoptosis Not specified 4T1 Not found IC50 : 132 μM
dbacp06129 SmacN7(R)8 AVPIAQKGGGRRRRRRRRGC SMAC Inducing apoptosis Not specified H460 Lung cancer Not found
dbacp06139 Solute carrier family 15 member 2 MNPFQKNESKETLFSPVSTEEMLPGPPSPPKKSTPKLFGSSYPLSIAFIVVNEFCERFSYYGMKAVLTLYFLYFLHWNEDTSTSVYHAFSSLCYFTPILGAAIADSWLGKFKTIIYLSLVYVLGHVFKSLGAIPILGGKMLHTILSLVGLSLIALGTGGIKPCVAAFGGDQFEEEHAEARTRYFSVFYLSINAGSLISTFITPMLRGDVKCFGEDCYALAFGIPGLLMVLALVVFAMGSKMYRKPPPEGNIVAQVTKCIWFAICNRFRNRSEDIPKRQHWLDWAAEKYPKHLIMDVKALTRILFLYIPLPMFWALLDQQGSRWTLQANKMDGDLGFFVLQPDQMQVLNPFLVLVFIPLFDLVIYRLISKCGVNFSSLRKMAVGMILACLAFAVAALVEIKINGMIHPQPASQEIFLQVLNLADGEIEVTVQGNRNNPLLVESISSFQNTTHYSKLRLETKSQDLHFHLKYNNLSVHNEYSVEEKNCYQLVVHENGESLSSMLVKDTGIKPANGMTAIRFINTLHKDMNISLDANAPLSVGKDYGVSEYRTVQRGKYPAVHCETEDNVFSLNLGQLDFGTTYLFVITNITNRGLQAWKAEDIPANKLSIAWQLPQYVLVTAAEVMFSVTGLEFSYSQAPSSMKSVLQAAWLLTVAVGNIIVLIVAQFSGLVQWAEFVLFSCLLLVVCLIFSVMGYYYVPLKSEGIHEATEKQIPHIQGnMINLETKNTRL Mouse Apoptosis; Cell proliferation Not specified Not found Not found Not found
dbacp06140 SP22 ACHWPWCHGWHSACDLPMHPMC Not found Inducing apoptosis Tunnel assay MCF-7 Breast cancer Not found
dbacp06141 SP22 ACHWPWCHGWHSACDLPMHPMC Not found Inducing apoptosis Tunnel assay NKM Stomach cancer Not found
dbacp06142 SP22 ACHWPWCHGWHSACDLPMHPMC Not found Inducing apoptosis Tunnel assay CHO Ovarian cancer Not found
dbacp06143 SP22 ACHWPWCHGWHSACDLPMHPMC Not found Inducing apoptosis Tunnel assay HEL Lung cancer Not found
dbacp06183 t Mastoparan-C(tMP-C, Tat (49-57)-Mastoparan-C) RKKRRQRRRLNLKALLAVAKKIL Synthetic construct Apoptosis inducing MTT assay H157 Non-small cell Lung cancer IC50 : 2.79 μM
dbacp06184 t Mastoparan-C(tMP-C, Tat (49-57)-Mastoparan-C) RKKRRQRRRLNLKALLAVAKKIL Synthetic construct Apoptosis inducing MTT assay MBD-MB-435S Melanocyte IC50 : 3.86 μM
dbacp06185 t Mastoparan-C(tMP-C, Tat (49-57)-Mastoparan-C) RKKRRQRRRLNLKALLAVAKKIL Synthetic construct Apoptosis inducing MTT assay PC-3 Human prostate carcinoma IC50 : 3.86 μM
dbacp06186 t Mastoparan-C(tMP-C, Tat (49-57)-Mastoparan-C) RKKRRQRRRLNLKALLAVAKKIL Synthetic construct Apoptosis inducing MTT assay U251-MG Human glioblastoma astrocytoma IC50 : 3.36 μM
dbacp06187 t Mastoparan-C(tMP-C, Tat (49-57)-Mastoparan-C) RKKRRQRRRLNLKALLAVAKKIL Synthetic construct Apoptosis inducing MTT assay MCF-7 Human breast cancer IC50 : 3.70 μM
dbacp06192 Tachyplesin I KWCFRVCYRGICYRRCR Hemocytes, Southeast Asia, Japanese horseshoe crab Apoptosis inducing Luciferase reporter assay, TUNEL assay T167 Squamous cell oral carcinoma Not found
dbacp06193 Tachyplesin I KWCFRVCYRGICYRRCR Hemocytes, Southeast Asia, Japanese horseshoe crab Apoptosis inducing Luciferase reporter assay, TUNEL assay T-409 Squamous cell oral carcinoma Not found
dbacp06195 Tat RKKRRQRRR HIV-Tat (49-57) Apoptosis inducing MTT/MTS assay HCT-116 Colon cancer ~10% cytotoxicity at 100 µM
dbacp06199 Tat-a5 KAQIRAMECNILGRKKRRQRRR HIV-Tat (49-57) Apoptosis inducing MTT/MTS assay HCT-116 Colon cancer ~80% cytotoxicity at 100 µM
dbacp06200 TAT-Bim (145-165) RKKRRQ(orn)RRREIWIAQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified EL4 Mouse T-cell lymphoma Not found
dbacp06201 TAT-Bim (145-165) RKKRRQ(orn)RRREIWIAQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Panc-02 Pancreatic cancer Not found
dbacp06202 TAT-Bim (145-165) RKKRRQ(orn)RRREIWIAQELRRIGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified B16 Melanoma Not found
dbacp06203 TAT-CTMP4 LDPKLMKEEQMSQAQLFTRSFDDGL Not found Inducing apoptosis Not specified Panc-1 Pancreatic cancer TAT-CTMP4 induced a dose-dependent increase in apoptosis as detected by %-TUNEL positive cells and %-active caspase-3 (% active caspase-3 ranged from 31.2 to 61.9 at the highest dose tested (10 µM).
dbacp06204 TAT-CTMP4 LDPKLMKEEQMSQAQLFTRSFDDGL Not found Inducing apoptosis Not specified Panc-02 Pancreatic cancer TAT-CTMP4 induced a dose-dependent increase in apoptosis as detected by %-TUNEL positive cells and %-active caspase-3 (% active caspase-3 ranged from 31.2 to 61.9 at the highest dose tested (10 µM).
dbacp06205 TAT-CTMP4 LDPKLMKEEQMSQAQLFTRSFDDGL Not found Inducing apoptosis Not specified AsPC-1 Pancreatic cancer TAT-CTMP4 induced a dose-dependent increase in apoptosis as detected by %-TUNEL positive cells and %-active caspase-3 (% active caspase-3 ranged from 31.2 to 61.9 at the highest dose tested (10 µM).
dbacp06206 TAT-CTMP4 LDPKLMKEEQMSQAQLFTRSFDDGL Not found Inducing apoptosis Not specified BxPC-3 Pancreatic cancer TAT-CTMP4 induced a dose-dependent increase in apoptosis as detected by %-TUNEL positive cells and %-active caspase-3 (% active caspase-3 ranged from 31.2 to 61.9 at the highest dose tested (10 µM).
dbacp06207 TAT-CTMP4 LDPKLMKEEQMSQAQLFTRSFDDGL Not found Inducing apoptosis Not specified CFPAC-1 Pancreatic cancer TAT-CTMP4 induced a dose-dependent increase in apoptosis as detected by %-TUNEL positive cells and %-active caspase-3 (% active caspase-3 ranged from 31.2 to 61.9 at the highest dose tested (10 µM).
dbacp06208 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay HCT116p53–/– Colon cancer Survival rate : 32.19 ± 6.42%
dbacp06209 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay HCT116p53+/+ Colon cancer Survival rate : 34.28 ± 8.93%
dbacp06210 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay GLC-82 Colon cancer Survival rate : 63.64 ± 4.80%
dbacp06211 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay SGC-7901 Colon cancer Survival rate : 64.75 ± 33.48%
dbacp06212 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay MDA-MB-231 Colon cancer Survival rate : 69.79 ± 6.71%
dbacp06213 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay HEK293 Colon cancer Survival rate : 115.85 ± 23.03%
dbacp06214 TAT-DV3-BH3 YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY BH3-only, Direct activators (PUMA, Bid) Inducing apoptosis CCK-8 assay 2BS Colon cancer Survival rate : 124.38 ± 22.05%
dbacp06215 TAT-Ras-GAP317-326 GRKKRRQRRRGGWMWVTNLRTD Not found Apoptosis inducing LDH leakage assay HeLa Cervical cancer 15% apoptosis at 10 µM
dbacp06216 TAT-Ras-GAP317-326 GRKKRRQRRRGGWMWVTNLRTD Not found Apoptosis inducing LDH leakage assay HeLa Cervical cancer 47% apoptosis at 20 µM
dbacp06217 TAT-Ras-GAP317-326 GRKKRRQRRRGGWMWVTNLRTD Not found Apoptosis inducing LDH leakage assay HeLa Cervical cancer 72% apoptosis at 30 µM
dbacp06218 TAT-Ras-GAP317-326 GRKKRRQRRRGGWMWVTNLRTD Not found Apoptosis inducing LDH leakage assay HeLa Cervical cancer 79% apoptosis at 50 µM
dbacp06219 TAT-RasGAP (317-326) From p120RasGAP GRKKRRQRRRGGWMWVTNLRTD Not found Inducing apoptosis Luciferase assay HeLa Breast cancer Not found
dbacp06220 TAT-RasGAP (317-326) From p120RasGAP GRKKRRQRRRGGWMWVTNLRTD Not found Inducing apoptosis Luciferase assay MCF-7 Human malignant mesothelomia Not found
dbacp06226 Temporin A FLPLIGRVLSGIL Common frog Disruption of electric potential of the cell membrane; Necrosis; Membranolytic activity leading to apoptosis MTT/MTS assay U-943 Lymphoma cancer IC50 : 80-90 µg/ml
dbacp06301 Tf-D-LP4 HAIYPRHSWTWEKKLETAVNLAWTAGNSNKWTWK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified CLL Leukemia IC50 : 1.2 ± 0.1 µM
dbacp06302 Tf-D-LP4 HAIYPRHSWTWEKKLETAVNLAWTAGNSNKWTWK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified MEC-1 Leukemia IC50 : 1.8 ± 0.2 µM
dbacp06303 Tf-LP4 HAIYPRHSWTWEKKLETAVNLAWTAGNSNKWTWK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified CLL Leukemia IC50 : 1.7 ± 0.2 µM
dbacp06304 Tf-LP4 HAIYPRHSWTWEKKLETAVNLAWTAGNSNKWTWK VDAC1(voltage-dependent anion channel1) Inducing apoptosis Not specified MEC-1 Leukemia IC50 : 3.6 ± 0.2 µM
dbacp06306 Tilapia piscidin 4 FIHHIIGGLFSAGKAIHRLIRRRRR Not found Inducing apoptosis MTT assay MG63 Bone cancer IC50 : 1–5 µM
dbacp06307 TLS peptide TLSGAFELSRDK Not found Inducing apoptosis Not specified SKOV3 Ovarian cancer Not found
dbacp06308 TO4, human Bax 21-mer (52–72) QDASTKKLSECLKRIGDELDS Effectors (BAK, BAX) Inducing apoptosis Not specified Not found Not specified Not found
dbacp06322 TP3 FIHHIIGGLFSVGKHIHSLIHGH Not found Inducing apoptosis MTT assay MG63 Bone cancer 10.02 ± 1.10 μM
dbacp06326 Transactivator of transcript-DV1-Bcl-2, AT-DV1-BH3 RRRQRRKKRGGGGLGASWHRPDK Transactivator of transcript-DV1-Bcl-2 TAT-DV1-BH3 Apoptosis inducing Cell viability assay, Transwell invasion assay MDA-MB-231 Breast cancer Not specified
dbacp06327 Transactivator of transcript-DV1-Bcl-2, AT-DV1-BH3 RRRQRRKKRGGGGLGASWHRPDK Transactivator of transcript-DV1-Bcl-2 TAT-DV1-BH4 Apoptosis inducing Cell viability assay, Transwell invasion assay MCF-7 Breast cancer Not specified
dbacp06328 Transactivator of transcript-DV1-Bcl-2, AT-DV1-BH3 RRRQRRKKRGGGGLGASWHRPDK Transactivator of transcript-DV1-Bcl-2 TAT-DV1-BH5 Apoptosis inducing Cell viability assay, Transwell invasion assay HEK-293 Kidney cancer Not specified
dbacp06381 TT 1 KIKAVLKVLTT Venom base Inducing apoptosis MTT assay TT Thyroid cancer IC50 : 18.23 ± 2.81 μg/ml
dbacp06382 TT 1 KIKAVLKVLTT Venom base Inducing apoptosis MTT assay TT Thyroid cancer IC50 : 3.87 ± 0.34 μg/ml
dbacp06383 TT 1 KIKAVLKVLTT Venom base Inducing apoptosis MTT assay TT Thyroid cancer IC50 : 2.76 ± 0.32 μg/ml
dbacp06384 TubB protein MTLDSRYANRGGGLYEIDGLAIGHSPPPCSIPGGVQLTATATAEHALKALRAKGLATSDEALPAVRHASGEKAPLSSSQRRMWFLEQLEPGNAAQHLLQSHHIQGPLQVEGLRRALGLMVKRHEALRLVVAIGAAGPEQRVRPEWWPELPLSDLSGVAQADRARALAELARVEAAAPFNLQQGPLFRVRLARLAETEHVLLVTLHHLISDGAWSCEVLIKELAMLYGQHVEGSSPELAPLPVQYRDYAGWEASFAPAGEALEAWWRQRLAGVPTVLELPTEGARPLRQTYRAGRVAITVQPRLRQALEDLAHKEGVSLFALLLTAFTTLLHRYSRQEELVVGWPAPQRPRPELHGLIGYFGTPVALRSRLEPHTRVREALRQLDQEVREANAHAALPFERLVSLLDIARSPSRHPLFQVLFDLLPEQPQPTAGGCAFRPWESFTGLVAYDLTLLLEPRGEGLEGALDYSADLFSEARMQRAATQYLHLLEQLVERPHERLSRLALLTPGEHEALLAGHGLGGPVEGAQVLAHHRFEHQVRLTPHHPALCFGPQVLSYEQLNRRANPLAHRLRRLGAGPDTLVGLCVERSLELPVALLAIWKAGAGFLPLDVNQPRERLAFLLGDASCRILLTQEHLLQRLPPTNAALLCLEREAEALEREPQEDAPHEAGLDNLAYVIHTSGSTGTPKGIAMVHRCLANLVAWQLTHERLGGPSRTLQFASLNFDICYQELFTTWAAGGTVVMVTEEVRRDPARLLEVLEQEQVSRLYLPFIALQQLARVADERGAAPRHLRQLITAGEQLQATPELQRLLSRMPECTLHNQYGPSECHVVTSHDLTREPSRWPRLPPVGRPLAHLRVLLLDGEQQLVPPGVAGEVFLGGPALARGYLGRPEQTADRFVPDPFSREPGARLYRTGDLARLREDGALEFLQRMDAQVKIRGYRIEPGEIEVVLCEHPAVHQAHVRPYVDSAGERRLVAYVAARLEDTDGAETEHVERWRAVWDETYGGPSGTAFDLAGWNDSVRGEPLPPEQMREWVETTVERLMELVPRRVLELGCGSGLLLRRLAPRCESYWGTELSPVAVERLREQLQTGGSPLAQRVRLMAQPADDFSGLPEAGFDTVILNSVTQLFPSVDYLLRVVEGALRVLQPGGTLFIGDVQNLRLFELFHASVALEQASADLEAPALLARTRQRMLLDERLYVDPDFFAALATHFPQLGAVRLHLKRGSGRNEMNRFRYDVELQLAPVAKAGPAQELPELDWRHEGLGLERLERMLAERPAGLVLRNVANARTADEAARLALLRTGNSVGRLRALPAVTSWNPEQLWRLAEAADYTCHVTWSAQDEEGRFDALLMARAAGSSRPAAWLTPPPPPPRPWKSYANQPLAASRRRTLVGVLRSHLEHKLPEYMVPSSFVLLDALPLKPTGKLEVAALPPPEPAQAEQTPGHLAPRTPTERRLAELWRRVLGVHRVGVEDNFFQLGGHSLLATRLLSLIRGELGLELPLRVLFEQPTLAAMAGCLEAQSWSTQAPHPPSASIEEGEL Aeromonads Apoptosis and thus cell nucleus fragmentation Toxicity assay, cell nucleus fragmentation assay (cnf) L929 Not specified MIC : 50 ng/ml
dbacp06385 TubC protein MSAGALLAHAASLGVRLWVEGERLRFQAPPGVMTPELQSRLGGARHELIALLRQLQPSSQGGSLLAPVARNGRLALSFAQQRLWFQEQLHPEAPANNLTGAVVFTGPLHVAALLGAVAALVRRHEALRTTLGEEGGVPYSLIGEPWQPALEVEALPGATVGERLEQAREVALAESRRRFALETEPHLRVRLLRLAEQQHVLVLSLHHIAADGVGLQVLEQELAALYGALSAGAEPRLPPLPLQVADLADWQRRWVEGEEYQVQLAYWRRQLAGLTPLEVPGDHPRPRIPSMRGAEVRAPLLSAPQAQVLRALGQGEGATLYMTLLAALGVLLQRWTGQHDMAVGSAAANRNRPGLEGILGFLLNIVLLRLDLRGRPRFRELLRQARRVCVEAYAHQELPFEHLVEALQPGSERGDSSLYRVALAVSDTPWMPGHGLKLEGVQAQPLDFPRGVLDLDLHLWVYDTGEGLTGRLEYAVDLYEEPTARRLLEGFRQVLEAVVEAPDRPVPELPVLGEQERHQVLSGWNRTQRPYPREASVHGLFQQRALQAPRAVAVVYGERSLTYGELAERARGLAQGLVARGVRRGDLVALRLERSPEQVESMLAVLQAGAAYVPLDPSYPVQRQEFMLQDSGARLLVHSGPLPFAPQGCATLDLQAWHPAPSDGGEPLPQCSGEDLAYVIYTSGSTGQPKGVAVCHRAMTRLVCNTDYVQLGPEDRVAQASNASFDAATFEVWGALLNGARLVGLATEEAIQARRLAEVLREQRISVLFVTTALFNHVAREQPQAFSTLRYLLFGGEAVDASSVRRVLKQGAPGHLLHVYGPTENTTFSTAWRVEHLAEQAHTVPMGHPIANSRLHVLDEALQPVPVGAMGEVYLGGDGLALGYWRHPEATAERFVPDPHGLEPGGRLYRTGDLARRQADGAVVFAGRVDRQVKLRGFRVEPAEIESHLCEHSEVSAAVVELRGEGALRRLVAYVVPRAGGRPGAEELRTFLRTRLPEYMLPASFSLLEALPLTPNGKVDRSALPESFEEASREQAPVVPPRGPVEALLVDIWREVLGTQRVSVHDDFFDLGGHSLLATRVVSRLREALQVELPLRTLFEAPQLSALAAQVEVLLGHRQLRPPPLVPAVRPPELPLSFAQQRLWFLQQLAPQSTAYQILDAWHVRGRVDVGALERALEQLVRRHEALRTTFEPGGDGVPRQRIHAPAPVPLRQVDLRSHGIAAREEALRWMREQALRPLELDKGPLLRVSLLRLEEAQSLLFLELHHIVGDGWSLSVWSRELSHLYEAALHGAEPGLAPLPVQYADFALWQRGWLQGPVLREELTWWRERLARLAPLRLPADHARPEVQRFNGATYRFTLPGVRVQALRRLGHEHGATLFMVLLAGFNALLARYTGQTDIAIGAPIANRTRGEVEGLIGFFVNTLVLRTRLEGNPSFLELLRRVRETTLEAYAHQELPFERLVEELQPERQANQNPLVQVLLALQNAPREPLRLAGLEAEHLEYLVATTRFDLELHLWEEEEGLSCIAVYDRALYGAGTVERLVGAWCTLLEGVAELPARRVAELPLVPARELRQVPPPSPAAAIETSIGARFSEVARRQPGATAVTQGGRHLTYAELEERSERLARYLAWLGVRAGDRVGLATERTLERIISLLGILKAGAAYVPLDVRQPARRLSLLVQAAGVRTVIAEEQARTVLSGLGQPLTLVDAAQEPASAQQVPALGPERSLGGDMLAYVLFTSGSTGEPKGVCIPHRAVLRLIHEPSYVQLSPREVMLHYAPLEFDASTFEVWGALLNGARLVLVPPEQQSLESLGQELSTQGVTVLWLTAGLFRLMVEEQLKSLRGVRQLLAGGDVLPMPQVRRLREALPECQLINGYGPTESCTFTCCHRVGSPQELGGSVPIGTPIDLGWVSVVDERLQPVPDGAPGELLVGGPGLAWGYLQHPELTAERFIPDPLSRTPGARVYRTGDLVRRREDGTLEFLGRVDHQLKVRGFRIEPGEVEAAVLTHPAVQSAVVVGREGPGGKELVCYAVPRVESSEQGSQQEQRLVHEWESVFDGHMYREAPVGGEPTFNIVGWKSSYTGQPVAVEEMRDWLRHRVERVRGLRPRRILEVGCGTGLMLFALLPHCERYVGTDFSPAALDYVRRYLPPEHPGRVELLHRTADEWSGVAAGSFDAVLLNSVVQYFPSQEYLRQVLARCVEAVEDGGFVFVGDVRSLPLLESFHASVELERAAPSMPLEAWRERVRRAVLEDNELVVDPALFVALAHQHPRVSHVDIELTRGTHPNEMARFRYNAVLHIGPRTPPPASEVPWVDWSTQGLSLDALRARLRQGPPGPLGVAGIPNARVLPAVRAAEALGSTGSARRVEELRRRLSQPGTGAQDPDPFWQLAESLGYTAAVSWSPGRRDGAFDVLFLPATPGMHPRWLGPTPLNRTPPPASARLSSEPRRASLSLRLGSALRAHLQTHLPDFMVPSRFVVLQSLPLTPNGKVDRAALPVPDSRRLESAPLVPPSNELERVLAQVWKEVLGLEEVSREDNFFDVGGHSLLLAQVCSRLEARLGRRLELVTLFRYSSIAALAEHLQAPQELAAAEAQVQRMATERALLQQQAAQRRRAGSKRGAPNDT Aeromonads Apoptosis and thus cell nucleus fragmentation Toxicity assay, cell nucleus fragmentation assay (cnf) L929 Not specified MIC : 50 ng/ml
dbacp06386 TubD protein MTPSGDEALQSSIALVGMAGRFPGAPDVESFWRNLVAGVESISFFSEEELRQAGVSEQIRRRPEYVPAKGVLEDLELFDAGFFGYSPREASHLDPQQRLLLECSWEALEDAGLRPDQLPGWVGVYVGAGDTSYRFQLLRGHGDPLSGSKDVAGFFGNYPDFLATRVAYKLNLRGPALGIHTACSTSLVSInMACSALRGFECDMALAGGVSLRLPARSGYLYEEGGVASKDGHCRPFDARATGTVTGDGVGVVVLKRLEDALKARDPIHAVIRGWALNNDGASRAGFTAPSVEGQSEVIALAHAAAGISARDITYVEAHGTGTPLGDPIEVAALTRAFRAHTADTAFCTLGAVKSNIGHLDAAAGVAGVIKTVQALRHRLIPPTLHFERPNPALHLEQSPFFVNTQPLPWESPRGPRLAGVSSFGIGGTNAHTLFEEAPPPPASGPTRPNQVLLLSARSTSALEHIAGRLAAHLRRHPDLELADVAFTLQVGRARFPYRRALTCRTLAEAMERLEAPEPRPPEPLAHEGERPPLVMLFPGQGTPLVGTARALHESEPTFRQAVEQCARLLRQTLGLDVREVLFPSAEQEEQARRLAAQTRVAQPALFTLEYALAQTWLGWGLQPQALAGHSLGELVAACLAGVFSLEDALQLVAARGQLMQGCPPGAMLAVPLPEAELAALLGSELCIAAVNGPRACVASGPLPAVEALTAALESRGVSSRRLETSHAFHSASMEACQGPLTTLLRRMRLQAPRLPCVSGLTGRWLTGEEATEPTYWARQLREPVRFSEALETLWSLKEPVLLEVGPGTTLTALARRHPTRPARTQEVASLPVQPDTAVPCIEEAVGELWQAGLELDWSALHAAPRHRAHLPPYPFERQRYWIEPEAAPQPRAQQPTPASLVPPEQPSREALEDWFYVPTWEQAPATSGGGQPLAGPVLAFMDSSGLAEQVLAALWPADSGALLTRVEPAGHYEQLSEHAFRLRPESEEDWDALFQALQSQGRLPRRILHAWALTAEPGPCTPDGEAVLEQGFFSLLRLARALGRHAPERPVQLEVLSSFVHAVGPREPLEPLKATLLGACAVLPLEYPHVQCRTIDVRPGSEPREVLVRSLAAELAAPMGESPVAWRDGQRYVRRATRQRLEASRPLRSLRERGVYLVAGGLGGIGLVLARALAQRARARLALLTHSPFPPREQWEQWLEEAPAHPEPAWRSEADPSERRRTQHRIRCLLELEQLGAEVQVYTADVAEEAAVRSVVEQVHARWGKIHGVLHAAATFDDGVIQLRTHEQSSRALRTKVRGSMVLHEVLASEGLDWFALCSSLASALGSFGQADYCAANAFQDAYAHHLRRQGFTGALALDWGTWRDTGAAMRLVARTRRGGHEKPPTPLTHPLFDCEQREPGGTHWLGLTLRGGEDWVVDEHRLQGVPTLPGVAYLELARAACAQALGAEAVELAELLLLEPLTVPRGESRQVRVVLQPEGQAHALRVESRSEEARGWNEHARGRVRAVPRLAERIQPELLRAACEHEQPVPGEPQEQGPVHAGARWHGLFQWVRRGPRQALAQLALPEPFHGDLERFELHPALMDMATSFAIPGGVPWLAFGYERVLIHGPLPPQVLSHVSLPEESQAGAQQLRLQVRLLDLEGWERVRIDGYLLRPLKPSDASVEPAAPNVEVAVGTPGLLESLGLRRCTRPAPGPRQVEIEVEAAGLNFLDVLGALGMMPALEAEESVLGRECSGRIAAVGEGVSGLRVGDEVLAVAPGCFRSYVLVDESQVVRRPASLGLAEGAAQMVPFATAYFALHTVGRLRRGERILIHAAAGGLGLAAVQLASRTGAEILATAGSEQKREYLRSLGIAHVLDSRSTSFVSEVRERTGGRGVDVVLNSLAGELLLAGLSVLAPHGRFLELGKRDLYADQQVGLRTLARGQTFAAIDFGPHHPDFRAVLEEVATQLTQGQLEPLPTRLFPARQVAEAFSFMARALHIGRVAVSMQGATALPASMTRGSRPAPVAVPPWEDPRLAGGISSEEGAEAFLRALEQGAPQLIISPQDFSSLLRGLGGSQGVREKERLVTGRAAAAEPQALPPSSLEQLIEQVWRKHLGVERVQPTDSFFQLGGDSLLGIQVAADLRRHLGVELPTATLFSHPTLAALAAALRARQGEAAAPTAPAPALVPDPAARFEPFPLTDVQEAYWVGRRSAFELGGVAAHGYFEIESPGLEVERFIQCWRQLLQRHDMLRMVVLPDGRQQVLEQVPEYTPEVVELRGLSPQEAESRRLQLRERMAHQVLRSDRWPLFELVLCRYEGGVRIHMSMDALMLDAWSSAVLRQDFAQLYHEPGRPLEPLAITFRDYVLAERRLREGEAHERARAYWWARLDTLPPPPELPLVKEPSQLEHARFTHREARLEPHRWARLQERARAHGLTPSAACMAAFAEVLARWSRHPRFTLNLTLFQRLPLHPQVDELVGDFTSLVLLEVEAHAASTFAERASRLQAQLWRDLEHGSVSAVQLIRELVRTGRRSPGAIMPVVFTSILSLDARRGPQGSLSFFEGELVYSISQTPQVWLDHGVHEEEGALVLAWDSVEALFPPGMVDDMFHAYQRLLGALAEEEQAWEGELPELLPPAQRELLARYNATQAPRPSGRLEEGFFTQARLHPELPALLAPERTLSYGELARRAQALAARLRELEVQPQELVAIAMHKGWEQATAVLGVLQAAAAYLPLDPEQPPLRLHQLLEEGPARVVLTQSSLLHTVPWPPGVQVIAVDELEPATEAPPLPPRGTPEHLAYVIYTSGSTGKPKGVAIEHRAALNTVVDLNTRFGVGPEDRVLGLSALTFDLSVYDVLGLLGAGGALVLPAAEAEKDPAHWWERLVAGRVTVWNSTPALMLLLVEYAEQRGLKLPAALRLVMLSGDWIPVALPDRIRALGRDVQVVSLGGATEASIWSIAYPIGQVAPQWKSIPYGMPLANQRFHVLDGRLEARPWWVPGELYIGGEGLAREYWRDEPLTATRFIRHPRTGERLYRTGDQGRMLPEGSIEFLGREDLQVKVQGFRVELGEIEAALAQHPALSASVVVARGEPRGVRRLVAYAVPRSGQTPAAGELRRYLAERLPAYMVPSAFVLLESLPRSRNGKIARDQLPEPQQTQGLAAQAAAADPLVERLAALVKEALRLERVEPQDSLLDLGADSVALIRLINRLEAELQFRPRLADIYENPTVQGLATLHQEKTKSQGEGGAPRLTAPRSTLLPAEEWGRFKANRPGLRRFPDGTPEVALPGSGLAPAPEELTALERRRSVRTYSLEPVSHEQLGRLLAPLREWEVQGSRRYLYASAGGLYPVQLYLHLKPGRARGLEPGTWYYDPSTHRLVLLSAGAGLDRRIHDPHQNQAIFDSAAFSLFLIARMGAVEPVYAEHALHFATLEAGLMTQLLDLGAAPSGLGLCHIGDLDFAQARGLFHLEEEHVLLHSLVGGVLPTRGQEAASVPAEGGTEARQLAQLLQQVKTLTPEAARALLEARRGSKGRPHE Aeromonads Apoptosis and thus cell nucleus fragmentation Toxicity assay, cell nucleus fragmentation assay (cnf) L929 Not specified MIC : 50 ng/ml
dbacp06387 TubE protein MSKLHEELESLAPEQRELLAALMKEQGLDEGALLMPVERKPEGLPLSSAQQRMWFLQQLRPTSPFYNVHAALRLTGKLKVECLVHSLNEFVRRHEPLRTVFPSAGGQPLQRILAPAPAALEQRDLSGVPAQEREAEVYRAVEHAALASFDLEREPPCRFLLVRVEPEEHVLVFATHHIAADGWSLGVFVQELCALYTAAVHAEPPALPPLRLQYADFAAWERSRLKGGRERELLEYWQEQLAGLPDLSTLPPERPRPPLSKQEGATFEFALPPHQVQALRSLAQARRTSLFSVLLAAFQWLLARCAGQDDVALGMPIANRNRKELEGLIGCFASTLVLRAKPSASTAFTSWLAQVSEQLHGALEHQEVPFERLVEVLQPRRRMDRHPLFQIFLAMQQHPLRRAELPGLLLSEFPLRSRVARFDLEFHLWESAQGVEGTLIYDVDLYGQEGVAQLVRRYVSLLEAVAADPTRTLGELAGETLAPPVRKQVLALSECPPLPRPSTAPRTLAEALLQTAERFPTATVSFVQAQGSCTAWTLPELVERARRLQAGLRQWGLRPGDSLVLVLGREEETVEALWACVLAGVAPLVLPAPPARAEASPALSRLRHARQLLGGPRVLTRQEMLPDLARQLQVSPTADILGAVEELRATGGEAPLPPGRMDDVALLNLTSGTTGKAKCAMLTHRNLLVRLEATNVVYESQPLERGLVWLQLHNIGALSEYHLRPLCAGMHTFHAPTEEVLAEPLRWLEWLERYGIAQTWAPSFAYSHLLERLRKVEDRRWSLGGVRVLLSAGEQISAPMVEELMRRLAPSGVREDAFVAAWGMTETASGVTYARRPGTPPRMHTLERASLSGPLRHAAPASPTALRLMDVGAPIAGTALRVVDASGELLSEECVGRIQVRGEMISPGYYGDPKASAALLTADGWLETGDLGFLSEGALTITGRAKDLVIIHGTNFSCYEIESAVEQVEGVAPSSAAAAAVRMLEGSREELAVFFVPTEGLAPQPPASLLSRIRQQVLEQVGVRIDHLIPLEPHQLPRTEGGKLRRSELRARFEAGELRAPQPAPVPSPSRPLEQLIASVWAEVLEHQDIAPEASFFDLGGNSILLVRVERALRARLGLELTLMDLFAYPTVHSLADYLEPRAAQLPAQASPPTQAERRRGMRGAALEQRRTRRQAQRDED Aeromonads Apoptosis and thus cell nucleus fragmentation Toxicity assay, cell nucleus fragmentation assay (cnf) L929 Not specified MIC : 50 ng/ml
dbacp06500 Vigno 5 GLPLCGETCVGGTCNTPGCSCGWPVCVRN Viola ignobilis Apoptosis inducing MTT assay, AO/EB and DAPI staining assay HeLa cells Cervical cancer IC50 : 2.5 – 10 μM
dbacp06501 Vigno 5 GLPLCGETCVGGTCNTPGCSCGWPVCVRN Viola ignobilis Apoptosis inducing MTT assay, AO/EB and DAPI staining assay L929 Cervical cancer IC50 : 2.5 – 10 μM
dbacp06532 VS-9 VKLRSLLCS Plant sources Inducing apoptosis MTT assay MOLT4 Leukemia Not found
dbacp06533 VS-9 VKLRSLLCS Plant sources Inducing apoptosis MTT assay K562 Leukemia Not found
dbacp06534 wtmda-7/IL-24 MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL Not found Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer Cell viability (% of control):0.5 at concentration 7 µg/ml
dbacp06535 wtmda-7/IL-24 MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL Not found Apoptosis inducing MTT/MTS assay Ket-3 Tumor Cell viability (% of control): 0.5 at concentration 8 µg/ml
dbacp06536 wtmda-7/IL-24 MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL Not found Apoptosis inducing MTT/MTS assay MCF-7 Breast cancer Apoptotic rate(%) : > 50% at concentration of 8 µg/ml
dbacp06537 wtmda-7/IL-24 MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL Not found Apoptosis inducing MTT/MTS assay Ket-3 Tumor Apoptotic rate(%) : > 30% at concentration of 8 µg/ml
dbacp06538 XD5 RPEIWYAQELRRNGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp06539 XF8 RPEIWFAQELKRNGDEYNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp06540 XG10 RPEIWYAQEIRRFGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp06541 XG12 RPEIWYAQELGRAGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp06542 XH11 RPEIWVAQELKRNGDEFNAYYAR BH3-only, Direct activators, BIM analogues Inducing apoptosis Not specified Not found Not found Not found
dbacp06544 YALPAG YALPAG Not found Inducing apoptosis Not specified PC-3 Not found IC50 : 42.0 mg/ml
dbacp06545 YALPAH YALPAH Not found Inducing apoptosis Not specified PC-3 Not found IC50 : 11.3 mg/ml
dbacp06546 YALPAR YALPAR Not found Inducing apoptosis Not specified PC-3 Not found IC50 : 13.1 mg/ml
dbacp06547 YALRAH YALRAH Not found Inducing apoptosis Not specified PC-3 Not found IC50 : 8.1 mg/ml
dbacp06598 ZXR-1 FKIGGFIKKLWRSKLA Venom base Inducing apoptosis MTT assay Hela Not found IC50 : 62.6 ± 8.4 µM
dbacp06599 ZXR-1 FKIGGFIKKLWRSKLA Venom base Inducing apoptosis MTT assay SACC-83 Not found IC50 : 27.9 ± 7.7 µM
dbacp06600 ZXR-1 FKIGGFIKKLWRSKLA Venom base Inducing apoptosis MTT assay PC-3 Not found IC50 : 69.1 ± 1.6 µM
dbacp06601 ZXR-1 FKIGGFIKKLWRSKLA Venom base Inducing apoptosis MTT assay HuH-7 Not found IC50 : 77.9 ± 0.9 µM
dbacp06602 ZXR-1 FKIGGFIKKLWRSKLA Venom base Inducing apoptosis MTT assay HepG2 Not found IC50 : 141.7 ± 12.2 µM
dbacp06603 ZXR-1 FKIGGFIKKLWRSKLA Venom base Inducing apoptosis MTT assay 293T Not found IC50 : 186.7 ± 13.1 µM
dbacp06604 ZXR-1 FKIGGFIKKLWRSKLA Venom base Inducing apoptosis MTT assay WPMY-1 Not found IC50 : 283.3 ± 19.0 µM
dbacp06605 αs1-casein f(90_95) RYLGYL Bovine milk Regulation of immune response; Apoptosis inducing MTT/MTS assay AZ-97 Colon cancer Inhibition at 12 - 15 g/l
dbacp06606 β-Casomorphins 5 f(60_64) YPFPG Bovine milk Regulation of immune response; Apoptosis inducing MTT/MTS assay AZ-97 Colon cancer Inhibition at 9 - 11 g/l
dbacp06656 LfcinB (21-25)Pal RWQWRWQWR LfcinB Apoptosis inducing MTT assay CaCo-2 Colorectal Cancer IC50 = 86 μM
dbacp06657 LfcinB (21-25)Pal RWQWRWQWR LfcinB Apoptosis inducing MTT assay HT-29 Colon Cancer IC50 = 100 μM
dbacp06658 LfcinB (21-25)Pal RWQWRWQWR LfcinB Apoptosis inducing MTT assay DU-145 Prostrate Cancer IC50 = 40 μM
dbacp06659 Ahx-[Pal] Ahx-RWQWRWQWR Synthetic Apoptosis inducing MTT assay HT-29 Colon Cancer IC50 = 119 μM
dbacp06660 Ahx-[Pal] Ahx-RWQWRWQWR Synthetic Apoptosis inducing MTT assay CaCo-2 Colorectal Cancer IC50 = 40 μM
dbacp06661 9[Orn] [Pal] RWQWRWQWO Synthetic Apoptosis inducing MTT assay HT-29 Colon Cancer IC50 = 109 μM
dbacp06662 9[Orn] [Pal] RWQWRWQWO Synthetic Apoptosis inducing MTT assay CaCo-2 Colorectal Cancer IC50 = 40 μM
dbacp06663 9[Orn] [Pal] RWQWRWQWO Synthetic Apoptosis inducing MTT assay DU-145 Prostrate Cancer IC50 = 62 μM
dbacp06664 CH3CO-Ahx-[Pal] CH3-CO-Ahx-RWQWRWQWR Synthetic Apoptosis inducing MTT assay CaCo-2 Colorectal Cancer IC50 = 31 μM
dbacp06665 1[dR][Pal] rWQWRWQWR Synthetic Apoptosis inducing MTT assay CaCo-2 Colorectal Cancer IC50 = 105 μM
dbacp06666 1[Orn] [Pal] OWQWRWQWR Synthetic Apoptosis inducing MTT assay CaCo-2 Colorectal Cancer IC50 = 91 μM
dbacp06667 5[Orn] [Pal] RWQWOWQWR Synthetic Apoptosis inducing MTT assay CaCo-2 Colorectal Cancer IC50 = 64 μM
dbacp06668 1[dR] 5[Orn] [Pal] rWQWOWQWR Synthetic Apoptosis inducing MTT assay CaCo-2 Colorectal Cancer IC50 = 109 μM
dbacp06704 P05 ADDGRPFPQVIK Aldolase A fragment Apoptosis inducing MTT assay MG-63 Bone Cancer Relative viability = 0.85 at 50 μg/ml
dbacp06705 P05 ADDGRPFPQVIK Aldolase A fragment Apoptosis inducing MTT assay U-2 OS Bone Cancer Relative viability = 0.98 at 50 μg/ml
dbacp06706 P02 AEEYEFLTPMEEAPK Rho GDP Dissociation Inhibitor Alpha fragment Apoptosis inducing MTT assay MG-63 Bone Cancer Relative viability = 0.88 at 50 μg/ml
dbacp06707 P02 AEEYEFLTPMEEAPK Rho GDP Dissociation Inhibitor Alpha fragment Apoptosis inducing MTT assay U-2 OS Bone Cancer Relative viability = 0.93 at 50 μg/ml
dbacp06708 P01 SETAPAAPAAPAPAEK Histone H1.4 (H1-4) Fragment Apoptosis inducing MTT assay MG-63 Bone Cancer Relative viability = 0.84 at 50 μg/ml
dbacp06709 P01 SETAPAAPAAPAPAEK Histone H1.4 (H1-4) Fragment Apoptosis inducing MTT assay U-2 OS Bone Cancer Relative viability = 1.13 at 50 μg/ml
dbacp06710 P03 HVFGESDELIGQK Triosephosphate Isomerase (TPI) fragment Apoptosis inducing MTT assay MG-63 Bone Cancer Relative viability = 1.04 at 50 μg/ml
dbacp06711 P03 HVFGESDELIGQK Triosephosphate Isomerase (TPI) fragment Apoptosis inducing MTT assay U-2 OS Bone Cancer Relative viability = 0.98 at 50 μg/ml
dbacp06712 P06 GAGTGGLGLAVEGPSEAK FLNA (Filamin A) fragment Apoptosis inducing MTT assay MG-63 Bone Cancer Relative viability = 0.92 at 50 μg/ml
dbacp06713 P06 GAGTGGLGLAVEGPSEAK FLNA (Filamin A) fragment Apoptosis inducing MTT assay U-2 OS Bone Cancer Relative viability = 1.17 at 50 μg/ml
dbacp06714 P07 VEPGLGADNSVVR FLNA (Filamin A) fragment Apoptosis inducing MTT assay MG-63 Bone Cancer Relative viability = 0.96 at 50 μg/ml
dbacp06715 P07 VEPGLGADNSVVR FLNA (Filamin A) fragment Apoptosis inducing MTT assay U-2 OS Bone Cancer Relative viability = 0.96 at 50 μg/ml
dbacp06716 P08 NSNLVGAAHEELQQSR Lamin A/C (LMNA) fragment Apoptosis inducing MTT assay MG-63 Bone Cancer Relative viability = 0.92 at 50 μg/ml
dbacp06717 P08 NSNLVGAAHEELQQSR Lamin A/C (LMNA) fragment Apoptosis inducing MTT assay U-2 OS Bone Cancer Relative viability = 1.06 at 50 μg/ml
dbacp06718 P09 AAGTLYTYPENWR Eukaryotic Translation Elongation Factor 1 Gamma (Eef1G) fragment Apoptosis inducing MTT assay MG-63 Bone Cancer Relative viability = 0.85 at 50 μg/ml
dbacp06719 P09 AAGTLYTYPENWR Eukaryotic Translation Elongation Factor 1 Gamma (Eef1G) fragment Apoptosis inducing MTT assay U-2 OS Bone Cancer Relative viability = 1.07 at 50 μg/ml
dbacp06720 P10 FAAATGATPIAGR 40S ribosomal protein fragment Apoptosis inducing MTT assay MG-63 Bone Cancer Relative viability = 1.08 at 50 μg/ml
dbacp06721 P10 FAAATGATPIAGR 40S ribosomal protein fragment Apoptosis inducing MTT assay U-2 OS Bone Cancer Relative viability = 1.01 at 50 μg/ml
dbacp06735 NKL-WT KLKSKLMVVCNKIGLLKSLCRKFVKSH Trematomus bernacchii Apoptosis inducing luciferase-based ATPlite assay B16-F10 Skin Cancer ATP level = 0.753 ± 0.254 at 40 μM
dbacp06736 NKL-MUT KLKSKLMVVANKIGLLKSLARKFVKSH Trematomus bernacchii Apoptosis inducing luciferase-based ATPlite assay B16-F10 Skin Cancer ATP level = 0.023 ± 0.007 at 40 μM
dbacp06749 mPNC-NLS QETFSDLWKLLVQRKRQKLMP Synthetic p53-mediated apoptosis MTT assay A-549 Lung Cancer IC50 = 44.9 μM
dbacp06750 mPNC-NLS QETFSDLWKLLVQRKRQKLMP Synthetic p53-mediated apoptosis MTT assay U-87 Brain Tumor IC50 = 56.9 μM
dbacp06751 mPNC-NLS QETFSDLWKLLVQRKRQKLMP Synthetic p53-mediated apoptosis Cytotoxicity assay A-549 Lung Cancer IC50 = 45 μM
dbacp06754 37-mer peptide TKEQKEQIAKATGLTTKQVRNWYVQLNASIKVCMCSC Synthetic Apoptosis inducing MTT assay SNU-449 Liver Cancer IC50 = 76.4 ± 0.6015 μM
dbacp06755 37-mer peptide TKEQKEQIAKATGLTTKQVRNWYVQLNASIKVCMCSC Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 33.65 ± 1.09 μM
dbacp06756 37-mer peptide TKEQKEQIAKATGLTTKQVRNWYVQLNASIKVCMCSC Synthetic Apoptosis inducing MTT assay SK-OV-3 Ovarian cancer IC50 = 27.45 ± 1.5085 μM
dbacp06757 ATMP5 THPPTTTTTTTTTTTYTAAPATTT Synthetic Analog of ATMP1 Apoptosis inducing MTT assay MDA-MB-231 Breast Cancer IC50 = 64.04 ± 0.021 μg /ml
dbacp06758 ATMP1 THPPTTTTTTTTTTTYTAAPATTT Anabas testudineus Apoptosis inducing MTT assay MDA-MB-231 Breast Cancer IC50 = 8.25 ± 0.14 μg/ml
dbacp06759 p28 LSTAADMQGVVTDGMASGLDKDYLKPDD Pseudomonas aeruginosa Apoptosis inducing MTT assay HT-29 Colon Cancer IC50 ~ 200 μg/ml
dbacp06760 p28 LSTAADMQGVVTDGMASGLDKDYLKPDD Pseudomonas aeruginosa Apoptosis inducing MTT assay CT-26 Colorectal Cancer IC50 ~ 150 μg/ml
dbacp06761 RP7 ATRQPNH RAGE(receptor for advanced glycation end product) inhibitor Apoptosis inducing MTT assay MDA-MB-231 Breast Cancer IC50 = 24.5 µM
dbacp06762 RP7 ATRQPNH RAGE(receptor for advanced glycation end product) inhibitor Apoptosis inducing MTT assay BT-549 Breast Cancer IC50 = 29.9 µM
dbacp06793 CPSA-CPSC-L-ACAN Not Available Recombinant Fusion Peptide Apoptosis inducing MTT assay HeLa Cervical Cancer IC50 = 63.15 μg/ml
dbacp06794 CM11 WKLFKKILKVL Cecropin-Melittin Hybrid Peptide Apoptosis inducing MTT assay Jurkat Blood Cancer Survival rate = 47% at 32 μg/ml
dbacp06795 CM11 WKLFKKILKVL Cecropin-Melittin Hybrid Peptide Apoptosis inducing MTT assay Raji Blood Cancer Survival rate = 51% at 32 μg/ml
dbacp06796 LHRH-BinBC QHWSYGLRPGGRGPKDAVRAVKGSALLPCIIVHDPNLNNSDKMKFNTYYLLEYKEYWHQLWSQIIPAHQTVKIQERTGISEVVQNSMIEDLNMYIGADFGMYFYLRSSGFKEQITRGLNRPLSQTTTQLGERVEEMEYYNSNDLDVRYVKYALAREFTLKRVNGEIVKNWVAVDYRMAGIQSYPNAPITNPLTLT Synthetic Apoptosis inducing MTT assay MCF-7 Breast Cancer IC50 = 10.96 μM
dbacp06797 LHRH-BinBC QHWSYGLRPGGRGPKDAVRAVKGSALLPCIIVHDPNLNNSDKMKFNTYYLLEYKEYWHQLWSQIIPAHQTVKIQERTGISEVVQNSMIEDLNMYIGADFGMYFYLRSSGFKEQITRGLNRPLSQTTTQLGERVEEMEYYNSNDLDVRYVKYALAREFTLKRVNGEIVKNWVAVDYRMAGIQSYPNAPITNPLTLT Synthetic Apoptosis inducing LDH leakage assay MCF-7 Breast Cancer 40% LDH efflux at 16 µM
dbacp06851 WP1 RLLRLMRLRMLLRM Derived from RLL peptide Apoptosis inducing HDAC inhibition assay HeLa Cervical Cancer IC50 = 0.310±0.064 µM
dbacp06852 WP1 RLLRLMRLRMLLRM Derived from RLL peptide Apoptosis inducing Cell Viability assay Huh-7 Liver Cancer IC50 = 43.74 ± 5.4 μM
dbacp06853 WP1 RLLRLMRLRMLLRM Derived from RLL peptide Apoptosis inducing Cell Viability assay HepG-2 Liver Cancer IC50 = 52.23 ± 0.9 μM
dbacp06854 WP1 RLLRLMRLRMLLRM Derived from RLL peptide Apoptosis inducing Cell Viability assay HT-29 Colon Cancer IC50 = 54.6 ± 2.1 μM
dbacp06855 WP2 RLLRLLRLRRLLRL Derived from RLL peptide Apoptosis inducing HDAC inhibition assay HeLa Cervical Cancer IC50 = 0.446±0.095 µM
dbacp06856 WP2 RLLRLLRLRRLLRL Derived from RLL peptide Apoptosis inducing Cell Viability assay Huh-7 Liver Cancer IC50 = 28.12 ± 1.5 μM
dbacp06857 WP2 RLLRLLRLRRLLRL Derived from RLL peptide Apoptosis inducing Cell Viability assay HepG-2 Liver Cancer IC50 = 34.05 ± 0.53 μM
dbacp06858 WP2 RLLRLLRLRRLLRL Derived from RLL peptide Apoptosis inducing Cell Viability assay HT-29 Colon Cancer IC50 = 42.6 ± 4.0 μM
dbacp06864 AMP-WF3 FLKSLWRGVKAIFNGARQGYKEHKN Poecilia Mexicana fish Apoptosis inducing MTT assay Jurkat Blood Cancer IC50 = 50 µM
dbacp06868 LfcinB(21-25)Pal RWQWRWQWR LfcinB Apoptosis inducing MTT assay MDA-MB-468 Breast Cancer IC50 = 72 µM
dbacp06869 LfcinB(21-25)Pal RWQWRWQWR LfcinB Apoptosis inducing MTT assay MDA-MB-231 Breast Cancer IC50 = 103 µM
dbacp06870 LfcinB(21-25)Pal RWQWRWQWR LfcinB Apoptosis inducing MTT assay MCF-7 Breast Cancer IC50 = 81 µM
dbacp06871 RR-1-RR RRWQWRWQWRR Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MCF-7 Breast Cancer IC50 = 58 µM
dbacp06872 RR-1-RR RRWQWRWQWRR Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MDA-MB-231 Breast Cancer IC50 = 67 µM
dbacp06873 R-1-RR RWQWRWQWRR Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MCF-7 Breast Cancer IC50 = 122 µM
dbacp06874 R-1-RR RWQWRWQWRR Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MDA-MB-231 Breast Cancer IC50 = 95 µM
dbacp06875 RR-1-R RRWQWRWQWR Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MCF-7 Breast Cancer IC50 = 68 µM
dbacp06876 RR-1-R RRWQWRWQWR Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MDA-MB-231 Breast Cancer IC50 = 73 µM
dbacp06877 1 WQWRWQW Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MCF-7 Breast Cancer IC50 = 105 µM
dbacp06878 1 WQWRWQW Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MDA-MB-231 Breast Cancer IC50 > 170 µM
dbacp06879 R-1 RWQWRWQW Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MCF-7 Breast Cancer IC50 = 58 µM
dbacp06880 R-1 RWQWRWQW Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MDA-MB-231 Breast Cancer IC50 > 150 µM
dbacp06881 1-R WQWRWQWR Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MCF-7 Breast Cancer IC50 = 130 µM
dbacp06882 1-R WQWRWQWR Synthetic analogue of LfcinB(21-25)Pal Apoptosis inducing MTT assay MDA-MB-231 Breast Cancer IC50 > 150 µM
dbacp06883 trichoderin A MDA-P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderma sp. fungus, strain 05FI48 Apoptosis inducing PrestoBlue assay BxPC-3 Pancreatic Cancer IC50 = 0.4 μM
dbacp06884 trichoderin A MDA-P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderma sp. fungus, strain 05FI48 Apoptosis inducing CyQUANT Direct assay PANC-1 Pancreatic Cancer IC50 = 0.3 μM
dbacp06885 trichoderin A analogue 4 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing PrestoBlue assay BxPC-3 Pancreatic Cancer IC50 = 0.4 μM
dbacp06886 trichoderin A analogue 12 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing PrestoBlue assay BxPC-3 Pancreatic Cancer IC50 > 1 μM
dbacp06887 trichoderin A analogue 13 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing PrestoBlue assay BxPC-3 Pancreatic Cancer IC50 > 1 μM
dbacp06888 trichoderin A analogue 14 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing PrestoBlue assay BxPC-3 Pancreatic Cancer IC50 = 0.6 μM
dbacp06889 trichoderin A analogue 15 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing PrestoBlue assay BxPC-3 Pancreatic Cancer IC50 = 0.5 μM
dbacp06890 trichoderin A analogue 16 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing PrestoBlue assay BxPC-3 Pancreatic Cancer IC50 = 0.4 μM
dbacp06891 trichoderin A analogue 17 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing PrestoBlue assay BxPC-3 Pancreatic Cancer IC50 = 0.4 μM
dbacp06892 trichoderin A analogue 18 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing PrestoBlue assay BxPC-3 Pancreatic Cancer IC50 = 0.2 μM
dbacp06893 trichoderin A analogue 4 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing CyQUANT Direct assay PANC-1 Pancreatic Cancer IC50 = 0.5 μM
dbacp06894 trichoderin A analogue 12 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing CyQUANT Direct assay PANC-1 Pancreatic Cancer IC50 > 9 μM
dbacp06895 trichoderin A analogue 13 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing CyQUANT Direct assay PANC-1 Pancreatic Cancer IC50 = 6.0 μM
dbacp06896 trichoderin A analogue 14 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing CyQUANT Direct assay PANC-1 Pancreatic Cancer IC50 = 1.8 μM
dbacp06897 trichoderin A analogue 15 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing CyQUANT Direct assay PANC-1 Pancreatic Cancer IC50 = 0.9 μM
dbacp06898 trichoderin A analogue 16 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing CyQUANT Direct assay PANC-1 Pancreatic Cancer IC50 = 0.5 μM
dbacp06899 trichoderin A analogue 17 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing CyQUANT Direct assay PANC-1 Pancreatic Cancer IC50 = 0.6 μM
dbacp06900 trichoderin A analogue 18 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing CyQUANT Direct assay PANC-1 Pancreatic Cancer IC50 = 0.2 μM
dbacp06901 trichoderin A analogue 19 P-Cha-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing CyQUANT Direct assay PANC-1 Pancreatic Cancer IC50 = 0.2 μM
dbacp06902 trichoderin A analogue 19 MDA-P-AHMOD-Aib-Aib-IV-Aib-Aib-AMAE Trichoderin A Apoptosis inducing PrestoBlue assay BxPC-3 Pancreatic Cancer IC50 = 0.1 μM
dbacp06904 LFcin17–30 FKCRRWQWRMKKLG Lectoferrin Peptide Apoptosis inducing MTT assay HepG-2 Liver Cancer cell viability ~ 50% at 1 µM
dbacp06905 LFcin17–30 FKCRRWQWRMKKLG Lectoferrin Peptide Apoptosis inducing MTT assay Jurkat Blood Cancer cell viability ~ 70% at 20 µM
dbacp06906 LFampin265–284 DLIWKLLSKAQEKFGKNKSR Lectoferrin Peptide Apoptosis inducing MTT assay HepG-2 Liver Cancer cell viability ~ 50% at 1 µM
dbacp06907 LFampin265–284 DLIWKLLSKAQEKFGKNKSR Lectoferrin Peptide Apoptosis inducing MTT assay Jurkat Blood Cancer cell viability ~ 47% at 10 µM
dbacp06908 LFchimera FKCRRWQWRMKKLG-K-RSKNKGFKEQAKSLLKWILD Synthetic - Lectoferrin chimera Apoptosis inducing MTT assay HepG-2 Liver Cancer cell viability ~ 44% at 10 µM
dbacp06909 LFchimera FKCRRWQWRMKKLG-K-RSKNKGFKEQAKSLLKWILD Synthetic - Lectoferrin chimera Apoptosis inducing MTT assay Jurkat Blood Cancer cell viability ~ 8% at 20 µM
dbacp06917 KM8 KLLKINLKALAALAKKIL Synthetic derivative of Mastoparan Apoptosis inducing Not Available Not Available Not Available Not Available
dbacp06918 KM8-Aib KLLKINLK(Aib)LAALAKKIL Synthetic derivative of KM8 Apoptosis inducing Not Available Not Available Not Available Not Available
dbacp06941 PS14 PTECQVGTTCKVES Aphanomyces invadans Apoptosis inducing MTT assay Hep-2 Larynx Cancer IC50 = 21 µM
dbacp06942 HTDT-6-2-3-2 GPLGAGP Enteromorpha prolifera Apoptosis inducing CCK-8 assay NCI-H-460 Lung Cancer IC50 = 0.3686 ± 0.0935 mg/mL
dbacp06943 HTDT-6-2-3-2 GPLGAGP Enteromorpha prolifera Apoptosis inducing CCK-8 assay HepG-2 Liver Cancer IC50 = 1.2564 ± 0.0548 mg/mL
dbacp06944 HTDT-6-2-3-2 GPLGAGP Enteromorpha prolifera Apoptosis inducing CCK-8 assay A-549 Lung Cancer IC50 = 0.9867 ± 0.0857 mg/mL
dbacp06980 Ponericin-W1 (11-25), At1 KLLPSVVGLFKKKKQ Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 > 100 µM
dbacp06981 Ponericin-W1 (11-25), At1 KLLPSVVGLFKKKKQ Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 >100 µM
dbacp06982 Ponericin-W1 (11-25) [P4K KLLKKVVKLFKKKKK Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 >100 µM
dbacp06983 Ponericin-W1 (11-25) [P4K KLLKKVVKLFKKKKK Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 >100 µM
dbacp06984 Ponericin-W1 (11-25) [P4K KLLKKVVKLFKKLLK Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 = 4.3 µM
dbacp06985 Ponericin-W1 (11-25) [P4K KLLKKVVKLFKKLLK Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 2.2 µM
dbacp06986 At4 KLLKKLLKLLKKLLK Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 = 7.2 µM
dbacp06987 At4 KLLKKLLKLLKKLLK Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 2.5 µM
dbacp06988 At5 KIIKKIIKIIKKIIK Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 = 3.6 µM
dbacp06989 At5 KIIKKIIKIIKKIIK Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 1.5 µM
dbacp06990 At6 KVVKKVVKVVKKVVK Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 > 100 µM
dbacp06991 At6 KVVKKVVKVVKKVVK Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 70.8 µM
dbacp06992 At7 KIIKKIKKKIKKIIK Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 = 10.3 µM
dbacp06993 At7 KIIKKIKKKIKKIIK Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 8.8 µM
dbacp06994 At8 KLLKKLKKKLKKLLK Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 = 13.4 µM
dbacp06995 At8 KLLKKLKKKLKKLLK Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 8.9 µM
dbacp06996 At9 KVVKKVKKKVKKVVK Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 = 100 µM
dbacp06997 At9 KVVKKVKKKVKKVVK Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 51.7 µM
dbacp06998 At10 IKKIIKIIKKIIKKI Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 = 4.4 µM
dbacp06999 At10 IKKIIKIIKKIIKKI Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 3.2 µM
dbacp07000 At11 IIIKKIKKKIKKIII Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 = 7.9 µM
dbacp07001 At11 IIIKKIKKKIKKIII Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 7.6 µM
dbacp07002 At12 KIIIKIKKKIKIIIK Synthetic Apoptosis inducing MTT assay A-549 Lung Cancer IC50 = 14.0 µM
dbacp07003 At12 KIIIKIKKKIKIIIK Synthetic Apoptosis inducing MTT assay HepG-2 Liver Cancer IC50 = 13.4 µM
dbacp07017 D-LAK-120-A kklalalakkwlalakklalalakk Synthetic ROS induction, mitochondria-mediated apoptosis. MTT assay A-549 Lung Cancer IC50 = 5.55 ± 0.13 μM
dbacp07018 D-LAK-120-A kklalalakkwlalakklalalakk Synthetic ROS induction, mitochondria-mediated apoptosis. MTT assay H-358 Non Small Cell Lung Cancer (NSCLC) IC50 = 4.00 ± 0.20 μM
dbacp07019 D-LAK-120-A kklalalakkwlalakklalalakk Synthetic ROS induction, mitochondria-mediated apoptosis. MTT assay H-1975 Non Small Cell Lung Cancer (NSCLC) IC50 between 4.0 and 5.5 μM
dbacp07020 D-LAK-120-A kklalalakkwlalakklalalakk Synthetic ROS induction, mitochondria-mediated apoptosis. MTT assay HCC-827 Lung Adenocarcinoma IC50 between 4.0 and 5.5 μM
dbacp07050 Temporin-PKE FLPLIIGALSSLLPKIF skin secretion of Pelophylax kl. esculentus Charge-optimized membranolysis induces apoptosis. MTT assay U251-MG Brain Tumor IC50 = 23.24 μM
dbacp07051 Temporin-PKE FLPLIIGALSSLLPKIF skin secretion of Pelophylax kl. esculentus Charge-optimized membranolysis induces apoptosis. MTT assay PC-3 Prostate Cancer IC50 = 7.29 μM
dbacp07052 Temporin-PKE FLPLIIGALSSLLPKIF skin secretion of Pelophylax kl. esculentus Charge-optimized membranolysis induces apoptosis. MTT assay H-838 Lung Cancer IC50 = 16.38 μM
dbacp07053 Temporin-PKE FLPLIIGALSSLLPKIF skin secretion of Pelophylax kl. esculentus Charge-optimized membranolysis induces apoptosis. MTT assay HCT-116 Colorectal Cancer IC50 = 21.31 μM
dbacp07054 Temporin-PKE FLPLIIGALSSLLPKIF skin secretion of Pelophylax kl. esculentus Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 17.40 μM
dbacp07055 Temporin-PKE-2K FLPLIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay U251-MG Brain Tumor IC50 = 2.49 μM
dbacp07056 Temporin-PKE-2K FLPLIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay PC-3 Prostate Cancer IC50 = 2.64 μM
dbacp07057 Temporin-PKE-2K FLPLIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-838 Lung Cancer IC50 = 3.07 μM
dbacp07058 Temporin-PKE-2K FLPLIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay HCT-116 Colorectal Cancer IC50 = 2.84 μM
dbacp07059 Temporin-PKE-2K FLPLIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 2.78 μM
dbacp07060 Temporin-PKE-K12 FLPLIIGALSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay U251-MG Brain Tumor IC50 = 25.75 μM
dbacp07061 Temporin-PKE-K12 FLPLIIGALSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay PC-3 Prostate Cancer IC50 = 27.32 μM
dbacp07062 Temporin-PKE-K12 FLPLIIGALSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-838 Lung Cancer IC50 = 22.67 μM
dbacp07063 Temporin-PKE-K12 FLPLIIGALSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay HCT-116 Colorectal Cancer IC50 = 22.09 μM
dbacp07064 Temporin-PKE-K12 FLPLIIGALSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 24.03 μM
dbacp07065 Temporin-PKE-3K FLPKIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay U251-MG Brain Tumor IC50 = 2.83 μM
dbacp07066 Temporin-PKE-3K FLPKIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay PC-3 Prostate Cancer IC50 = 3.01 μM
dbacp07067 Temporin-PKE-3K FLPKIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-838 Lung Cancer IC50 = 0.51 μM
dbacp07068 Temporin-PKE-3K FLPKIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay HCT-116 Colorectal Cancer IC50 = 0.38 μM
dbacp07069 Temporin-PKE-3K FLPKIIGKLSSLLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 3.29 μM
dbacp07070 Temporin-PKE-4K FLPKIIGKLSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay U251-MG Brain Tumor IC50 = 85.52 μM
dbacp07071 Temporin-PKE-4K FLPKIIGKLSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay PC-3 Prostate Cancer IC50 = 49.50 μM
dbacp07072 Temporin-PKE-4K FLPKIIGKLSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-838 Lung Cancer IC50 = 35.28 μM
dbacp07073 Temporin-PKE-4K FLPKIIGKLSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay HCT-116 Colorectal Cancer IC50 = 99.36 μM
dbacp07074 Temporin-PKE-4K FLPKIIGKLSSKLPKIF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 27.76 μM
dbacp07075 Temporin-PKE-i FLPLIIGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay U251-MG Brain Tumor IC50 = 4.46 μM
dbacp07076 Temporin-PKE-i FLPLIIGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay PC-3 Prostate Cancer IC50 = 3.35 μM
dbacp07077 Temporin-PKE-i FLPLIIGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-838 Lung Cancer IC50 = 5.28 μM
dbacp07078 Temporin-PKE-i FLPLIIGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay HCT-116 Colorectal Cancer IC50 = 3.07 μM
dbacp07079 Temporin-PKE-i FLPLIIGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 2.94 μM
dbacp07080 Temporin-PKE-3i FLPLiiGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay U251-MG Brain Tumor IC50 = 120.6 μM
dbacp07081 Temporin-PKE-3i FLPLiiGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay PC-3 Prostate Cancer IC50 = 167 μM
dbacp07082 Temporin-PKE-3i FLPLiiGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-838 Lung Cancer IC50 = 193.4 μM
dbacp07083 Temporin-PKE-3i FLPLiiGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay HCT-116 Colorectal Cancer IC50 = 72.06 μM
dbacp07084 Temporin-PKE-3i FLPLiiGALSSLLPKiF Synthetic Charge-optimized membranolysis induces apoptosis. MTT assay H-157 Lung Cancer IC50 = 71.18 μM
dbacp07097 K2F6K2 KKFFFFFFKK Synthetic Positive charge–driven membrane disruption apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 1146.23 ± 346.83 μg/mL
dbacp07098 K3F6K3 KKKFFFFFFKKK Synthetic Positive charge–driven membrane disruption apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 123.10 ± 35.19 μg/mL
dbacp07099 K4F6K4 KKKKFFFFFFKKKK Synthetic Positive charge–driven membrane disruption apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 62.64 ± 9.55 μg/mL
dbacp07100 K4F6K4 KKKKFFFFFFKKKK Synthetic Positive charge–driven membrane disruption apoptosis AnnexinV-FITC/PI double staining assay A-549 Lung Cancer apoptotic cells (early and late) increased from 9.59 ± 1.00% to 43.03 ± 2.13%
dbacp07101 K4F8K4 KKKKFFFFFFFFKKKK Synthetic Positive charge–driven membrane disruption apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 571.87 ± 66.23 μg/mL
dbacp07102 rScyreprocin MKEDSNILDKTAKMTKQNKALLFTAGGAAAFMAGYYYYHCNYRNPAPKKSGSTTSQDKTDAQAVQSIPSPSGNKGKESKDPKVKHHHHHH Recombinant product of Scyreprocin Membrane disruption triggers ROS-mediated apoptosis MTS assay H-460 Lung Cancer IC50 = 6.27 µM
dbacp07103 rScyreprocin MKEDSNILDKTAKMTKQNKALLFTAGGAAAFMAGYYYYHCNYRNPAPKKSGSTTSQDKTDAQAVQSIPSPSGNKGKESKDPKVKHHHHHH Recombinant product of Scyreprocin Membrane disruption triggers ROS-mediated apoptosis MTS assay HepG-2 Liver Cancer IC50 = 441.01 µM
dbacp07104 rScyreprocin MKEDSNILDKTAKMTKQNKALLFTAGGAAAFMAGYYYYHCNYRNPAPKKSGSTTSQDKTDAQAVQSIPSPSGNKGKESKDPKVKHHHHHH Recombinant product of Scyreprocin Membrane disruption triggers ROS-mediated apoptosis MTS assay T-24 Urinary Bladder Cancer IC50 = 1.94 x 105 µM
dbacp07105 rScyreprocin MKEDSNILDKTAKMTKQNKALLFTAGGAAAFMAGYYYYHCNYRNPAPKKSGSTTSQDKTDAQAVQSIPSPSGNKGKESKDPKVKHHHHHH Recombinant product of Scyreprocin Membrane disruption triggers ROS-mediated apoptosis MTS assay DU-145 Prostate cancer IC50 = 1158.30 µM
dbacp07106 rScyreprocin MKEDSNILDKTAKMTKQNKALLFTAGGAAAFMAGYYYYHCNYRNPAPKKSGSTTSQDKTDAQAVQSIPSPSGNKGKESKDPKVKHHHHHH Recombinant product of Scyreprocin Membrane disruption triggers ROS-mediated apoptosis MTS assay HeLa Cervical cancer IC50 = 3.34 x 104 µM
dbacp07112 Galaxamide (N-Me-L)L(N-Me-L)LL Galaxaura filamentosa Cell-cycle arrest induces apoptosis MTT assay HepG-2 Liver Cancer IC50 = 5.20 ± 0.52 µg/ml
dbacp07113 Galaxamide (N-Me-L)L(N-Me-L)LL Galaxaura filamentosa Cell-cycle arrest induces apoptosis MTT assay MCF-7 Breast Cancer IC50 = 11.33 ± 2.95 µg/ml
dbacp07114 Galaxamide (N-Me-L)L(N-Me-L)LL Galaxaura filamentosa Cell-cycle arrest induces apoptosis MTT assay HeLa Cervical Cancer IC50 = 8.53 ± 0.73 µg/ml
dbacp07115 Galaxamide (N-Me-L)L(N-Me-L)LL Galaxaura filamentosa Cell-cycle arrest induces apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 8.73 ± 0.29 µg/ml
dbacp07116 Galaxamide (N-Me-L)L(N-Me-L)LL Galaxaura filamentosa Cell-cycle arrest induces apoptosis MTT assay A-549 Lung Cancer IC50 = 6.99 ± 0.63 µg/ml
dbacp07117 Z-1 L(N-Me-L)LPL Synthetic Cell-cycle arrest induces apoptosis MTT assay MCF-7 Breast Cancer IC50 = 5.85 ± 1.28 µg/ml
dbacp07118 Z-1 L(N-Me-L)LPL Synthetic Cell-cycle arrest induces apoptosis MTT assay HepG-2 Liver Cancer IC50 = 7.57 ± 0.17 µg/ml
dbacp07119 Z-1 L(N-Me-L)LPL Synthetic Cell-cycle arrest induces apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 17.81 ± 0.6 µg/ml
dbacp07120 Z-1 L(N-Me-L)LPL Synthetic Cell-cycle arrest induces apoptosis MTT assay HeLa Cervical Cancer IC50 = 11.56 ± 0.65 µg/ml
dbacp07121 Z-1 L(N-Me-L)LPL Synthetic Cell-cycle arrest induces apoptosis MTT assay A-549 Lung Cancer IC50 = 4.92 ± 0.84 µg/ml
dbacp07275 LCP-2 WAHT Laminaria japonica Mitochondrial apoptosis via p53 activation. MTT assay SGC-7901 Gastric Cancer IC50 = 116 ± 12.4 μM
dbacp07276 LCP-2 WAHT Laminaria japonica Mitochondrial apoptosis via p53 activation. MTT assay MKN-45 Gastric Cancer IC50 = 107 ± 11.8 μM
dbacp07277 LCP-2 WAHT Laminaria japonica Mitochondrial apoptosis via p53 activation. MTT assay HepG-2 Gastric Cancer IC50 = 96.9 ± 9.91 μM
dbacp07278 LCP-2 WAHT Laminaria japonica Mitochondrial apoptosis via p53 activation. MTT assay CaCo-2 Colon Cancer IC50 = 100 ± 11.6 μM
dbacp07279 LCP-3 WHLV Laminaria japonica Mitochondrial apoptosis via p53 activation. MTT assay SGC-7901 Gastric Cancer IC50 = 101 ± 10.6 μM
dbacp07280 LCP-3 WHLV Laminaria japonica Mitochondrial apoptosis via p53 activation. MTT assay MKN-45 Gastric Cancer IC50 = 86.9 ± 9.11 μM
dbacp07281 LCP-3 WHLV Laminaria japonica Mitochondrial apoptosis via p53 activation. MTT assay HepG-2 Gastric Cancer IC50 = 85.2 ± 9.27 μM
dbacp07282 LCP-3 WHLV Laminaria japonica Mitochondrial apoptosis via p53 activation. MTT assay CaCo-2 Colon Cancer IC50 = 68.2 ± 7.11 μM
dbacp07283 AtMP1 THPPTTTTTTTTTTTTTAAPATTT Anabastestudineus skin mucus fraction 2 p53-mediated Bax/Bcl-2 apoptosis activation MTT assay MCF-7 Breast Cancer IC50 = 8.25 ± 0.14 μg/ml
dbacp07284 AtMP1 THPPTTTTTTTTTTTTTAAPATTT Anabastestudineus skin mucus fraction 2 p53-mediated Bax/Bcl-2 apoptosis activation MTT assay MDA-MB-231 Breast Cancer IC50 = 9.35 ± 0.25 μg/ml
dbacp07285 AtMP2 TGIATSGLATFTLHTGSLAPAT Anabastestudineus skin mucus fraction 2 p53-mediated Bax/Bcl-2 apoptosis activation MTT assay MCF-7 Breast Cancer IC50 = 5.89 ± 0.14 μg/ml
dbacp07286 AtMP2 TGIATSGLATFTLHTGSLAPAT Anabastestudineus skin mucus fraction 2 p53-mediated Bax/Bcl-2 apoptosis activation MTT assay MDA-MB-231 Breast Cancer IC50 = 6.97 ± 0.24 μg/ml
dbacp07287 P264-G274 PARDVLNTTSG Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-480 Colorectal Cancer EC50 = 90.98 ± 0.75 µM
dbacp07288 P264-G274 PARDVLNTTSG Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-620 Colorectal Cancer EC50 = 11.28 ± 0.52 µM
dbacp07289 Loop1-PS2Aa NNETYFNAVKP Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-480 Colorectal Cancer EC50 = 23.76 ± 1.25 µM
dbacp07290 Loop1-PS2Aa NNETYFNAVKP Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-620 Colorectal Cancer EC50 = 106.2 ± 1.67 µM
dbacp07291 Loop2-PS2Aa TYFNAVKPPITA Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-480 Colorectal Cancer EC50 = 92.99 ± 0.98 µM
dbacp07292 Loop2-PS2Aa TYFNAVKPPITA Parasporin-2Aa1 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-620 Colorectal Cancer EC50 = 15.95 ± 0.69 µM
dbacp07293 Loop1-HCoV-229E FKPQSGGGKCF Alphacoronavirus (HCoV-229E) h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-480 Colorectal Cancer EC50 = 125.0 ± 1.32 µM
dbacp07294 A4W-GGN5 FLGWLFKVASK Gaegurin 5 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-480 Colorectal Cancer EC50 = 98.63 ± 1.17 µM
dbacp07295 A4W-GGN5 FLGWLFKVASK Gaegurin 5 h-APN receptor–mediated apoptosis induction. Sulforhodamine B assay SW-620 Colorectal Cancer EC50 = 22.07 ± 1.63 µM
dbacp07309 LyeTxI-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Apoptosis induction and immune modulation. MTT assay 4T1 Breast Cancer IC50 = 6.5 ± 5.30 µM
dbacp07310 LyeTxI-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Apoptosis induction and immune modulation. MTT assay MCF-7 Breast Cancer IC50 = 7.34 ± 3.09 µM
dbacp07311 LyeTxI-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Apoptosis induction and immune modulation. MTT assay MDA-MB-231 Breast Cancer IC50 = 5.77 ± 0.83 µM
dbacp07322 PCC-1 KKRKKKAFALKFVVDLI Poecilocoris lewisi Sp1 suppression, apoptosis, cell-cycle arrest MTS assay SK-Mel-28 Skin Cancer IC50 = 50.8 µM
dbacp07323 PCC-1 KKRKKKAFALKFVVDLI Poecilocoris lewisi Sp1 suppression, apoptosis, cell-cycle arrest MTS assay G361 Skin Cancer IC50 = 57.8 µM
dbacp07324 IK13 CIIKKIIKKIIKK Synthetic Mitochondrial mediated apoptosis MTT assay HCT-116 Colorectal Cancer IC50 = 29 ± 6 µM
dbacp07325 IK13 CIIKKIIKKIIKK Synthetic Mitochondrial mediated apoptosis MTT assay HeLa Cervical Cancer IC50 = 47±5 µM
dbacp07326 LK13 CLLKKLLKKLLKK Synthetic Mitochondrial mediated apoptosis MTT assay HCT-116 Colorectal Cancer IC50 = 23 ± 2 µM
dbacp07327 LK13 CLLKKLLKKLLKK Synthetic Mitochondrial mediated apoptosis MTT assay HeLa Cervical Cancer IC50 = 83 ± 9 µM
dbacp07328 IR13 CIIRRIIRRIIRR Synthetic Mitochondrial mediated apoptosis MTT assay HCT-116 Colorectal Cancer IC50 > 100 µM
dbacp07329 IR13 CIIRRIIRRIIRR Synthetic Mitochondrial mediated apoptosis MTT assay HeLa Cervical Cancer IC50 > 100 µM
dbacp07330 LR13 CLLRRLLRRLLRR Synthetic Mitochondrial mediated apoptosis MTT assay HCT-116 Colorectal Cancer IC50 = 15.6 ± 1.0 µM
dbacp07331 LR13 CLLRRLLRRLLRR Synthetic Mitochondrial mediated apoptosis MTT assay HeLa Cervical Cancer IC50 = 26.7 ± 1.3 µM
dbacp07332 CI-15 CIIKKIIKKIIKKII Synthetic Mitochondrial mediated apoptosis MTT assay HCT-116 Colorectal Cancer IC50 = 7.7 ± 0.2 µM
dbacp07333 CI-15 CIIKKIIKKIIKKII Synthetic Mitochondrial mediated apoptosis MTT assay HeLa Cervical Cancer IC50 = 2.7 ± 0.5 µM
dbacp07334 GI-15 LC-Propargyl-GIIKKIIKKIIKKII Synthetic Mitochondrial mediated apoptosis MTT assay HCT-116 Colorectal Cancer IC50 = 13.6 ± 0.2 µM
dbacp07335 GI-15 LC-Propargyl-GIIKKIIKKIIKKII Synthetic Mitochondrial mediated apoptosis MTT assay HeLa Cervical Cancer IC50 = 16.6 ± 0.8 µM
dbacp07347 GA - 2 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay MCF-7 Breast Cancer IC50 = 7.70 ± 1.3 µg/mL
dbacp07348 GA - 2 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay HCT-116 Colon Cancer IC50 = 70.30 ± 0.9 µg/mL
dbacp07349 GA - 3 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay MCF-7 Breast Cancer IC50 = 5.1 ± 0.7 µg/mL
dbacp07350 GA - 3 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay HCT-116 Colon Cancer IC50 = 7.40 ± 0.4 µg/mL
dbacp07351 GA - 4 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay MCF-7 Breast Cancer IC50 = 6.10 ± 0.4 µg/mL
dbacp07352 GA - 4 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay HCT-116 Colon Cancer IC50 = 73.0 ± 1.4 µg/mL
dbacp07353 GA - 5 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay MCF-7 Breast Cancer IC50 = 5.0 ± 0.3 µg/mL
dbacp07354 GA - 5 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay HCT-116 Colon Cancer IC50 = 5.2 ± 0.8 µg/mL
dbacp07355 GA - 7 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay MCF-7 Breast Cancer IC50 = 3.70 ± 0.2 µg/mL
dbacp07356 GA - 7 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay HCT-116 Colon Cancer IC50 = 3.0 ± 1.1 µg/mL
dbacp07357 GA - 7 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay HepG-2 Liver Cancer IC50 = 3.30 ± 0.1 µg/mL
dbacp07358 GA - 8 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay MCF-7 Breast Cancer IC50 = 6.90 ± 1.1 µg/mL
dbacp07359 GA - 8 Structure given in figure Synthetic (glycyrrhetinic acid (GA)-based peptides) Apoptosis induction, Bax/p53/caspase activation MTT assay HCT-116 Colon Cancer IC50 = 60.70 ± 0.6 µg/mL
dbacp07373 HPRP-A1 FKKLKKLFSKLWNWK N-terminal region of Helicobacter pylori ribosomal protein L1 Apoptosis induction, p53-mediated cell cycle arrest MTT assay CT-26 Colorectal Cancer IC50 between 0.5 and 1 µg/mL
dbacp07374 HPRP-A1 FKKLKKLFSKLWNWK N-terminal region of Helicobacter pylori ribosomal protein L1 Apoptosis induction, p53-mediated cell cycle arrest MTT assay HT-29 Colon Cancer IC50 ~ 0.5 µg/mL
dbacp07395 17BIPHE2 GBKRLVQRLKDBLRNLV Derivative of LL-37 ERK-mediated apoptosis and mitochondrial disruption MTT assay A-549 Lung Cancer IC50 = 34.33 µmol
dbacp07396 17BIPHE2 GBKRLVQRLKDBLRNLV Derivative of LL-37 ERK-mediated apoptosis and mitochondrial disruption MTT assay NCI-H-1975 Lung Cancer IC50 = 71.42 µmol/L
dbacp07401 NMTP-5 zffygwyggmekllrggrgerppr Not Available NRP1/MDM2 inhibition induces apoptosis MTT assay SK-HEP-1 Liver Cancer IC50 = 53.84 ± 4.35 µM
dbacp07404 LvHemB1 DVNFLLHKIYGNIRY hemocyanin of Litopenaeus vannamei Mitochondrial targeting induces apoptosis MTS assay HeLa Cervical cancer 65.1% apoptotic cells at 50 μg/mL
dbacp07405 LvHemB1 DVNFLLHKIYGNIRY hemocyanin of Litopenaeus vannamei Mitochondrial targeting induces apoptosis MTS assay EC-109 Esophageal Cancer 57.1% apoptotic cells at 50 μg/mL
dbacp07406 LvHemB1 DVNFLLHKIYGNIRY hemocyanin of Litopenaeus vannamei Mitochondrial targeting induces apoptosis MTS assay HepG-2 Liver Cancer 44.2% apoptotic cells at 50 μg/mL
dbacp07407 LvHemB1 DVNFLLHKIYGNIRY hemocyanin of Litopenaeus vannamei Mitochondrial targeting induces apoptosis MTS assay EJ Bladder Cancer 89.6% apoptotic cells at 50 μg/mL
dbacp07411 Si1 (KLAKLAK)2 Synthetic Membrane disruption induces cancer apoptosis MTT assay MCF-7 Breast Cancer IC50 = 124.1 ± 8.12 µM
dbacp07412 Si1 (KLAKLAK)2 Synthetic Membrane disruption induces cancer apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 746.5 ± 7.6 µM
dbacp07413 Si3 KL(Beta-A)KL(Beta-A)AK Synthetic Membrane disruption induces cancer apoptosis MTT assay MCF-7 Breast Cancer IC50 = 176.3 ± 4.66 µM
dbacp07414 Si2 KL(Beta-A)KL(Beta-A)K Synthetic Membrane disruption induces cancer apoptosis MTT assay MCF-7 Breast Cancer IC50 = 662.9 ± 20.02 µM
dbacp07415 Si2 KL(Beta-A)KL(Beta-A)K Synthetic Membrane disruption induces cancer apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 840 ± 21.18 µM
dbacp07416 Si11 KL(Beta-A)KL(Beta-A)K Synthetic Membrane disruption induces cancer apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 1087 ± 70.71 µM
dbacp07417 Si11 KL(Beta-A)KLAK Synthetic Membrane disruption induces cancer apoptosis MTT assay MCF-7 Breast Cancer IC50 = 228.8 ± 7.18 µM
dbacp07418 Si13 KnLAKnLAK Synthetic Membrane disruption induces cancer apoptosis MTT assay MCF-7 Breast Cancer IC50 = 1704 ± 112 µM
dbacp07419 Si14 KnLAKnLAK Synthetic Membrane disruption induces cancer apoptosis MTT assay MCF-7 Breast Cancer IC50 = 593.3 ± 60.3 µM
dbacp07420 Si14 KnLAKnLAK Synthetic Membrane disruption induces cancer apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 1049 ± 49.77 µM
dbacp07421 Si15 KnLAKnLAK Synthetic Membrane disruption induces cancer apoptosis MTT assay MCF-7 Breast Cancer IC50 = 140.3 ± 7.12 µM
dbacp07422 Si15 KnLAKnLAK Synthetic Membrane disruption induces cancer apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 346.3 ± 7.91 µM
dbacp07423 GP-1 FKEHGY Ginseng Leaf Peptide Mitochondrial apoptosis via p53 activation MTT assay CT-26 Colorectal Cancer IC50 = 86.4 ± 9.46 µM
dbacp07424 GP-1 FKEHGY Ginseng Leaf Peptide Mitochondrial apoptosis via p53 activation MTT assay CaCo-2 Colon Cancer IC50 = 104 ± 11.3 µM
dbacp07425 GP-1 FKEHGY Ginseng Leaf Peptide Mitochondrial apoptosis via p53 activation MTT assay Colo-320 Colon Cancer IC50 = 111 ± 12.0 µM
dbacp07426 GP-2 EGFHL Ginseng Leaf Peptide Mitochondrial apoptosis via p53 activation MTT assay CT-26 Colorectal Cancer IC50 = 114 ± 12.1 µM
dbacp07427 GP-2 EGFHL Ginseng Leaf Peptide Mitochondrial apoptosis via p53 activation MTT assay CaCo-2 Colon Cancer IC50 = 154 ± 15.8 µM
dbacp07428 GP-2 EGFHL Ginseng Leaf Peptide Mitochondrial apoptosis via p53 activation MTT assay Colo-320 Colon Cancer IC50 = 142 ± 14.9 µM
dbacp07429 GP-3 FSHTYV Ginseng Leaf Peptide Mitochondrial apoptosis via p53 activation MTT assay CT-26 Colorectal Cancer IC50 = 133 ± 12.5 µM
dbacp07430 GP-3 FSHTYV Ginseng Leaf Peptide Mitochondrial apoptosis via p53 activation MTT assay CaCo-2 Colon Cancer IC50 = 162 ± 17.1 µM
dbacp07431 GP-3 FSHTYV Ginseng Leaf Peptide Mitochondrial apoptosis via p53 activation MTT assay Colo-320 Colon Cancer IC50 = 149 ± 15.2 µM
dbacp07435 L9H5-1 LHLLLHLLHHLLHL Synthetic Acid-triggered membrane disruption apoptosis MTT assay HeLa Cervical Cancer IC50 = 5.4 µM
dbacp07436 L8H6 LHHLLHLLHHLLHL Synthetic Acid-triggered membrane disruption apoptosis MTT assay HeLa Cervical Cancer IC50 = 16.4 µM
dbacp07437 A4K14 - Citropin 1.1 - Sp 7 GLFAVR8KKVASVS5KGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay C4-2B Prostate Cancer IC50 = 10.23 µM
dbacp07438 A4K14 - Citropin 1.1 - Sp 7 GLFAVR8KKVASVS5KGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 16.37 µM
dbacp07439 A4K14 - Citropin 1.1 - Sp 7 GLFAVR8KKVASVS5KGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay U-87 Brain Tumor IC50 = 14.72 µM
dbacp07440 A4K14 - Citropin 1.1 - Sp 7 GLFAVR8KKVASVS5KGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay MCF-7 Breast Cancer IC50 = 12.1 µM
dbacp07441 A4K14 - Citropin 1.1 - Sp 6 GR8FAVIKKS5ASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay C4-2B Prostate Cancer IC50 = 35.84 µM
dbacp07442 A4K14 - Citropin 1.1 - Sp 6 GR8FAVIKKS5ASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 30.19 µM
dbacp07443 A4K14 - Citropin 1.1 - Sp 6 GR8FAVIKKS5ASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay U-87 Brain Tumor IC50 = 34.49 µM
dbacp07444 A4K14 - Citropin 1.1 - Sp 6 GR8FAVIKKS5ASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay MCF-7 Breast Cancer IC50 = 23.78 µM
dbacp07445 A4K14 - Citropin 1.1 - Sp 5 GLFAVIKKVAS5VIKS5L Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay C4-2B Prostate Cancer IC50 = 11.9 µM
dbacp07446 A4K14 - Citropin 1.1 - Sp 5 GLFAVIKKVAS5VIKS5L Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 9.899 µM
dbacp07447 A4K14 - Citropin 1.1 - Sp 5 GLFAVIKKVAS5VIKS5L Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay U-87 Brain Tumor IC50 = 8.229 µM
dbacp07448 A4K14 - Citropin 1.1 - Sp 5 GLFAVIKKVAS5VIKS5L Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay MCF-7 Breast Cancer IC50 = 12.42 µM
dbacp07449 A4K14 - Citropin 1.1 - Sp 4 GLFAVIKKS5ASVS5KGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay C4-2B Prostate Cancer IC50 = 8.9 µM
dbacp07450 A4K14 - Citropin 1.1 - Sp 4 GLFAVIKKS5ASVS5KGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 10.51 µM
dbacp07451 A4K14 - Citropin 1.1 - Sp 4 GLFAVIKKS5ASVS5KGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay U-87 Brain Tumor IC50 = 7.277 µM
dbacp07452 A4K14 - Citropin 1.1 - Sp 4 GLFAVIKKS5ASVS5KGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay MCF-7 Breast Cancer IC50 = 10.49 µM
dbacp07453 A4K14 - Citropin 1.1 - Sp 3 GLFAVS5KKVS5SVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay C4-2B Prostate Cancer IC50 = 17.89 µM
dbacp07454 A4K14 - Citropin 1.1 - Sp 3 GLFAVS5KKVS5SVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 12.11 µM
dbacp07455 A4K14 - Citropin 1.1 - Sp 3 GLFAVS5KKVS5SVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay U-87 Brain Tumor IC50 = 11.93 µM
dbacp07456 A4K14 - Citropin 1.1 - Sp 3 GLFAVS5KKVS5SVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay MCF-7 Breast Cancer IC50 = 11.92 µM
dbacp07457 A4K14 - Citropin 1.1 - Sp 2 GLFAS5IKKS5ASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay C4-2B Prostate Cancer IC50 = 10.14 µM
dbacp07458 A4K14 - Citropin 1.1 - Sp 2 GLFAS5IKKS5ASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 12.55 µM
dbacp07459 A4K14 - Citropin 1.1 - Sp 2 GLFAS5IKKS5ASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay U-87 Brain Tumor IC50 = 14.76 µM
dbacp07460 A4K14 - Citropin 1.1 - Sp 2 GLFAS5IKKS5ASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay MCF-7 Breast Cancer IC50 = 12.65 µM
dbacp07461 A4K14 - Citropin 1.1 - Sp 1 GS5FAVS5KKVASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay C4-2B Prostate Cancer IC50 = 8.94 µM
dbacp07462 A4K14 - Citropin 1.1 - Sp 1 GS5FAVS5KKVASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 12.48 µM
dbacp07463 A4K14 - Citropin 1.1 - Sp 1 GS5FAVS5KKVASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay U-87 Brain Tumor IC50 = 11.88 µM
dbacp07464 A4K14 - Citropin 1.1 - Sp 1 GS5FAVS5KKVASVIKGL Synthetic Stapled peptide enhances helical apoptosis CCK-8 assay MCF-7 Breast Cancer IC50 = 11.26 µM
dbacp07465 ΔM4 NFFKRIRRAWKRIWKWIYSA Synthetic Membrane disruption triggers mitochondrial apoptosis Not Available A-375 Skin Cancer IC50 = 9.31 μM
dbacp07466 Tachyplesin KWCFRVCYRGICYIRRCR Horseshoe crab Fas activation drives apoptosis/necroptosis MTT assay A-549 Lung Cancer IC50 = 35 µg/ml
dbacp07467 Tachyplesin KWCFRVCYRGICYIRRCR Horseshoe crab Fas activation drives apoptosis/necroptosis MTT assay H-460 Lung Cancer IC50 = 25 µg/ml
dbacp07475 Latcripin-7A MTTESKVKNATTLLHSGKVKERQEGLSALRNIFSQNSSIERFYNVAGRDGRKPSHEIWAPILDGLQTCIRSEKSAFVTAKKSTDVIEKRLAAAAGTYRWFVEKSMMHFAKKTVLEICHFLYREMKVRETLIPSVALDFIKAYECVASHPPHLARLEEDEIEWEE Lentinula edodes Cell-cycle arrest, apoptosis, autophagy induction CCK-8 assay MCF-7 Breast Cancer IC50 = 91 μg/mL
dbacp07476 Latcripin-7A MTTESKVKNATTLLHSGKVKERQEGLSALRNIFSQNSSIERFYNVAGRDGRKPSHEIWAPILDGLQTCIRSEKSAFVTAKKSTDVIEKRLAAAAGTYRWFVEKSMMHFAKKTVLEICHFLYREMKVRETLIPSVALDFIKAYECVASHPPHLARLEEDEIEWEE Lentinula edodes Cell-cycle arrest, apoptosis, autophagy induction CCK-8 assay MDA-MB-231 Breast Cancer IC50 = 122 μg/mL
dbacp07477 (LLKK)4 linear peptide LLKKLLKKLLKKLLKK Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay SK-HEP-1 Liver Cancer Cell Viability (%) ~ 14.1 ± 0.8 at 30 µg/mL
dbacp07478 (LLKK)4 linear peptide LLKKLLKKLLKKLLKK Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay HCT-116 Colon Cancer Cell Viability (%) ~ 10.73 ± 2.4 at 30 µg/mL
dbacp07479 (LLKK)4 linear peptide LLKKLLKKLLKKLLKK Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay Bcap-37 Breast Cancer Cell Viability (%) ~ 15.07 ± 0.5 at 30 µg/mL
dbacp07480 (LLKK)4 linear peptide LLKKLLKKLLKKLLKK Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay PC-3 Prostate Cancer Cell Viability (%) ~ 17.1 ± 5.0 at 30 µg/mL
dbacp07481 2-arm branched peptide [LLKKLLKK]2kC Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay SK-HEP-1 Liver Cancer Cell Viability (%) ~ 85.7 ± 4.3 at 30 µg/mL
dbacp07482 2-arm branched peptide [LLKKLLKK]2kC Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay HCT-116 Colon Cancer Cell Viability (%) ~ 78.6 ± 10.5 at 30 µg/mL
dbacp07483 2-arm branched peptide [LLKKLLKK]2kC Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay Bcap-37 Breast Cancer Cell Viability (%) ~ 81.8 ± 8.8 at 30 µg/mL
dbacp07484 2-arm branched peptide [LLKKLLKK]2kC Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay PC-3 Prostate Cancer Cell Viability (%) ~ 73.5 ± 2.2 at 30 µg/mL
dbacp07485 4-arm branched peptide {[LLKKLLKK]2kC}2 Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay SK-HEP-1 Liver Cancer Cell Viability (%) ~ 31.7 ± 5.1 at 30 µg/mL
dbacp07486 4-arm branched peptide {[LLKKLLKK]2kC}2 Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay HCT-116 Colon Cancer Cell Viability (%) ~ 67.6 ± 5.8 at 30 µg/mL
dbacp07487 4-arm branched peptide {[LLKKLLKK]2kC}2 Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay Bcap-37 Breast Cancer Cell Viability (%) ~ 51.4 ± 4.2 at 30 µg/mL
dbacp07488 4-arm branched peptide {[LLKKLLKK]2kC}2 Synthetic Apoptosis, drug-resistance reversal, tumor suppression MTT assay PC-3 Prostate Cancer Cell Viability (%) ~ 49.0 ± 0.8 at 30 µg/mL
dbacp07512 Dermaseptin-PP ALWKDMLKGIGKLAGKAALGAVKTLV Phyllomedusa palliata Membrane disruption triggers dual apoptosis MTT assay H-157 Lung Cancer IC50 = 1.55 μM
dbacp07513 Dermaseptin-PP ALWKDMLKGIGKLAGKAALGAVKTLV Phyllomedusa palliata Membrane disruption triggers dual apoptosis MTT assay MCF-7 Breast Cancer IC50 = 2.92 μM
dbacp07514 Dermaseptin-PP ALWKDMLKGIGKLAGKAALGAVKTLV Phyllomedusa palliata Membrane disruption triggers dual apoptosis MTT assay PC-3 Prostate Cancer IC50 = 4.15 μM
dbacp07515 Dermaseptin-PP ALWKDMLKGIGKLAGKAALGAVKTLV Phyllomedusa palliata Membrane disruption triggers dual apoptosis MTT assay U-251 Brain Tumor IC50 = 2.47 μM
dbacp07516 Dermaseptin-PP ALWKDMLKGIGKLAGKAALGAVKTLV Phyllomedusa palliata Membrane disruption triggers dual apoptosis LDH leakage assay H-157 Lung Cancer 80% LDH release at 10−4 M
dbacp07534 rCT-II LKCKKLVPLFSKTCPAGKNLCYKMFMVAAPHVPVKRGCIDVCPKSSLLVKYVCCNTDKCN Naja naja Apoptosis via intrinsic (mitochondrial) and extrinsic (death receptor) pathways MTT assay MCF-7 Breast Cancer IC50 = 3.66 µg/mL
dbacp07546 Sur-X YGRKKRRQRRRKDHRISTFKNWPFLEGCACTPERM Synthetic Disrupts XIAP-survivin, induces apoptosis/necroptosis MTT assay HCT-116 Colon Cancer 20% cell viability at at 20 μM
dbacp07547 Sur-X YGRKKRRQRRRKDHRISTFKNWPFLEGCACTPERM Synthetic Disrupts XIAP-survivin, induces apoptosis/necroptosis MTT assay HCT-15 Colon Cancer Not Available
dbacp07548 Sur-X YGRKKRRQRRRKDHRISTFKNWPFLEGCACTPERM Synthetic Disrupts XIAP-survivin, induces apoptosis/necroptosis MTT assay RKO Colon Cancer 25% cell viability at at 20 μM
dbacp07549 Sur-X YGRKKRRQRRRKDHRISTFKNWPFLEGCACTPERM Synthetic Disrupts XIAP-survivin, induces apoptosis/necroptosis MTT assay HT-29 Colon Cancer Not Available
dbacp07578 R-DIM-P-LF11 FQWQRNIRKVRPRVKRINRQWQF Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay A-375 Skin Cancer LC50 = 125.0 ± 16.8 μM
dbacp07579 R-DIM-P-LF11 FQWQRNIRKVRPRVKRINRQWQF Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay SBcl2 Skin Cancer LC50 = 10.7 ± 0.2 μM
dbacp07580 R-DIM-P-LF11 FQWQRNIRKVRPRVKRINRQWQF Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay WM164 Skin Cancer LC50 = 20.9 ± 3.9 μM
dbacp07581 R-DIM-P-LF11-322 PFWRIRIRRPRRIRIRWFP Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay A-375 Skin Cancer LC50 = 4.2 ± 0.2 μM
dbacp07582 R-DIM-P-LF11-322 PFWRIRIRRPRRIRIRWFP Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay SBcl2 Skin Cancer LC50 = 2.5 ± 0.1 μM
dbacp07583 R-DIM-P-LF11-322 PFWRIRIRRPRRIRIRWFP Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay WM164 Skin Cancer LC50 = 4.7 ± 0.2 μM
dbacp07584 DIM-LF11-322 PFWRIRIRRPFWRIRIRR Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay A-375 Skin Cancer LC50 = 6.3 ± 0.3 μM
dbacp07585 DIM-LF11-322 PFWRIRIRRPFWRIRIRR Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay SBcl2 Skin Cancer LC50 < 1 ± 0.0 μM
dbacp07586 DIM-LF11-322 PFWRIRIRRPFWRIRIRR Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay WM164 Skin Cancer LC50 = 4.6 ± 0.1 μM
dbacp07587 R-DIM-P-LF11-215 FWRIRIRRPRRIRIRWF Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay A-375 Skin Cancer LC50 = 2.7 ± 0.9 μM
dbacp07588 R-DIM-P-LF11-215 FWRIRIRRPRRIRIRWF Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay SBcl2 Skin Cancer LC50 < 1 ± 0.0 μM
dbacp07589 R-DIM-P-LF11-215 FWRIRIRRPRRIRIRWF Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay WM164 Skin Cancer LC50 = 4.6 ± 0.1 μM
dbacp07590 R-DIM-P-LF11-334 PWRIRIRRPRRIRIWP Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay A-375 Skin Cancer LC50 = 6.6 ± 0.3 μM
dbacp07591 R-DIM-P-LF11-334 PWRIRIRRPRRIRIWP Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay SBcl2 Skin Cancer LC50 = 3.4 ± 0.4 μM
dbacp07592 R-DIM-P-LF11-334 PWRIRIRRPRRIRIWP Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay WM164 Skin Cancer LC50 = 5.0 ± 0.1 μM
dbacp07593 R-DIM-LF11-334-LF11-334 PWRIRIRRRRIRIRWPPWRIRIRR Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay A-375 Skin Cancer LC50 < 1 ± 0.1 μM
dbacp07594 R-DIM-LF11-334-LF11-334 PWRIRIRRRRIRIRWPPWRIRIRR Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay SBcl2 Skin Cancer LC50 < 1 ± 0.1 μM
dbacp07595 R-DIM-LF11-334-LF11-334 PWRIRIRRRRIRIRWPPWRIRIRR Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay WM164 Skin Cancer LC50 = 3.6 ± 0.7 μM
dbacp07596 DIM-LF11-339 RRWFWRRRRWFWRR Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay A-375 Skin Cancer LC50 = 4.8 ± 0.4 μM
dbacp07597 DIM-LF11-339 RRWFWRRRRWFWRR Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay SBcl2 Skin Cancer LC50 = 4.7 ± 0.3 μM
dbacp07598 DIM-LF11-339 RRWFWRRRRWFWRR Synthetic Peptides target phosphatidylserine, trigger apoptosis MTS assay WM164 Skin Cancer LC50 = 3.8 ± 0.3 μM
dbacp07644 Colicin N HGDNNSKPKPGGNSGNRGNNGDGASAKVGEITITPDNSKPGRYISSNPEYSLLAKLIDAESIKGTEVYTFHTRKGQYVKVTVPDSNIDKMRVDYVNWKGPKYNNKLVKRFVSQFLLFRKEEKEKNEKEALLKASELVSGMGDKLGEYLGVKYKNVAKEVANDIKNFHGRNIRSYNEAMASLNKVLANPKMKVNKSDKDAIVNAWKQVNAKDMANKIGNLGKAFKVADLAIKVEKIREKSIEGYNTGNWGPLLLEVESWIIGGVVAGVAISLFGAVLSFLPISGLAVTALGVIGIMTISYLSSFIDANRVSNINNIISSVIR Apoptosis via integrin-Akt suppression MTT assay H-460 Lung Cancer Dose dependent % cell viability resuctuction at 1-15 µM
dbacp07645 Colicin N HGDNNSKPKPGGNSGNRGNNGDGASAKVGEITITPDNSKPGRYISSNPEYSLLAKLIDAESIKGTEVYTFHTRKGQYVKVTVPDSNIDKMRVDYVNWKGPKYNNKLVKRFVSQFLLFRKEEKEKNEKEALLKASELVSGMGDKLGEYLGVKYKNVAKEVANDIKNFHGRNIRSYNEAMASLNKVLANPKMKVNKSDKDAIVNAWKQVNAKDMANKIGNLGKAFKVADLAIKVEKIREKSIEGYNTGNWGPLLLEVESWIIGGVVAGVAISLFGAVLSFLPISGLAVTALGVIGIMTISYLSSFIDANRVSNINNIISSVIR Apoptosis via integrin-Akt suppression MTT assay H-292 Lung Cancer Dose dependent % cell viability resuctuction at 1-15 µM
dbacp07646 Colicin N HGDNNSKPKPGGNSGNRGNNGDGASAKVGEITITPDNSKPGRYISSNPEYSLLAKLIDAESIKGTEVYTFHTRKGQYVKVTVPDSNIDKMRVDYVNWKGPKYNNKLVKRFVSQFLLFRKEEKEKNEKEALLKASELVSGMGDKLGEYLGVKYKNVAKEVANDIKNFHGRNIRSYNEAMASLNKVLANPKMKVNKSDKDAIVNAWKQVNAKDMANKIGNLGKAFKVADLAIKVEKIREKSIEGYNTGNWGPLLLEVESWIIGGVVAGVAISLFGAVLSFLPISGLAVTALGVIGIMTISYLSSFIDANRVSNINNIISSVIR Apoptosis via integrin-Akt suppression MTT assay NCI-H23 Lung Cancer Dose dependent % cell viability resuctuction at 1-15 µM
dbacp07647 AP1-Z1 FLFSLIPHAISGLISAFK AcrAP1 from the venom of the Arabian scorpion Charge–hydrophobicity balance drives apoptosis MTT assay MCF-7 Breast Cancer IC50 = 7.222 μM
dbacp07648 AP1-Z1 FLFSLIPHAISGLISAFK AcrAP1 from the venom of the Arabian scorpion Charge–hydrophobicity balance drives apoptosis MTT assay A-375 Skin Cancer IC50 = 9.478 μM
dbacp07649 AP1-Z1 FLFSLIPHAISGLISAFK AcrAP1 from the venom of the Arabian scorpion Charge–hydrophobicity balance drives apoptosis MTT assay U-87 Brain Tumor IC50 = 10.21 μM
dbacp07650 AP1-Z5a FLFKLIPKAIKGLIKAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay MCF-7 Breast Cancer Graph Figure 2A
dbacp07651 AP1-Z5a FLFKLIPKAIKGLIKAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay A-375 Skin Cancer Graph Figure 2B
dbacp07652 AP1-Z5a FLFKLIPKAIKGLIKAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay U-87 Brain Tumor Graph Figure 2C
dbacp07653 AP1-Z5b FLFKLIKHAIKGLIKAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay MCF-7 Breast Cancer IC50 = 1.037 μM
dbacp07654 AP1-Z5b FLFKLIKHAIKGLIKAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay A-375 Skin Cancer IC50 = 2.607 μM
dbacp07655 AP1-Z5b FLFKLIKHAIKGLIKAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay U-87 Brain Tumor IC50 = 3.115 μM
dbacp07656 AP1-Z3a FLFSLIKHAIKGLISAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay MCF-7 Breast Cancer Graph Figure 2A
dbacp07657 AP1-Z3a FLFSLIKHAIKGLISAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay A-375 Skin Cancer Graph Figure 2B
dbacp07658 AP1-Z3a FLFSLIKHAIKGLISAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay U-87 Brain Tumor Graph Figure 2C
dbacp07659 AP1-Z3b FLFSLIKHAISKLISAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay MCF-7 Breast Cancer Graph Figure 2A
dbacp07660 AP1-Z3b FLFSLIKHAISKLISAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay A-375 Skin Cancer Graph Figure 2B
dbacp07661 AP1-Z3b FLFSLIKHAISKLISAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay U-87 Brain Tumor Graph Figure 2C
dbacp07662 AP1-Z7 FLFKLIKKAIKKLIKAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay MCF-7 Breast Cancer Graph Figure 2A
dbacp07663 AP1-Z7 FLFKLIKKAIKKLIKAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay A-375 Skin Cancer Graph Figure 2B
dbacp07664 AP1-Z7 FLFKLIKKAIKKLIKAFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay U-87 Brain Tumor Graph Figure 2C
dbacp07665 AP1-Z9 FLFKLIKKKIKKLIKKFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay MCF-7 Breast Cancer Graph Figure 2A
dbacp07666 AP1-Z9 FLFKLIKKKIKKLIKKFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay A-375 Skin Cancer Graph Figure 2B
dbacp07667 AP1-Z9 FLFKLIKKKIKKLIKKFK Mutant of APR-Z1 Charge–hydrophobicity balance drives apoptosis MTT assay U-87 Brain Tumor Graph Figure 2C
dbacp07668 Longicalycinin A linear analogue 1 GYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.66 ± 0.0007 µg/ml
dbacp07669 Longicalycinin A linear analogue 1 GYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.45 ± 0.0042 µg/ml
dbacp07670 Longicalycinin A linear analogue 1 GYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 13.29% Cell death at 100 µg/ml
dbacp07671 Longicalycinin A linear analogue 1 GYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 83.02% Cell death at 100 µg/ml
dbacp07672 Longicalycinin A Cyclic analogue 1 GYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.2 ± 0.007 µg/ml
dbacp07673 Longicalycinin A Cyclic analogue 1 GYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 11.4 ± 0.0028 µg/ml
dbacp07674 Longicalycinin A Cyclic analogue 1 GYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 69.73% Cell death at 100 µg/ml
dbacp07675 Longicalycinin A Cyclic analogue 1 GYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 71.5% Cell death at 100 µg/ml
dbacp07676 Longicalycinin A linear analogue 2 LYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 8.76 ± 0.0035 µg/ml
dbacp07677 Longicalycinin A linear analogue 2 LYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 12.33 ± 0 µg/ml
dbacp07678 Longicalycinin A linear analogue 2 LYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 71.37% Cell death at 100 µg/ml
dbacp07679 Longicalycinin A linear analogue 2 LYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 88.47% Cell death at 100 µg/ml
dbacp07680 Longicalycinin A FYPFG Dianthus superbus Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 13.52 µg/ml
dbacp07681 Longicalycinin A FYPFG Dianthus superbus Cyclization enhances apoptosis via lysosomes MTT assay DLA cell line Lung Cancer CTC50 = 2.62 µM
dbacp07682 Longicalycinin A FYPFG Dianthus superbus Cyclization enhances apoptosis via lysosomes MTT assay EAC cell Line Breast Cancer CTC50 = 6.17 µM
dbacp07683 Longicalycinin A FYPFG Synthetic Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.45 ± 0.0042 µg/ml
dbacp07684 Longicalycinin A FYPFG Synthetic Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 11.87 ± 0.0021 µg/ml
dbacp07685 Longicalycinin A (Linear) FYPFG Synthetic Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.18 ± 0.0014 µg/ml
dbacp07686 Longicalycinin A (Linear) FYPFG Synthetic Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 9.61 ± 0.0007 µg/ml
dbacp07687 Longicalycinin A linear analogue 14 PYFFL Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.67 ± 0.0007 µg/ml
dbacp07688 Longicalycinin A linear analogue 14 PYFFL Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 9.12 ± 0.0042 µg/ml
dbacp07689 Longicalycinin A linear analogue 14 PYFFL Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 13.02% Cell death at 100 µg/ml
dbacp07690 Longicalycinin A linear analogue 14 PYFFL Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 82.36% Cell death at 100 µg/ml
dbacp07691 Longicalycinin A cyclic analogue 14 PYFFL Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.46 ± 0.0028 µg/ml
dbacp07692 Longicalycinin A cyclic analogue 14 PYFFL Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.92 ± 0.0021 µg/ml
dbacp07693 Longicalycinin A cyclic analogue 14 PYFFL Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 70.69% Cell death at 100 µg/ml
dbacp07694 Longicalycinin A cyclic analogue 14 PYFFL Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 52.38% Cell death at 100 µg/ml
dbacp07695 Longicalycinin A linear analogue 3 GYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.77 ± 0.0007 µg/ml
dbacp07696 Longicalycinin A linear analogue 3 GYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 11.4 ± 0 µg/ml
dbacp07697 Longicalycinin A linear analogue 3 GYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 82.33% Cell death at 100 µg/ml
dbacp07698 Longicalycinin A linear analogue 3 GYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 87.56% Cell death at 100 µg/ml
dbacp07699 Longicalycinin A cyclic analogue 3 GYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.5 ± 0.0056 µg/ml
dbacp07700 Longicalycinin A cyclic analogue 3 GYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 11.28 ± 0.0063 µg/ml
dbacp07701 Longicalycinin A cyclic analogue 3 GYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 56.72% Cell death at 100 µg/ml
dbacp07702 Longicalycinin A cyclic analogue 3 GYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 28.51% Cell death at 100 µg/ml
dbacp07703 Longicalycinin A linear analogue 4 AYPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.53 ± 0.0014 µg/ml
dbacp07704 Longicalycinin A linear analogue 4 AYPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.78 ± 0.0021 µg/ml
dbacp07705 Longicalycinin A linear analogue 4 AYPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 27.13% Cell death at 100 µg/ml
dbacp07706 Longicalycinin A linear analogue 4 AYPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 75.91% Cell death at 100 µg/ml
dbacp07707 Longicalycinin A cyclic analogue 4 AYPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.77 ± 0.007 µg/ml
dbacp07708 Longicalycinin A cyclic analogue 4 AYPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 11.33 ± 0.0035 µg/ml
dbacp07709 Longicalycinin A cyclic analogue 4 AYPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 71.1% Cell death at 100 µg/ml
dbacp07710 Longicalycinin A cyclic analogue 4 AYPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 52.49% Cell death at 100 µg/ml
dbacp07711 Longicalycinin A linear analogue 5 FSPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 8.99 ± 0.0014 µg/ml
dbacp07712 Longicalycinin A linear analogue 5 FSPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.97 ± 0.0049 µg/ml
dbacp07713 Longicalycinin A linear analogue 5 FSPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 76.72% Cell death at 100 µg/ml
dbacp07714 Longicalycinin A linear analogue 5 FSPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 91.52% Cell death at 100 µg/ml
dbacp07715 Longicalycinin A cyclic analogue 5 FSPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.45 ± 0.0056 µg/ml
dbacp07716 Longicalycinin A cyclic analogue 5 FSPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 9.98 ± 0.4256 µg/ml
dbacp07717 Longicalycinin A cyclic analogue 5 FSPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 41.37% Cell death at 100 µg/ml
dbacp07718 Longicalycinin A cyclic analogue 5 FSPFG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 97.74% Cell death at 100 µg/ml
dbacp07719 Longicalycinin A linear analogue 6 VYPIA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.98 ± 0.0014 µg/ml
dbacp07720 Longicalycinin A linear analogue 6 VYPIA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 12.31 ± 0.0063 µg/ml
dbacp07721 Longicalycinin A linear analogue 6 VYPIA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 38.64% Cell death at 100 µg/ml
dbacp07722 Longicalycinin A linear analogue 6 VYPIA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 49.33% Cell death at 100 µg/ml
dbacp07723 Longicalycinin A cyclic analogue 6 VYPIA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 17.34 ± 0.0014 µg/ml
dbacp07724 Longicalycinin A cyclic analogue 6 VYPIA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.2 ± 0.0021 µg/ml
dbacp07725 Longicalycinin A cyclic analogue 6 VYPIA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 51.79% Cell death at 100 µg/ml
dbacp07726 Longicalycinin A cyclic analogue 6 VYPIA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 27.61% Cell death at 100 µg/ml
dbacp07727 Longicalycinin A linear analogue 7 PYVFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.6 ± 0.0007 µg/ml
dbacp07728 Longicalycinin A linear analogue 7 PYVFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 9.78 ± 0.0212 µg/ml
dbacp07729 Longicalycinin A linear analogue 7 PYVFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 82.33% Cell death at 100 µg/ml
dbacp07730 Longicalycinin A linear analogue 7 PYVFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 84.17% Cell death at 100 µg/ml
dbacp07731 Longicalycinin A cyclic analogue 7 PYVFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.21 ± 0.0056 µg/ml
dbacp07732 Longicalycinin A cyclic analogue 7 PYVFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 12.11 ± 0.0035 µg/ml
dbacp07733 Longicalycinin A cyclic analogue 7 PYVFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 47.68% Cell death at 100 µg/ml
dbacp07734 Longicalycinin A cyclic analogue 7 PYVFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 22.86% Cell death at 100 µg/ml
dbacp07735 Longicalycinin A linear analogue 8 FYPVG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.35 ± 0.0014 µg/ml
dbacp07736 Longicalycinin A linear analogue 8 FYPVG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 12.88 ± 0.0014 µg/ml
dbacp07737 Longicalycinin A linear analogue 8 FYPVG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 15.35% Cell death at 100 µg/ml
dbacp07738 Longicalycinin A linear analogue 8 FYPVG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 88.01% Cell death at 100 µg/ml
dbacp07739 Longicalycinin A cyclic analogue 8 FYPVG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.12 ± 0.0007 µg/ml
dbacp07740 Longicalycinin A cyclic analogue 8 FYPVG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 12.67 ± 0.0028 µg/ml
dbacp07741 Longicalycinin A cyclic analogue 8 FYPVG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 36.85% Cell death at 100 µg/ml
dbacp07742 Longicalycinin A cyclic analogue 8 FYPVG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 29.87% Cell death at 100 µg/ml
dbacp07743 Longicalycinin A linear analogue 9 FYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.33 ± 0.0007 µg/ml
dbacp07744 Longicalycinin A linear analogue 9 FYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.44 ± 0.5536 µg/ml
dbacp07745 Longicalycinin A linear analogue 9 FYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 72.74% Cell death at 100 µg/ml
dbacp07746 Longicalycinin A linear analogue 9 FYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 1.59% Cell death at 100 µg/ml
dbacp07747 Longicalycinin A cyclic analogue 9 FYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.67 ± 0 µg/ml
dbacp07748 Longicalycinin A cyclic analogue 9 FYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.7 ± 0.0056 µg/ml
dbacp07749 Longicalycinin A cyclic analogue 9 FYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 73.98% Cell death at 100 µg/ml
dbacp07750 Longicalycinin A cyclic analogue 9 FYPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 76.25% Cell death at 100 µg/ml
dbacp07751 Longicalycinin A linear analogue 10 FYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.5 ± 0.0014 µg/ml
dbacp07752 Longicalycinin A linear analogue 10 FYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.5 ± 0.0007 µg/ml
dbacp07753 Longicalycinin A linear analogue 10 FYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 76.72% Cell death at 100 µg/ml
dbacp07754 Longicalycinin A linear analogue 10 FYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 92.09% Cell death at 100 µg/ml
dbacp07755 Longicalycinin A cyclic analogue 10 FYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.28 ± 0 µg/ml
dbacp07756 Longicalycinin A cyclic analogue 10 FYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 11.56 ± 0.0028 µg/ml
dbacp07757 Longicalycinin A cyclic analogue 10 FYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 72.06% Cell death at 100 µg/ml
dbacp07758 Longicalycinin A cyclic analogue 10 FYPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 71.27% Cell death at 100 µg/ml
dbacp07759 Longicalycinin A linear analogue 11 TVPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.56 ± 0.0021 µg/ml
dbacp07760 Longicalycinin A linear analogue 11 TVPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 11.67 ± 0.0014 µg/ml
dbacp07761 Longicalycinin A linear analogue 11 TVPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 70.28% Cell death at 100 µg/ml
dbacp07762 Longicalycinin A linear analogue 11 TVPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 88.47% Cell death at 100 µg/ml
dbacp07763 Longicalycinin A cyclic analogue 11 TVPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.36 ± 0 µg/ml
dbacp07764 Longicalycinin A cyclic analogue 11 TVPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.61 ± 0.0007 µg/ml
dbacp07765 Longicalycinin A cyclic analogue 11 TVPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 72.06% Cell death at 100 µg/ml
dbacp07766 Longicalycinin A cyclic analogue 11 TVPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 74.89% Cell death at 100 µg/ml
dbacp07767 Longicalycinin A linear analogue 12 FYPFI Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 11.32 ± 0.0014 µg/ml
dbacp07768 Longicalycinin A linear analogue 12 FYPFI Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 14.2 ± 0.0014 µg/ml
dbacp07769 Longicalycinin A linear analogue 12 FYPFI Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 12.06% Cell death at 100 µg/ml
dbacp07770 Longicalycinin A linear analogue 12 FYPFI Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 81.34% Cell death at 100 µg/ml
dbacp07771 Longicalycinin A cyclic analogue 12 FYPFI Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 12.37 ± 0.0014 µg/ml
dbacp07772 Longicalycinin A cyclic analogue 12 FYPFI Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 13.2 ± 0 µg/ml
dbacp07773 Longicalycinin A cyclic analogue 12 FYPFI Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 63.84% Cell death at 100 µg/ml
dbacp07774 Longicalycinin A cyclic analogue 12 FYPFI Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 52.72% Cell death at 100 µg/ml
dbacp07775 Longicalycinin A cyclic analogue 15 PYGFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.33 ± 0 µg/ml
dbacp07776 Longicalycinin A cyclic analogue 15 PYGFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 11.23 ± 0.0007 µg/ml
dbacp07777 Longicalycinin A cyclic analogue 15 PYGFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 52.33% Cell death at 100 µg/ml
dbacp07778 Longicalycinin A cyclic analogue 15 PYGFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 27.43% Cell death at 100 µg/ml
dbacp07779 Longicalycinin A linear analogue 16 FTPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 11.1 ± 0.0007 µg/ml
dbacp07780 Longicalycinin A linear analogue 16 FTPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 12.11 ± 0.0056 µg/ml
dbacp07781 Longicalycinin A linear analogue 16 FTPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 15.76% Cell death at 100 µg/ml
dbacp07782 Longicalycinin A linear analogue 16 FTPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 88.24% Cell death at 100 µg/ml
dbacp07783 Longicalycinin A cyclic analogue 16 FTPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 12.1 ± 0.0007 µg/ml
dbacp07784 Longicalycinin A cyclic analogue 16 FTPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.4 ± 0.0028 µg/ml
dbacp07785 Longicalycinin A cyclic analogue 16 FTPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 42.33% Cell death at 100 µg/ml
dbacp07786 Longicalycinin A cyclic analogue 16 FTPFV Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 29.87% Cell death at 100 µg/ml
dbacp07787 Longicalycinin A linear analogue 17 FSPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.33 ± 0.0007 µg/ml
dbacp07788 Longicalycinin A linear analogue 17 FSPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 11.33 ± 0.0035 µg/ml
dbacp07789 Longicalycinin A linear analogue 17 FSPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 27.54% Cell death at 100 µg/ml
dbacp07790 Longicalycinin A linear analogue 17 FSPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 75.68% Cell death at 100 µg/ml
dbacp07791 Longicalycinin A cyclic analogue 17 FSPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.4 ± 0.0014 µg/ml
dbacp07792 Longicalycinin A cyclic analogue 17 FSPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 11.2 ± 0.0007 µg/ml
dbacp07793 Longicalycinin A cyclic analogue 17 FSPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 74.53% Cell death at 100 µg/ml
dbacp07794 Longicalycinin A cyclic analogue 17 FSPFA Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 76.14% Cell death at 100 µg/ml
dbacp07795 Longicalycinin A linear analogue 18 FSPAG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 10.33 ± 0.0007 µg/ml
dbacp07796 Longicalycinin A linear analogue 18 FSPAG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 10.2 ± 0.0014 µg/ml
dbacp07797 Longicalycinin A linear analogue 18 FSPAG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 15.55% Cell death at 100 µg/ml
dbacp07798 Longicalycinin A linear analogue 18 FSPAG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer 56.51% Cell death at 100 µg/ml
dbacp07799 Longicalycinin A cyclic analogue 18 FSPAG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer IC50 = 9.68 ± 0.0014 µg/ml
dbacp07800 Longicalycinin A cyclic analogue 18 FSPAG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colorectal Cancer IC50 = 9.06 ± 0.0014 µg/ml
dbacp07801 Longicalycinin A cyclic analogue 18 FSPAG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HepG-2 Liver Cancer 46.58% Cell death at 100 µg/ml
dbacp07802 Longicalycinin A cyclic analogue 18 FSPAG Synthetic Analogue of Longicalycinin A Cyclization enhances apoptosis via lysosomes MTT assay HT-29 Colon Cancer 22.8% Cell death at 100 µg/ml
dbacp07859 HN-1 FALGAVTKLLPSLLCMITRKC Amolops hainanensis Apoptosis induction and immune activation MTT assay MCF-7 Breast Cancer IC50 = 6.9 μM
dbacp07860 HN-1 FALGAVTKLLPSLLCMITRKC Amolops hainanensis Apoptosis induction and immune activation MTT assay A-549 Lung Cancer Not Available
dbacp07861 HN-1 FALGAVTKLLPSLLCMITRKC Amolops hainanensis Apoptosis induction and immune activation MTT assay SGC-7901 Stomach Cancer Not Available
dbacp07862 HN-1 FALGAVTKLLPSLLCMITRKC Amolops hainanensis Apoptosis induction and immune activation MTT assay MDA-MB-453 Breast Cancer Not Available
dbacp07863 HN-1 FALGAVTKLLPSLLCMITRKC Amolops hainanensis Apoptosis induction and immune activation MTT assay PC-3 Prostate Cancer Not Available
dbacp07864 HN-1 FALGAVTKLLPSLLCMITRKC Amolops hainanensis Apoptosis induction and immune activation MTT assay 4T1 Breast Cancer Not Available
dbacp07879 Nubein6.8 LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN Naja nubiae DNA damage and apoptosis induction MTT assay A-375 Skin Cancer EC50 = 0.54 ± 0.04 μM
dbacp07880 Nubein6.8 LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN Naja nubiae DNA damage and apoptosis induction MTT assay A-2780 Ovarian Cancer EC50 = 1.249 ± 0.06 μM
dbacp07881 Nubein6.8 LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN Naja nubiae DNA damage and apoptosis induction MTT assay PANC-1 Pancreatic Cancer slight toxicity above 3.7 μM
dbacp07889 H-58 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 0.62 ± 0.12 μM
dbacp07890 H-58 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 1.29 ± 0.08 μM
dbacp07891 H-58 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 2.13 ± 0.07 μM
dbacp07892 H-57 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 0.62 ± 0.12 μM
dbacp07893 H-57 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 1.29 ± 0.08 μM
dbacp07894 H-57 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 2.13 ± 0.07 μM
dbacp07895 H-18 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 0.89 ± 0.21 μM
dbacp07896 H-18 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 1.11 ± 0.21 μM
dbacp07897 H-18 IKLSKKTKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.61 ± 0.21 μM
dbacp07898 H-21 IKLSKS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 3.26 ± 0.36 μM
dbacp07899 H-21 IKLSKS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 3.05 ± 0.21 μM
dbacp07900 H-21 IKLSKS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.50 ± 0.28 μM
dbacp07901 H-20 IKLSPS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 2.10 ± 0.32 μM
dbacp07902 H-20 IKLSPS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 2.63 ± 0.35 μM
dbacp07903 H-20 IKLSPS5TKKS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 4.93 ± 0.53 μM
dbacp07904 H-19 IKLSKETKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 1.00 ± 0.36 μM
dbacp07905 H-19 IKLSKETKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 1.78 ± 0.35 μM
dbacp07906 H-19 IKLSKETKKNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.64 ± 0.36 μM
dbacp07907 H-17 IKLSKS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 0.96 ± 0.33 μM
dbacp07908 H-17 IKLSKS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 1.49 ± 0.45 μM
dbacp07909 H-17 IKLSKS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.64 ± 0.47 μM
dbacp07910 H-16 IKLSPS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 1.85 ± 0.31 μM
dbacp07911 H-16 IKLSPS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 2.65 ± 0.35 μM
dbacp07912 H-16 IKLSPS5TKKS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 3.14 ± 0.46 μM
dbacp07913 H-15 IKLSKS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 2.26 ± 0.24 μM
dbacp07914 H-15 IKLSKS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 2.95 ± 0.25 μM
dbacp07915 H-15 IKLSKS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 2.20 ± 0.27 μM
dbacp07916 H-10 IKLSPS5TKDS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 3.59 ± 0.12 μM
dbacp07917 H-10 IKLSPS5TKDS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 3.51 ± 0.37 μM
dbacp07918 H-10 IKLSPS5TKDS5LKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.50 ± 0.21 μM
dbacp07919 H-5 IKLSPETKDNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 7.35 ± 0.22 μM
dbacp07920 H-5 IKLSPETKDNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 4.16 ± 0.21 μM
dbacp07921 H-5 IKLSPETKDNLKKVLKGS5IKGS5IAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 2.82 ± 0.23 μM
dbacp07922 H-2 IKLSPS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay A-549 Lung Cancer IC50 = 4.26 ± 0.52 μM
dbacp07923 H-2 IKLSPS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HCT-116 Colon Cancer IC50 = 3.54 ± 0.72 μM
dbacp07924 H-2 IKLSPS5TKDS5LKKVLKGAIKGAIAVAKMV Synthetic Cell entry, DNA damage, apoptosis. MTT assay HepG-2 Liver Cancer IC50 = 1.60 ± 0.24 μM
dbacp07925 oligopeptide 1 AGAPGG Sarcophyton glaucum Selective cytotoxicity, DNA damage, apoptosis MTT assay HeLa Cervical Cancer EC50 = 8.6 mmol/L
dbacp07926 Phylloseptin-PBa3 FLSLIPHIVSGVAALANHL Phyllomedusa burmeisteri Membrane disruption, apoptosis, selective cytotoxicity MTT assay MDA-MB-435S Breast Cancer IC50 = 208 µM
dbacp07927 Phylloseptin-PBa3 FLSLIPHIVSGVAALANHL Phyllomedusa burmeisteri Membrane disruption, apoptosis, selective cytotoxicity MTT assay H-838 Lung Cancer Cell viability ~ 65% at 10-5 M
dbacp07928 B11 RIRDAIAHGYIVDKV Litopenaeus vannamei hemocyanin-derived peptide Mitochondrial dysfunction, caspase-dependent apoptosis MTS assay HeLa Cervical Cancer Decreased cell viability by 20% at 50 μg/mL
dbacp07929 B11 RIRDAIAHGYIVDKV Litopenaeus vannamei hemocyanin-derived peptide Mitochondrial dysfunction, caspase-dependent apoptosis MTS assay HepG-2 Liver Cancer Decreased cell viability by 23% at 50 μg/mL
dbacp07930 B11 RIRDAIAHGYIVDKV Litopenaeus vannamei hemocyanin-derived peptide Mitochondrial dysfunction, caspase-dependent apoptosis MTS assay EC-109 Esophageal Cancer Decreased cell viability by 13% at 50 μg/mL
dbacp07931 myristoyl-CM4 GRWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI Bombyx mori Cell penetration, Mitochondrial dysfunction, Apoptosis pathway activation MTT assay MCF-7 Breast cancer IC50 = 6 μM
dbacp07932 myristoyl-CM4 GRWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI Bombyx mori Enhanced binding, mitochondrial dysfunction, apoptosis MTT assay MDA-MB-231 Breast cancer IC50 = 4 μM
dbacp07933 myristoyl-CM4 GRWKIFKKIEKVGQNIRDGIVKAGPAVAVVGQAATI Bombyx mori Enhanced binding, mitochondrial dysfunction, apoptosis MTT assay MX-1 Breast cancer IC50 = 3 μM
dbacp07934 LyeTx-I-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Membrane disruption, necroptosis, limited apoptosis MTT/Resazurin dye assay U-87-MG Brain Tumor IC50 = 29.20 ± 7.96 µM
dbacp07935 LyeTx-I-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Membrane disruption, necroptosis, limited apoptosis MTT/Resazurin dye assay U-373-MG Brain Tumor IC50 = 20.94 ± 5.18 µM
dbacp07936 LyeTx-I-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Membrane disruption, necroptosis, limited apoptosis MTT/Resazurin dye assay SH-SY5Y Brain Tumor IC50 = 93.80 ± 2.17 µM
dbacp07937 Pantinin-1 GILGKLWEGFKSIV Synthetic Selective binding, membrane disruption, apoptosis MTS assay MDA-MB-231 Breast Cancer IC50 = 28.5 ± 1.0 µM
dbacp07938 Pantinin-1 GILGKLWEGFKSIV Synthetic Selective binding, membrane disruption, apoptosis MTS assay DU-145 Prostate Cancer IC50 = 47.5 ± 2.0 µM
dbacp07939 Pantinin-2 IFGAIWKGISSLL Synthetic Selective binding, membrane disruption, apoptosis MTS assay MDA-MB-231 Breast Cancer IC50 = 12.5 ± 1.0 µM
dbacp07940 Pantinin-2 IFGAIWKGISSLL Synthetic Selective binding, membrane disruption, apoptosis MTS assay DU-145 Prostate Cancer IC50 = 16.5 ± 1.0 µM
dbacp07941 Pantinin-3 FLSTIWNGIKSLL Synthetic Selective binding, membrane disruption, apoptosis MTS assay MDA-MB-231 Breast Cancer IC50 = 13.5 ± 2.0 µM
dbacp07942 Pantinin-3 FLSTIWNGIKSLL Synthetic Selective binding, membrane disruption, apoptosis MTS assay DU-145 Prostate Cancer IC50 = 17.3 ± 1.0 µM
dbacp07943 TC22 MTVVLLLIVLPLLGGVHSSGIL Tribolium castaneum ROS, p53, mitochondrial apoptosis activation MTT assay HeLa Cervical Cancer Fig 4a
dbacp07944 TC22 MTVVLLLIVLPLLGGVHSSGIL Tribolium castaneum ROS, p53, mitochondrial apoptosis activation MTT assay MCF-7 Breast Cancer Fig 4a
dbacp07951 S-24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Synthetic Analogue of Ranatuerin-2PLx R2PLx induces caspase-dependent apoptosis MTT assay PC-3 Prostate Cancer IC50 = 792.60 µM
dbacp07952 S-24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Synthetic Analogue of Ranatuerin-2PLx R2PLx induces caspase-dependent apoptosis MTT assay H-157 Lung Cancer IC50 = 58.18 µM
dbacp07953 S-24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Synthetic Analogue of Ranatuerin-2PLx R2PLx induces caspase-dependent apoptosis MTT assay MDA-MB-435S Skin Cancer IC50 = 179.00 µM
dbacp07954 S-24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Synthetic Analogue of Ranatuerin-2PLx R2PLx induces caspase-dependent apoptosis MTT assay U-251-MG Brain Tumor IC50 = 278.30 µM
dbacp07955 S-24-R2PLx GIMDTVKNAAKNLAGQLLDKLKCSITAC Synthetic Analogue of Ranatuerin-2PLx R2PLx induces caspase-dependent apoptosis MTT assay MCF-7 Breast Cancer IC50 = 316.90 µM
dbacp07985 R-C16 RGWFRAMRSIARFIARERLREHL R-Lycosin-I Fatty-acid modification enhances peptide apoptosis CCK-8 assay A-549 Lung Cancer IC50 ~ 5 µM
dbacp07986 SmacN7-Arg8 fused peptide P4 Ahx-AVPIAQK(KRRRRRRRRRE) Synthetic Apoptosis inducing Cell Titer Blue Cell Viability assay U-266 Skin Cancer Cell viability < 50% at 50 μM
dbacp07987 SmacN7-Arg8 fused peptide P5 Ahx-(KAVPIAQKE)RRRRRRRR Synthetic Apoptosis inducing Cell Titer Blue Cell Viability assay U-266 Skin Cancer Cell viability < 50% at 50 μM
dbacp07988 SmacN7-Arg8 fused peptide P7 Ahx-(KAVPIAQKE)GG(KRRRRRRRRE) Synthetic Apoptosis inducing Cell Titer Blue Cell Viability assay U-266 Skin Cancer Cell viability < 50% at 50 μM
dbacp08014 Ec-LDP-hBD1 MANCVVGYIGERCQYRDLKWWELRGGGGSGGGGSAPAFSVSPASGLSDGQSVSVSVSGAAAGETYYIAQCAPVGGQDACNPATATSFTTDASGAASFSFVVRKSYTGSTPEGTPVGSVDCATAACNLGAGNSGLDLGHVALTFGGGGGSGGGGSDHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCKLEHHHHHH Synthetic EGFR-targeted defensin induces mitochondrial apoptosis CCK-8 assay A-431 Skin Cancer IC50 = 1.8 μM
dbacp08015 Ec-LDP-hBD1 MANCVVGYIGERCQYRDLKWWELRGGGGSGGGGSAPAFSVSPASGLSDGQSVSVSVSGAAAGETYYIAQCAPVGGQDACNPATATSFTTDASGAASFSFVVRKSYTGSTPEGTPVGSVDCATAACNLGAGNSGLDLGHVALTFGGGGGSGGGGSDHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCKLEHHHHHH Synthetic EGFR-targeted defensin induces mitochondrial apoptosis CCK-8 assay A-549 Lung Cancer IC50 = 11.9 μM
dbacp08016 Ec-LDP-hBD1 MANCVVGYIGERCQYRDLKWWELRGGGGSGGGGSAPAFSVSPASGLSDGQSVSVSVSGAAAGETYYIAQCAPVGGQDACNPATATSFTTDASGAASFSFVVRKSYTGSTPEGTPVGSVDCATAACNLGAGNSGLDLGHVALTFGGGGGSGGGGSDHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCKLEHHHHHH Synthetic EGFR-targeted defensin induces mitochondrial apoptosis CCK-8 assay H-460 Lung Cancer IC50 = 5.19 μM
dbacp08017 Ec-LDP-hBD1 MANCVVGYIGERCQYRDLKWWELRGGGGSGGGGSAPAFSVSPASGLSDGQSVSVSVSGAAAGETYYIAQCAPVGGQDACNPATATSFTTDASGAASFSFVVRKSYTGSTPEGTPVGSVDCATAACNLGAGNSGLDLGHVALTFGGGGGSGGGGSDHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCKLEHHHHHH Synthetic EGFR-targeted defensin induces mitochondrial apoptosis CCK-8 assay PG-BE1 Lung Cancer IC50 = 31.3 μM
dbacp08089 B1 KKLFKKILKYLK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562 Leukemia Cancer IC50 = 17.9 ± 1.4 μM
dbacp08090 B1 KKLFKKILKYLK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7 Breast Cancer IC50 = 15.7 ± 1.5 μM
dbacp08091 B1 KKLFKKILKYLK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7/ADM Breast Cancer IC50 = 18.2 ± 1.3 μM
dbacp08092 B1 KKLFKKILKYLK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562/ADM Leukemia Cancer IC50 = 19.1 ± 2.1 μM
dbacp08093 B2 KKLFKKILKYLKK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562 Leukemia Cancer IC50 = 33.6 ± 4.2 μM
dbacp08094 B2 KKLFKKILKYLKK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7 Breast Cancer IC50 = 30.8 ± 3.4 μM
dbacp08095 B2 KKLFKKILKYLKK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7/ADM Breast Cancer IC50 = 36.1 ± 6.7 μM
dbacp08096 B2 KKLFKKILKYLKK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562/ADM Leukemia Cancer IC50 = 39.6 ± 5.7 μM
dbacp08097 B3 KKLFKKILKYLKKL Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562 Leukemia Cancer IC50 = 47.4 ± 12.5 μM
dbacp08098 B3 KKLFKKILKYLKKL Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7 Breast Cancer IC50 = 25.3 ± 3.2 μM
dbacp08099 B3 KKLFKKILKYLKKL Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7/ADM Breast Cancer IC50 = 28.4 ± 3.1 μM
dbacp08100 B5 LKKLFKKILKYLK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562 Leukemia Cancer IC50 = 26.5 ± 1.5 μM
dbacp08101 B5 LKKLFKKILKYLK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7 Breast Cancer IC50 = 27.3 ± 2.4 μM
dbacp08102 B5 LKKLFKKILKYLK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7/ADM Breast Cancer IC50 = 28.2 ± 2.7 μM
dbacp08103 B5 LKKLFKKILKYLK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562/ADM Leukemia Cancer IC50 = 28.3 ± 2.3 μM
dbacp08104 B6 LKKLFKKILKYLKK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562 Leukemia Cancer IC50 = 19.2 ± 2.3 μM
dbacp08105 B6 LKKLFKKILKYLKK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7 Breast Cancer IC50 = 18.4 ± 1.5 μM
dbacp08106 B6 LKKLFKKILKYLKK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7/ADM Breast Cancer IC50 = 20.7 ± 1.6 μM
dbacp08107 B6 LKKLFKKILKYLKK Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562/ADM Leukemia Cancer IC50 = 22.7 ± 2.3 μM
dbacp08108 B9 KLKKLFKKILKY Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562 Leukemia Cancer IC50 = 60.7 ± 5.4 μM
dbacp08109 B9 KLKKLFKKILKY Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7 Breast Cancer IC50 = 38.3 ± 2.5 μM
dbacp08110 B9 KLKKLFKKILKY Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay MCF-7/ADM Breast Cancer IC50 = 30.6 ± 5.7 μM
dbacp08111 B9 KLKKLFKKILKY Analogue of BP 100 Membrane disruption triggers apoptosis MTT assay K-562/ADM Leukemia Cancer IC50 = 83.7 ± 5.3 μM
dbacp08112 FR-15 FRRFFKWFRRFFKFF Synthetic Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 3.15 μM
dbacp08113 FR-15 FRRFFKWFRRFFKFF Synthetic Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 4.9 μM
dbacp08114 FR-15 FRRFFKWFRRFFKFF Synthetic Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 6.7 μM
dbacp08115 FR-15 FRRFFKWFRRFFKFF Synthetic Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 2.5 μM
dbacp08116 FR4P FRRPFKWFRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 6.3 μM
dbacp08117 FR4P FRRPFKWFRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 7.7 μM
dbacp08118 FR4P FRRPFKWFRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 9.4 μM
dbacp08119 FR4P FRRPFKWFRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 2.5 μM
dbacp08120 FR8P FRRFFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 6.4 μM
dbacp08121 FR8P FRRFFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 10.5 μM
dbacp08122 FR8P FRRFFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 10.8 μM
dbacp08123 FR8P FRRFFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 4.2 μM
dbacp08124 FR11P FRRFFKWFRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 7 μM
dbacp08125 FR11P FRRFFKWFRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 11 μM
dbacp08126 FR11P FRRFFKWFRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 12.9 μM
dbacp08127 FR11P FRRFFKWFRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 4.8 μM
dbacp08128 FR4,8P FRRPFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 15.4 μM
dbacp08129 FR4,8P FRRPFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 13.8 μM
dbacp08130 FR4,8P FRRPFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 15.3 μM
dbacp08131 FR4,8P FRRPFKWPRRFFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 5 μM
dbacp08132 FR8,11P FRRFFKWPRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay MDA-MB-231 Breast Cancer IC50 = 27 μM
dbacp08133 FR8,11P FRRFFKWPRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HeLa Cervical Cancer IC50 = 18.9 μM
dbacp08134 FR8,11P FRRFFKWPRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay DLD-1 Colon Cancer IC50 = 22 μM
dbacp08135 FR8,11P FRRFFKWPRRPFKFF Analogue of FR-15 Proline-substituted AMP triggers mitochondrial apoptosis MTT assay HepG-2 Liver Cancer IC50 = 15 μM
dbacp08136 Laterosporulin10 (LS10) ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEGGPCQL Brevibacillus sp. strain SKDU10 Apoptosis inducing MTT assay MCF-7 Breast Cancer 40% cytotoxicity at 5 μM concentration
dbacp08137 Laterosporulin10 (LS10) ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEGGPCQL Brevibacillus sp. strain SKDU10 Apoptosis inducing LDH leakage assay MCF-7 Breast Cancer >80% LDH release at 15 μM
dbacp08138 Laterosporulin10 (LS10) ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEGGPCQL Brevibacillus sp. strain SKDU10 Apoptosis inducing MTT assay HEK-293T Renal Cancer 20% cytotoxicity 5 μM concentration
dbacp08139 Laterosporulin10 (LS10) ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEGGPCQL Brevibacillus sp. strain SKDU10 Apoptosis inducing MTT assay HT-1080 Fibrosarcoma 20% cytotoxicity 5 μM concentration
dbacp08140 Laterosporulin10 (LS10) ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEGGPCQL Brevibacillus sp. strain SKDU10 Apoptosis inducing MTT assay HeLa Cervical Cancer 20% cytotoxicity 5 μM concentration
dbacp08141 Laterosporulin10 (LS10) ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEGGPCQL Brevibacillus sp. strain SKDU10 Apoptosis inducing LDH leakage assay HeLa Cervical Cancer ~80% LDH release at 15 μM
dbacp08142 Laterosporulin10 (LS10) ACVNQCPDAIDRFIVKDKGCHGVEKKYYKQVYVACMNGQHLYCRTEGGPCQL Brevibacillus sp. strain SKDU10 Apoptosis inducing MTT assay H-1299 Lung Cancer 80% cytotoxicity 10 μM concentration
dbacp08143 MccJ25-18-4 GGAGHVPEYFVGIGTPISFYG-WxEAAYQrFL Synthetic Apoptosis inducing MTT assay MCF-7 Breast Cancer IC50 = 14.2 ± 1.5 μM
dbacp08144 MccJ25-18-4 GGAGHVPEYFVGIGTPISFYG-WxEAAYQrFL Synthetic Apoptosis inducing MTT assay MDA-MB-435 Breast Cancer IC50 = 20.0 ± 0.5 μM
dbacp08145 MccJ25-18-4 GGAGHVPEYFVGIGTPISFYG-WxEAAYQrFL Synthetic Apoptosis inducing MTT assay MDA-MB-435-MDR Breast Cancer IC50 = 25.0 ± 0.5 μM
dbacp08146 LfcinB-P13 KCRRWLKRMKKLG Synthetic analog of LFcinB LfcinB-P13 induces liver cancer apoptosis MTT assay SMMC-7721 Liver Cancer IC50 = 41.8 µg/ml
dbacp08253 Cecropin XJ APEPRWKIFKKIEKMGRNIRDGIVKAGPAIEVLGSAKAIGK Larvae of Bombyx mori CecropinXJ induces apoptosis in HCC MTT assay Huh-7 Liver Cancer Cell viability = 50% at 50 µmol/l